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Abstract 
In this thesis, a novel sequential genes selection and classification (k-SS) method is 
proposed. The method is analogous to the classical non-linear stepwise variable 
selection (SVS) methods but unlike any of the SVS methods, this new method uses 
the misclassification error rates (MERs) as its search criteria for informative marker 
genes in any given microarray data. Here, the importance of any selected gene is 
determined based on its marginal contribution at improving the prediction accuracy 
of the classification rule. This method ensures continuous selection of more genes in 
as much as the improvements brought into the decision models by the selected genes 
are considered to be significant enough by some established test criteria. However, 
further gene selection terminates when none of the remaining genes is capable at 
improving the prediction accuracy (lowering the MER) of the current model. 
Therefore, our approach only seeks to select the best combination of ݇ marker genes 
that are most predictive of the biological samples in any given microarray data sets.   
An important feature of our new ݇-SS method is that the size ߙ used by its test is not 
arbitrarily fixed by the user as common to some of the classical SVS methods. 
Rather, the value of ߙ at which the best prediction accuracy is achieved (or the best 
combination of genes is selected) is determined by cross-validation. 
The new k-SS classifier competes favourably with selected eight existing 
classification methods using eleven published microarray data sets. The k-SS 
classifier is very simple to apply and does not require any rigid assumption for its 
implementation. Another merit of this method lies in its ability to select only those 
genes that are of biological relevance to the existing cancer sub-groups in microarray 
data sets. 
Lastly, we proposed a new preliminary feature selection procedure that employs the 
cross-validated area under the ROC curve (CVAUC) for gene selection. This method 
is capable at removing all the irrelevant genes at the preliminary selection stage 
before any standard classifier like the k-SS method is employed on the remaining 
data set for final optimum gene selection and classification of mRNA samples. Unlike 
some other data pruning methods, the new method employs the sub-sampling 
technique of the ݒ-fold cross-validation to ensure consistency and efficiency of 
selections made at the preliminary selection stage. 
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Zusammenfassung 
In dieser Arbeit wird eine neuartige sequentielle Geneselection und klassifikation (k-SS) 
vorgeschlagen. Die Methodik verhält sich analog zu nichtlinearen schrittweisen 
Variablenselektionmethoden (SVS). Im Gegensatz zu diesen benützt die neue Methode 
die Fehlklassifikationsrate (MER) als Suchkriterium für informative Marker-Gene in 
beliebigen microarray Datensätzen. Hierbei wird die Wichtigkeit eines Genes durch 
seinen marginalen Beitrag zur Verbesserung der Vorhersagegüte einer 
Klassifikationsregel bestimmt. Die Methode gewährleistet eine fortwährende Selektion 
weiterer Gene solange die Verbesserungen der Entscheidungsmodelle durch die 
ausgewählten Gene durch ein ebenfalls eingeführtes Testkriterium als signifikant genug 
erachtet werden. Indes endet die weitere Geneselektion sobald keines der verbleibenden 
Gene geeignet ist die Vorhersagegüte im aktuellen Modell zu verbessern bzw. die MER 
zu vermindern. Deshalb ist die Bestrebung unseres Ansatzes die beste Kombination aus k 
Marker-Genen, die am prädiktivsten für biologische Proben in beliebigen microarray 
Datensätzen sind zu selektieren. 
Eine wichtige Eigenschaft unserer neuartigen k-SS Methode ist dass das Maß ߙ, dass in 
ihrem Test benützt wird nicht eigenmächtig durch den Anwender bestimmt wird wie 
allgemein in klassischen SVS Methoden. Vielmehr wird der Wert von ߙ, bei dem die beste 
Vorhersagegüte erlangt wird (oder die beste Kombination von Genen selektiert wird) 
durch Kreuzvalidierung bestimmt. 
Der neue k-SS Klassifizierer konkurriert erfolgreich mit acht ausgewählten 
Klassifizierungsmethoden unter Verwendung von elf publizierten microarray 
Datensätzen. Der k-SS Klassifizierer ist sehr einfach anzuwenden und benötigt keine 
rigiden Annahmen für seine Durchführung. Ein weiterer Vorzug dieser Methode liegt in 
seiner Fähigkeit nur solche Gene zu selektieren, die von biologischer Relevanz bezüglich 
existierender Tumoruntergruppen in microarray Datensätzen sind. 
Letztlich schlagen wir eine neue vorausgehende Variablenselektionsprozedur vor, die die 
kreuzvalidierte Fläche unter der ROC-Kurve (CVAUC) für die Genselektion benützt. 
Diese Methode ist fähig alle irrelevanten Gene in einem vorausgehenden 
Selektionsschritt zu entfernen, bevor klassische Klassifizierer wie die k-SS Methode auf 
dem verbleibenden Datensatz zur abschließenden, optimalen Genselektion und 
Klassifikation von mRNA-Proben angewendet werden. Ungleich einigen anderen pruning 
Methoden verwendet die neue Methode die ݒ-fache Kreuzvalidierung als Methode zur 
wiederholten Stichprobenteilung um Konsistenz und Effizienz der Selektion zu einem 
vorausgehenden Selektionspunkt zu gewährleisten. 
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Preamble  
A common problem in most of the microarray (cancer) studies is how to identify 
and select, among several available thousands, the most informative marker 
genes whose expression levels are predictive of clinical or other outcomes of 
interest. A major constraint however, is that the expression levels of all these 
genes are often collected on relatively few samples which makes the use of 
classical regression methods inappropriate for genes selection and prediction of 
biological samples. Several methods have been proposed in the literature to 
handle this task, but unfortunately, apart from procedural complexities, some of 
these methods like Partial least squares, Principal component analysis and the 
like only provide accurate classifiers that are often difficult to interpret. In this 
thesis therefore, we provide a novel but simple sequential selection procedure              
(݇-Sequential Selection (݇-SS) method) that efficiently selects from several 
thousand transcripts, the most informative ݇ genes that are suitable for the 
prediction of biological samples. The ݇-SS procedure adopts the performance 
index of the average misclassification error rates (MERs) as its gene selection 
criteria.  
The performance of the new method was evaluated and compared with eight 
existing standard classification methods (Support vector machines, k-nearest 
neighbours, Partial least squares, Prediction analysis for microarray, Decision 
trees, Naïve bayes, Top scoring pair, k-Top scoring pair) using eleven different 
microarray cancer data sets ten of which are publicly available. The eleventh 
data set is based on microarray cancer study of 43 patients with locally advanced 
rectal carcinomas (LARC) from whom 24,026 human genome U133 plus 2.0 gene-
chip arrays were generated. The clinical study was carried out in the Department 
of Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, 
Germany.  
 Several results from this work showed that the new ݇-SS method performs 
efficiently well like any of the existing methods considered. In addition to this, 
this new approach provides stable and easily interpretable classifiers (genes) that 
seems to be of biological relevance to the sub-classes of tumour that are present 
in any given microarray data set. This obviously meets the expectations of the 
biologists and physicians who are not only interested in the classification of the 
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mRNA samples into their various tumour types but also want to know the 
relevant informative genes that induced such classification. In addition, the ݇-SS 
method is generally simple and requires no stringent conditions for its 
implementation as common to some of the existing methods. 
Since a typical microarray data set usually contains expression measures of both 
relevant and irrelevant transcripts, it has therefore become a usual practice in 
many microarray studies to primarily reduce the whole gene data to a 
manageable size of all the potentially relevant genes. This is usually done to save 
computation time and efforts. To this end, we proposed another new preliminary 
feature selection procedure that employs the cross-validated estimates of the 
area under the ROC curve of each observed gene for selection. This method, as a 
classifier-like method, improves on some of the existing methods like the t-
statistic procedure for being capable of removing from microarray data set, only 
those genes that are absolutely non-predictive of the biological sub-groups of the 
mRNA samples. This method eliminates the risk of possible exclusion of some of 
the important genes at the preliminary selection stage before any standard gene 
selection and prediction method, like k-SS, could be employed on the 
preliminarily selected genes for further analysis. The application of the new 
preliminary feature selection procedure was also demonstrated using some of the 
microarray data sets considered in this work. 
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1 Background into Microarray studies 
1.1  Introduction 
A gene is a unit of deoxyribonucleic acid (DNA) that occupies a spot 
on a chromosome and helps to determine a trait in an organism. 
Genes are passed on from parents to child and constitute important 
part of what determines physical appearance and behaviour of an 
individual. The total amount of genes carried by individual living 
organism is called genome which in turn defines the genetic 
construction of the organism called genotype. 
The existence of genes was first discovered by Gregor Mendel (1822-
1884), who, in the 1860s, studied inheritance in pea plants and 
discovered a factor that conveys traits from parent to offspring. His 
various works were reported by Olby (1979).  
Following Mendel’s line of argument is Herman J. Muller (1951) who 
claimed that genes are fundamentally endowed with two basic 
properties: autocatalysis that allowed the genes to reproduce as 
units of transmission that connected the genotype of one generation 
to that of the next and heterocatalysis which connected the genes to 
the phenotype, as units involved in the expression of a particular 
character.  
Several studies have however shown that thousands of these genes 
and their products (ribonucleic acid, proteins, etc.) are functioning in 
a complicated and orchestrated way in any living organisms which 
at times creates some mystery of life. The earlier traditional 
approach of studying one gene per experiment using radioactive 
detection reagents had made it difficult to understand the whole 
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functioning processes of several thousands of genes most of which 
are interconnected.  
Over the past few years, a new technology called DNA microarray or 
simply, microarray technology (MT) as it is often referred, Burnside 
et al (2008), was developed. This has made it possible to monitor and 
measure the expression levels of several thousands of genes 
simultaneously. By this, better understanding of the inherent 
relationships among various genes is accomplished.  
The gene expression is the process by which messenger ribonucleic 
acid (mRNA) and protein are synthesised from the DNA template of 
each gene. The DNA is a nucleic acid that contains the genetic 
instructions used in the development and functioning of living 
organisms. Ribonucleic acid (RNA) on the other hand is a nucleic 
acid made from a long chain of nucleotide and structurally differs 
from DNA. While DNA contains deoxyribose and is double stranded, 
RNA contains ribose sugar and is single stranded. Messenger RNA 
(mRNA) is the RNA that carries information from DNA to the 
ribosomes which again translate the information they carry into 
proteins. Further details about the structural form of these two 
molecules can be found in Salazar et al (1993), Mikkola et al (1999), 
Hermann & Patel (2000), Cooper & Hausman (2004) and in many 
other related works. 
The advent of modern methods into microarray profiling and 
sequencing has made it easy to generate several volumes of 
complimentary DNA (cDNA) through reverse transcription of 
mRNAs. It is then easy to measure the activity of thousands of genes 
at once and creating a global picture of cellular function. MT 
method, like serial analysis of gene expression (SAGE or 
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SuperSAGE) is commonly adopted for gene expression profiling 
which has made it possible to identify the cells that are actively 
dividing based on their mRNA functions.  
Another important task after the generation of microarray data sets 
is to identify the genes that are differentially expressed (DE) within 
the mRNA samples. The DE genes are the group of genes that 
belong to the same functional class whose expression patterns are 
strong enough to classify any future mRNA samples with similar 
molecular features. Many statistical techniques have been proposed 
in many studies for proper classification of mRNA samples into their 
various biological sub-groups. A more flexible dimension reduction 
and response class prediction method is equally provided in this 
thesis. 
However, to analyse any experimental data correctly, it is 
fundamental to understand the experiment that generated such data 
set.  Therefore, in what follows, we provide some insights into the 
basic platforms upon which microarray data sets are usually 
developed. 
1.2 The cDNA and Affymetrix microarrays  
Microarray technology has provided us with a compelling approach 
that allows for simultaneous evaluation of all cellular processes at 
once. This has greatly assisted the process of identification of new 
molecular markers that could be useful in the diagnosis, prognosis, 
and prediction of different categories of cancers. However, there are 
several microarray technological platforms on which mRNA samples 
are processed. In all the platforms, oligonucleotide or cDNA probe 
sets are used for fabrication. 
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The common procedure especially in spotted microarray experiments 
is that, the DNA or oligonucleotide probes are synthesized prior to 
deposition on the array surface and are then robotically spotted onto 
glass. Thereafter, purified RNA samples are fluorescently or 
radioactively labelled and hybridized to the slide or membrane. In 
some cases, hybridization is done simultaneously with reference 
RNA to facilitate comparison of data across multiple experiments. 
After thorough washing, the raw data is obtained by laser scanning 
or autoradiographic imaging. At this point, the data are entered into 
a database and analyzed by a number of statistical methods. 
Oligonucleotide is a small chain of nucleic acid residues which are 
used to detect the presence of larger mRNA molecules.  
Oligonucleotide microarray is a type of microarray technology 
developed at Affymetrix, Inc., California, (Affymetrix, Inc; 2001a,b). 
Here, short oligonucleotide sequences (20~80-mers oligos) or peptide 
nucleic acid (PNA) probes are synthesized either in-situ (on-chip) or 
by conventional synthesis onto the array surface followed by on-chip 
immobilization.  
A particular technique due to Pease et al (1994) is sometimes used to 
produce oligonucleotide arrays. In this method, photolithographic 
synthesis (Agilent and Affymetrix) is performed on a silica substrate 
where light and light-sensitive masking agents are used to build a 
sequence one nucleotide at a time across the entire array. 
In spotted complementary DNA (cDNA), Two-colour or Two-channel 
microarrays are typically hybridized with cDNA prepared from two 
samples to be compared (e.g. diseased tissue & healthy tissue) and 
they are labelled with two different fluorophores, Shalon et al (1996). 
Fluorophores are molecules that have fluorescent properties. The 
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Fig 1.2: A typical two-colour spotted cDNA microarray experiment 
1.3 DNA microarrays in cancer research 
Cancer, sometimes called malignant neoplasm, is a complex disease 
in which a group of cells display certain traits of uncontrolled growth 
and invasion which may possibly spread (metastasize) to other parts 
of the body. Cancer can develop in any part of human body which 
eventually give rise to various kinds of cancer like lung, prostate, 
breast, renal, brain, gastric, rectal, colon, and head & neck cancers 
among others. 
Over the past few decades, classification and diagnosis of cancer 
patients are based on the examination of the organs where the 
tumour is developed. This often resulted into the exhaustive physical 
and histopathological assessments of the organs that harbour the 
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tumour. However, diagnoses are only achievable either through 
laboratory tests which might be too costly to bear or through surgical 
operations which might expose the patients to different kind of risks. 
In some instances, some of the test results, like autopsy can be 
available only after the passage of time, thus causing some delay 
before any diagnoses or cancer classification could be performed.   
Fortunately, the advent of DNA microarray technology in the recent 
past has introduced dramatic changes into cancer research. With 
this new technology, it is possible to simultaneously analyse the 
expressions of several thousands of genes at once and relate their 
expression patterns to clinical phenotypes, Lonning et al (2005).  By 
this, it is possible to identify molecular signatures whose expression 
patterns are capable of discriminating between infected (cancer) 
cells and uninfected (normal) cells. It is therefore easy to predict 
(diagnose) the prognostic stage (whether cancerous or normal) of all 
the cancer patients using the gene expression profiles without taken 
them through the rigour of expensive laboratory tests or surgery.   
Due to high dimensional nature of microarray data typically with ݍ 
genes and ݊ biological samples, ݊ ا ݍ, many supervised and 
unsupervised methods have been developed to handle dimension 
reduction, patterns recognition as well as prediction of biological 
samples using gene expression data.  
The use of gene expression profiles for cancer diagnoses has been the 
major focus in many microarray studies. One of the most highly 
referred studies in this area is that of Golub et al (1999).   In their 
study, the expression levels of 7129 Affymetrix gene chips generated 
on 72 human acute leukemia tumour subjects were used to classify 
the subjects into two sub-types of leukemia: acute myeloid leukemia 
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(AML) and acute lymphoblastic leukemia (ALL). An unsupervised 
class discovery method was used to identify these two classes of 
leukemia without a priori knowledge of the subjects’ prognostic 
status. The use of gene expression data for class discovery and class 
prediction was firmly established in this work. 
In a related study, Alizadeh et al (2000) used DNA microarrays to 
conduct a systematic characterization of gene expression in B-cell 
malignancies. The expression patterns of patients with diffuse large 
B-cell lymphoma (DLBCL) were studied. Hierarchical clustering 
with average linkage search was used on the gene expression 
patterns of 88 biological samples to identify two previously 
unidentified molecularly distinct forms of DLBCL (germinal centre 
B-like DLBCL and in vitro activated peripheral blood B-like DLBCL) 
which had gene expression patterns indicative of different stages of 
B-cell differentiation. They equally demonstrated that patients with 
the two sub-groups of tumour are susceptible to different clinical 
outcomes. Bhattacharjee et al (2001) also used hierarchical 
clustering method on expression patterns of lung cancer patients to 
identify patients with various kind of this cancer type that are 
characterized by different prognostic outcomes.  
Also, Bittner et al (2000) used hierarchical clustering on gene 
expression profiles of 31 melanomas biological samples to discover 
identical cluster of 19 melanomas that had similar gene expression 
patterns. In another study, Pomeroy et al (2002) applied some 
supervised and unsupervised methods on Affymetrix oligonucleotide 
microarrays to distinguish between new and existing sub-classes of 
embryonic tumours of the central nervous system (CNS) using gene 
expression patterns.   
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In hereditary breast cancer studies, Hedenfalk et al (2001) used the 
gene expression profiles of breast cancer patients to identify 176 
genes that are capable to discriminate patients with sub-types of 
breast cancer tumours: i.e. tumour with BRCA1 mutations and 
tumour with BRC2 mutations. 
As application in survival studies, Nguyen & Rocke (2002c) used 
partial least square (PLS) components constructed from gene 
expression patterns of patients with locally advanced breast 
carcinomas as predictors in proportional hazard (PH) regression 
model to predict patients’ survival outcomes.  
A good number of classification methods have been proposed in the 
literature to properly classify biological samples into their respective 
tumour types using their gene expression profiles. The most 
commonly used ones include the linear discriminant analysis (Lee, 
2004; Ye et al, 2004; Hastie et al, 2009), classification and regression 
trees (Zhang et al, 2001 & 2003), logistic discriminant analysis (Ding 
& Gentleman, 2004), ݇-nearest neighbours (Fix & Hodges, 1951; 
Cover & Hart, 1967; Giordano et al, 2001; Baoli et al, 2003), support 
vector machines (Vapnik, 1998; Christianini & Shawe-Taylor, 2000; 
Bennett & Campbell, 2000; Furey et al , 2000;  Peng et al, 2003; Liu 
et al, 2005; Chu & Wang, 2005), artificial neural networks (Hertz et 
al, 1991; Ripley, 1996; Khan et al, 2001; Bicciato et al, 2003; Hastie 
et al, 2009), boosting (Dettling & Buhlmann, 2003) and bagging 
(Dudoit & Fridlyand, 2003) among others. 
The various microarray studies highlighted above are just a few 
instances among several thousands of studies hitherto being 
undertaken by many scientists all over the world. While some of the 
methods adopted are relatively simple to apply, a good number of 
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them are characterized by rigorous procedural complexities. 
Nonetheless, the ever-increasing challenges in microarrays 
technology have made it imperative on the scientists to continuously 
thinking and developing more concise techniques that are suitable to 
address fundamental questions which often accompany new 
discoveries in genes expression profiling on daily basis.    
Most of the studies discussed so far focused on proper classification 
or prediction of biological samples into difference cancer sub-classes. 
Another important aspect of microarray studies is the selection of 
the marker genes that characterized different tumour classes and 
responsible for the identification, prediction or diagnosis of various 
sub-groups of cancers. Some of the classification methods combined 
feature selection with class prediction while some of them only 
perform classification of biological samples into their various tumour 
categories. However, the huge numbers of data sets generated by 
microarray experiments have raised a lot of methodological and 
computational challenges in the analysis of high-dimensional 
genomic data. 
1.4  Prior to dimension reduction and class prediction 
In analysing microarray data, a number of preliminary steps need to 
be taken before getting to the real dimension reduction and response 
class prediction. We discuss the major two of such steps which 
centres on data normalization and preliminary gene selection. 
1.4.1 Data normalization 
In microarray studies, normalization is the process of identifying 
and removing the effects of systematic variations other than the 
biological differences in the measured fluorescence intensities of 
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genes across the hybridized mRNA samples. It refers to a set of data 
pre-processing steps often employed to eliminate the influence of 
non-biological variations that might unavoidably be present in 
microarray data sets, so that differential expressions in genes can be 
truly identified.  
Within the purview of cDNA microarray experiment, the expression 
level of each gene is measured by the ratio of two fluorescent dyes, 
Cy3 and Cy5 over the mRNA samples. Variations in print-tip, 
labelling efficiencies, spatial and hybridization specific effects, and 
several other scanning properties of Cy3 and Cy5 may introduce a 
lot of systematic variations into the observed fluorescence 
intensities.  As a result, the actual biological differences (differential 
expression) inherent in a set of genes might be clouded by the effects 
of all the extraneous variations which may eventually lead to wrong 
biological decisions. Hence, the need to free microarray data sets 
from all these noises. 
In a loose term, the process of normalizing the ݊ ൈ ݍ matrix of 
microarray data set with ݊ arrays and vector ࢄ ൌ ሺ ଵܺ, … , ܺ௤ሻ of ݍ 
genes can be viewed as transforming all the expression patterns ௜ܺ௝ 
of ݆௧௛ gene across the ݊ mRNA samples by 
      ܼ௜௝ ൌ ݄൫ ௜ܺ௝൯ െ
ଵ
௡כא ௡,௤
∑ ݄ሺ ௟ܺሻ௟א௜,௝       (1.4.1) 
where ݄ሺ. ሻ represents the monotonically increasing Box-Cox family 
of transformations of ௜ܺ௝ given by  
    ݄൫ ௜ܺ௝൯ ൌ  
௑೔ೕ೘ିଵ
௠
        (1.4.2) 
for some constant ݉ ൐ 0. Here, ݄൫ ௜ܺ௝൯ ൌ ௜ܺ௝ if ݉ ൌ 1, indicating no 
transformation except for shift in location, and ݄൫ ௜ܺ௝൯ becomes the 
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square root transformation of ௜ܺ௝ if ݉ ൌ 1/2 while it tends to the 
logarithm transformation as ݉ ՜ 0. However, the gene expression 
patterns ௜ܺ௝ reported in most microarray data sets are already the 
log of the fluorescent ratios which might not require further log 
transformation. 
Literally by (1.4.1), gene normalization across the arrays is 
performed by subtracting the mean expression levels of each gene 
from its expression level for each array while normalization across 
the ݍ genes is performed by subtracting the mean expression levels 
of all the genes for each array from their respective individual 
expression levels. 
Apart from the general normalization form given by (1.4.1), several 
other forms of normalization have been proposed to further improve 
the quality of microarray data before analysis could begin. Three of 
these approaches are discussed below. 
i) Intensity-dependent normalization 
Yang et al (2002) suggested the use of intensity-dependent 
normalization which is based on the locally weighted regression 
(LOWESS)(Cleveland, 1979; 1981) smoothing of the MA-plot. Let 
௜ܺ௝
ீ  and ௜ܺ௝ோ  denote the green and red intensities of expressions of 
gene ݆ on ݅ mRNA samples, ݅ ൌ 1, … , ݊, ݆ ൌ 1, … , ݍ, as observed 
from the fluorescent dyes, Cy3 and Cy5 respectively. What is 
often reported as the gene expressions are the ratios ௜ܺ௝ோ/ ௜ܺ௝ீ  or 
log-ratios ݈݋݃൫ ௜ܺ௝ோ/ ௜ܺ௝ீ൯ of the fluorescent dyes. Conventionally, we 
denote the log intensity ratios by  
ܯ ൌ ݈݋݃൫ ௜ܺ௝ோ/ ௜ܺ௝ீ൯ ൌ ݈݋݃ ௜ܺ௝ோ െ ݈݋݃ ௜ܺ௝ீ                (1.4.3) 
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     and the average log intensity of the two colours by  
   ܯ෩ ൌ ݈݋݃ට ௜ܺ௝ோ ൈ ௜ܺ௝ீ ൌ
ଵ
ଶ
൫݈݋݃ ௜ܺ௝ோ ൅ ݈݋݃ ௜ܺ௝ீ൯           (1.4.4) 
The plot of ܯ against ܯ෩ is call the MA-plot which gives a 450 
rotation and rescaling of the plot of ݈݋݃ ௜ܺ௝ோ  against ݈݋݃ ௜ܺ௝ீ , Dudoit 
et al (2002), Huber et al(2005). A fit of LOWESS function  ݈൫ܯ෩൯ of 
the average intensity ܯ෩ is then obtained and this is used to 
normalize ܯ by computing the difference ܯ െ ݈൫ܯ෩൯. Thus, the 
general normalization form in (1.4.1) becomes ܼ௜௝ ൌ ܯ െ ݈൫ܯ෩൯. 
This normalization type is design to remove extraneous colour 
effects that may be induced by different pin tips. More details 
about this approach could be found in Lee (2004), Huber et 
al(2002) and many other related studies. 
ii) Rank-Invariant genes normalization 
The rank-invariant method as proposed by Tseng et al (2001) as a 
non-linear normalization method considers a microarray 
experiment in which two differentially expressed specimens are 
separately labelled with green (Cy3) and red (Cy5) flours and co-
hybridized to the same slide. Unlike in the intensity-dependent 
normalization in which all the genes are used to determine 
normalization factor, here, a sub-set of genes that are biologically 
assumed not to be differentially expressed in the two specimens 
are selected for normalization.  Thus, a particular gene ௝ܺ is used 
for normalization if the ranks of its green and red intensities are 
similar up to a threshold value ݀ and the rank of its average 
intensities is not among the highest ݍ െ ݈ ranks or lowest ݈ ranks 
for any choosing constant ݍ and ݈. These statements are given by  
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    หܴܽ݊݇൫ ௝ܺோ൯ െ ܴܽ݊݇൫ ௝ܺீ൯ห ൏ ݀      (1.4.5) 
    ݈ ൏ ቤܴܽ݊݇ ቊ
ቀ௑ೕ
ೃቁାቀ௑ೕ
ಸቁ
ଶ
ቋቤ ൏ ݍ െ ݈      (1.4.6) 
iii) Global normalization 
Another widely adopted genes normalization approach is the 
global normalization method which uses analysis of variance 
(ANOVA) model introduced by Kerr et al (2000). This procedure 
assumes linear normalization factor and incorporates both main 
and/or interaction effects of these factors into the ANOVA models. 
The global normalization model is given by 
  ݈݋݃൫ ௜ܺ௖௧௝൯ ൌ ߤ ൅ ߙ௜ ൅ ߜ௖ ൅ ߬௧ ൅ ݍ௝ ൅ ሺߙݍሻ௜௝ ൅ ሺ߬ݍሻ௧௝ ൅ ߝ௜௖௧௝   (1.4.7) 
where ݈݋݃൫ ௜ܺ௖௧௝൯ is the logarithm of the gene expression measure 
of gene ݆ over cDNA array ݅, dye ܿ, and tissue sample type ݐ. 
Parameters ߤ is the overall population average log-expression 
(average signal), ߙ௜ represents the effect of ݅௧௛ array, ߜ௖ is the 
effect of ܿ௧௛ dye, ߬௧ is the effect of ݐ௧௛ tissue type, ݍ௝ is the effect of 
݆௧௛ gene, ሺߙݍሻ௜௝ is the interaction effect of ݅௧௛ array and ݆௧௛ gene, 
ሺ߬ݍሻ௧௝ is the interaction effect of ݐ௧௛ tissue type and ݆௧௛ gene while 
ߝ௜௖௧௝ is an independent and identically distributed error term. This 
approach has been employed in many other related studies (Lee et 
al, 200; Wolfinger et al, 2001; Lee, 2004; etc.).  
There are many other variants of normalization procedures apart 
from the three provided above (see Smyth et al, 2002; Smyth & 
Speed, 2003; Huber et al, 2003; Steinhoff & Vingron, 2006; etc.). The 
choice of any of the method depends on the nature of microarray 
data set being investigated. 
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A particular important aspect of normalization is data 
standardization. It is all about standardizing microarray data so 
that each array has zero mean and unit variance. It is a scale 
adjustment measure that prevents the expression measures in a 
particular array to dominate the overall average expression, Yang et 
al (2001).  
1.4.2   Preliminary feature selection  
A typical microarray data set is characterized by having several 
thousands of ݍ genes measured on relatively small number ݊ of 
biological samples with ݊ ൏ ݍ. Several experimental microarray 
studies (Botstein & Risch, 2003; Su et al, 2002; etc.) have revealed 
that very few numbers of these numerous genes are differentially 
expressed (DE) and might actually be relevant to the clinical status 
of the biological samples.  Therefore, our objective here is to perform 
a primary selection of potentially relevant ݍכgenes from all the 
available ݍ genes such that all the ݍ െ ݍכ non-predictive (irrelevant) 
genes are removed prior to proper analysis. The reasons for this are 
two-fold: One is to save a lot of computation time and efforts while 
analysing the data. If the ݍ െ ݍכ ‘useless’ genes are not removed 
before any dimension reduction and/or class prediction is performed, 
a good classifier will still filter them out during the analysis proper, 
but at a huge cost of analysis time. To avoid this therefore, it is 
proper to filter all the apparently irrelevant genes before proper 
analysis could begin. The second reason which is not too far from the 
first one is to minimize unnecessary ‘noise’ in the data before proper 
analysis could commence. In a nutshell, a good preliminary gene 
selection is expected to prevent undue influence of the irrelevant 
genes on prediction.  
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Among the preliminary feature selection methods commonly adopted 
in the literature are the p-value method (Golub et al, 1999), the 
Wilcoxon-Mann-Whitney rank sum test (Thomas et al, 2001), the 
student-t test or its equivalent; the Welch test (Nguyen & Rocke, 
2002a; Rimkus et al, 2008) and the Wilks’ lambda score (Dillon & 
Goldstein, 1984; Johnson & Wichern, 1992; Hwang et al, 2002) 
among others.  
Generally speaking, no single method can efficiently be suitable to 
handle all kinds of microarray data sets. The choice of method to 
adopt at times may depend on the nature of the data or the taste of 
the investigator. The common denominator is to ensure that the 
method adopted retains all the potential differentially expressed 
genes among the primarily selected ݍכ genes. 
We shall discuss the procedure of the student-t test as used in this 
thesis and later in Chapter 2, we propose another flexible classifier-
like preliminary feature selection method – the AUC feature 
selection method- which has not been given much attention in the 
literature. The reasons for this shall be provided later.  
It is intuitively reasonable to ask that, why seeking for further 
dimension reduction methods when some of the methods adopted for 
preliminary feature selection can perform similar function? The 
answers to this are two-folds. First, after the preliminary gene 
selection where ݍ െ ݍכ non-DE genes are pruned out, the remaining 
potentially relevant ݍכgenes selected might still be more than what 
is optimally suitable for good prediction. In other words, not all the 
preliminarily selected ݍכgenes would still be suitable for good 
classification of mRNA samples into their respective cancer sub-
classes. Hence, there is need to evolve a more robust method that 
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would further extract the most relevant and informative ݇ genes 
(݇ ൏ ݍכ) from the preliminarily selected ݍכ genes. The second but less 
important reason is that, the number of ݍכ genes selected might still 
be more than ݊, the number of biological samples. This would again 
render the use of any standard regression methods practically 
impossible for response class prediction due to the violation of non-
singularity condition of the design matrix of the predictors.  
Feature selection by Student-t statistic 
By Student-t statistic approach, each of the measured genes ௝ܺ, 
݆ ൌ 1, … , ݍ, are divided into two, ܺ଴௝ and ଵܺ௝ based on the response 
class categories ሺ0,1ሻ with corresponding sample sizes ݊଴ and ݊ଵ 
respectively. The equality of the group means തܺ଴௝ and തܺଵ௝ is 
examined via the t-statistic 
          ݐ௦ ൌ  
௑തభೕି௑തబೕ 
ඨቆ
ሺ೙బషభሻೄబ
మశሺ೙భషభሻೄభ
మ 
೙బశ೙భషమ
ቇൈቀ೙బశ೙భ೙బ೙భ
ቁ 
      (1.4.8) 
or its equivalent, the Welch test (Welch, 1947) that gives an 
approximate solution to Behrens-Fisher problem (correcting for 
unequal variances within each class) given by  
                                             ݐ௪ ൌ  
௑തభೕି௑തబೕ 
ඨೄబ
మ 
೙బ
ାೄభ
మ
೙భ
 
                                       (1.4.9)         
with modified degree of freedom   
    ݒ ൌ
ቆೄబ
మ 
೙బ
ାೄభ
మ
೙భ
ቇ
మ
ቆ
ೄబ
ర 
೙బ
మሺ೙బషభሻ
ା ೄభ
ర 
೙భ
మሺ೙భషభሻ
ቇ
 
where, for each gene ݆, തܺ௬௝, ܵ௬ଶ and ݊௬ is the mean, the variance and 
the sample size for subject class ݕ, ݕ ൌ 0, 1  respectively. The Welch 
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approximation is often preferred in many microarray studies. The 
estimates of the ݐ௪ or ݐ௦ above is computed for all the ݍ genes and for 
each computation a high positive t-score corresponds to high 
expression in favour of class 1 while the least negative t-score 
corresponds to high expression for class 0. The absolute values of all 
the t-scores are taken and subsequently sorted in descending order 
to identify the top ݍכ genes base on the estimated t (ݐ௪ or ݐ௦) values. 
The cut-point for the selection of the top ݍכ genes from the ordered 
list is determined either by a pre-specified implied ݌-value, ݌כ or its 
critical value equivalent for the upper tail of the student-t 
distribution. For instance, selection of all genes whose ݌-values are 
less than or equal to ݌כ ൌ 0.001 may be desirable. This would be 
equivalent to selecting all genes whose critical values, |̂ݐ௦| or |̂ݐ௪| 
values, are greater than or equal to ݐ଴.ଽଽଽ, ௡బା௡భିଶ or ݐ଴.ଽଽଽ,   ௩ 
respectively. The higher the value of ݌כ chosen (i.e. as  ݌כ ՜ 1 or as 
the chosen cut-point ݐఈ ՜ 0 ) the higher the chance of retaining more 
genes and vice-versa.   
While using Student t-test for preliminary feature selection in this 
work, we have allowed our choice of cut-point ݌כ to be dictated by the 
underlying features of the various data being analysed. Our study 
here have shown that, it is wrong to fix a general cut-off point, say 
݌כ ൌ 0.001, as a benchmark for all microarray data sets as done in 
many studies irrespective of the nature of the data under study. The 
value of ݌כ used for a particular microarray data might not be 
suitable for another data, hence the need to consider the peculiar 
features of each data as a guide for selecting the cut-off points.  
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1.5 Research motivation and objectives 
The advent of DNA microarray technology has made it possible to 
simultaneously study the expression profiles of several thousand of 
genes on a given number of mRNA samples. This has helped the 
researchers to have a clear understanding of different kinds of 
diseases like  heart diseases, mental illness, infectious disease and of 
course, the cancer varieties. In cancer research for instance, the 
evolution of microarray technology has made it possible for 
molecular biologists and physicians to classify various sub-classes of 
cancer types on the basis of the patterns of gene activity in the 
tumour cells. This strongly underscores the biological relationship 
between the gene expression profiles and various sub-classes of 
cancer types.  
In a more statistical term, let us consider a DNA microarray 
experiment that generated expression data on ݍ genes ࢄ ൌ ሺ ଵܺ, … , ܺ௤ሻ 
for ݊ mRNA samples where response of interest represented by 
௜ܻ , ݅ ൌ 1, … , ݊, is recorded for each sample. Response variable ௜ܻ may 
be binary or categorical, especially if the response of interest is the 
cancer tumour sub-group as in leukemia study of Golub et al (1999), 
in which case,  ௜ܻ ൌ 0 for acute lymphoblastic leukemia (ALL) while 
௜ܻ ൌ 1 for acute myeloid leukemia (AML). When the tumour sub-
groups are more than two, typical of the molecular cancer study by 
Ramaswamy et al (2001), then the outcome variable ௜ܻ may be given 
by the set ሼ ௜ܻሽ ൌ ሼ0, 1, 2, … , ঙሽ. Also, variable ௜ܻ may be continuous 
denoting a desired continuous clinical outcome like blood pressure 
readings, x-rays’ results, laboratory tests’ results and so on.  
It should be noted that both ࢄ and ௜ܻ represent random samples from 
a given population of interest and it is often desirable in microarray 
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studies to use the observed sample data on expression measures of ݍ 
genes ௝ܺ, ݆ ൌ 1, … , ݍ and observed response ௜ܻ to make inference 
about the population or future subjects. Specifically, a common goal 
is to use information on the observed data ሺࢄ෡, ෠ܻ௜ሻ to predict 
independent future subject ݊כ ב ሼ݊ሽ in the population. 
Typically, microarray data sets are characterized by having very few 
number of experimental mRNA samples, often less than 100, on 
which expression levels of several thousands of genes are 
simultaneously being observed. Hence, the situation where ݊ ا ݍ is 
a common scenario in genomic analysis. Therefore, to predict the 
clinical/tumour status of future subjects ݊כ, a functional relationship 
between ࢄ and ௜ܻ of the form ௜ܻ ൌ ݃ሺࢄࢼ;  ߝሻ may be desirable for any 
link function ݃ሺ. ሻ. If the relationship is linear, then, the task is to fit 
the model   
                                               ௜ܻ ൌ ࢄࢼ ൅  ߝ                                      (1.5.1) 
But with the condition that ݊ ا ݍ, obviously, the linear model (1.5.1) 
cannot be estimated using the classical least square (LS) method. 
The reason for this is that, the ݍ ൈ ݍ variance-covariance (design) 
matrix ࢄ்ࢄ would be singular (non-invertible). 
Several attempts directed at circumventing this common 
dimensionality problem in microarray data resulted to the 
development of many supervised and unsupervised techniques for 
dimension reduction and tumour classification in several microarray 
studies. Among the earlier methods developed for response class 
prediction include the support vector machines (SVM), ݇-nearest 
neighbours ( ݇-NN), principal component analysis (PCA), sliced 
inverse regression (SIR) and the much celebrated approach of the 
partial least squares regression (PLSR) among many others. While 
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some of these methods (e.g. SVM, ݇-NN etc.) are mainly design for 
response class prediction, few other ones (e.g. PCA, PLS etc.) are 
shrinkage techniques that are only meant for dimension reduction of 
original ݍ genes to a small number of ݇ gene components, ݇ ൏ ݊, 
using the expression patterns of all the ݍ genes. For both PCA and 
PLS techniques for instance, tumour classifications are only possible 
through the use of other standard discriminant methods like linear, 
logistic or quadratic discriminant analyses on the ݇ gene components 
constructed.  
Expectedly, some of the existing methods perform accurate 
classification of tumour classes using the observed gene expression 
profiles, but unfortunately the classifiers they provided are often 
difficult to interpret in relation to the tumour sub-classes they 
predicted. For instance, the partial least squares (PLS) procedures 
can only reduce the entire  ݍ genes to a few number of ݇ gene 
orthogonal components, say, ܼଵ, … , ܼ௞, ݇ ൏ ݊ using the expression 
measures of all the original ݍ genes. The constructed ݇ components 
are then being used as predictors in replacement of the original ݍ 
genes, ଵܺ, … , ܺ௤, in regression model (1.5.1) to predict the tumour 
categories of any future biological subjects ݊כ (see Nguyen & Rocke, 
2002a-d; Rosipal & Kräme, 2006; Rimkus et al, 2008; etc.). Although, 
PLS method has been reputed to provide accurate predictions 
especially when suitable cross-validation method is employed, but 
regrettably in most cases, the ݇ components it constructed for 
prediction are not easily tend to direct biological interpretations in 
relation to the response groups they predicted. This has made it 
imperative to evolve a separate procedure that could actually 
identify and select the most relevant gene combinations that are 
actually related to different tumour categories. Obviously, this 
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important goal are difficult to accomplished using the factor loadings 
of the constructed ݇ PLS components as suggested in some studies, 
Barker & Rayens (2003), Ding & Gentleman (2004). 
One of the most important advantages of DNA microarray 
technology lies in gene discovery. Due to the dynamic nature of 
general hormone systems of individual organism, molecular 
biologists and physicians are not only interested in proper 
identification and prediction (diagnosis) of different categories of 
tumour types, but rather, they are now more interested about 
knowing those human transcripts (genes) that are responsible for 
each of the identified tumour conditions. Identification of these 
relevant transcripts would immensely help in the development of 
appropriate therapeutic measures (drug discovery). This could be 
further useful to pharmacogenomists in determining the relationship 
between therapeutic responses to drugs and the genetic profiles of 
patients.   However, all these important benefits may be difficult to 
achieve if appropriate statistical techniques that are capable to 
select the most relevant and informative marker genes among 
several available thousands are not developed. Again, it is obvious 
that the latent components constructed by PLS or PCA technique 
might not be suitable to address this problem. It is based on this 
premise that the study carried out in this thesis is conceived. 
The prime goal of this work therefore, is to develop a new flexible 
dual-purpose approach that would efficiently identify and select the 
most relevant gene chips that are informative enough to predict the 
various tumour conditions of mRNA subjects in any given 
microarray data set. 
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Our method shall be evaluated on some of the existing microarray 
data sets while its general performance relative to those provided by  
some of the few selected existing methods (PLS, SVM, ݇-NN, etc.) 
shall be examined. 
The high-dimensional nature of microarray data sets has made 
preliminary feature selection a desirable task before further analysis 
like final optimal gene selection and classification are performed. 
Due to this end, we shall review some of the existing preliminary 
feature selection methods and provide yet another approach that 
would efficiently handle features selections at the preliminary stage. 
This becomes necessary because the prediction performance of any 
classification rules largely depends on the crop of genes selected for 
analyses at the preliminary selection stage. 
1.6 Main research contributions 
The main contributions of this research work include, but not 
limited to the following: 
 We developed a dual-purpose flexible method that 
simultaneously performs informative genes selection and 
classifies mRNA samples into their respective biological 
groups using the sub-set of genes selected irrespective of 
the dimension of the microarray data involve. 
 Our new method is capable at selecting those genes that 
are of biological relevance to the tumour conditions of 
the mRNA subjects in any given microarray data sets. 
This, we hope, shall be helpful in the determination of 
appropriate therapeutic measures for the treatment of 
various cancer sub-groups. 
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 We equally proposed a new classifier-like preliminary 
feature selection method that is capable at reducing the 
huge number of genes in any microarray data set to a 
manageable size by selecting all the potentially 
discriminative marker genes for further analysis by any 
standard gene selection and/or classification method. 
The new approach eliminates the risk of leaving out 
some of the important genes at the preliminary selection 
stage.  
 In addition to all these, this research work avails us the 
opportunity to thoroughly review the fundamental basis 
of some of the existing classification techniques and offer 
useful contributions, suggestions and recommendations 
based on our experience in this study. 
1.7 Outline of the Thesis 
The rest of this thesis is arranged as follows. We presented our 
newly proposed sequential dimension reduction and prediction 
method in Chapter two including a review of various performance 
indices that are used to assess the efficiency of the proposed method. 
This is followed by introducing a new versatile preliminary feature 
selection procedure. We conclude this chapter by presenting an 
overview of some of the existing classification methods as employed 
in this thesis. Several simulation studies carried out and few 
applications of our proposed classifier are provided in Chapter three 
while its applications on real microarray data sets are presented in 
Chapter four.  Chapter five presents the summary of our results, 
necessary conclusions and suggestions for future studies. 
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2 The ࢑-Sequential Selection (࢑-SS) 
method 
2.1 Introduction 
The characteristic feature of a typical microarray data set has posed 
a lot of challenges to statisticians and experimental biologists due to 
high dimensional nature of such data. A typical microarray data set 
consists of ݍ transcripts and response class information on ݊ subjects 
with ݍ >> ݊. In most cases, the number of transcripts measured on 
each biological subject ranges between 1,000 to more than 50,000 
transcripts while the available experimental unit may fall below 
100. Hence, the need to evolve a robust method that will be capable 
to identify and select from the cloud of several thousand of observed 
genes, the most relevant informative genes for the prediction of 
biological sample. This is particularly important to the biologists and 
physicians who are interested to know which genes have correlated 
expression levels with the biological samples for determination of 
proper therapeutic measures among other intents. We therefore 
present in this work, a novel but flexible approach that is capable at 
selecting the most relevant gene sets as well as providing accurate 
prediction of the tumour sub-groups of biological samples in any 
given genomic data. We have used some of the existing microarray 
data sets to demonstrate the application of our method. Nonetheless, 
this new approach can be applied, for instance to proteomic, 
chemometrics or any other data sets in which high-dimensionality is 
a common scenario.  
Consider a total of ܰ subjects that belong to two different population 
groups Ωଵ and Ωଶ, Ωଵ,Ωଶ א ሼΩሽ. Let a random sample of size ݊ be 
drawn from population ܰ with ݊ଵ from population Ωଵ and ݊ଶ from 
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population Ωଶ, ݊ଵ ൅  ݊ଶ ൌ ݊ and let the ݍ-dimensional vector ࢄ ൌ
ሺ ଵܺ, … , ܺ௤ሻ, ࢄ א  Ը௡ൈ௤ denotes the expression levels of ݍ genes 
simultaneously measured on ݊ biological samples with ݊ ൏ ݍ as 
earlier presented in Section 1.5. Under the classical regression 
settings, the primary goal is to establish the association between 
predictor vector ࢄ and a (continuous or categorical) response 
variable ௜ܻ א  Ը, ݅ ൌ 1, … , ݊, of the form  
                                                ௜ܻ ൌ ݃ሺࢄࢼ;  ߝሻ                                  (2.1.1) 
for some link function ݃ሺ. ሻ. Within the framework of this study, we 
define the response variable ௜ܻ by 
                                              ௜ܻ ൌ ൜
0, if ݕ א Ωଵ
1, if ݕ א Ωଶ
        (2.1.2) 
for any realization ݕ of ௜ܻ in Ω. This literally indicates a binary 
response group (0,1) for all the ݊ biological samples, which by far, is 
the most common in many microarray studies. While 
implementation of our proposed method shall be demonstrated 
extensively on dichotomous response class microarray data sets, the 
extension of its application to multi-categorical response cases shall 
be equally discussed.  
The definition of the outcome variable ௜ܻ in (2.1.2) implies that any 
given subject in ݊ is labelled 1 if it has a particular characteristic of 
interest of those in group Ωଶ  א Ω and a given subject is label 0 if it 
possesses the features of those in group Ωଵ  א Ω. In microarray 
cancer studies for instance, the characteristic of interest may be 
patients having particular cancer tumour types labelled 1 if 
tumourous, and labelled 0 if the subject is normal. This particular 
instance existed in many studies (Alon et al 1999, Singh et al 2002, 
Stuart et al 2004, Welsh et al 2001, Ramaswamy et al 2001, etc.). In 
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survival analysis studies however, such characteristic of interest 
may be the survival outcome of the patients after a given follow-up 
period with ௜ܻ ൌ 1 for death outcome and ௜ܻ ൌ 0 if the patient is still 
alive at the end of the study (censored).    
Assuming a linear form of the link function ݃ሺ. ሻ in (2.1.1), obviously 
it is impossible to apply the usual least square method to establish 
the linear relationship between ࢄ and ௜ܻ due to dimensionality 
constraint imposed with ݊ ا ݍ as remarked in Section 1.5. Our 
major goal in this thesis therefore, is to design a classification rule 
based on variable pair ൫ ௜ܻ, ௜ܺ௝൯, ݅ ൌ 1, … , ݊, ݆ ൌ 1, … , ݍ, that will use 
subset ࢞ of the measured gene expressions ࢄ to correctly 
predict/classify any independent future subjects into either of the 
two biological groups ௜ܻ ൌ ݕ,  ݕ א ሼ0,1ሽ. 
Most often, it is difficult to get independent samples to test the 
accuracy of any developed classification rule. The usual practice is to 
randomly partition the original sample size ݊ into training/design 
sample, ்݊ோ and test sample, ்݊ா using a suitable ratio. The 
classifiers are usually built using ்݊ோ while the goodness of the 
classifiers is assessed on the test set ்݊ா. Some splitting ratios 2:1, 
4:1 and 9:1 in favour of the training and test data respectively have 
been suggested in some studies (Dudoit et al, 2002; Lee et al, 2005; 
etc.). However, a common practice in most studies is to train the 
classifier with large proportion of the original data while its 
goodness is assessed using the remaining left-out sample.  
The adverse effects associated with the partitioning of the already 
small biological sample ݊ into training and test sets for classifiers’ 
construction and assessment have been reported in many studies, 
e.g. see Bura & Pfeiffer (2003), Molinaro et al (2005), Boulesteix et al 
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(2008) and several others. A common argument is that, classifier 
that is constructed with a fraction of already small sample size ݊ 
might underestimate the misclassification error rate (MER). In other 
words, a classifier that is trained with a relatively large number of 
subjects is likely to provide more accurate and stable results than 
the one trained with smaller sample. In view of this fact, we have 
adopted a splitting ratio of 19:1 for  ்݊ோ: ்݊ா in this thesis. This 
literally translates to using 95% of original ݊ subjects to build our 
classifier and using the remaining 5% as external data to evaluate 
the performance of the classifier. The justification of our choice is 
discussed in Section 3.5. With this partitioning ratio, sufficient part 
of the original data is used to construct the classifiers which 
considerably improved prediction results as shall be seen later. 
To further ensure generalization and stability of results, several 
replicates of the original data sets are generated at the  construction 
and evaluation stages of our classifier using sub-sampling technique 
of Monte Carlo Cross Validation (MCCV) (Dudoit et al, 2002), 
Bootstrap (Efron & Gong 1983), and Bootstrap .632+ (Efron and 
Tibshirani, 1997). The details of these sampling methods as adopted 
in this thesis are provided in Section 2.5. 
Since the variable selection and class prediction method proposed in 
this thesis adapts the estimation procedures of logistic regression 
method, in the next two sections therefore, we briefly provide the 
basic theoretical background into the generalized linear models 
(GLM) and logistic discriminant (LD) analysis. 
2.2 Generalized Linear Models (GLMs) 
Under the classical linear regression models (LRMs), the 
relationship between the response variable ௜ܻ א Ը௡ൈଵ, ݅ ൌ 1, … , ݊, and 
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a set of predictors ࢄ ൌ ሺ ଵܺ, … , ܺ௤ሻ, ࢄ א Ը௡ൈ௤  in the form ܻ ൌ ࢄࢼ ൅  ߝ, 
ࢼ ൌ ሺߚ૚, … , ߚࢗሻࢀ, is usually established by assuming Gaussian 
distribution with constant variance, ߪଶ for both ܻ and the error 
component, ߝ with each of them having means ෠ܻ ൌ  ࢄࢼ෡  and zero 
respectively. 
When the outcome variable ܻ is not Gaussian, but rather 
dichotomous with distinct class labels ሺ0, 1ሻ, then, the Gaussian 
distribution cannot be assumed for ܻ. This implies that the linear 
regression model ܻ ൌ ࢄࢼ ൅  ߝ cannot be fitted on ܻ because the range 
of the conditional expectation ෠ܻ ൌ ܧሺܻ|ࢄሻ is no loger bounded 
between zero and one. 
The generalized linear model (GLM), first developed by John Nelder 
& Robert Wedderburn in 1972, provides a flexible generalization of 
the linear regression concepts which unifies various other statistical 
models including linear, logistic, Poisson and many other regression 
models with or without Gaussian responses under one framework. 
This led to the development of general algorithms for the maximum 
likelihood estimation (MLE) of all the models’ parameters.  
In GLM, each response variable ܻ is assumed to come from a 
particular member of the exponential family of distributions (EFD) 
with a probability distribution ௒݂ሺݕ௜; ߠ௜, ߱ሻ, ߠ௜, ߱ א Θ. The form of this 
distribution is given by 
                      ௒݂ሺݕ௜; ߠ௜, ߱ሻ ൌ ݁ݔ݌ ቄ
ሾ௬೔ఏ೔ି௕ሺఏ೔ሻሿ
௔ሺఠሻ
൅  ܿሺݕ௜, ߠ௜ሻቅ               (2.2.1) 
where, ܽሺ. ሻ, ܾሺ. ሻ, ܿሺ. ሻ are known functions that take the form of ݕ௜. 
For each form of ݕ௜, ߠ௜ is the natural parameter. The dispersion 
function ܽሺ߱ሻ is sometimes written as ܽሺ߱ሻ ൌ ఠ
௪೔
 where ߱ is the 
dispersion parameter which is constant for all observations and ݓ௜ is 
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a prior weight meant to correct for the violation of unequal variances 
which might arise contrary to the constancy of ߱ already assumed.  
The EDF family include among others, the Gaussian, Binomial, 
Poisson, Exponential and Gamma distributions.  
Consider a general regression function ܻ ൌ ݃ሺࢄࢼ;  ߝሻ as defined in 
(2.1.1). Within the framework of GLM, the relationship between the 
random component, ߤ ൌ ܧሺܻ|ࢄሻ and the systematic component 
ߟ ൌ ࢄࢼ, a linear combination of the predictors, is specified by a 
linear or non-linear monotonic and differentiable link function 
ߟ ൌ ݃ሺߤሻ. This link is a function of response variable ܻ which enables 
the relationship between ܻ and vector of predictors ࢄ to be linear in 
parameter ࢼ. Dropping subscript ݅ from ߠ௜ for simplicity, it then 
follows from EFD in (2.2.1) that 
    ܧሺܻ|ࢄሻ ൌ ߤ ൌ ܾᇱሺߠሻ        (2.2.2) 
                             ܸܽݎሺܻ|ࢄሻ ൌ ܾᇱᇱሺߠሻܽሺ߱ሻ       (2.2.3) 
where ܾᇱሺߠሻ and ܾᇱᇱሺߠሻ are the first and second derivatives of ܾሺߠሻ 
respectively. 
The special case of the link function which concerns us here is the 
logit link when response variable ܻ is Bernoulli distributed with ܻ ൌ 
0 or 1. Here, the link function is given by ݃ሺߤሻ ൌ ݈݋݃ ቂ௣ሺ௒ୀଵ|ࢄሻ
௣ሺ௒ୀ଴|ࢄሻ
ቃ = ࢄࢼ. 
More details on this are provided in the next section. Other forms of 
GLMs as applied into different fields can be found in Bliss (1935), 
Berkson (1944), Cox (1972), Finney (1972), Kleinbaum & Kupper 
(1978), Draper & Smith (1981), McCullagh & Nelder (1989) and 
many others. 
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2.3 The basics in logistic discriminant analysis  
The concepts of the logistic regression analysis are the primary basis 
for the construction of logistic discriminant (LD) analysis technique. 
Ripley (1996), Dudoit et al (2002) and several other authors have 
argued at different times in favour of using LD analysis for class 
prediction purposes. Their unanimous conclusion is that LD analysis 
provides a more direct and unambiguous way of estimating the 
posterior probabilities  ݌ሺܻ ൌ ݕ|ࢄሻ that are used in the construction 
of logistic discriminant (LD) rules. It has been equally reported that 
LD procedure tends to more easy generalization than some of the 
other classifiers like linear discriminant analysis (LDA) and 
quadratic discriminant analysis (QDA), Dudoit et al (2002).  
Suppose we consider a set of ݊ biological samples belonging to two 
outcome groups (0,1) according to response variable ܻ as defined in 
(2.1.2). Let ࢞ ൌ ሺ ଵܺ, … , ܺ௞ሻ be the subset of measured ݍ genes 
ࢄ ൌ ሺ ଵܺ, … , ܺ௤ሻ, ࢄ ߳ Ը௡ൈ௤, ݇ ൏ ݍ, selected using a suitable variable 
selection method for predicting the response group ܻ.  
Suppose that all the ݊ samples represent independent and 
identically distributed random samples from an unknown 
distribution Ψ over ॿ ൈ ঀ א Ը,  ॿ and ঀ being the feature space of ࢞ 
and ܻ respectively. Without loss of generality therefore, the LD rule  
߮ሺ࢞ሻ to be constructed can be seen as the mapping of ॿ into the real 
line ঀ i.e. ߮ሺ࢞ሻ: ॿ ՜ ঀ (for continuous response variable ܻ) or as the 
partitioning of the feature space ॿ into ݕ disjoint and exhaustive 
groups ॿሺݕሻ of ঀ (for categorical response variable ܻ), ݕ ൌ 0, 1, … , ঙ. 
For binary response class, ঙ ൌ 1. Therefore, the predicted response 
class ෠ܻ by classification rule ߮ሺ࢞ሻ based on the observed feature ࢞ 
can be denoted by ෠ܻ ൌ  ො߮ሺ࢞ሻ.  
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Since response variable ܻ can only assume value 0 or 1 it follows 
that ܻ is Bernoulli distributed with parameter ߨሺ࢞ሻ. The equivalent 
form of the linear model ܻ ൌ ܧሺܻ|࢞ሻ ൅  ߝ under this condition is given 
by 
ܻ ൌ ߨሺ࢞ሻ ൅  ߝ          (2.3.1) 
which implies that 
    ߝ ൌ  ܻ െ ߨሺ࢞ሻ        (2.3.2) 
Thus, from (2.3.2) it is obvious that ܧሺߝሻ ൌ 0 and ܸܽݎሺߝሻ ൌ
ߨሺ࢞ሻሾ1 െ ߨሺ࢞ሻሿ. This shows that under the regression form in (2.3.1), 
the error term ߝ, though has zero mean but do not have constant 
variance (ߪଶ as in Gaussian model) but rather, an heteroscendastic 
form that depends on the values of ࢞. A specific form of ߨሺ࢞ሻ is the 
logistic regression function given by  
    ݌ሺܻ ൌ 1|࢞ሻ ൌ ߨሺ࢞ሻ ൌ ௘௫௣ ሺ࢞ࢼሻ
ଵା௘௫௣ ሺ࢞ࢼሻ
     (2.3.3) 
The quantity that transforms ߨሺ࢞ሻ as a linear function of ࢄ and ࢼ is 
the logit link ߟሺ࢞ሻ as described in Section 2.2 and is given by 
    ߟሺ࢞ሻ ൌ  ݈݊ ቂ గሺ࢞ሻ 
ଵିగሺ࢞ሻ 
ቃ ൌ  ࢞ࢼ     (2.3.4) 
Thus, when ܻ has two groups (0,1), the link function ߟሺ࢞ሻ is the 
natural logarithm of the ratio of conditional probability  ݌ሺܻ ൌ 1|࢞ሻ 
and ݌ሺܻ ൌ 0|࢞ሻ ൌ 1 െ  ݌ሺܻ ൌ 1|࢞ሻ. That is,  ߟሺ࢞ሻ ൌ ݈݊ ቂ௣ሺ௒ୀଵ|࢞ሻ
௣ሺ௒ୀ଴|࢞ሻ
ቃ ൌ  ࢞ࢼ. 
Now, given any ݊ biological samples with dichotomous class group ܻ 
and a vector of observed predictors (genes) ࢞, the parameter vector ࢼ 
of the logistic regression model (2.3.3) can then be estimated 
iteratively using the iterative weighted least squares as implemented 
in the Newton-Raphson algorithm (Anderson et al, 1993). This is the 
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GLM procedure for a regression model with binary (Bernoulli) 
outcome variable ܻ. 
After the fit of the logit model (2.3.4) as described above, the next 
task is to construct a logistic discriminant (LD) rule, ߮ሺ࢞ሻ that would 
be used to predict the response class ଴ܻ of any independent external 
subjects ்݊ா. By procedure of LD rule, the response class predictions 
are made using the estimated conditional probability ݌̂ሺܻ ൌ ݕ|࢞ሻ, 
ݕ א ሼ0, 1ሽ. The predicted class of any subject is then given by                     
ݕො ൌ ܫ൫݌̂ሺݕ|࢞ሻ ൐ 1 െ ݌̂ሺݕ|࢞ሻ൯ where ܫሺ. ሻ is an indicator function that is 
1 if its argument is true and 0 otherwise. Thus, subject ݅ would be 
classified by rule ߮ሺ࢞ሻ into class ݕ א ܻ if it has the highest estimated 
posterior probability ݌̂ሺݕ|࢞ሻ of being in that class. Therefore, the 
connection between ߮ሺ࢞ሻ  and ݌̂ሺݕ|࢞ሻ could be stated as 
    ߮ሺ࢞ሻ ൌ  ܽݎ݃݉ܽݔ௬ ݌̂ሺݕ|࢞ሻ                (2.3.5) 
The predicted conditional probabilities ݌̂ሺݕ|࢞ሻ may be formally 
converted to the predicted class labels ݕො א ሼ0, 1ሽ for each subject by 
choosing a cut-point ܿ, 0 ൏ ܿ ൏ 1, which finally yield the following 
classifications;  
                                        ߮ሺ࢞ሻ ൌ ൜1,   if ݌̂ሺ1|࢞ሻ  ൒  ܿ 0,   if ݌̂ሺ0|࢞ሻ  ൏  ܿ                        (2.3.6) 
By (2.3.6), a subject would be classified into response class 1 if its 
estimated posterior probability ݌̂ሺ1|࢞ሻ ൒ ܿ and into class 0 if 
otherwise. 
If the sample class prior probabilities ݌̂௬ ൌ ݊ሺݕሻ/݊, ݊ሺݕሻ being the 
number of class ݕ subjects in the sample, ݕ ൌ 0, 1, are very close to 
0.5, the choice of 0.5 for value of ܿ has been found more appropriate. 
But if one of these priors is very close to 1, then, it is recommended 
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to use the estimated prior probability of class 0 as the cut point, ܿ. 
Nonetheless, the general practice, which we equally adopted here is 
to use ܿ ൌ 0.5  (Efron,1975; O'Gorman & Woolson, 1991; Pohar et al, 
2004; etc.). The close connection between logistic discriminant (LD) 
analysis and linear discriminant analysis (LDA) has been equally 
reported as a factor that favours the choice of 0.5 cut-point in logistic 
discriminant analysis (Efron,1975; Hosmer & Lemeshow, 1989). 
If the class conditional density of ࢞ given ܻ, ݌ሺ࢞|ݕሻ, ݕ ൌ 0,1, is 
multivariate Gaussian with mean ߤ௬ and constant variance-
covariance matrix Σ, i.e., ࢞|ݕ ~ ܰሺߤ௬, Σሻ, then, with known class prior 
probabilities ݌̂௬, the posterior probability of ܻ given ࢞, ݌ሺݕ|࢞ሻ, is 
provided by Bayes theorem as ݌ሺݕ|࢞ሻ ൌ ௣ሺ௬ሻ௣ሺ௫|௬ሻ
௣ሺ௫ሻ
. With known class 
priors ݌ሺ1ሻ ൌ ݌̂ଵ and ݌ሺ0ሻ ൌ ݌̂଴ of the subjects’ groups ݕ א ሼ0,1ሽ, the 
logarithm of the ratio ௣ሺଵ|࢞ሻ
௣ሺ଴|࢞ሻ
 is given by                         
݈݊ ቄ௣ሺ௒ୀଵ|࢞ሻ
௣ሺ௒ୀ଴|࢞ሻ
ቅ ൌ ݈݊ ቄ௣ොభ௣ሺ࢞|௒ୀଵሻ
௣ොబ௣ሺ࢞|௒ୀ଴ሻ
ቅ. This implies that, 
                 ݈݊ ቄ௣ሺ௒ୀଵ|࢞ሻ
௣ሺ௒ୀ଴|࢞ሻ
ቅ ൌ  ݈݊ ቐ
೛ෝభ
ሺమഏሻ
೜
మ|ಂ|
భ
మ
௘௫௣ቂିభమሺ࢞ିఓభሻ
೅ஊషభሺ࢞ିఓభሻቃ
೛ෝబ
ሺమഏሻ
೜
మ|ಂ|
భ
మ
௘௫௣ቂିభమሺ࢞ିఓబሻ
೅ஊషభሺ࢞ିఓబሻቃ
ቑ              (2.3.7)  
which reduces to  
 ݈݊ ቄ௣ሺ௒ୀଵ|࢞ሻ
௣ሺ௒ୀ଴|࢞ሻ
ቅ ൌ ࢞Σିଵሺߤଵ െ ߤ଴ሻ െ  
ଵ
ଶ
ߤଵ்Σିଵߤଵ ൅  
ଵ
ଶ
ߤ଴்Σିଵߤ଴ ൅  ݈݊
௣ොభ
௣ොబ
       (2.3.8) 
  ՜                    ݈݊ ቄ௣ሺ௒ୀଵ|࢞ሻ
௣ሺ௒ୀ଴|࢞ሻ
ቅ ؆ ࢞ࢼ          (2.3.9) 
This is the same as the logit model given in (2.3.4).  
The procedure (2.3.7) through (2.3.9) simply provides alternative 
way of constructing logistic discriminant (LD) function especially 
when predictor vector ࢞ has multivariate Gaussian density. 
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However, it can be easily shown (Cornfield, 1962; Lachenbruch, 
1975; Hosmer & Lemeshow, 1989) that the estimates of the ݇ 
parameters ࢼ ൌ ሺߚ૚, … , ߚ࢑ሻࢀ of the model (2.3.9) can be obtained non-
iteratively from LD functions in (2.3.8) as follows:   
   ߚመ૚ ൌ ݈݊
௣ොభ
௣ොబ
െ 0.5ሺߤଵ െ ߤ଴ሻ்Σିଵሺߤଵ ൅ ߤ଴ሻ   (2.3.10) 
           ࢼ෡௞ିଵ ൌ ሺߤଵ െ ߤ଴ሻ்Σିଵ                              (2.3.11)      
where ߚመ૚ is the estimate of the constant parameter (intercept) of 
logistic regression model (2.3.3) and ࢼ෡௞ିଵ ൌ ሺߚመ૛, … , ߚመ࢑ሻ are the 
estimates of the remaining ݇ െ 1 parameters. All the parameters are 
obtained by substituting the estimators of Σ and ߤ௬, ݕ ൌ 0,1, into   
(2.3.10) and (2.3.11). Thus, for subject group ܻ, ߤ௬ is estimated by 
the mean of predictors ܺ௬௝, ݆ ൌ 1, 2, … , ݇, as ̂ߤ௬ ൌ തܺ௬௝ and covariance Σ 
is estimated by the estimate of the pooled sample variance-
covariance defined by subjects group ܻ  as 
    Σ෠ ൌ ሺ௡బିଵሻࡿబାሺ௡భିଵሻࡿభ
௡బା௡భିଵ
            (2.3.12) 
where ࡿ௬ is the ݇ ൈ ݇ unbiased estimator of the sub-groups variance-
covariances computed for each subjects’ groups as defined by ܻ. 
The discriminant function estimators given above may be bias, 
especially when normality condition does not hold for the predictors. 
It may however, be adopted for preliminary analysis after which the 
final parameter estimates can be obtained using a more robust 
maximum likelihood estimation (MLE) as implemented in Newton-
Raphson algorithm or any other suitable iterative procedure as 
earlier discussed. 
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2.4 The ࢑-SS set-up 
2.4.1 The need for ࢑-SS technique  
The new method proposed in this thesis is a comprehensive but 
flexible dual-purpose gene selection technique which simultaneously 
performs dimension reduction, informative genes selection and 
accurate classification of biological samples into their respective 
tumour sub-classes in any given high-dimensional microarray data. 
This new procedure is analogous to the non-linear stepwise variable 
selection technique under the classical logistic regression settings. 
The prime objective is to develop a robust variable selection 
approach that will provide flexible but efficient models that are 
suitable for proper prediction of biological samples in any given 
genomic data sets. Our procedure would select the most informative 
predictors (genes) from the cloud of several available thousand of 
genes based on some fixed decision rules. 
The variable selection procedure of the stepwise logistic regression 
(SLR) for instance, as implemented in some statistical packages [e.g. 
SAS® (SAS institute Inc., 1995), SPSS 12.0 (Chicago, IL), STATA/SE 
8.0 (Stata Corporation, Texas, USA)] is purely based on two 
parameters: SLENTRY, ݌௘ which is the significant level specified for 
any variable to enter the model and SLSTAY, ݌௦ which is the 
significant level for a variable selected to remain in the model. A 
major flaw of the SLR method is that the values of both ݌௘ and ݌௦ are 
determined arbitrarily by the investigator the choice of which may, 
of course, vary from one person to another. Hence, the whole 
procedure under this set-up is not too far from a trial and error 
exercise. Nonetheless, the SLR approach has been successfully 
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adopted in many studies (Stevens et al, 1992; Seligman & Pullinger, 
1996; Valenzuela et al, 1997; etc.) and is still in use till date. 
Apart from SLR method, several other approaches have been 
proposed purposely to shrink the number of predictors in any 
regression set-up. For instance, a shrinkage method, the least 
absolute shrinkage and selection operator (LASSO), proposed by 
Robert Tibshirani (1996) uses quadratic programming technique to 
minimize the residual sum of squares subject to the sum of absolute 
value of the coefficients being less than a predetermined constant. In 
other words, LASSO method provides the estimate of parameters 
ࢼ෡ ൌ arg ݉݅݊ ቄ∑ ൫ ௜ܻ െ ∑ ߚ௝ ௜ܺ௝
௤
௝ୀଵ ൯
ଶ௡
௜ୀଵ ቅ subject to the constraint that 
∑ |ߚ௝|
௤
௝ୀଵ ൑ ݐ. Here, the value of ݐ, the tuning parameter, is usually 
fixed by the user, which, like the choice of ݌௘ and ݌௦ under the SLR 
method, might vary from one investigator to another. Similar 
arguments hold for the use of non-negative Garrote method due to 
Breiman (1993) for features selection. 
Another method reported in Zucknick et al (2008) is the univariate 
filtering method that equally adapts the logistic regression approach 
concept in its implementation. In this approach, the logit model is 
fitted to each of the gene variable ௝ܺ, ݆ ൌ 1, … , ݍ, separately and the 
gene effects, ఉ
෡ೕ
௦.௘ሺఉ෡ೕሻ
 is computed where ߚመ௝ and ݏ. ݁ሺߚመ௝ሻ is the estimated 
regression coefficient and its standard error for gene ௝ܺ respectively. 
The best set of ݍכ genes, ݍכ ൏ ݍ , with the largest absolute effects 
|ఉ෡ೕ|
௦.௘ሺఉ෡ೕሻ
 are then selected using arbitrarily chosen cut-point ߚመ଴. 
It has been established in many studies that the use of the default 
significant level ߙ ൌ 0.05 or less for ݌௘ in the implementation of SLR 
method may yield a highly sensitive selection criteria that might 
 
 
 38 
result into the exclusion of some of the important variables from the 
model (Bendel & Afifi, 1977; Hosmer & Lemeshow, 1989; Shtatland 
et al 2000, etc). On the other hand, if the value of  ݌௘ is set too high, 
the resulting model might be loaded with noise due to the presence 
of both needed and unwanted variables in the model (Hosmer & 
Lemeshow, 1989). Therefore, there is need to strike a balance 
between the selection of not too sensitive and not too conservative 
values for both ݌௘ and ݌௦. 
In an attempt to solve this problem, Hosmer & Lemeshow (1989) 
advocated the choice of ݌௘ (i.e. ߙ) between 0.15 to 0.25 and further 
suggested a choice of ݌௦ ൐  ݌௘ for any given value of ݌௘ within this 
range. However, this submission sharply contradicts what was 
proposed by SAS institute Inc., 1995, page 51, in which a value 
relatively smaller than 0.05 is suggested for ݌௘. Specifically, it was 
remarked that the choice of ݌௘ ൏ 0.05 could be a better choice if the 
sole objective of performing variable selection is to describe and 
interpret the data under investigation. These differing positions 
notwithstanding, what is common to all the submissions is that the 
choice of  ݌௘ and ݌௦ are highly subjective and are at the discretion of 
the investigator. 
Shtatland et al (2000) proposed alternative approach; output delivery 
system (ODS) to the SLR implementation. Their approach uses both 
Akaike information criterion (AIC), Akaike (1974, 1983) and 
Schwarz information criterion (SIC), Schwarz (1978) for variable 
selection. Here again, any arbitrary values very close to 1 are 
suggested for both ݌௘ and ݌௦ in the implementation of their method. 
 Basically, two main objectives are desirable while performing 
variable selections which might apparently result to the 
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development of two different models in any given regression 
problems. One might be to develop a parsimonious model (with fewer 
predictors) that best describes and interprets the data at hand. To 
select variables for this kind of model, the values of ݌௘ to chose may 
range from 0.001 to 0.05, Shtatland et al (2000), as equally 
recommended by SAS institute Inc., 1995. Secondly, another 
objective might be to have a robust model that best predicts the 
response class.  For this type of model, the use of default significant 
level ߙ ൌ 0.05 or less for ݌௘ might not be suitable, the reason why 
any value between 0.15 and 0.25 was suggested for ߙ (݌௘) by Hosmer 
& Lemeshow (1989). Considering the above two possible models, it is 
clear that more variables are likely to be selected under the latter 
than the former. This clearly suggests that, a single regression 
model might not be capable enough to provide both the best fit and 
best prediction of the response class at the same time. A good 
regression model that fits (describes) a data very well might poorly 
predict the response class (Hosmer & Lemeshow, 1989).  
In any microarray studies however, two important objectives are 
always intended. One is to identify and select the few marker genes 
whose expression patterns are related to the various cancer tumour 
status of the biological subjects under study. In other words, it is 
mostly intended to identify those genes whose expression levels 
could, for instance, accelerate the discovery of key biological 
processes for proper therapeutic measures among other things. The 
next is to correctly classify the subjects into their respective 
biological groups (e.g. cancerous or normal) based on the expression 
levels of the marker genes already identified and selected. This 
usually serves as a measure to screen the mRNA samples for early 
detection of cancer or other tumour types before it metastasize to 
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other neighbouring cells. The major tasks in this thesis are therefore 
targeted at achieving these two cardinal objectives by  
i) identifying and selecting the most relevant marker 
genes that are related to the biological properties of the 
tissue samples. 
ii) classifying the RNA samples properly into their 
respective tumour classes based on the selected marker 
genes. 
Therefore, the sequential variable selection procedure we proposed 
here is basically aimed at building models not just for data 
description or interpretation but also for accurate prediction of 
tumour conditions of the biological samples. Our new method shall 
strive to optimize both the variable selection and response class 
prediction processes by ensuring that the criteria set for achieving 
the best optimal prediction model are not subjectively imposed by 
the investigator as common to most of the existing methods.  
2.4.2 The ࢑-SS set-up in details 
Let the ݍ-dimensional vector ࢄ ൌ ൫ ଵܺ, … , ܺ௤൯, ࢄ ߳ Ը௡ൈ௤ of measured ݍ 
genes on ݊ biological samples with two outcome groups ܻ א ሼ0,1ሽ be 
as defined under Section 2.1. Our task in this thesis is to develop a  
k-sequential selection and prediction (k-SS) rule ߮ሺ࢞ሻ that would 
select the most informative ݇ genes subset ࢞ ൌ ሺ ଵܺ, … , ܺ௞ሻ from ࢄ, 
݇ ൏ ݍ, to predict the binary response classes ሼ0,1ሽ of any future 
(external) subjects ݊כ ב ሼ݊ሽ 
As discussed in Chapter one, Section 1.4.2, a preliminary selection of 
ݍכ genes, ݍכ ൏  ݍ, may be necessary to filter out the irrelevant genes 
from the whole ݍ genes to a manageable size number, ݍכ before the 
 
 
 41 
final selection of the most informative ݇ marker genes are made for 
classification purposes. This concept shall be revisited in Section 2.5 
where we propose a new preliminary gene selection procedure based 
on cross-validated area under the receiver operating characteristics 
curve (CVAUC). However, both ݍכ and ݍ may be used 
interchangeably in this thesis to mean a large set of genes from 
which the selection of ݇ informative marker genes is desirable.  
We begin by dividing randomly, the original sample size ݊ into 
training set ்݊ோ and test set ்݊ா as described earlier. This is followed 
by fitting univariate generalized linear models (GLMs) ݈݃݉ଵ, … , ݈݃݉௤ 
with logit link (i.e. ݈݋݃݅ݐ൫ߨሺ ௝ܺሻ ൯ ൌ ߙ ൅ ߚ௝ܺ௝, ݆ ൌ 1, … , ݍ) on each of the 
ݍ genes (variables) using the training set ்݊ோ and constructing 
classification rules ߮൫ ௝ܺ൯ ൌ  ܽݎ݃݉ܽݔ௬ ݌̂൫ݕห ௝ܺ൯ for each gene ௝ܺ, 
݆ ൌ 1, … , ݍ, and predict the two class labels ሼ0,1ሽ of the (external) test 
sample ்݊ா via the following classification scheme; 
                        ො߮௜൫ ௝ܺ൯ ൌ ቊ
1,   if ݌̂௜൫1ห ௝ܺ൯  ൒  0.5 
0,   if ݌̂௜൫0ห ௝ܺ൯  ൏  0.5
, ݅ ൌ 1,2, … , ்݊ா.      (2.4.0) 
For each of the true response class ݕ௜, ݅ ൌ 1, … , ்݊ா, of the test sample 
predicted by ො߮௜൫ ௝ܺ൯, ݆ ൌ 1, … , ݍ, the risk (error) of misclassifying any 
subject is estimated through the loss function ܮ൛߮௜൫ ௝ܺ൯,  ௜ܻൟ. We shall 
digress a little here to provide a brief discussion on the prediction 
error rate’s estimators. 
The true error of misclassification by rule ߮൫݆ܺ൯ is usually defined by 
 ௝ߴ ൌ ܧࢄ௒~Ψൣܮ൛߮௜൫ ௝ܺ൯,  ௜ܻൟ൧   
                           ՜   ௝ߴ ൌ ܧࢄ௒~Ψ ቂܫ൛ఝ೔൫௑ೕ൯ஷ ௒೔ൟቃ,  0 ൑ ௝ߴ ൑ 1,              (2.4.1)                         
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where ܫሼ.ሽ is an indicator function with a value of 1 if its argument is 
true and 0 if otherwise. Since the joint distribution, Ψ of ࢞ and ܻ in 
(2.4.1) is not known, the true error (conditioning on both ࢞ and ܻ) 
cannot be determined directly. The usual practice is to estimate ௝ߴ by 
its empirical risk using observed finite independent sample, in this 
case, the test sample ்݊ா. This is computed by   
                                         መߴ௝ ൌ
ଵ
௡೅ಶ
∑ ቂܫ൛ఝෝ೔൫௑ೕ൯ஷ ௒೔ൟቃ
௡೅ಶ
௜ୀଵ                (2.4.2) 
and it measures the proportion of the subjects in the test sample 
that are incorrectly classified by classification rule ߮௝൫ ௝ܺ൯ (Efron and 
Tibshirani, 1997). We shall therefore, call መߴ௝ the misclassification 
error rate (MER) and in a later section, we are going to present two 
other variants of the MER’s estimators; the brier score which 
considers the discrepancies between the true class labels and the 
estimated conditional (posterior) probabilities ݌̂ሺݕ|࢞ሻ, ݕ ൌ 0, 1, of 
subjects belonging to that class and the logarithmic scores which 
equally uses ݈݋݃ሼ݌̂ሺݕ|࢞ሻሽ in its error rate estimation. 
Generally, the empirical error rate of classification rule ߮ሺ࢞ሻ 
constructed using any subset of measured feature ࢞ is given by  
        መߴ ൌ ଵ
௡೅ಶ
∑ ൣܫሼఝෝ೔ሺ࢞ሻஷ ௒೔ሽ൧
௡೅ಶ
௜ୀଵ             (2.4.3) 
 where indicator function ܫሼ.ሽ is as defined in (2.4.1), 0 ൑ መߴ ൑ 1, 
ො߮௜ሺ࢞ሻ, ௜ܻ א ሼ0,1ሽ. 
Using the MER concepts and its estimator as presented above, the 
response class predictions by discriminant rules ߮௜ሺ ଵܺሻ, … , ߮௜ሺܺ௤ሻ 
produced a set of ݍ MERs መߴଵ, … , መߴ௤, one for each predictor (gene) ௝ܺ, 
݆ ൌ 1, … , ݍ. From each prediction made by ߮௜൫ ௝ܺ൯, a 2 ൈ 2 confusion 
matrix, typical of the one given in Table 2.1 can be constructed. The 
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confusion matrix cross-classifies the predicted response class 
(predicted by classification rule ߮ሺ࢞ሻ) by the observed true class 
labels, the confusion being in the off-diagonal cells. This matrix 
enables us to see at a glance, in the main and off-diagonals, the 
number of subjects that are correctly and incorrectly classified by 
rule ߮ሺ࢞ሻ respectively. From this matrix, several performance 
indices can be estimated to assess the goodness of the classifier. For 
instance, from Table 2.1, MER can be simply estimated by ሺܾ ൅
ܿሻ/ሺܽ ൅ ܾ ൅ ܿ ൅ ݀ሻ.  
                       True Class (T)  
P
re
di
ct
ed
 
cl
as
s 
(P
) b
y 
࣐
ሺ ࢄ
ሻ  
 1 0 Marginal Total 
1 ܽ ܾ ܽ + ܾ 
0 ܿ ݀ ܿ + ݀ 
 Marginal 
Total ܽ + ܿ ܾ + ݀ ܽ + ܾ + ܿ + ݀ 
 
Table 2.1: A typical confusion matrix showing the cross-classification of subjects by their true class 
labels T and predicted class labels (P) by classification rule ߮ሺ࢞ሻ 
A number of re-sampling techniques are commonly adopted in the 
literature to eliminate bias from the estimated prediction error 
rates. This is termed cross-validation (CV) and it starts by drawing 
randomly, sub-samples of the training set ்݊ோ from the original ݊ 
samples ܴ number of times (with or without replacement). The 
classification rules are constructed on ்݊ோ while the response 
categories of the remaining test samples ்݊ா are predicted using the 
constructed classification rules for each successive sample drawn 
over ܴ repetitions. A set of ܴ MERs መߴଵ௝, … , መߴோ௝, are then computed for 
each gene variable ௝ܺ after which the ݍ average MERs ҧߴመଵ, ҧߴመଶ, … , ҧߴመ௤ 
are estimated for all the ݍ gene variables ଵܺ, … , ܺ௤ respectively. The 
average MERs ҧߴመ௝, ݆ ൌ 1, … , ݍ now become the cross-validated MERs 
and their estimate are expected to be more efficient than the MERs 
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መߴ௝ which are estimated based on a single sample. A typical table of 
matrix of the MERs መߴ௥௝ provided by classifier ߮ሺ࢞ሻ at different 
repetitions for each gene ௝ܺ is presented in Table 2.2. Detail 
discussions on various cross-validation methods are provided in 
Section 2.7. 
Repetitions 
Genes ࢄ࢐ 
ଵܺ ܺଶ … ܺ௤ 
Misclassification error rates (MERs) መߴ௥௝ 
1 መߴଵଵ መߴଵଶ … መߴଵ௤ 
2 መߴଶଵ መߴଶଶ … መߴଶ௤ 
ڭ ڭ ڭ … ڭ 
ࡾ መߴோଵ መߴோଶ … መߴோ௤ 
Mean MERs ҧߴመଵ ҧߴመଶ … ҧߴመ௤ 
 
Table 2.2: A typical table of matrix of misclassification error rates (MERs) provided by classification 
rule ߮ሺ࢞ሻ for each gene ௝ܺ at different repetitions. 
At this stage, all the ݍ gene variables might be ordered in order of 
their prediction performance based on their respective average MER 
values. Suppose we allow the sequence ҧߴመሺଵሻ,  ҧߴመሺଶሻ, … , ҧߴመሺ௤ሻ be the 
observed order of the above observed ݍ average MERs satisfying the 
condition that ҧߴመሺଵሻ ൏  ҧߴመሺଶሻ ൏ ڮ ൏  ҧߴመሺ௤ሻ. Based on this ordered average 
MERs we let the corresponding order of all the original ݍ genes be 
given by ሺܺଵሻ, ሺܺଶሻ, … , ሺܺ௤ሻ. By this representation, gene ሺܺଵሻ with 
estimated mean MER  ҧߴመሺଵሻ becomes the best gene followed by the 
second best ሺܺଶሻ with respective mean MER estimate ҧߴመሺଶሻ and so on. 
However, if we define ܺ௠భ ൌ ሺܺଵሻ and ҧߴመሺଵሻ ൌ ҧߴመ௠భ, then  superscript  
݉ଵ would indicate that gene ܺ௠భ is the first gene with minimum 
average MER contribution to be selected into our prediction model. 
Thus, ҧߴመሺଵሻ ൌ ҧߴመ௠భ ൌ ݉݅݊ ቀ ҧߴመሺଵሻ, ҧߴመሺଶሻ, … , ҧߴመሺ௤ሻቁ. 
Under the conventional stepwise variable selection procedure, the 
importance of any variable to enter the model is judged by an 
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arbitrarily selected implied significance level ݌௘ against which the 
respective p-values of the estimated likelihood ratio statistics are 
compared. Under this new proposal however, individual genes and 
their combinations are judged to be suitable for inclusion into the 
model based on their predictive strength of the response classes. 
This we simply assessed through their estimated MER values. By 
this criterion, the marginal contribution of each selected gene at 
reducing the prediction error rate of the successive models is 
examined. If this marginal contribution is significant enough based 
on some test criteria (to be developed), the selected gene is retained 
in the model, but if otherwise, it is not selected. The significant 
level(s) ߙ at which the best set of genes are selected is determined 
through internal cross-validation and is not to be subjectively fixed 
by the investigator. At the end of the whole exercise, the 
combination of genes that yielded the minimum overall estimated 
average MER value among the family of all possible gene 
combinations in the data is chosen as the best by our method.  
In a nutshell, our sequential selection procedure begins at step 0 
with the selection of gene ܺ௠భ, being the gene that yielded the 
minimum mean MER ҧߴመ௠భ among all the ݍ genes. To determine 
whether any of the remaining ݍ െ 1 genes is important once the gene 
ܺ௠భ is in the model, we construct ݍ െ 1 classification rules ߮௠భሺమሻሺ࢞ሻ, 
߮௠భሺయሻሺ࢞ሻ, … , ߮௠భሺ೜ሻሺ࢞ሻ on the respective gene pairs ܺ௠భ ሺܺଶሻ, ܺ௠భ ሺܺଷሻ, 
… , ܺ௠భ ሺܺ௤ሻ according to the same scheme given in (2.4.0). Based on 
the constructed ݍ െ 1 prediction rules, the response classes of the 
test sample ்݊ா are predicted and with the use of suitable cross-
validation technique the respective average MERs 
ҧߴመ௠భሺమሻ, ҧߴመ௠భሺయሻ, … , ҧߴመ௠భሺ೜ሻ are computed.  
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Let ܺ௠భܺ௠మ א ൛ܺ௠భ ሺܺଶሻ, ܺ௠భ ሺܺଷሻ, … , ܺ௠భ ሺܺ௤ሻൟ be the gene pair that 
yielded the minimum average MER defined by 
ҧߴመ௠భ௠మ ൌ ݉݅݊ ቀ ҧߴመ௠భሺమሻ , ҧߴመ௠భሺయሻ, … , ҧߴመ௠భሺ೜ሻ ቁ.  Therefore, at step 1, gene ܺ௠మ 
is chosen for possible consideration into our prediction model for 
being the gene that contributed to the estimated minimum mean 
MER ҧߴመ௠భ௠మ out of the remaining ݍ െ 1 genes. Like ݉ଵ, subscript ݉ଶ 
in the above representations also indicates that gene ܺ௠మ is the 
second gene, with minimum average MER contribution, desirable for 
consideration into our prediction model. Thus, gene ܺ௠మ becomes the 
next best gene candidate suitable for selection into the model 
provided it satisfies certain test criteria.  
Without loss of generality therefore, for any set of sequentially 
selected genes ܺ௠భܺ௠మ … ܺ௠ೕశభ, the last gene ܺ௠ೕశభ is the next best 
ሺ݆ ൅ 1ሻ௧௛ gene to be considered into the model among all the 
remaining ݍ െ ݆ genes at the ݆௧௛ selection step. Therefore, gene ܺ௠ೕశభ 
is the gene that has the highest contribution at reducing the average 
prediction error rate of the preceding model that uses ݆ set of genes 
ܺ௠భܺ௠మ … ܺ௠ೕ. This gene selection procedure shall continue for all 
the possible combination of genes for which their marginal 
contributions into the successive model(s) are significant as 
established by our test criteria. Further gene selection processes 
only terminate when none of the remaining (left-out) genes is 
capable at improving the prediction strength of the current model. 
We presented in Table 2.3, the schematic representation of the MER 
computations required while searching for the second best gene, ܺ௠మ 
to be included with ܺ௠భ in the classification model. 
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Test 
sample  
Repetitions 
(ࡾ) 
Sequence of genes selection 
ܺ௠భ ܺ௠భ ሺܺଶሻ ܺ௠భ ሺܺଷሻ … ܺ௠భ ሺܺ௤ሻ 
Misclassification Error rates (MERs) 
࢔ࢀࡱ 1 መߴଵ
௠భ መߴଵ
௠భሺమሻ መߴଵ
௠భሺయሻ … መߴଵ
௠భሺ೜ሻ 
࢔ࢀࡱ 2 መߴଶ
௠భ መߴଶ
௠భሺమሻ መߴଶ
௠భሺయሻ … መߴଶ
௠భሺ೜ሻ 
࢔ࢀࡱ 3 መߴଷ
௠భ መߴଷ
௠భሺమሻ መߴଷ
௠భሺయሻ … መߴଷ
௠భሺ೜ሻ 
ڭ ڭ ڭ ڭ ڭ … ڭ 
࢔ࢀࡱ ܴ መߴோ
௠భ መߴோ
௠భሺమሻ መߴோ
௠భሺయሻ … መߴோ
௠భሺ೜ሻ 
Average MERs ҧߴመ௠భ ҧߴመ௠భሺమሻ ҧߴመ௠భሺయሻ … ҧߴመ௠భሺ೜ሻ 
 
Table 2.3: The schematic representation of the MER computations required while searching for the 
second best gene to be added to the first selected best gene ܺ௠భ into classification the model. 
The next step is to determine the significance of the marginal 
contribution of gene ܺ௠మ into the new classification rule ߮ሺܺ௠భ, ܺ௠మሻ 
(later defined as ߮௠భ,௠మሺ࢞ሻ) with an average MER of ҧߴመ௠భ௠మ over the 
previous rule ߮ሺܺ௠భሻ (later defined as ߮௠భሺ࢞ሻ) with an average MER 
performance of ҧߴመ௠భ based on some test criteria (to be developed). If 
this marginal contribution is significant as established by such test 
criteria, then gene ܺ௠మ stays in the model and the search for the 
next best gene, say gene ܺ௠య, to be added with genes ܺ௠భ, ܺ௠మ in the 
model would begin.  
The marginal improvement of the current classification rule 
߮௠భ,௠మሺ࢞ሻ over the preceding rule ߮௠భሺ࢞ሻ is determined by the 
difference between ҧߴመ௠భ,௠మ and ҧߴመ௠భ, their respective average MERs. 
However, two forms of such mean MER differences exist which 
eventually returned similar results as would be established later. 
These are denoted by ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ and ߜመଵమ ൌ ҧߴመ௠భ,௠మ െ ҧߴመ௠భ. 
Appropriate test procedures shall be constructed for the two 
formulations in what follows. 
Let the population mean MERs of the estimated empirical mean 
MERs ҧߴመ௠భ and ҧߴመ௠భ,௠మ be represented by ߤణ
௠భ and ߤణ
௠భ௠మ respectively. 
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Then, the following one directional hypothesis of difference are 
desirable; 
ܪ଴ଵଵ : ߤణ
௠భ െ ߤణ
௠భ,௠మ ൑ 0  vs.  ܪ௔ଵଵ : ߤణ
௠భ െ ߤణ
௠భ,௠మ ൐ 0 
՜              ܪ଴ଵଵ : ߜଵభ ൑ 0 vs. ܪ௔ଵଵ : ߜଵభ ൐ 0 
or           ܪ଴ଵଶ : ߤణ
௠భ,௠మ െ ߤణ
௠భ ൒  0 vs.  ܪ௔ଵଶ : ߤణ
௠భ,௠మ െ ߤణ
௠భ ൏ 0 
՜           ܪ଴ଵଶ : ߜଵమ ൒ 0 vs. ܪ௔ଵଶ: ߜଵమ ൏ 0 
where ߜଵభ ൌ ߤణ
௠భ െ ߤణ
௠భ,௠మ and ߜଵమ ൌ ߤణ
௠భ,௠మ െ ߤణ
௠భ with their respective 
unbiased estimators given by ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ and ߜመଵమ ൌ ҧߴመ௠భ,௠మ െ
ҧߴመ௠భ. This hypotheses sets shall be used later to illustrate the basic 
steps involved in the sequential gene selection method we proposed 
in this thesis. But before we go into that, it is necessary to establish 
the sampling distribution of ҧߴመ௠భ (or more generally ҧߴመ௠భ,௠మ,…,௠ೕ) and 
that of ߜመଵభ (or ߜመ௝భ) under some special cross-validation techniques as 
used in the construction of our test procedure for testing (2.4.4). The 
sampling distribution of ߜመଵమ (or ߜመ௝మ) takes the same form as that of 
ߜመଵభ. 
Let the class label ௜ܻ଴ א ሼ0,1ሽ of all the subjects in the test sample ்݊ா 
be as earlier defined in (2.1.2). It then follows that classification rule 
߮௠భሺ࢞ሻ, for instance, can correctly (if ߮௠భሺ࢞ሻ ൌ ௜ܻ଴) or incorrectly (if 
߮௠భሺ࢞ሻ ് ௜ܻ଴) classify any subject in sample ்݊ா as being a class 0 or 
1 subject. For those cases for which ߮௠భሺ࢞ሻ ് ௜ܻ଴, let the rule ߮௠భሺ࢞ሻ 
has a chance ߴ௠భ, 0 ൑ ߴ௠భ ൑ 1, of misclassifying any subject in the 
population containing test sample ்݊ா into either being a class 0 or 1 
subject. It then follows that the classification function ߮௠భሺ࢞ሻ is a 
random variable having a Bernoulli process ߴ௠భ. The probability 
mass function of ߮௠భሺ࢞ሻ for a single subject classification is given by  
(2.4.4) 
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    ݌ሺ߮௠భሺ࢞ሻ ൌ ߮௠భ|ߴ௠భሻ ൌ  ሺߴ௠భሻఝ೘భ ሺ1 െ ߴ௠భሻଵିఝ೘భ ,  ߮௠భ ൌ 0,1.  (2.4.5) 
The distribution of the sum, Φሺ࢞ሻ ൌ ∑ ௜߮
௠భ௡೅ಶ
௜ୀଵ ሺ࢞ሻ over the entire test 
sample ்݊ா is given by 
   ݌ሺΦሺ࢞ሻ ൌ Φ|ߴ௠భሻ ൌ  ൫௡೅ಶ஍ ൯ሺߴ௠భሻ஍ሺ1 െ ߴ௠భሻ௡೅ಶ ି ஍, Φ ൌ 1, … , ்݊ா.(2.4.6) 
 The unbiased estimator of ߴ௠భ is መߴ௠ଵ ൌ ∑ ఝ೔
೘భ೙೅ಶ
೔సభ ሺ࢞ሻ
௡೅ಶ
 which simply 
equals to the empirical error rate, as given in (2.4.3), of wrongly 
classifying any subject in the test sample ்݊ா by classification rule 
߮௠భሺ࢞ሻ but presently using only one gene ܺ௠భ. From sampling 
distribution of መߴ௠భ it follows that 
                                     ܧ൫ መߴ௠భ൯ ൌ ∑ ாሾఝෝ೔
೘భ೙೅ಶ
೔సభ ሺ࢞ሻሿ
௡೅ಶ
ൌ ߴ௠భ                     (2.4.7)         
                               ߪଶ൫ መߴ௠భ൯ ൌ ∑ ఙ
మሾఝෝ೔
೘భ೙೅ಶ
೔సభ ሺ࢞ሻሿ
௡೅ಶ
మ ൌ
ణ೘భሺଵ ି ణ೘భሻ
௡೅ಶ
             (2.4.8) 
and by central limit theorem (CLT) we simply have that 
                                          ܼ ൌ ణ
෡೘భିா൫ణ෡೘భ൯
ටఙమ൫ణ෡೘భ൯
~ܰሺ0,1ሻ                (2.4.9) 
It should be recalled that when any of the cross-validation 
techniques (MCCV or bootstrap) is used, a set of ܴ estimates of 
average MERs መߴଵ
௠భ ൌ
∑ ఝෝ೔భ
೘భ೙೅ಶ
೔సభ ሺ࢞ሻ
௡೅ಶ
,  መߴଶ
௠భ ൌ
∑ ఝෝ೔మ
೘భ೙೅ಶ
೔సభ ሺ࢞ሻ
௡೅ಶ
, … , መߴோ
௠భ ൌ
∑ ఝෝ೔ೃ
೘భ೙೅ಶ
೔సభ ሺ࢞ሻ
௡೅ಶ
 would be computed, one for each of the classification rules 
߮ଵ
௠భሺ࢞ሻ, ߮ଶ
௠భሺ࢞ሻ, … , ߮ோ
௠భሺ࢞ሻ that were constructed over all the ܴ 
repeatedly drawn random samples of size ்݊ா from the original 
sample size ݊. By this, the response class of a total of ்݊ா ൈ ܴ future 
subjects would be predicted. Hence, the sampling distribution of the 
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mean prediction error rate ҧߴመ௠భ ൌ ଵ
ோ
∑ መߴ௥
௠భோ
௥ୀଵ  according to (2.4.7), 
(2.4.8) and (2.4.9) is as follows; 
                      ܧ ቀ ҧߴመ௠భቁ ൌ ଵ
ோ
∑ ܧ൫ መߴ௥
௠భ൯ோ௥ୀଵ ൌ
ଵ
ோ
∑ ௥ߴ
௠భோ
௥ୀଵ ൌ ߤణ
௠భ                
  ՜   ܧ ቀ ҧߴመ௠భቁ ൌ ߤణ
௠భ                                      (2.4.10) 
          ߪଶ ቀ ҧߴመ௠భቁ ൌ ଵ
ோమ
∑ ߪଶ൫ መߴ௥
௠భ൯ோ௥ୀଵ ൌ
ଵ
ோమൈ௡೅ಶ
∑ ௥ߴ
௠భሺ1 െ ௥ߴ
௠భሻோ௥ୀଵ      (2.4.11) 
Also, by CLT we have that 
                                          ҧܼଵ ൌ
ణഥ෡೘భ ି ாቀణഥ෡೘భቁ
ටఙమቀణഥ෡೘భቁ
~ܰሺ0,1ሻ                     (2.4.12) 
Similarly, for the mean misclassification error rate ҧߴመ௠భ,௠మ estimated 
by classification rule ߮௠భ,௠మሺ࢞ሻ using the gene pair ܺ௠భ, ܺ௠మ, we shall 
have that 
                                            E ቀ ҧߴመ௠భ,௠మቁ ൌ ߤణ
௠భ,௠మ                           (2.4.13) 
                         ߪଶ ቀ ҧߴመ௠భ,௠మቁ ൌ ଵ
ோమൈ௡೅ಶ
∑ ௥ߴ
௠భ,௠మሺ1 െ ௥ߴ
௠భ,௠మሻோ௥ୀଵ       (2.4.14) 
and also that 
                                      ҧܼଶ ൌ
ణഥ෡೘భ,೘మ ି ாቀణഥ෡೘భ,೘మቁ
ටఙమቀణഥ෡೘భ,೘మቁ
~ܰሺ0,1ሻ.                (2.4.15) 
Without loss of generality therefore, the mean prediction error rate 
ҧߴመ௠భ,௠మ,…,௠ೕ, ݆ ൌ 1, 2, … , ݍ, computed by classification rule ߮௠భ,௠మ,…,௠ೕሺ࢞ሻ 
using the set of ݆ genes ܺ௠భ, ܺ௠మ, … , ܺ௠ೕ would have the following 
distributional properties; 
                    E ቀ ҧߴመ௠భ,௠మ,…,௠ೕቁ ൌ ߤణ
௠భ,௠మ,…,௠ೕ                    (2.4.16) 
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         ߪଶ ቀ ҧߴመ௠భ,௠మ,…,௠ೕቁ ൌ ଵ
ோమൈ௡೅ಶ
∑ ௥ߴ
௠భ,௠మ,…,௠ೕሺ1 െ ௥ߴ
௠భ,௠మ,…,௠ೕሻோ௥ୀଵ    (2.4.17)   
and                       ҧܼ௝ ൌ
ణഥ෡೘భ,೘మ,…,೘ೕ ି ாቀణഥ෡೘భ,೘మ,…,೘ೕቁ
ටఙమቀణഥ෡೘భ,೘మ,…,೘ೕቁ
~ܰሺ0,1ሻ.              (2.4.18) 
All the above sampling distributions of the mean MERs work 
perfectly under the MCCV sub-sampling scheme. If the cross-
validation by bootstrapping is to be used, little modification has to be 
effected. We shall only present the sampling distribution of the 
average MER estimates for the bootstrap.632+ scheme (Efron & 
Tibshirani, 1997) as used in this thesis. 
The estimator of the average MER employed by classification rule 
߮௠భ,௠మ,…,௠ೕሺ࢞ሻ using a set of genes ܺ௠భ, ܺ௠మ, … , ܺ௠ೕ according to the 
bootstrap.632+ sub-sampling scheme is given by  
ҧߴመ
௕௢௢௧௦௧௥௔௣
௠భ,௠మ,…,௠ೕ ൌ 0.632 כ ଵ
ோ
∑ መߴ௥.௧௘௦௧
௠భ,௠మ,…,௠ೕோ
௥ୀଵ ൅ 0.368 כ
ଵ
ோ
∑ መߴ௥.௧௥௔௜௡
௠భ,௠మ,…,௠ೕோ
௥ୀଵ   
From the above estimator, the following results are trivial; 
E ቀ ҧߴመ௕௢௢௧௦௧௥௔௣
௠భ,௠మ,…,௠ೕቁ ൌ 0.632 כ ଵ
ோ
∑ ௥ߴ.௧௘௦௧
௠భ,௠మ,…,௠ೕோ
௥ୀଵ ൅ 0.368 כ
ଵ
ோ
∑ ௥ߴ.௧௥௔௜௡
௠భ,௠మ,…,௠ೕோ
௥ୀଵ      
՜        E ቀ ҧߴመ௕௢௢௧௦௧௥௔௣
௠భ,௠మ,…,௠ೕቁ ൌ 0.632 כ ߤణ.௧௘௦௧
௠భ,௠మ,…,௠ೕ ൅ 0.368 כ ߤణ.௧௥௔௜௡
௠భ,௠మ,…,௠ೕ       (2.4.19) 
 Also,  ߪଶ ቀ ҧߴመ௕௢௢௧௦௧௥௔௣
௠భ,௠మ,…,௠ೕቁ ൌ ሺ0.632ሻଶ כ ଵ
ோమ
∑ ߪଶ൫ መߴ௥.௧௘௦௧
௠భ,௠మ,…,௠ೕ൯ோ௥ୀଵ        
                     ൅ሺ0.368ሻଶ כ ଵ
ோమ
∑ ߪଶ൫ መߴ௥.௧௥௔௜௡
௠భ,௠మ,…,௠ೕ൯ோ௥ୀଵ  
՜ ߪଶ ቀ ҧߴመ௕௢௢௧௦௧௥௔௣
௠భ,௠మ,…,௠ೕቁ ൌ ሺ0.632ሻଶ כ ଵ
ோమൈ௡೅ಶ
∑ ௥ߴ.௧௘௦௧
௠భ,௠మ,…,௠ೕ൫1 െ ௥ߴ.௧௘௦௧
௠భ,௠మ,…,௠ೕ൯ோ௥ୀଵ     
                     +ሺ0.368ሻଶ כ ଵ
ோమൈ௡೅ೃ
∑ ௥ߴ.௧௥௔௜௡
௠భ,௠మ,…,௠ೕ൫1 െ ௥ߴ.௧௥௔௜௡
௠భ,௠మ,…,௠ೕ൯ோ௥ୀଵ  (2.4.20) 
and similarly we have that 
                        ҧܼ௝.௕௢௢௧௦௧௥௔௣ ൌ
ణഥ෡್೚೚೟ೞ೟ೝೌ೛
೘భ,೘మ,…,೘ೕ ି ாቀణഥ෡್೚೚೟ೞ೟ೝೌ೛
೘భ,೘మ,…,೘ೕቁ
ටఙమቀణഥ෡್೚೚೟ೞ೟ೝೌ೛
೘భ,೘మ,…,೘ೕቁ
~ܰሺ0,1ሻ.      (2.4.21) 
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where ்݊ோ ൌ ݊, the bootstrap sample. Further details on 
bootstrap.632+ MER estimator are provided in Section 2.5. 
Now, let us consider the unbiased estimator of δଵభ ൌ ߤణ
௠భ െ ߤణ
௠భ,௠మ 
given by δ෠ଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ as defined under one directional 
hypothesis set (2.4.4). It then follows that 
  ܧ൫δ෠ଵభ൯ ൌ ܧ ቀ ҧߴመ௠భቁ െ E ቀ ҧߴመ௠భ,௠మቁ ൌ ߤణ
௠భ െ ߤణ
௠భ,௠మ         (2.4.22) 
and if we consider any possible association between ҧߴመ௠భ and ҧߴመ௠భ,௠మ 
since both of them are estimated using the cross-validated random 
samples ்݊ா ൈ ܴ that are generated from original sample size ݊, 
then, the variance of δ෠ଵభ could be estimated by 
             ߪଶ൫δ෠ଵభ൯ ൌ ߪଶ ቀ ҧߴመ௠భቁ ൅ ߪଶ ቀ ҧߴመ௠భ,௠మቁ െ 2ܿ݋ݒ ቀ ҧߴመ௠భ,௠మ, ҧߴመ௠భቁ  (2.4.23) 
where ܿ݋ݒ ቀ ҧߴመ௠భ,௠మ, ҧߴመ௠ଵቁ is the covariance estimate that accounts for 
any possible association that may exist between the two empirical 
average MERs. This could be simply estimated by  
ܿ݋ݒ ቀ ҧߴመ௠భ,௠మ, ҧߴመ௠ଵቁ ൌ ߩො ቀ ҧߴመ௠భ,௠మ, ҧߴመ௠భቁ כ ටߪଶ ቀ ҧߴመ௠భ,௠మቁ כ ߪଶ ቀ ҧߴመ௠భቁ,   (2.4.25) 
where ߩො ቀ ҧߴመ௠భ,௠మ, ҧߴመ௠భቁ is the Pearson correlation coefficient estimate 
between  ҧߴመ௠భ and ҧߴመ௠భ,௠మ. 
If Gaussian distribution is assumed for random variable δ෠ଵభ ൌ ҧߴመ௠భ െ
ҧߴመ௠భ,௠మ, the difference of two successive MERs estimated at step 1, 
then, it follows that δ෠ଵభ~ܰ ቀܧ൫δ෠ଵభ൯, ߪଶ൫δ෠ଵభ൯ቁ and consequently, we 
shall have that ܼఋ෡భభ ൌ
ఋ෡భభିா൫ఋ
෡
భభ൯
ටఙమ൫ఋ෡భభ൯
~ܰሺ0,1ሻ.    
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More generally, for any observed pair of empirical average MERs 
ҧߴመ௠భ,௠మ,…,௠ೕ and ҧߴመ௠భ,௠మ,…,௠ೕశభ, ݆ ൌ 1, 2, … , ݍ െ 1, for which Gaussian 
distribution is assumed for the difference of successive pair of 
average MERs δ෠௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ or δ෠௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ
ҧߴመ௠భ,௠మ,…,௠ೕ, that is,  δ෠௝ೞ~ܰ ቀߜ௝ೞ, ߪଶ൫δ෠௝ೞ൯ቁ , ݏ ൌ 1,2, it is obvious that 
                                 ߜ௝భ ൌ ܧ൫δ෠௝భ൯ ൌ ߤణ
௠భ,௠మ,…,௠ೕ െ ߤణ
௠భ,௠మ,…,௠ೕశభ     
                          ߜ௝మ ൌ ܧ൫δ෠௝మ൯ ൌ ߤణ
௠భ,௠మ,…,௠ೕశభ െ ߤణ
௠భ,௠మ,…,௠ೕ             
and with δ෠௝ೞ ൌ േ ቀ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభቁ for ݏ ൌ 1 or 2, we shall 
have that 
ߪଶ൫δ෠௝ೞ൯ ൌ ߪଶ ቀ ҧߴመ௠భ,௠మ,…,௠ೕቁ ൅ ߪଶ ቀ ҧߴመ௠భ,௠మ,…,௠ೕశభቁ 
                                േ2ܿ݋ݒ ቀ ҧߴመ௠భ,௠మ,…,௠ೕశభ, ҧߴመ௠భ,௠మ,…,௠ೕቁ                  (2.4.27) 
Hence, the assumption that 
                                         ܼஔ෡ೕೞ ൌ
ஔ෡ೕೞିఋೕೞ
ටఙమቀஔ෡ೕೞቁ
~ܰሺ0,1ሻ                         (2.4.28) 
equally holds. 
However, when considering the differences between two successive 
pair of bootstrap MERs, the modifications effected on the bootstrap 
.632+ MER estimator as provided in equations (2.4.19) to (2.4.21) 
need to be incorporated.  
In what follows, we present the procedure for testing the general 
form of the hypothesis set in (2.4.4) over successive ݆ average MER 
differences. Its optimality properties shall also be discussed. The 
(2.4.26) 
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simple case of two gene selection as considered by hypothesis set 
(2.4.4) shall be illustrated at the end of this section. 
Let ܺ௠భ,  ܺ௠భܺ௠మ,  ܺ௠భܺ௠మܺ௠య, … , ܺ௠భܺ௠మܺ௠య … ܺ௠೜ be the sequence 
of selected gene combinations by respective classification rules 
߮௠భሺ࢞ሻ,  ߮௠భ,௠మሺ࢞ሻ,  ߮௠భ,௠మ,௠యሺ࢞ሻ ,…, ߮௠భ,௠మ,௠య,…,௠೜ሺ࢞ሻ  based on their 
marginal contributions at reducing the average MERs in successive 
models with the last classifier using all the ݍ genes. The 
corresponding average cross-validated MERs produced by the above 
sets of gene combinations are given by ҧߴመ௠భ,   ҧߴመ௠భ,௠మ,  ҧߴመ௠భ,௠మ,௠య,
… , ҧߴመ௠భ,௠మ,௠య,…,௠೜ respectively. However, the prediction accuracy of 
each successive classification rule is expected to improve as 
additional genes are selected into the model. Therefore, the following 
order of the estimated mean MERs is expected for all the selection 
steps at which additional genes are selected for prediction: 
                     ҧߴመ௠భ ൐ ҧߴመ௠భ,௠మ ൐ ҧߴመ௠భ,௠మ,௠య ൐, … , ൐ ҧߴመ௠భ,௠మ,…,௠೜         (2.4.29) 
If the complete ordered form of average MERs in (2.4.29) is observed 
by our new classifier in any given microarray data set, it simply 
indicates that the best prediction model with the least (optimum) 
average MER ҧߴመ௠భ,௠మ,…,௠೜ uses all the ݍ genes. However, this is not 
practically feasible, because the apparent improvement in prediction 
accuracies due to successive inclusion of additional genes would 
vanish at a particular selection step. When such a step is reached, 
the inclusion of additional gene(s) would either brings no further 
improvement in prediction accuracy into the current model or 
worsen the prediction performance of the previous model. Our 
proposed classification rule here therefore seeks to determine the 
optimal gene selection level at which the best prediction accuracy 
would be achieved. 
 
 
 55 
If we consider the difference between the  ݆௧௛ and ሺ݆ ൅ 1ሻ௧௛ average 
MERs as indexed by ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ or                    
ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ, ݆ ൌ 1, … , ݍ െ 1, using the ݍ expected 
order of performance formulated in (2.4.29), then we shall            
have two ways by which the ݍ െ 1 mean MER differences                 
can be formulated. We present these two                         
formulations as ࢾ෡૚ ൌ ቀ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ, … , ҧߴመ௠భ,௠మ,…,௠೜షభ െ ҧߴመ௠భ,௠మ,…,௠೜ቁ and                      
ࢾ෡૛ ൌ ቀ ҧߴመ௠భ,௠మ െ ҧߴመ௠భ, … , ҧߴመ௠భ,௠మ,…,௠೜ െ ҧߴመ௠భ,௠మ,…,௠೜షభቁ. The estimators of 
the two vectors ࢾ෡૚ and ࢾ෡૛ are identical except for the sign 
differences. These two formulations are again presented in Table 2.4. 
We shall develop the test procedures that will handle the two 
formulations for our gene selection problem. The two vectors may 
therefore be represented in terms of ߜመ௝ೞ, ݏ ൌ 1,2, as 
                                       ࢾ෡૚ ൌ ൫ߜመଵభ, ߜመଶభ, … , ߜመሺ௤ିଵሻభ൯                        (2.4.30) 
                              ࢾ෡૛ ൌ ൫ߜመଵమ, ߜመଶమ, … , ߜመሺ௤ିଵሻమ൯                        (2.4.31) 
Mean MERs ݆ ൌ 1 … ݆ ൌ ݍ െ 1 
ߜመ௝భ ൌ ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ െ ࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ … ҧߴመ௠భ,௠మ,௠య,…,௠೜షభ െ ҧߴመ௠భ,௠మ,௠య,…,௠೜ 
ߜመ௝మ ൌ ࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ െ ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ ҧߴመ௠భ,௠మ െ ҧߴመ௠భ … ҧߴመ௠భ,௠మ,௠య,…,௠೜ െ ҧߴመ௠భ,௠మ,௠య,…,௠೜షభ 
 
Table 2.4: Table of the two average MER difference formulations ߜመ௝ೞ ൌ േሺ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభሻ 
for s = 1 or 2 respectively at any two successive  gene selection steps ݆ and ݆ ൅ 1. 
It should be noted that, the expected order of mean MERs in (2.4.29) 
does not necessarily suggest that the respective minimum mean 
MER pair differences as given in (2.4.30) and (2.4.31) would also 
followed that unique order. The implementation of the k sequential 
selection procedure (k-SS) we proposed under the two minimum 
mean MER difference formulations in (2.4.30) and (2.4.31) are 
presented in what follows. 
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 The ݇-SS procedures under the ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ 
difference formulations 
For any two successive selection steps ݆ and ݆ ൅ 1, let ߜመ௝భ ൌ
ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ, ݆ ൌ 1, … , ݍ െ 1 be the vector of minimum 
mean MER differences as presented in (2.4.30). Better 
improvements in successive models are expected as additional genes 
are being selected into the models. Thus, at any two successive 
selection steps ݆ and ݆ ൅ 1 at which additional gene is selected, 
positive values of ߜመ௝భ ’s would be observed in as much as the 
inequality ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ ൐  ܥଵఈ is maintained for some 
critical value ܥଵఈ of the k-SS test procedure to be determined. This is 
the stage 1 of our sequential selection procedure. Improvement in 
prediction performance as observed at stage 1 shall continue until 
the second selection stage, stage 2, is reached at which the marginal 
improvements in successive models begin to diminish. At this stage, 
the estimated average minimum mean MERs ҧߴመ௠భ,௠మ,…,௠ೕశభ would be 
approaching that of ҧߴመ௠భ,௠మ,…,௠ೕ an indication that the current model 
(with additional one gene) is no more having significant marginal 
gain in terms of better prediction accuracy over the preceding model 
since   ߜመ௝భ ՜ 0.  
At the last selection stage, stage 3, considerable losses in prediction 
accuracy of the succeeding models are expected as more genes are 
selected. This selection stage is characterized by having the 
estimated ҧߴመ௠భ,௠మ,…,௠ೕశభԢݏ ൐ ҧߴመ௠భ,௠మ,…,௠ೕԢݏ which consequently implies 
that the ߜመ௝భԢݏ ൏ 0. Nonetheless, the optimal gene selection is 
expected at any of the last two selection stages (stage 2 or stage 3) at 
which further selection of additional genes into the model would 
yield no improvement in model’s prediction performance. The 
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moment such stage is reached, further gene selection stops. The 
schematic illustration of the three basic selection stages as described 
above with respect to the ߜመ௝ೞ formulation is presented in Fig 2.1a for 
ݏ ൌ 1.  
 
 
 
 
 
 
Fig 2.1: The schematic representations of the three stages of gene selection processes by the newly 
proposed  k-sequential selection (݇-SS) method under the two minimum mean MER differences 
ࢇ. ሻ ߜ෡௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ and ࢈. ሻ ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ at any two successive gene 
selection   steps  ݆ and ݆ ൅ 1, ݆ ൌ 1, … , ݍ െ 1. The  ܿଵఈ   represents   some   critical   value  of   the  k-SS  
                                                                     test procedure. 
 
For any two successive ݆௧௛ and ሺ݆ ൅ 1ሻ௧௛ gene selection steps, the 
appropriate general one directional hypothesis test required to 
justify the selection of additional gene at step ݆ is given by    
         ܪ଴ଵ௝: ߤణ
௠భ,௠మ,…,௠ೕ െ ߤణ
௠భ,௠మ,…,௠ೕశభ ൑ 0   vs. ܪ௔ଵ௝ : ߤణ
௠భ,௠మ,…,௠ೕ െ ߤణ
௠భ,௠మ,…,௠ೕశభ ൐ 0     
              ՜        ܪ଴ଵ௝ : ߜ௝భ ൑ 0 vs. ܪ௔ଵ௝ : ߜ௝భ ൐ 0, ݆ ൌ 1, … , ݍ െ 1           (2.4.32) 
where ߜ௝భ ൌ  ߤణ
௠భ,௠మ,…,௠ೕ െ ߤణ
௠భ,௠మ,…,௠ೕశభ. Obviously, the unbiased 
estimator of ߜ௝భ is given by ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ. However, 
the test hypothesis set (2.4.32) is the general form of the one 
directional hypothesis test (2.4.4).  
If ܪ଴ଵ௝ is accepted in the test hypothesis set (2.4.32) for any 
successive ݆௧௛ and ሺ݆ ൅ 1ሻ௧௛ pair of steps, this is an indication that the 
ሺࢇ. ሻ ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ 
 Stage 3          
 ߜመ௝భ ൏  ܥଵఈ (Loss in prediction power 
of successive models). Gene selection 
stops 
Stage 2                       
  ߜመ௝భ ൎ ܥଵఈ (No improvement in 
successive models) Gene selection 
stops 
 Stage 1                        
 ߜመ௝భ> ܥଵఈ (Improvement in 
successive models) Gene selection 
continues 
+∞ -∞ 0 
 ሺ࢈. ሻ ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ 
Stage 1                        
  ߜመ௝మ ൏  ܥଵఈ (Improvement in 
successive models)  Gene selection 
continues 
Stage 2 
ߜመ௝మ ൎ ܥଵఈ (No improvement in 
successive models) Gene selection 
stops 
Stage 3                      
     ߜመ௝మ> ܥଵఈ (Loss in prediction 
power of successive models). Gene 
selection stops 
+∞ -∞ 0 
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selection of additional one gene into the preceding ݆௧௛ model that 
yielded the mean MER ҧߴመ௠భ,௠మ,…,௠ೕ is no longer necessary because 
i) no further improvement in prediction accuracy is achieved 
from the current ሺ݆ ൅ 1ሻ௧௛ model despite the selection of 
additional one gene into the preceding ݆௧௛ model if 
ҧߴመ௠భ,௠మ,…,௠ೕ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ and that 
ii) the misclassification error rate of the current ሺ݆ ൅ 1ሻ௧௛ 
model is further worsened if one more gene is included in 
the ݆௧௛ model for which ҧߴመ௠భ,௠మ,…,௠ೕ ൏ ҧߴመ௠భ,௠మ,…,௠ೕశభ, as 
represented by the null hypothesis ܪ଴ଵ௝ where ҧߴመ௠భ,௠మ,…,௠ೕ 
and ҧߴመ௠భ,௠మ,…,௠ೕశభ are the average MER of the ݆௧௛(preceding) 
and ሺ݆ ൅ 1ሻ௧௛ (current) models respectively.   
Therefore in a loose term, at any two successive gene selection     
steps ݆௧௛ and ሺ݆ ൅ 1ሻ௧௛ the performance difference ҧߴመ௠భ,௠మ,…,௠ೕ െ
ҧߴመ௠భ,௠మ,…,௠ೕశభ ൐ ܥଵఈ need to be satisfied to guarantee the inclusion of 
additional one more gene into the preceding ݆௧௛ model, for some 
critical value ܥଵఈ  א Թ. This literally translates to stopping the 
selection of additional gene at step ݆ if ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ ൑
ܥଵఈ. 
To construct a formal statistical test for hypothesis set (2.4.32), let  
ܼࢾ෡૚ ൌ ቌ
ఋ෡భభିா൫ఋ
෡
భభ൯
ටఙమ൫ఋ෡భభ൯
,
ఋ෡మభିா൫ఋ
෡
మభ൯
ටఙమ൫ఋ෡మభ൯
, … ,
ఋ෡ሺ೜షభሻభିாቀఋ
෡
ሺ೜షభሻభቁ
ටఙమቀఋ෡ሺ೜షభሻభቁ
ቍ   (2.4.33) 
be the vector of test statistics for testing the set of ݆ one directional 
hypothesis in (2.4.32), ݆ ൌ 1, … , ݍ െ 1.  According to (2.4.28), each of 
the test statistics  ܼఋ෡ೕభ ൌ
ఋ෡ೕభିாቀఋ
෡
ೕభቁ
ටఙమቀఋ෡ೕభቁ
א ܼࢾ෡૚ in (2.4.33) is assumed to have 
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a standard Gaussian distribution. It then follows that vector 
ܼࢾ෡૚ ൌ  ቀܼఋ෡భభ , ܼఋ෡మభ , … , ܼఋ෡ሺ೜షభሻభ ቁ of the test statistics could be assumed to 
have a multivariate standard Gaussian distribution with ሺݍ െ 1ሻ ൈ
ሺݍ െ 1ሻ unit variance-covariance matrix Σ. It should be noted that, 
we only assumed Gaussian distribution for ܼఋ෡ೕభ  or ߜ
መ௝భ, its true 
theoretical distribution (if different from Gaussian) shall be 
determined at a later part of this work.  
Nonetheless, under the null hypothesis ܪ଴ଵ௝,  ܧ൫ߜመ௝భ൯ ൌ ߜ௝భ ൌ 0, and by 
our earlier distributional assumption on ߜመ௝ೞ, ݏ ൌ 1,2, we have that 
ߜመ௝భ ܽݏݕ݉݌ݐ෧ ܰ ቀ0, ߪଶ൫ߜመ௝భ൯ቁ and that ܼఋ෡ೕభ ൌ
ఋ෡ೕభ
ටఙమቀఋ෡ೕభቁ
ܽݏݕ݉݌ݐ෧ ܰሺ0,1ሻ. It then 
follows that each successive pair of mean MERs ҧߴመ௠భ,௠మ,…,௠ೕ and 
ҧߴመ௠భ,௠మ,…,௠ೕశభ computed at ݆௧௛ and ሺ݆ ൅ 1ሻ௧௛ steps could be tested 
sequentially using the test statistic 
ఋ෡ೕభ
ටఙమቀఋ෡ೕభቁ
. Therefore, the decision 
rules for such sequential test could be stated as follows; 
i) Stop the selection of additional one gene into the ݆௧௛ model 
(accept ܪ଴ଵ௝ at the ݆௧௛ step) if 
                                ܼఋ෡ೕభ ൌ
ఋ෡ೕభ
ටఙమቀఋ෡ೕభቁ
൑ ܥఈଵ     (2.4.34) 
ii) Select additional one gene into the ݆௧௛ model (accept ܪ௔ଵ௝ at 
the ݆௧௛ step) if 
                                ܼఋ෡ೕభ ൌ
ఋ෡ೕభ
ටఙమቀఋ෡ೕభቁ
൐ ܥఈଵ     (2.4.35) 
where ܥఈଵ is the critical value of the percentage point of the 
hypothesized distribution (e.g. Gaussian, etc.) of ܼఋ෡ೕభat a significance 
level ߙ to be determined. 
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Equivalently, the above decision rules (2.4.34) and (2.4.35) can be re-
stated respectively as follows; 
iii) Stop the selection of additional one gene into the ݆௧௛ model 
(accept ܪ଴ଵ௝ at the ݆௧௛ step) if 
          ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ ൑ ܥఈଵටߪଶ൫ߜመ௝భ൯           (2.4.36) 
iv) Select additional one gene into the ݆௧௛ model (accept ܪ௔ଵ௝ at 
the ݆௧௛ step) if 
                   ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ ൐ ܥఈଵටߪଶ൫ߜመ௝భ൯           (2.4.37) 
Using the decision rules (2.4.36) and (2.4.37), the new critical value 
ܥఈଵටߪଶ൫ߜመ௝భ൯ of ߜመ௝భ directly substitutes for ܥଵఈ as used earlier. 
Therefore, at the ݆௧௛ selection step, the decision is to stop the 
selection of additional one gene into the ݆௧௛ model if the inequality in 
(2.4.36) is satisfied while the selection of additional one gene is 
accepted if the inequality (2.4.37) is satisfied.  
An important aspect of this new test procedure is that for any 
hypothesized distribution of our test statistics ܼఋ෡ೕభ  or ߜ
መ௝భ, the value of 
the significance level ߙ used by the test which consequently 
determines the size of the critical values ܥఈଵ or ܥఈଵටߪଶ൫ߜመ௝భ൯is not pre-
determined by us as often the case with some variable selection 
methods (see our comments on SLR method and some other variable 
selection techniques as earlier discussed under this chapter). In 
other words, the size ߙ of our sequential test procedure at which 
optimal sub-set of genes are selected is determined through internal 
cross-validation and not arbitrarily fixed, for instance, to 0.05 or 
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something else by the investigator. Our procedure seeks to perform 
gene selections and response class predictions over all possible range 
of values of significance level ߙ within the interval [0,1]. That value 
(range of values) of ߙ between 0 and 1 at which the decision rule 
(2.4.36) is satisfied and for which the optimal (best) prediction 
accuracy is achieved becomes the size of ߙ of our test. Consequently, 
the selected ݇ ൌ ݆ gene(s), ݆ ൌ 1, … , ݍ െ 1 at which further gene 
selection terminates becomes the needed optimal informative ݇ 
genes suitable for classifying the mRNA subjects into their 
appropriate the tumour sub-groups. More details on this shall be 
provided in Chapter 3. 
It should be recalled that each of the estimated average MERs 
ҧߴመ௠భ,   ҧߴመ௠భ,௠మ,  ҧߴመ௠భ,௠మ,௠య, … , ҧߴመ௠భ,௠మ,௠య,…,௠೜ is a minimum statistic 
estimate computed at each gene selection steps. This literally 
implies that at any given successive ݆th and ሺ݆ ൅ 1ሻth pair of gene 
selection steps, ݆ ൌ 1, … , ݍ െ 1, the statistic ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ
ҧߴመ௠భ,௠మ,…,௠ೕశభ or ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ is a difference between 
two observed minimum mean MERs ҧߴመ௠భ,௠మ,…,௠ೕ and ҧߴመ௠భ,௠మ,…,௠ೕశభ 
obtained at ݆௧௛ and   ሺ݆ ൅ 1ሻ௧௛ steps respectively.  
Although, Gaussian distribution has been earlier assumed for the 
estimators ߜመ௝ೞ ൌ േሺ ҧߴመ௠భ,௠మ,…,௠ೕെ ҧߴመ௠భ,௠మ,…,௠ೕశభሻ, ݏ ൌ 1 or 2, their true 
distribution might be different from Gaussian due to the fact that 
their realizations are the differences of two minimum statistics. 
Therefore, in testing the null hypothesis ܪ଴ଵ௝: ߤణ
௠భ,௠మ,…,௠ೕ െ
ߤణ
௠భ,௠మ,…,௠ೕశభ ൑ 0 in (2.4.32), we suspected that the test statistic 
ܼఋ෡ೕభ ൌ
ఋ෡ೕభ
ටఙమቀఋ෡ೕభቁ
  constructed for the test might not follow a standard 
Gaussian distribution as would have been expected under the null. If 
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our suspicion is correct, then, the use of the critical values of the 
percentage point of the standard normal distribution Zଵିఈ for ܥఈଵ in 
(2.4.34) to (2.4.37) for the test might not be appropriate. Base on this 
suspicion, it is necessary to determine the true distribution of the 
difference ߜመ௝భ or ܼఋ෡ೕభ  whose quantile values could be suitably 
determine as the correct value of ܥఈଵටߪଶ൫ߜመ௝భ൯ or ܥఈଵ as appropriate. 
We shall use the gene selection results at steps 0 and 1 to illustrate 
the procedures that leads to the determination the distribution of 
ߜመ௝భ. At step 0, gene  ܺ௠భ א ൛ ሺܺଵሻ, ሺܺଶሻ, …  , ሺܺ௤ሻൟ that yielded the 
minimum mean MER ҧߴመ௠భ ൌ ݉݅݊ ቀ ҧߴመሺଵሻ, ҧߴመሺଶሻ, … , ҧߴመሺ௤ሻቁ among the set of 
ordered mean MERs ҧߴመሺଵሻ, ҧߴመሺଶሻ, … , ҧߴመሺ௤ሻ is selected with ҧߴመ௠భ ൌ ҧߴመሺଵሻ.  
Therefore, for ݆ ൌ 1, … , ݍ, let ҧߴመሺ௝ሻ has unknown density function 
݂ణഥ෡ሺೕሻሺߦ଴ሻ. Then, from the distribution of ordered statistics, it is very 
easy to establish the density function of ҧߴመ௠భ as  
                               ݂ ҧߴ෠݉1 ሺݏ଴ሻ ൌ ݍሾ1 െ ܨ ҧߴ෠݆݉ ሺߦ଴ሻሿ௤ିଵ݂ణഥ෡ሺೕሻሺߦ଴ሻ               (2.4.38) 
where ܨణഥ෡ሺೕሻሺߦ଴ሻ ൌ ׬ ݂ణഥ෡ሺೕሻሺݑሻ݀ݑ
కబ
ିஶ .  
Similarly, at step 1, our sequential procedure selected the gene pair 
ܺ௠భܺ௠మ א ൛ܺ௠భ ሺܺଶሻ, ܺ௠భ ሺܺଷሻ, … , ܺ௠భ ሺܺ௤ሻൟ that yielded the minimum 
mean MERs ҧߴመ௠భ,௠మ = ݉݅݊ ቀ ҧߴመ௠భሺమሻ , ҧߴመ௠భሺయሻ, … , ҧߴመ௠భሺ೜ሻቁ among the set of 
ݍ െ 1 mean MERs ҧߴመ௠భሺమሻ , ҧߴመ௠భሺయሻ, … , ҧߴመ௠భሺ೜ሻ. Let the ordered statistics of 
the ݍ െ 1 mean MER sequence ҧߴመ௠భሺమሻ, ҧߴመ௠భሺయሻ, … , ҧߴመ௠భሺ೜ሻ be given by 
ҧߴመሺଵଶሻ, ҧߴመሺଵଷሻ, … , ҧߴመሺଵ௤ሻ respectively with ҧߴመ௠భ,௠మ ൌ ҧߴመሺଵଶሻ. Also let the 
unknown density function of each ҧߴመሺଵ௝ሻ, ݆ ൌ 2, … , ݍ, be given by 
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݂ ҧߴ෠ሺ1݆ሻሺߦଵሻ. Then, it can be easily verified that the density function of 
ҧߴመ௠భ,௠మ is of the form  
                         ݂ ҧߴ෠݉1,݉2 ሺݏଵሻ ൌ ሺݍ െ 1ሻሾ1 െ ܨ ҧߴ෠ሺ1݆ሻሺߦଵሻሿ௤ିଶ݂ ҧߴ෠ሺ1݆ሻሺߦଵሻ         (2.4.39) 
Given that the difference of the two minimum average MERs ҧߴመ௠భ 
and ҧߴመ௠భ,௠మ is ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ, then, the distribution of ߜመଵభ is 
desired from which the critical value ܥఈଵ of our one directional 
hypothesis tests (2.4.4) and by extension, that of the general test in 
(2.4.32) can be determined. 
If we represent the joint density of ҧߴመ௠భ and ҧߴመ௠భ,௠మ by           
݂ߴҧመ݉1 ,ߴҧመ݉1,݉2 ሺ ҧߴመ
݉1
, ҧߴመ݉1,݉2ሻ, then, the distribution of ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ can be 
determined as follows; 
Let the distribution function of  ߜመଵభ be given by  
    ܨ̂ߜ11 ൫ߜመ൯ ൌ ܲ൫ߜመଵభ ൑ ߜመ൯ ൌ ܲ ቀ ҧߴ
መ௠భ െ ҧߴመ௠భ,௠మ ൑ ߜመቁ 
                     ܨ̂ߜ11 ൫ߜመ൯ ൌ  ׭ ݂ߴҧመ݉1 ,ߴҧመ݉1,݉2 ሺ ҧߴመ
݉1
, ҧߴመ݉1,݉2ሻ݀ሺ ҧߴመ݉1ሻ݀ҧߴ෠݉1 െ ҧߴ෠݉1,݉2 ൑̂ߜ ሺ ҧߴመ
݉1,݉2ሻ  
      ؠ           ܨ̂ߜ11 ൫ߜመ൯ ൌ  ׬ ቂ׬ ݂ߴҧመ݉1 ,ߴҧመ݉1,݉2 ሺ ҧߴመ
݉1
, ҧߴመ݉1,݉2ሻҧߴ
෠݉1 െ̂ߜ
ିஶ ݀ሺ ҧߴመ
݉1,݉2ሻቃ ݀ሺ ҧߴመ݉1ሻஶିஶ    (2.4.40) 
If we substitute ҧߴመ௠భ െ ݒ for ҧߴመ௠భ,௠మ in (2.4.40) for any arbitrary 
variable ݒ, then we shall have that, 
                    ܨ̂ߜ11 ൫ߜመ൯ ൌ  ׬ ቂ׬ ݂ߴҧመ݉1 ,ߴҧመ݉1,݉2 ሺ ҧߴመ
݉1
, ҧߴመ݉1 െ ݒሻ̂ߜିஶ ݀ሺݒሻቃ ݀ሺ ҧߴመ
݉1ሻஶିஶ         (2.4.41)   
Similarly, if ҧߴመ௠భ,௠మ ൅ ݒ  is substituted for ҧߴመ௠భ in (2.4.40), we have  
                  ܨ̂ߜ11 ൫ߜመ൯ ؠ ׬ ቂ׬ ݂ߴҧመ݉1 ,ߴҧመ݉1,݉2 ሺ ҧߴመ
݉1,݉2
൅ ݒ, ҧߴመ݉1,݉2ሻ̂ߜିஶ ݀ሺݒሻቃ ݀ሺ ҧߴመ
݉1,݉2ሻஶିஶ   (2.4.42) 
The representations (2.4.41)   and (2.4.42) are the expressions for the 
distribution function of ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ . To obtain the density 
 
 
 64 
function of ߜመଵభ,  ݂̂ߜ11 ൫ߜመ൯, we simply take the derivative of the 
distribution function in (2.4.41)   and (2.4.42) respectively. Therefore, 
from (2.4.41) we shall have that; 
            ݂̂ߜ11 ൫ߜመ൯ ൌ  
ௗி̂ߜ
11
൫ఋ෡൯
ௗఋ෡
ൌ ௗ
ௗఋ෡
ቄ׬ ൣ׬ ݂ߴҧመ݉1 ,ߴҧመ݉1,݉2 ሺ ҧߴመ
݉1
, ҧߴመ݉1 െ ݒሻஶିஶ ݀ሺ ҧߴመ
݉1ሻ൧݀ሺݒሻ̂ߜିஶ ቅ  
while from (2.4.42) we shall have that;   
         ݂̂ߜ11 ൫ߜመ൯ ൌ  
ௗி̂ߜ
11
൫ఋ෡൯
ௗఋ෡
ൌ ௗ
ௗఋ෡
ቄ׬ ൣ׬ ݂ߴҧመ݉1 ,ߴҧመ݉1,݉2 ሺ ҧߴመ
݉1,݉2
൅ ݒ, ҧߴመ݉1,݉2ሻஶିஶ ݀ሺ ҧߴመ
݉1,݉2ሻ൧݀ሺݒሻ̂ߜିஶ ቅ   
These consequently yield the two forms of ݂̂ߜ11 ൫ߜመ൯ given by  
                             ݂̂ߜ11 ൫ߜመ൯ ൌ ׬ ݂ߴҧመ݉1 ,ߴҧመ݉1,݉2 ሺ ҧߴመ
݉1
, ҧߴመ݉1 െ ݒሻ݀ሺ ҧߴመ݉1ሻஶିஶ              (2.4.43) 
                             ݂̂ߜ11 ൫ߜመ൯ ൌ ׬ ݂ߴҧመ݉1 ,ߴҧመ݉1,݉2 ሺ ҧߴመ
݉1,݉2
൅ ݒ, ҧߴመ݉1,݉2ሻஶିஶ ݀ሺ ҧߴመ
݉1,݉2ሻ        (2.4.44) 
respectively. 
If Gaussian densities with means ߤణ
௠భ & ߤణ
௠భ,௠మ and variances 
ߪଵ ൌ ߪଶ ቀ ҧߴመ௠భቁ & ߪଶ ൌ ߪଶ ቀ ҧߴመ௠భ,௠మቁ are as initially assumed for the 
distribution of both ҧߴመ௠భ & ҧߴመ௠భ,௠మ respectively hold, then, the density 
function ݂̂ߜ11 ൫ߜመ൯ in (2.4.43) can be expressed in terms of the joint 
density function of both ҧߴመ௠భ and ҧߴመ௠భ,௠మ as  
                     ݂ఋ෡భభ ൫ߜ
መ൯ ൌ ׬ ଵ
ଶగఙభఙమඥଵିఘమ
݁ݔ݌ ቂെ ௭భ
ଶሺଵିఘమሻ
ቃ ݀ ቀ ҧߴመ௠భቁஶିஶ       (2.4.45) 
where   ݖଵ ൌ
ቀణഥ෡೘భିఓഛ
೘భቁ
మ
ఙభ
൅
ቀణഥ෡೘భି௩ିఓഛ
೘భ,೘మቁ
మ
ఙమ
െ
ଶఘቀణഥ෡೘భିఓഛ
೘భቁቀణഥ෡೘భି௩ିఓഛ
೘భ,೘మቁ
ఙభఙమ
  
and ߩ ൌ ܿ݋ݎݎሺ ҧߴመ௠భ, ҧߴመ௠భ,௠మሻ. Also, from (2.4.44), the equivalent form of 
݂ఋ෡భభ ൫ߜ
መ൯ as in (2.4.45) can be established in terms of ҧߴመ௠భ,௠మ as 
                  ݂ఋ෡భభ ൫ߜ
መ൯ ൌ ׬ ଵ
ଶగఙభఙమඥଵିఘమ
݁ݔ݌ ቂെ ௭మ
ଶሺଵିఘమሻ
ቃ ݀ ቀ ҧߴመ௠భ,௠మቁஶିஶ      (2.4.46) 
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where   
ݖଶ ൌ
ቀణഥ෡೘భ,೘మା௩ିఓഛ
೘భቁ
మ
ఙభ
൅
ቀణഥ෡೘భ,೘మିఓഛ
೘భ,೘మቁ
మ
ఙమ
െ
ଶఘቀణഥ෡೘భ,೘మା௩ିఓഛ
೘భቁቀణഥ෡೘భ,೘మିఓഛ
೘భ,೘మቁ
ఙభఙమ
 
More generally, for any pair of minimum average MERs  ҧߴመ௠భ,௠మ,…,௠ೕ 
and ҧߴመ௠భ,௠మ,…,௠ೕశభ having Gaussian densities with respective means 
ߤణ
௠భ,௠మ,…,௠ೕ and ߤణ
௠భ,௠మ,…,௠ೕశభ and variances ߪଵ ൌ ߪଶ ቀ ҧߴመ௠భ,௠మ,…,௠ೕቁ and 
ߪଶ ൌ ߪଶ ቀ ҧߴመ௠భ,௠మ,…,௠ೕశభቁ, the density function of the difference ߜመ௝భ ൌ
ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ could be obtained from the marginal density 
functions of  both  ҧߴመ௠భ,௠మ,…,௠ೕ and ҧߴመ௠భ,௠మ,…,௠ೕ as  
             ݂ఋ෡ೕభ ൫ߜ
መ൯ ൌ ׬ ଵ
ଶగఙభఙమඥଵିఘమ
݁ݔ݌ ቂെ ௭భభ
ଶሺଵିఘమሻ
ቃ ݀ ቀ ҧߴመ௠భ,௠మ,…,௠ೕቁஶିஶ     (2.4.47) 
or equivalently as 
          ݂ఋ෡ೕభ ൫ߜ
መ൯ ൌ ׬ ଵ
ଶగఙభఙమඥଵିఘమ
݁ݔ݌ ቂെ ௭భమ
ଶሺଵିఘమሻ
ቃ ݀ ቀ ҧߴመ௠భ,௠మ,…,௠ೕశభቁஶିஶ     (2.4.48) 
where ߩ ൌ ܿ݋ݎݎሺ ҧߴመ௠భ,௠మ,…,௠ೕ, ҧߴመ௠భ,௠మ,…,௠ೕశభሻ, ݖଵଵ and ݖଵଶ are respectively 
given as 
             ݖଵଵ ൌ
ቀణഥ෡೘భ,೘మ,…,೘ೕିఓഛ
೘భ,೘మ,…,೘ೕቁ
మ
ఙభ
൅
ቀణഥ෡೘భ,೘మ,…,೘ೕି௩ିఓഛ
೘భ,೘మ,…,೘ೕశభቁ
మ
ఙమ
  
                     െ
ଶఘቀణഥ෡೘భ,೘మ,…,೘ೕିఓഛ
೘భ,೘మ,…,೘ೕቁቀణഥ෡೘భ,೘మ,…,೘ೕି௩ିఓഛ
೘భ,೘మ,…,೘ೕశభቁ
ఙభఙమ
 
and      ݖଵଶ ൌ
ቀణഥ෡೘భ,೘మ,…,೘ೕశభା௩ିఓഛ
೘భ,೘మ,…,೘ೕቁ
మ
ఙభ
൅
ቀణഥ෡೘భ,೘మ,…,೘ೕశభିఓഛ
೘భ,೘మ,…,೘ೕశభቁ
మ
ఙమ
  
                 െ
ଶఘቀణഥ෡೘భ,೘మ,…,೘ೕశభା௩ିఓഛ
೘భ,೘మ,…,೘ೕቁቀణഥ෡೘భ,೘మ,…,೘ೕశభିఓഛ
೘భ,೘మ,…,೘ೕశభቁ
ఙభఙమ
 
However, since we have suspected earlier that the Gaussian density 
might not be appropriate as the distribution of ߜመ௝భ, the true density 
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function, ݂ఋ෡ೕభ ൫ߜ
መ൯ in (2.4.47) or (2.4.48) of ߜመ௝భ estimator would be 
determined through simulation studies in Chapter 3 in line with the 
set-up of our proposed sequential test procedures. The quantile 
values of the true theoretical density of ߜመ௝భ (or ߜመ௝మ) to be determined 
shall then be true critical value ܥఈଵ (or ܥఈଶ) of our test.  
 The ݇-SS procedures under the ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ 
difference formulations 
In a similar manner, if the differences of the successive pairs of 
minimum mean MERs ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ as presented in 
equation (2.4.31) and Table 2.4 are used to construct our k-SS 
method, the same results and conclusion as obtained under the ߜመ௝భ 
formulations would be obtained. Under the ߜመ௝మ formulation however, 
negative values of ߜመ௝మ ’s would be observed at all selection steps for 
which ҧߴመ௠భ,௠మ,…,௠ೕశభ ൏ ҧߴመ௠భ,௠మ,…,௠ೕ, denoting the stage 1 of the 
sequential selection stages. At this stage, the prediction power of the 
succeeding models would continue to improve. At stage 2 however, 
the situation for which ҧߴመ௠భ,௠మ,…,௠ೕశభ ՜ ҧߴመ௠భ,௠మ,…,௠ೕ would exist, 
implying that the difference ߜመ௝మ ՜ 0. Thus, no significant 
improvements in successive models in terms of prediction accuracies 
would be expected at this selection stage. Finally, at stage 3, it is 
expected that ҧߴመ௠భ,௠మ,…,௠ೕశభ ൐ ҧߴመ௠భ,௠మ,…,௠ೕ so that ߜመ௝మ ൐ 0. Considerable 
losses in prediction accuracies of successive models would be 
recorded at this stage. The schematic presentation of these three 
selection stages under the ߜመ௝మ formulation of our k-SS method is 
presented in Fig 2.1b.  
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Now, if we consider the difference formulation ߜመ௝మ, the appropriate 
one directional hypothesis of interest would be of the form 
ܪ଴ଶ௝: ߤణ
௠భ,௠మ,…,௠ೕశభ െ ߤణ
௠భ,௠మ,…,௠ೕ ൒  0 vs. ܪ௔ଶ௝ : ߤణ
௠భ,௠మ,…,௠ೕశభ െ ߤణ
௠భ,௠మ,…,௠ೕ ൏ 0 
 ՜                          ܪ଴ଶ௝ : ߜ௝మ ൒ 0  vs.  ܪ௔ଶ௝ : ߜ௝మ ൏ 0, ݆ ൌ 1, … , ݍ െ 1                   (2.4.49) 
where ߜ௝మ ൌ ߤణ
௠భ,௠మ,…,௠ೕశభ െ ߤణ
௠భ,௠మ,…,௠ೕ with its unbiased estimator 
given by ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ.  As defined in (2.4.43), vector 
ܼࢾ෡૛ ൌ  ቀܼఋ෡ೕమ ቁ, for ݆ ൌ 1, … , ݍ െ 1, is the vector of the test statistics for 
testing the ݍ െ 1 hypothesis set (2.4.49), where ܼఋ෡ೕమ ൌ
ఋ෡ೕమିாቀఋ
෡
ೕమቁ
ටఙమቀఋ෡ೕమቁ
, 
ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ, and ܧ൫ߜመ௝మ൯ ൌ 0 under ܪ଴ଶ௝ . The 
decision rules with respect to ߜመ௝మ formulation are as follows; 
i) Stop the selection of additional one gene into the ݆௧௛ model 
(accept ܪ଴ଶ௝) at the ݆௧௛ step if 
       ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ ൒ ܥఈଶටߪଶ൫ߜመ௝మ൯        (2.4.50) 
ii) Select additional one gene into the ݆௧௛ model (accept ܪ௔ଶ௝) at 
the ݆௧௛ step if 
        ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ ൏ ܥఈଶටߪଶ൫ߜመ௝మ൯       (2.4.51) 
where the critical values ܥఈଶ for the test shall equally be determined 
through cross-validation using the theoretical distribution of ߜመ௝మ or 
ܼఋ෡ೕమ . The true distribution of ߜ
መ௝మ is similar to that of ߜመ௝భ. Necessary 
details on this are provided in Chapter 3.  
It should however be noted that the use of either of the hypothesis 
test (2.4.32) or (2.4.49) would yield the same selection and 
classification results. All these are demonstrated in the next chapter. 
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In summary, when ܪ଴ଵ௝ or ܪ଴ଶ௝ is accepted using decision rules 
(2.4.34)-(2.4.37) or (2.4.50)-(2.4.51) depending on whether hypothesis 
set (2.4.32) or (2.4.49) is used respectively at any particular  ݆ step, 
further gene selection into the ݆௧௛ model stops and the ݇ ൌ ݆ genes 
selected at that point becomes the optimal informative genes. If on 
the other hand, ܪ௔ଵ௝ or ܪ௔ଶ௝ is accepted, additional one gene is added 
at step ݆ after which the search for the next best gene begins. A 
single algorithm that captures the whole k-SS procedures is 
presented in Section 3.2. Nonetheless, we present clearly in what 
follows, the basic steps required in the implementation of our k-SS 
method. We shall provide illustrations using the hypothesis set 
(2.4.4) designed for only two gene selection steps.   
Here, we shall revert to the use of our initial notations in which gene 
ܺ௠భ is the first gene to be selected at Step 0 being the gene that 
yielded the minimum mean MER ҧߴመ௠భ among the ordered sequence of 
the original ݍ genes, ܺሺଵሻ, ሺܺଶሻ, … , ሺܺ௤ሻ and the gene pair ܺ௠భܺ௠మ is 
the set of genes that yielded the minimum mean MER ҧߴመ௠భ௠మ among 
the ݍ െ 1 sequence of gene pairs ܺ௠భ ሺܺଶሻ, ܺ௠భ ሺܺଷሻ, … , ܺ௠భ ሺܺ௤ሻ. Here, 
we shall test whether the inclusion of additional gene ܺ௠మ into the 
preceding classification model that contains only gene ܺ௠భ improves 
or worsen the prediction strength of the current model through the 
average minimum MERs difference ߜመ௝భ ൌ ҧߴመ௠భ െ ҧߴመ௠భ௠మ or ߜመ௝మ ൌ
ҧߴመ௠భ௠మ െ ҧߴመ௠భ. If this difference is not significant based on appropriate 
decision rule (2.4.37) or (2.4.51) depending on whether test statistic 
ߜመ௝భ or ߜመ௝మis used, it simply shows that the marginal contribution of 
gene ܺ௠మ at improving the current model is not significant. Then, 
further gene selection stops and the model containing only gene ܺ௠భ 
becomes the best optimal model. On the other hand, if its 
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contribution is significant according to decision rule (2.4.36) or 
(2.4.50), the new selected gene ܺ௠మ would be retained with ܺ௠భ in 
the model   while the search for the next best gene to be added with 
ܺ௠భ ܺ௠మ would begin.  
This sequential selection steps continues until none of the remaining 
genes could satisfy the decision criteria (2.4.37) or (2.4.51) that 
allows the selection of additional genes into the model. The ݇ genes 
selected, ݇ ൏ ݍ, at which no additional genes can be selected into the 
model becomes the required optimal ݇ informative genes and the 
response class predictions provided by such set of genes becomes the 
optimal prediction.  
Backward checks 
It is suspected that at each gene selection step where new gene is 
selected into the model, it might be possible for some of the 
previously selected genes not to be useful again for prediction given 
that a new gene is now in the model. Based on this suspicion, we 
perform backward checks on each of the previously selected genes 
whenever a new gene is selected. The procedure is straight forward, 
if a new gene is selected into the model and an average MER, say 
ҧߴመ ௙௨௟௟ is computed for the full model, then each of the previously 
selected gene is removed from the model and a new model is fitted 
using all other genes except the removed gene. An average MER, say 
ҧߴመ ௥௘௠௢௩௘ is computed for each model without the removed gene. If 
ҧߴመ ௥௘௠௢௩௘ ൐ ҧߴመ ௙௨௟௟, it simply suggests that the removed gene is 
important in the model and should be retained. But if ҧߴመ ௥௘௠௢௩௘ ൑
ҧߴመ ௙௨௟௟, then the removed gene is not useful again in the model and it 
is permanently removed from the model. Generally, the number of 
backward checks, denoted by ݊஻஼, to be performed at each gene 
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selection step ݆ for which ݇ ൌ ݆ ൅ 1 genes have been selected is 
݊஻஼ ൌ ݇ െ 1 
Our newly proposed ݇-sequential gene selection (݇-SS) method is 
implemented using R statistical package (http://www.r-project.org/) 
and the R code we developed for its implementation is presented in 
Appendix B.1. The R code that performs the backward checks is also 
provided in Appendix B.2. 
The dimension reduction, informative gene selection and response 
class prediction procedures as executed by our new ݇-SS method for 
binary response class can be generalized to a polytomous class 
prediction with true class categories ݕ ൌ 0, 1, … , ঙ  (ݕ ൐ 1) using any 
of the following approaches: 
 Pair-wise coupling: This approach is adapted from Hastie & 
Tibshirani (1998) and it begins by constructing a separate 
binary ݇-SS classifier for each of the distinct pair of classes 
ݕᇱ, ݕᇱᇱ א ঙ, ݕᇱ ് ݕᇱᇱ.  For any microarray data set that contains 
a fixed response class ঙ ൐ 1, a total of ঙሺঙ െ 1ሻ/2 distinct 
binary ݇-SS classifiers would be constructed with each of them 
predicting a class member in ঙ. At the end, the results of all 
the classifiers are combined and final decision is made by 
majority voting. The class category with the highest votes 
would be chosen as the predicted class for each subject. This 
approach is also called One-vs-One-scheme (Tan et al, 2005) or 
Round Robin Ensemble (Furnkranz, 2002).  
 One-vs-Others scheme: For a polytomous response class 
ݕ ൌ ሼ0, 1, … , ঙሽ in which the class members follow some natural 
ordering, the ݇-SS classifier can be constructed to distinguish 
a reference class ݕכ א ঙ from all other class labels. By this, all 
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other complementary classes are put into one group. The log of 
the ratio of the posterior probabilities used in the logit model 
would be of the form ݈݊ ൤ ௣ሺ௬
כ|ࢄሻ
∑ ௣ሺ௬|ࢄሻঙషభ೤
൨. Other variants of this 
approach can be found in Hand (1997), Speed (2003), Dudoit et 
al(2002) and some other related works. 
2.5   Assessment of the ࢑-SS classifier  
As remarked earlier, the goodness of classification rule ߮ሺ࢞ሻ is 
generally assessed through a discrepancy function ܮሼ ଴ܻ, ߮ሺ࢞ሻሽ called 
the loss function, where  ଴ܻ ൌ ݕ௜, ݅ ൌ 1, … ,  ்݊ா, is the true class labels 
(0,1) of any independent ்݊ா subjects that are predicted by ߮ሺ࢞ሻ. 
From now on, ߮ and ߮௝ shall be used to represent ߮ሺ࢞ሻ and ߮௝൫ ௝ܺ൯ 
respectively, dropping both ࢞ and ௝ܺ for simplicity. For instance, the 
loss function ܮሼ ଴ܻ, ߮ሺ࢞ሻሽ shall become ܮሺ ଴ܻ, ߮ሻ. 
As demonstrated in the previous section, the main concern while 
assessing any classification function is to find that rule ߮ that 
minimizes the loss function ܮሺ ଴ܻ, ߮ሻ. The concept of 0-1 loss function 
as commonly used is to describe a situation where ߮ correctly or 
incorrectly predicts each of the  ்݊ா subjects. In this case, the 
respective loss is 0 or 1 for any subject that is correctly or incorrectly 
predicted by rule ߮. That is, the loss is ܮ൫ ෠ܻ଴ ൌ 1, ො߮ ൌ 1൯ ൌ ܮ൫ ෠ܻ଴ ൌ
0, ො߮ ൌ 0ሻ ൌ 0 for correct prediction and is ܮ൫ ෠ܻ଴ ൌ 1, ො߮ ൌ 0൯ ൌ
ܮ൫ ෠ܻ଴ ൌ 0, ො߮ ൌ 1൯ ൌ 1 for incorrect prediction. 
However, the loss function may be given in terms of absolute or 
square error loss functions. An absolute error loss function is defined 
by  
                        ܮሺ ଴ܻ, ߮ሻ ൌ | ଴ܻ െ ߮|                              (2.5.1)  
 
 
 72 
while the square error loss function is given by  
                                         ܮሺ ଴ܻ, ߮ሻ ൌ ሺ ଴ܻ െ ߮ሻଶ                   (2.5.2) 
The expected loss of using rule ߮ to classify all the ்݊ா subjects is 
then given by the risk function  
     ݎሺ߮ሻ ൌ  ܧ࢞ሾܮሺ ଴ܻ, ߮ሻሿ       (2.5.3) 
            ՜   ݎሺ߮ሻ ൌ  ∑ ܮሺݕ௜,  ො߮௜ሻ݌ሺ࢞|ݕ௜ሻ݌௡బ௜ୀଵ , ݕ ൌ 0, 1.            (2.5.4) 
But since the true density function ݌ሺ࢞|ݕ௜ሻ in (2.5.4) is not known, 
the risk ݎሺ߮ሻ is usually estimated from the sample by  
           መߴ ൌ ̂ݎሺ߮ሻ ൌ ଵ
 ௡೅ಶ
∑ |ݕ௜ െ  ො߮௜|
 ௡బ
௜ୀଵ                (2.5.5) 
if absolute error loss function is used, or by   
                                      መߴ ൌ ̂ݎሺ߮ሻ ൌ ଵ
 ௡೅ಶ
∑ ሺݕ௜ െ  ො߮௜ሻଶ
 ௡బ
௜ୀଵ                (2.5.6) 
if the square error loss function is used. 
The risk estimator given by (2.5.5) is the equivalent form of the 
empirical misclassification error rate (MER) given by (2.4.3).  
Among other estimators of prediction error rate suggested in the 
literature are the brier or quadratic score and logarithmic score. 
The brier score, proposed by Brier (1950), is the average deviation 
between the predicted probabilities ݌̂ሺ1|࢞ሻ that a set of subjects 
belong to particular response class and the true subjects classes. The 
brier score simply replaces the predicted class labels  ො߮௜ with the 
predicted class probabilities ݌̂௜ሺ1|࢞ሻ in the square error loss function 
definition of the MER in (2.5.6) that the subjects belong to the 
predicted classes. This is given by 
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        መߴ஻௥௜௘௥ ൌ
ଵ
 ௡೅ಶ
∑ ሺݕ௜ െ ݌̂௜ሺ1|࢞ሻሻଶ
 ௡೅ಶ
௜ୀଵ                      (2.5.7) 
where 0 ൑ መߴ஻௥௜௘௥ ൑ 1. 
The logarithmic or informational score has been equally reported as 
a reliable measure of performance of classifiers (Hand, 1997; Witten 
& Frank, 2000). Like brier score, it also uses the predicted 
probabilities  ݌̂௜ሺ1|࢞ሻ in its assessment. Its definition for a two-class 
prediction is given by  
         መߴ௟௢௚ ൌ െ
ଵ
 ௡೅ಶ
∑ ሼݕ௜݈݋݃ሾ݌̂௜ሺ1|࢞ሻሿ ൅ ሺ1 െ ݕ௜ሻ݈݋݃ሾ1 െ ݌̂௜ሺ1|࢞ሻሿሽ
 ௡೅ಶ
௜ୀଵ  (2.5.8) 
where 0 ൑ መߴ௟௢௚ ൏ ∞. Like both the MER and the brier scores, a small 
value of the log score equally shows a better performance of the 
classifier. What distinguishes the log score index from the other two 
scores is that it produces a set of general and uncalibrated scores 
that are not bounded between 0 and 1. 
Nonetheless, both the MER and brier scores are part of assessment 
measures adopted to evaluate the performance of our new ݇-SS 
classifier.  
Apart from MER, brier or logarithm scores, there are some other 
performance measures under the pseudo name of similarity indices 
as well as the receiver operating characteristics (ROC) analysis that 
are equally appropriate to assess the goodness of a classification 
rule.  
The similarity indices 
The most prominent similarity indices among others are the Jaccard 
index (Jaccard, 1901), Dice-Sørensen index (Dice, 1945), Ochiai index 
(Ochiai, 1957) and the Simple Matching index (Sokal & Michener, 
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1958). Some other variants to these four can be found in Simpson 
(1960), Hazel (1970), Sokal & Sneath (1973) and many others.  It has 
been reported, Zucknick et al (2008), that both Dice-Sørensen and 
Ochiai indexes are simple modification of Jaccard index. Expectedly, 
these three indices tend to similar results’ interpretation. Therefore, 
we shall only consider the Jaccard index being the most popular 
among the three measures.  
The simple matching index, as would be seen shortly, is just the 
complement of the misclassification error rate (MER) given by (2.13), 
(2.14), and (2.63), which we have adopted in the construction of our 
݇-SS classifier. In an unambiguous term, SMI = 1-MER. Therefore, 
the SMI shall not be given any separate treatment here again.  
More generally, using the 2 ൈ 2 confusion matrix in Table 2.1, the 
following similarity indices can be estimated as follows; 
 Jaccard index (JI) is an asymmetric similarity measure 
between two classifiers (subjects’ true class grouping and 
classification by ݇-SS classifier) which attaches more 
importance to the correct or incorrect classification of subjects 
with outcome of interest (group 1 subjects). It is estimated by    
                               ߩ௃ሺܶ, ܲሻ ൌ  
௡ሺ்ת௉ሻ
௡ሺ்׫௉ሻ
ൌ ௔
௔ା௕ା௖
      (2.5.9) 
 Dice-Sørensen index: ߩ஽ିௌሺܶ, ܲሻ ൌ  
ଶ௔
ଶ௔ା௕ା௖
 
 Ochiai index: ߩைሺܶ, ܲሻ ൌ  
௔
√௔ା௕כ√௔ା௖
 
 Simple matching index (SMI): ߩௌெሺܶ, ܲሻ ൌ
௔ାௗ
௔ା௕ା௖ାௗ
 
Like any other performance measures adopted in this work, the 
estimates of the Jaccard index, as will be reported later, are the 
cross-validated estimates based on the respective subsampling 
scheme adopted for estimation. The R code that computes the JI are 
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already part of the main code we developed for the implementation 
of our ݇-SS method as provided in Appendix B.1. Therefore, the 
cross-validated estimates of the JI indices shall be part of our ݇-SS 
results’ outputs. 
The receiver operating characteristic (ROC) analysis 
The ROC analysis is an integral part of measures commonly adopted 
to assess the worth of any classification rule. It was originally 
developed by Egan (1975) for analysis of radar images in signal 
detection theory. Its procedure was later adapted into the screening 
of diagnostic tests to aid medical decisions (Swets, 1988; Zou, 2002; 
Shapiro & Brutlag, 2004; etc.). This has helped to determine 
whether a particular patient will benefit from a given treatment or 
not. The extension of ROC analysis to assess the performance of 
classifiers has been reported in Swets et al (2000), Fawcett (2006) 
and many other related studies. 
The excellent use of ROC analysis lies in the construction and uses 
of the ROC curve and the area under the curve (AUC). The ROC 
curve is a useful tool to describe the performance of a classifier (or 
diagnostic test) that discriminates between normal (healthy) and 
cancerous (diseased) subjects based on variable(s) measured on 
continuous scale.  In other words, both the ROC curve and the area 
under the curve (AUC) are measures of ranking of the quality of a 
classifier.   
Suppose the expression level of gene ௝ܺ is measured on ݊ subjects 
with two outcome groups 1 (for tumour subjects) and 0 (for normal 
subjects). Let ଵܺ௝ and ܺ଴௝ ( ଵܺ௝,ܺ଴௝ א ௝ܺ) denote the expression levels of 
݊ଵ and ݊଴ subjects in groups 1 and 0 respectively, ݊ଵ ൅ ݊଴ ൌ ݊. 
Necessarily, ଵܺ௝ measures are assumed to be greater that ܺ଴௝ if gene 
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௝ܺ is to discriminated the response group ݊ଵ from ݊଴. What AUC then 
does is to rank all the ݊ subjects based on their gene expression 
levels and compute the probability of correct ranking of any 
randomly selected (tumour, normal) subject pair given by (Green & 
Swets, 1966), 
    ܣ ൌ ݌ሺ ଵܺ௝ ൐ ܺ଴௝ሻ,  0 ൑ ܣ ൑ 1.    (2.5.10) 
This is the true area under the ROC curve and its estimate can be 
obtained in different ways. We highlighted below, four of the 
methods by which AUC can be computed as equally being reported 
in Hanley & McNeil (1983):  
 The trapezoidal rule, Morrison (2005), Fawcett (2006). 
 The output from Dorfman & Alf maximum likelihood 
estimation program, Dorfman & Alf (1969). 
 Plot of the original data on binomial graph paper and compute 
the AUC area from the slope and intercept of the plot by 
ܣመ ൌ ݌ሺܼ ൑  መܼ஺ሻ, where መܼ஺ ൌ
௜௡௧௘௥௖௘௣௧
ඥଵା௦௟௢௣௘మ
, and ܼ~ܰሺ0,1ሻ, Swets 
(1979). 
 The use of the Wilcoxon-Mann-Whitney test statistics 
approximation, Bamber (1975).   
After the AUC estimate ܣመ௝ has been computed for each gene ௝ܺ, the 
(null) hypothesis test that ௝ܺ is not capable to discriminate between 
any two subjects’ groups can be tested. This is given by,  
       ܪ଴: ݌൫ ଵܺ௝ ൐ ܺ଴௝൯ ൑ 0.5   vs.   ܪ௔: ݌൫ ଵܺ௝ ൐ ܺ଴௝൯ ൐ 0.5     (2.5.11) 
The value of ܣመ௝ very close to 1 will provide evidence to support that 
௝ܺ is a good discriminator of the two subjects’ groups (accepting ܪ௔) 
while a value of ܣመ௝ very close to 0.5 or less will suggest otherwise 
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(accepting ܪ଴). One can arrive at any of these two decisions using the 
100ሺ1 െ ߙሻ% confidence interval of ܣመ௝ given by  ܣመ௝ േ ܼఈݏ. ݁ሺܣመ௝ሻ where 
ݏ. ݁ሺܣመ௝ሻ is the standard error of ܣመ௝ as defined in Section 2.6, and ܼఈ is 
the percentiles of the standard normal distribution at a specified 
Type I error, ߙ. 
The plot of the ROC curve can be obtained for each gene ௝ܺ to 
visualize the performance of each of them as reported by their AUC 
estimates, ܣመ௝. The ROC curve is a 2-dimensional plot of sensitivity of 
the classifier against 1-specificity. The sensitivity, sometimes called 
the true positive (TP) rate or recall is plotted on the y-axis while 1-
specificity, also called the false positive (FP) /false alarm (FA) rate is 
plotted on the x-axis. In other words, the sensitivity of a classifier ߮ 
is given by the probability ݌ሺ߮ ൌ 1|ܻ ൌ 1ሻ while its specificity is 
estimated as ݌ሺ߮ ൌ 0|ܻ ൌ 0ሻ. The ROC curve however, shows the 
trade-off between the benefits (TP) and the costs (FP) of a 
classification or ranking rule ߮. Some of the metrics used to compute 
the sensitivity, specificity and other related measures are presented 
in the confusion matrix in Table 2.5.   
                      True Class (T)  
P
re
di
ct
ed
 
cl
as
s 
(P
) b
y 
࣐ෝ
 
 1 0 Marginal 
Total 
1 ܶܲ ܨܲ ܶܲ + ܨܲ 
0 ܨܰ ܶܰ ܨܰ+ ܶܰ 
 Marginal 
Total 
ܶܲ + ܨܰ ܨܲ + ܶܰ  
 
Table 2.5: Confusion matrix showing common performance metrics calculated from it.  
Along the column of the confusion matrix is the true class label of 
the outcome variable ܻ for the two biological sub-groupings of mRNA 
samples and along the row are the predicted classes of these subjects 
by the classifier ߮ሺ࢞ሻ. The cell entries ܶܲ, ܨܲ, ܨܰ, ܶܰ represent the 
true positive, false positive, false negative and true negative 
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respectively. Therefore, given the observed biological groups ݕ א ሼ0,1ሽ 
of the test sample ்݊ா and the predicted response class ො߮ א ሼ0,1ሽ as 
provided by ݇-SS classifier ߮ሺ࢞ሻ, the following performance 
measures can be computed from the confusion matrix in Table 2.5 
among others:  
 Sensitivity = ்௉
்௉ାிே
ൌ  
∑ ூሺ௬೔ୀଵ; ఝෝ೔ୀଵሻ
೙೅ಶ
೔సభ
∑ ூሺ௬೔ୀଵሻ
೙೅ಶ
೔సభ
        
 Specificity = ்ே
ி௉ା்ே
ൌ  
∑ ூሺ௬೔ୀ଴; ఝෝ೔ୀ଴ሻ
೙೅ಶ
೔సభ
∑ ூሺ௬೔ୀ଴ሻ
೙೅ಶ
೔సభ
 
 Positive predictive value = ்௉
்௉ାி௉
ൌ  
∑ ூሺ௬೔ୀଵ; ఝෝ೔ୀଵሻ
೙೅ಶ
೔సభ
∑ ூሺఝෝ೔ୀଵሻ
೙೅ಶ
೔సభ
 
 Negative predictive value = ்ே
்ேାிே
ൌ  
∑ ூሺ௬೔ୀ଴; ఝෝ೔ୀ଴ሻ
೙೅ಶ
೔సభ
∑ ூሺఝෝ೔ୀ଴ሻ
೙೅ಶ
೔సభ
 
where ܫሺ. ሻ is an indicator function whose value is 1 if its argument is 
true and 0 otherwise. The positive predictive value (PPV) measures 
the precision of the classifier. It shows the proportion of the true 
class 1 (tumour) subjects that are correctly classified into that class 
among those that were classified as class 1 subjects by classifier 
߮ሺ࢞ሻ. Similarly, the negative predictive value gives the proportion of 
group 0 (healthy) subjects that are correctly classified into that 
group among the subjects classified as group 0 subjects. 
The estimates of all the above performance measures are obtained as 
cross-validated estimates for each of the ݇-SS classifiers constructed. 
The R codes we developed to compute all the cross-validated 
performance measures are already incorporated into the main R 
codes we developed for the construction of our ݇-SS classifier as 
given in Appendix B.1. 
To construct the ROC curves for the ݇-SS classifiers, all the test 
samples ்݊ாଵ, … , ்݊ாோ generated by MCCV or bootstrap over ܴ 
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random partitions are merged into one large sample                     
்݊ாכ ൌ ሺ்݊ாଵ, … , ்݊ாோሻ. The true class labels ݕ א ሼ0,1ሽ and the predicted 
probabilities ݌̂ሺݕ|࢞ሻ א ሾ0,1ሿ of belonging to any of the ݕ classes 
estimated for each subject in ்݊ாכ  are observed. These two values are 
then passed into our algorithm to generate the cross-validated ROC 
(CVROC) curves for each of the ݇-SS classifiers. More details on 
various ways to construct a typical ROC curve are provided by 
Fawcett (2006). 
A flexible procedure for  generating ROC curve in R as implemented 
in the ROCR library (library(ROCR)) by Sing et al (2005) was 
adapted into our main R codes (see Appendix B.1) to generate the 
CVROC curves for our ݇-SS classifier.  
A particular variant of the ROC curve which we do not consider in 
this thesis is the ordinal dominance curve (ODC) proposed by 
Bamber (1975). The ODC is obtained by reversing the axes of the 
ROC curve. By this, a plot of specificity (on the y-axis) against 1-
sensitivity (on the x-axis) produces a typical ODC curve. More 
details on this could be found in Hsieh & Turnbull(1996). 
2.6    The AUC preliminary feature selection method  
A new preliminary feature selection procedure we introduce in this 
work is based on the concepts and criteria of the area under the ROC 
curve (AUC). The importance of the ROC curve as a good measure of 
performance of a classification or ranking rule has been reported in 
many works as discussed in Section 2.3.1. The exact relationship 
between the empirical prediction error rate (PER) and the estimated 
area beneath the ROC curve (AUC) has been established by Cortes 
& Mohri (2004). In their study, they established that if the empirical 
PER of a given ranking function, say ߮ሺܺሻ, is given by ߴ, then,  the 
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average estimated AUC over all possible rankings of subjects 
corresponding to ߮ሺܺሻ could be approximated by 1 െ ߴ especially 
when the two class probabilities  ݌̂଴ ൌ
 ௡బ
௡
 and  ݌̂ଵ ൌ
 ௡భ
௡
 are very close 
to each other. This argument particularly underscores the relevance 
of the AUC as another efficient measure to assess the goodness of 
classification or ranking rules. Therefore, the preliminary selection 
we are proposing here using AUC criteria could be seen as a 
classifier-like preliminary feature selection method. 
The reasons for proposing this new preliminary selection method are 
two-fold. The fact remains that there are no unique standard criteria 
for determining which genes to be selected at the preliminary 
selection stage while working with most of the preliminary feature 
selection methods. This is very true of the t-test approach as 
presented in Chapter 1 Section 1.4.2. For example, the choice of the 
cut-point ݌כ or its t-statistic (̂ݐ௦ or ̂ݐ௪) equivalent the under this 
approach is at the discretion of the investigators. Due to the absence 
of standard way of choosing such cut-point, it is not uncommon for 
different analysts to select different number and types of transcripts 
at preliminary selection stage for analysis under this method.  
Secondly, the common practice of using all the available mRNA 
sample size ݊ while performing preliminary feature selection 
without leaving out certain proportion of the sample for cross-
validation has been criticized to be capable of increasing the 
prediction bias of classification rules (Ambroise & McLachlan, 2002). 
This might consequently result to poor gene selection at the 
preliminary stage. This line of argument was equally corroborated 
by Ioannidis (2005) and recently by Boulesteix et al (2008). Hence, 
there is need to evolve a preliminary feature selection procedure, 
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like the one proposed here, that will allow for easy cross-validation 
through via external (independent) test samples.   
Consider a set of ݍ genes, ࢄ ൌ ሺ ଵܺ, … , ܺ௤ሻ, whose expression levels 
are measured on two groups ௜ܻ א ሼ0,1ሽ of ݊ biological subjects as 
previously described in relevant sections.  The main goal here is to 
perform a preliminary (primary) selection of potentially relevant 
ݍכgenes from all the available ݍ genes such that all the ݍ െ ݍכ non-
predictive genes are removed prior to model construction proper. The 
reasons for this are two-fold: One is to save a lot of computation time 
and efforts while carrying out the analysis. If the ݍ െ ݍכ ‘unwanted’ 
genes are not removed before any dimension reduction and 
prediction exercise is performed, a good classifier will still filter 
them out during the analysis proper, but at a huge cost of analysis 
time. To avoid this therefore, it is proper to filter them out before 
proper classifiers construction could begin. The second reason that is 
not too far from the first one is to reduce noise from the data before 
proper analysis could commence. This is to avoid undue influence of 
the irrelevant genes on classification results.  
Our procedure starts by partitioning the entire sample size ݊ into 
training sample, ்݊ோ and test sample, ்݊ா. This is followed by fitting 
univariate logit model, ݈݋݃݅ݐ൫ߨሺ ௝ܺሻ ൯ ൌ ߙ ൅ ߚ௝ܺ௝, ݆ ൌ 1, … , ݍ, on each of 
the ݍ genes using the training sample, ்݊ோ. Next is to use the fitted 
model to estimate the predicted class probabilities, ݌̂௜ሺ ௜ܻ ൌ ݕ| ௝ܺሻ, 
 ݅ ൌ 1, … , ்݊ா, (probability of subjects belonging to class ݕ), for each 
subject in the left out test sample, ்݊ா. This is followed by cross-
validation using sub-sampling scheme of ݒ-fold-cross-validation, the 
concepts of which shall be discussed fully in Section 2.7. By this 
choice of cross-validation method, the entire sample size ݊ is divided 
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into a number of equal fold ݒ with each of the ݒ fold serving as the 
test sample at each sample selection. The remaining ݒ െ 1 is then 
used to build the logit model. This method has the advantage of 
ensuring that all the observations are being used as both the 
training and test samples at different time. Thereafter, both the 
predicted probabilities ݌̂௜ሺ ௜ܻ ൌ ݕ| ௝ܺሻ and the true class labels ݕ א ሼ0,1ሽ 
for each subject in the test sample ்݊ா as observed from the fitted 
model for each gene ௝ܺ are used to construct the cross-validated ROC 
(CVROC) curve from which the respective area under the curve 
(AUC) would be estimated. 
Let the estimated AUC for each gene ௝ܺ using the test sample ்݊ா be 
denoted by ܣመ௑ೕ and let ܣҧመ௑ೕ be the respective average AUC obtained 
over the entire ݒ fold. To establish the significance or otherwise of 
the estimated average AUC ܣҧመ௑ೕ for each gene, we simply test one 
directional hypothesis set given in (2.6.1) for each ܣҧመ௑ೕ. By this, we 
construct and tested a total of ݍ hypothesis set of the form  
      ܪ଴௝: ݌൫ ଵܺ௝ ൐ ܺ଴௝൯ ൑ 0.5   vs.   ܪ௔௝: ݌൫ ଵܺ௝ ൐ ܺ଴௝൯ ൐ 0.5 ,  ݆ ൌ 1, … , ݍ,   
This could be equivalently written in terms of the average AUC, ܣҧ௑ೕ 
for the population as  
       ܪ଴௝: ܣҧ௑ೕ ൑ 0.5   vs.   ܪ௔௝: ܣҧ௑ೕ ൐ 0.5                    (2.6.1) 
Since the estimated AUC, ܣመ௑ೕ has a Gaussian distribution, Hanley & 
McNeil (1982), it then becomes easier to develop a test procedure for 
the hypothesis set in (2.6.1) as follows; 
                    ܣመ௑ೕ~ܰሺߤ஺, ߪ஺ଶሻ ՞ ܣҧመ௑ೕ~ܰሺߤ஺ҧ, ߪ஺ҧ
ଶሻ 
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          ՜                          ҧܼመ௑ೕ ൌ
஺ҧ෠೉ೕି ఓಲഥ
ටఙಲഥ
మ
~ܰሺ0, 1ሻ                               (2.6.2) 
where ߤ஺ҧ and ߪ஺ҧଶ are the mean and variance of ܣҧመ௑ೕ respectively. If we 
adapt Bamber’s estimator of standard error of the AUC, Bamber 
(1975),  ߪ஺ҧଶ could be estimated  by   
             ߪ஺ҧଶ ൌ  
஺ҧ෠೉ೕቀଵି஺ҧ
෠೉ೕቁାሺ௡భିଵሻ൬௉෠ೕೣశೣశೣషି஺ҧ
෠
೉ೕ
మ ൰ାሺ௡బିଵሻሺ௉෠ೕೣశೣషೣషି஺ҧ
෠
೉ೕ
మ ሻ
௡భ௡బ
       (2.6.3) 
where ෠ܲ௝௫శ௫శ௫ష is defined as the probability that a classifier ranks 
any two randomly chosen tumour subjects higher than a normal 
subject and ෠ܲ௝௫శ௫ష௫ష is the probability that a classifier ranks two 
randomly chosen normal subjects lower that a tumour subject. These 
two probabilities can be estimated by adapting the statistics 
proposed by Hanley & McNeil (1982) for which 
                       ෠ܲ௝௫శ௫శ௫ష ൌ
஺ҧ෠೉ೕ
ቀଶି஺ҧ෠೉ೕቁ
  and  ෠ܲ௝௫శ௫ష௫ష ൌ
ଶቀ஺ҧ෠೉ೕቁ
మ
ቀଵା஺ҧ෠೉ೕቁ
               (2.6.4) 
For any pre-specified level of significance ߙ, the apparent decision 
rule for the test hypothesis in (2.6.1) is to reject the null, ܪ଴௝ in 
favour of ܪ௔ if ҧܼመ௑ೕ ൌ
஺ҧ෠೉ೕି ఓಲഥ
ටఙಲഥ
మ
൒ ܼଵିఈ. This can be equivalently re-
constructed as; reject ܪ଴௝ in favour of ܪ௔௝ if 
                              ܣҧመ௑ೕ ൒ ߤ஺ҧ ൅ ܼଵିఈටߪ஺ҧଶ                                   (2.6.5) 
Under ܪ଴௝,  ܧ ቀܣҧመ௑ೕቁ ൌ ߤ஺ҧ ൌ 0.5, then, ܪ଴௝ is rejected in favour of ܪ௔௝ if 
               ܣҧመ௑ೕ ൒ 0.5 ൅ ܼଵିఈටߪ஺ҧଶ                                  (2.6.6) 
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and for any preliminary feature selection, the decision rule is to 
select that gene ௝ܺ whose estimated average AUC value ܣҧመ௑ೕ satisfies 
the inequality in (2.6.6).  
It should be noted that ܣҧመ௑ೕ ൌ 0.5 corresponds to AUC area that lies 
on the 450 diagonal line of a typical ROC plane as shown in Fig 2.2. 
Any gene whose AUC value revolves around the diagonal, as the 
case with gene OIP106 in Fig 2.2, does not possess any useful 
information to correctly predict (rank) the response group. Such gene 
lacks any good predictive power and should be dropped. In a 
nutshell, any gene whose AUC value is greater than 0.5 by ܼଵିఈ of 
its standard error would be selected primarily by this method for 
further analysis, where ܼଵିఈ is the quantile of the standard 
Gaussian density obtained at significance level ߙ. The size of ߙ for 
this test could be any of the conventional default values in the range 
ߙ א ሺ0, 0.05ሿ.  
 
Fig 2.2: A typical ROC curve for three (CASP1, SF3A1, OIP106) of the 24,026 genes in the rectal 
cancer microarray data. While the two genes, CASP1 and SF3A1 are informative as shown by their 
ROC curves being far away from the diagonal reference line with their respective high AUC 
estimates of 0.8916 and 0.9039, gene OIP106 contains no information to be able to predict the 
response group, hence, its own ROC curve revolves round or  below  the diagonal  reverence line with 
                                                relatively small AUC estimate of 0.4495.  
Using this procedure, a total of ݍכ potential discriminating genes 
would be selected at the preliminary gene selection stage with 
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extremely small chance of leaving out any of the potentially good 
genes from further analysis.   
The new preliminary feature selection method proposed here is 
implemented using R statistical package. The sub-sampling 
technique of ݒ-fold-cross-validation is adopted in the implementation 
of this method and the R codes that implement the procedure is 
presented in Appendix B.3. Due to the huge number of gene 
variables involved (usually in thousands) in microarray data sets, 
any choice of fold ݒ between 2 to 10 would be suitable for the test. 
The application of this new preliminary feature selection method is 
demonstrated in Chapter 3 in relation to our new k-SS method. The 
k-SS algorithms under the two sub-sampling scheme of MCCV and 
bootdtrap.632+ for which the new AUC preliminary feature selection 
is incorporated are provided in Appendix B.5 and B.7 respectively.  
2.7   Cross-validation techniques in brief 
In any typical microarray data, the number of available biological 
samples is usually very small. Since genes selections, biological 
sample predictions and all other performance measures are based on 
these small samples, it is therefore possible for the estimated results 
to be bias. As a result of this, it is important to device some 
estimation procedures that would ensure that the results obtained 
from the small sample would be a good representation of the 
population, thereby removing any form of bias from the estimators. 
For instance, the empirical prediction error rate (PER), መߴ௘௠௣ሺ௉ாோሻ 
estimated by classification rule ߮ሺ࢞ሻ using ݊ sample is expected to be 
close to the unseen true PER, ߴ௧௥௨௘ሺ௉ாோሻ for the entire population. The 
difference between the expected value of the PER estimator መߴ௘௠௣ሺ௉ாோሻ 
and the true PER value from the population is called the bias of 
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መߴ௘௠௣ሺ௉ாோሻ. That is, መߴ௕௜௔௦ ൌ ܧ൫ መߴ௘௠௣ሺ௉ாோሻ൯ െ ߴ௧௥௨௘ሺ௉ாோሻ.  If the bias, መߴ௕௜௔௦ is 
zero, it implies that ܧ൫ መߴ௘௠௣ሺ௉ாோሻ൯ ൌ ߴ௧௥௨௘ሺ௉ாோሻ an indication that the 
estimator መߴ௘௠௣ሺ௉ாோሻ is a good estimator of the population parameter 
ߴ௧௥௨௘ሺ௉ாோሻ. Hence, መߴ௘௠௣ሺ௉ாோሻ becomes an unbiased estimator of 
ߴ௧௥௨௘ሺ௉ாோሻ. But a large value of bias indicates that መߴ௘௠௣ሺ௉ாோሻ is not a 
good estimator of the population parameter and its results might not 
be suitable for generalization.  
One of the popular short cuts at removing bias from an estimator is 
through cross-validation techniques first introduced by Seymour 
Geisser (1993) with additional discussions on his works by Berry 
(2005). By cross-validation approach, the original sample size ݊ is 
partitioned into subsets such that the analysis is initially performed 
on a single subset of ݊ called the training sample, while the other 
subset(s), called the test sample(s) are retained for subsequent use 
in confirming and validating the results from previous analysis. 
Several forms of this method are available in the literature. The 
most prominent ones are discussed in what follows. 
i.) Holdout method 
By this method, the original ݊ sample is splitted randomly 
into two, ்݊ோ, ்݊ா, with ்݊ோ ൅ ்݊ா ൌ ݊. One part (்݊ோ) is used 
to train the classifier while the second part (்݊ா) is held out 
to test the goodness of the classifier. This is sometimes 
called out-of-bag method. In practice, it is customary to 
holdout 1/3 of ݊ (்݊ா) for testing and the remaining 2/3 of ݊ 
(்݊ோ) for training, McLachlan (1992). The empirical 
prediction error rate is computed over the test sample ்݊ா 
by 
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     መߴ௛௢௟ௗ௢௨௧ ൌ
ଵ
௡೅ಶ
∑ ൣܫሼఝෝ ሺࢄ೔ሻஷ ௒೔బሽ൧
௡೅ಶ
௜ୀଵ             (2.7.1) 
                                  Original sample size ሺ݊ሻ 
Training set Test set 
 
Fig 2.3: Schematic representation of the sample splitting under the Holdout cross- 
                                                    validation method 
The schematic representation of the sample split under this 
method is presented in Fig 2.3. This method poses no 
computational burden. Its major disadvantage apart from 
small sample size problem is that the sample used as the 
training or test sample might not be representative of the 
original sample. It is possible to miss out all members of a 
certain class in a training or test set. Therefore, whatever 
error rate reported might be misleading.  
ii.) Monte Carlo cross validation (MCCV)  
 
The MCCV method sometimes called random subsampling 
is one of the cross-validation techniques proposed to 
overcome the limitations of the holdout method. The 
approach is to repeat the process of taken random sub-
samples of training set, ்݊ோ and test set, ்݊ா from the 
original sample size ݊ several number of ሺܴሻ times (e.g. 50, 
100, 500, 1000 or 10000 repetitions) without replacement. 
At each random split, classifier is learned on the training 
set while its goodness is assessed on the test set via 
prediction error rate መߴ௥ ൌ
ଵ
௡೅ಶ
∑ ൣܫሼఝෝ೔ሺࢄሻஷ ௒೔బሽ൧
௡೅ಶ
௜ୀଵ  which is 
computed at each ݎ repetition, ݎ ൌ 1,2, … , ܴ. The different 
prediction error rates over the entire ܴ repetitions are then 
averaged to yield an overall average prediction error rate. 
That is 
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     ҧߴመோ ൌ  
ଵ
ோ
∑ መߴ௥ோ௥ୀଵ                                (2.7.2) 
However, the maximum number of subsamples of test set 
்݊ா that can be drawn from ݊ without replacement is 
ܴ ൌ ௡ሺ௡ିଵሻ…ሺ௡ି௡೅ಶାଵሻ
௡೅ಶ!
. This approach has been widely adopted 
in many works (Xu & Liang, 2001; Dudoit et al, 2002; Xu et 
al, 2004; Lee et al, 2005; Du et al, 2006; Zucknick et al, 
2008; etc.) due to its reliability and results’ consistencies. 
The supremacy of MCCV over the leave-one-out cross-
validation method (discussed below) was equally reported 
in Xu et al(2004). However, the MCCV approach is 
computationally demanding unlike the holdout method. A 
schematic representation of subsampling stages under 
MCCV is given by Fig 2.4. 
Original sample size ሺ݊ሻ 
Test set  
 
 
 
 
ڭ 
 
Fig 2.4: Schematic representation of the random sub-sampling for cross-validation  
                                                     under the MCCV method 
iii.) ݒ-fold-cross-validation 
In this method, the ݊ sample is divided into a number of 
mutually exclusive equal subsamples of fixed fold, ݒ. Each 
fold is used for testing while the remaining ݒ െ 1 folds are 
used for training. This exercise is repeated  ݒ times such 
that each of the ݒ test samples is used once. The prediction 
error rate መߴ௩ ൌ
ଵ
௡೅ಶ
∑ ൣܫሼఝෝ ሺࢄ೔ሻஷ ௒೔బሽ൧
௡೅ಶ
௜ୀଵ  is computed at each fold 
and the average of all the prediction error rates, averaged 
 Test set  
 Test set  
1st repetition 
2nd repetition 
ڭ 
Rth repetition 
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over ݒ, is computed as the true prediction error rate.  Thus, 
we have that 
     ҧߴመ௩ ൌ
ଵ
௩
∑ መߴआ௩आୀଵ                                 (2.7.3) 
A major challenge of this method is the determination of 
the best number of fold to be adopted. However, ten-fold 
cross-validation has been suggested in many studies as a 
standard way of measuring the misclassification error rate 
using this approach, Witten & Frank (2000), Molinaro et 
al(2005). Advantage of this approach is that one is sure that 
all the original samples are used for both classifier 
construction and its assessment. Nonetheless, the 
estimated prediction error rate may be associated with high 
variance due to the smallness of the sample size. A 
schematic representation of this subsampling procedure 
with ݒ ൌ 3 is given by Fig 2.5. 
       Original sample size ሺ݊ሻ 
Test sample  
 
 
 
 
 
Fig 2.5: Schematic representation of the ݒ-fold cross-validation method with ݒ ൌ 3 
iv.) Leave-one-out cross-validation (LOOCV) 
The LOOCV is an extreme case of ݒ-fold cross-validation 
with ݒ ൌ ݊. Here, each subject in the sample is left out and 
the remaining ݊ െ 1subjects are used to learn the classifier. 
The left out sample in turn is used to test the goodness of 
the classifier. This exercise is performed ݊ times to ensure 
that each subject has been used in the construction and 
validation of the classifier. Fig 2.6 gives its schematic form 
 Test sample  
 Test sample 
1st fold 
2nd fold 
3th fold 
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at each evaluation. The prediction error is obtained for each 
left out sample and the average for all the ݊ samples is 
taken as the empirical prediction error rate. That is 
      መߴ௟௢௢௖௩ ൌ
ଵ
௡
∑ ൣܫሼఝෝ ሺࢄ೔ሻஷ ௒೔బሽ൧
௡
௜ୀଵ             (2.7.4)  
where indicator function ܫሼ.ሽ is as defined in (2.4.3). 
Original sample size ሺ݊ሻ 
 ݊ െ 1 sample Training set 
 
 
 
 
ڭ 
 
Fig 2.6: Schematic representation of the Leave-one-out cross-validation method 
The advantage of this method is that it returns low bias for 
prediction error rate since almost all the sample size is used 
to train. Like in the ݒ-fold method, the LOOCV is equally 
associated with high variance of the prediction error rate. 
Nonetheless, it has been described as an elegant cross-
validation measure suitable for eliminating bias from an 
estimator provided that the original sample size ݊ is a true 
representation of the targeted population. This method has 
received a wider application in many research studies due 
to its simplicity, (Nguyen & Rocke, 2002a; Man et al, 2004; 
Boulesteix, 2004; Statnikov et al, 2005; etc.). 
v.) Bootstrap 
The bootstrap method is based on sampling with 
replacement. All the ݊ subjects is sampled ݊ times with 
replacement to give another ‘new’ ݊ data set. The new ݊ 
sample now becomes the training set and the original ݊ 
sample is the test set. Since sampling is done with 
replacement, there is tendency to have some observations 
            ݊ െ 1 sample Training set 
           ݊ െ 1 sample Training set  
1st evaluation 
2nd evaluation 
One sample test set ڭ 
݊ th evaluation 
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repeated in the new sample while some may not be sampled 
at all from the original sample. Therefore, the unsampled 
subjects in the original data become the test set by 
implication. A particular variant to this general 
bootstrapping is the bootstrap.632+ (Efron & Gong, 1983; 
Efron & Tibshirani,1997; etc.). The idea behind this new 
modification is that each subject in the original ݊ sample 
has a probability ଵ
௡
 of being selected into the new sample 
and ሺ1 െ ଵ
௡
ሻ of not being selected. Since the samples are 
drawn ݊ times with replacement, the chance that a subject 
is not selected into the new sample is then ቀ1 െ ଵ
௡
ቁ
௡
ൎ ଵ
௘
ൌ
0.368. Thus, for ݊ random bootstrap sampling, about 36.8% 
of ݊ will not be selected into the new data set (the training 
set). It shows that only about 1 െ ቀ1 െ ଵ
௡
ቁ
௡
ൎ 0.632 of ݊ 
would be in the training set while the remaining 0.368 of ݊ 
would be in the test set, hence, the term bootstrap.632+. 
Suppose we define መߴ௧௥௔௜௡ as the re-substitution prediction 
error rate computed over the training set and መߴ௧௘௦௧ as the 
bootstrap prediction error rate computed over the test set. 
The empirical prediction error rate for bootstrap.632+ 
scheme is given (Efron & Tibshirani,1997; Gerds & 
Schumacher, 2007; Binder & Schumacher, 2008) by  
  መߴ௕௢௢௧ ൌ 0.632 כ መߴ௧௘௦௧ ൅ 0.368 כ መߴ௧௥௔௜௡        (2.7.5) 
The entire bootstrap procedures are then repeated ܴ 
number of times as in MCCV, and respective average 
prediction error rates  ҧߴመ௧௘௦௧ ൌ 0.632
ଵ
ோ
∑ መߴ௥.௧௘௦௧ோ௥ୀଵ  and 
ҧߴመ௧௥௔௜௡ ൌ 0.368
ଵ
ோ
∑ መߴ௥.௧௥௔௜௡ோ௥ୀଵ  are computed.  These estimators 
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are then used to compute the overall average prediction 
error rate, ҧߴመ௕௢௢௧ for bootstrap.632+. Thus, we have that 
       ҧߴመ௕௢௢௧ ൌ
ଵ
ோ
∑ ൫0.632 כ መߴ௥.௧௘௦௧ ൅ 0.368 כ መߴ௥.௧௥௔௜௡൯ோ௥ୀଵ      (2.7.6) 
Out of all these cross-validation techniques, the methods of MCCV 
and bootstrap are adopted in this thesis for the implementation of 
our proposed k-SS classifier.  
2.8 Overview of some other classification methods 
In this section we provide brief overview of three of the existing 
state-of-the art classification methods as considered in this thesis. 
The three methods discussed here are the Support vector machines 
(SVM), ݇-nearest neighbours (݇-NN), and Partial least squares (PLS) 
methods. The theoretical background of other classification methods 
considered in this thesis can be found in the relevant literatures. 
The relative performance of all the methods as compared to the 
prediction results provided by our new ݇-SS classifier are discussed 
in later chapters.   
2.8.1   Support Vector Machines (SVM) 
Support vector machines (SVM) is one of the state-of-the art 
techniques developed in the field of statistical learning theory and 
pattern recognition. The original SVM algorithm was pioneered in 
Russia by Vapnik and his co-workers in the early sixties (Vapnik & 
Lerner, 1963; Vapnik & Chervonenkis, 1964; etc.) after which 
several modifications were incorporated into the original theory (see 
Vapnik & Chervonenkis, 1974; Vapnik, 1982; 1995; & 1998). The 
SVM method has become increasingly popular among the kernel 
based methods as an excellent tool in response group classification, 
regression and statistical pattern recognition.  Because of the huge 
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contributions of Vapnik and Chervonenkis to the present form of the 
SVM methodology, the SVM theory is now been referred to as the 
Vapnik-Chervonenkis (VC) theory. We have adopted SVM 
methodologies in this work mainly for the prediction/classification of 
mRNA samples into their respective biological groups using various 
microarray data sets. In what follows therefore, we present a brief 
theoretical background of the SVM procedure for classification. 
There are several forms of SVM algorithms available in the 
literature, see McCormick (1983), Vapnik (1995),  Cortes & Vapnik 
(1995), Smola (1998), Smola & Schölkopf (2004), Lee (2004) and a 
host of others. However, we shall present the SVM procedures of 
Burges (1998) and Lee (2004) which essentially are adaptations of 
the original algorithm of Vapnik (1995).  
Let ࢚࢘ ൌ ൛൫ݔଵ௝, ݕଵ൯, ൫ݔଶ௝, ݕଶ൯, … , ൫ݔ௡೅ೃ௝, ݕ௡೅ೃ൯ൟ, ݆ ൌ 1, … , ݍ, be the training 
set of ்݊ோ biological samples with the corresponding test sample ்݊ா 
defined by ࢚ࢋ ൌ ൛൫ݔଵ௝, ݕଵ൯, ൫ݔଶ௝, ݕଶ൯, … , ൫ݔ௡೅ಶ௝, ݕ௡೅ಶ൯ൟ, ݊ ൌ ்݊ோ ൅  ்݊ா. 
Each ݕ௜, ݅ ൌ 1, … , ݊, is the true class label that correspond to the 
observed ݔ௜௝ genes expression levels. For simplicity, we shall use the 
variable pair ሺ࢞௜, ݕ௜ሻ to denote the input vector ࢞௜ of observed gene 
expression profiles on ݅ biological sample with response class label 
ݕ௜. With little modification of the definition of the response groups 
given in (2.1.2), we assume that both the training and test data sets 
come from only two response classes Ωଵ and Ωଶ but with ݕ௜ ൌ 1 if  
subject ݅ comes from class Ωଶ and ݕ௜ ൌ െ1 if the ݅ subject comes from 
class Ωଵ with both classes remained as defined under Section 2.1. 
The goal in SVM methods is to find a decision function of the form 
                                           ݄ሺ࢞௜ሻ ൌ ݏ݃݊ሺۃ࢝. ࢞௜ۄ ൅  ܾሻ                      (2.8.1) 
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that would classify any unseen subject in the test sample ்݊ா into 
their respective class labels ݕ௜ א ሼെ1,1ሽ, where ࢝ is a vector of 
weights with Euclidean norm ԡ࢝ԡ ൌ  ۃ࢝. ࢝ۄଵ/ଶ ൌ 1 with ܾ being the 
bias. The quantity ۃ࢝. ࢞௜ۄ is the inner product of vectors ࢝ and ࢞௜ 
defined as ۃ࢝. ࢞௜ۄ ൌ ࢝ᇱ࢞௜. Suppose we define a hyperplane ܪ଴ א ܪ, 
simply called the separating hyperplane, that separates the training 
samples into the two existing response class labels ሺെ1,1ሻ. If the two 
response groups Ωଵ and Ωଶ of subjects that make up the training 
sample are linearly separable, then we can define the maximal 
distance of the separating hyperplane ܪ଴ from the closest positive 
sample (ݕ௜ ൌ 1) by ݀ାunits and its respective maximal distance from 
the closest negative sample ሺݕ௜ ൌ െ1ሻ by ݀ିunits.  If the two 
maximal distances are the same, that is, ݀ା ൌ ݀ି ൌ ݀, then the two 
sample groups are 2݀units apart. The task in SVM procedure 
therefore, is to find the weight vector ࢝ and bias ܾ that will 
maximize the distance ݀. In a linearly separable sample, the SVM 
algorithm seeks for the separating hyperplane with the maximal 
margin (distance) ݀. This essentially results to the following 
optimization problem using (2.8.1); 
                                                 ݉ܽݔ࢝,௕ ݀                                         (2.8.2) 
subject to the conditions that; 
                                        ۃ࢝. ࢞௜ۄ ൅  ܾ ൒ ݀, if ݕ௜ ൌ 1                         (2.8.3) 
                                        ۃ࢝. ࢞௜ۄ ൅  ܾ ൑ െ݀, if ݕ௜ ൌ െ1                    (2.8.4) 
with ࢝ having  a unit norm ԡ࢝ԡ ൌ  1. Therefore, for any given 
linearly separable set of training data, we define a maximal margin 
hyperplane ܪଵ א ܪ for which the equality ۃ࢝. ࢞௜ۄ ൅  ܾ ൌ ݀ in (2.8.3) 
holds and maximal margin hyperplane ܪିଵ א ܪ for which the 
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equality ۃ࢝. ࢞௜ۄ ൅  ܾ ൌ െ݀ in (2.8.4) also holds. All vectors ࢞௜ for which 
these two equalities are satisfied are called support vectors and the 
solutions of the optimization problem depend only on these vectors 
and not on the entire dimension of the training set. In other words, 
support vectors are those points ࢞௜ that lie on the two maximal 
margin hyperplanes ܪଵ and ܪିଵ. Thus, a subject would be classified 
into group ݕ௜ ൌ 1 if the condition (2.8.3) is satisfied and into group 
ݕ௜ ൌ െ1 if condition (2.8.4) is satisfied. This concept is geometrically 
illustrated in Fig 2.7. 
 
Fig 2.7: The figure showing the typical separating hyperplane and the maximal margin hyperplanes 
for the linearly separable subjects with two distinct subject groups. This is an example of linear  
SVM  classification  function  given  by  equation (2.8.1).  The  support  vectors  lie  on  the  margins. 
If the two constraints in (2.8.3) and (2.8.4) are multiplied by their 
respective class labels and the weight vector ࢝ is divided by its norm 
ԡ࢝ԡ we shall have a single constraint of the form  
   ଵ
ԡ࢝ԡ
ݕ௜ሾۃ࢝. ࢞௜ۄ ൅  ܾሿ ൒ ݀, ׊௜, ݅ ൌ 1, … , ݊                (2.8.5) 
Since the two maximal margin hyperplanes ܪଵ and ܪିଵ have the 
same normal (parallel), it shows that there exist a pair of 
hyperplanes in ܪ that will provide the maximum margin between 
the two subject groups in the training set. This can be achieved by 
setting ݀ ൌ ଵ
ԡ࢝ԡ
. Therefore, maximizing the value of  ݀ as given in 
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(2.8.2) is equivalent to minimizing the value of ԡ࢝ԡ. Hence, the 
whole problem becomes that of looking for the weight vector ࢝ and 
bias ܾ that minimizes ԡ࢝ԡ. Thus, the optimization problem in (2.8.2) 
shall become that of; 
        ݉݅݊࢝,௕ԡ࢝ԡ                  (2.8.6) 
 subject to the constraint that 
      ݕ௜ሾۃ࢝. ࢞௜ۄ ൅  ܾሿ ൒ 1, ׊௜, ݅ ൌ 1, … , ݊          (2.8.7) 
Under the new formulation of (2.8.6), all points ࢞௜ with margins 
ݕ௜ሾۃ࢝. ࢞௜ۄ ൅  ܾሿ ൌ 1 are now the support vectors.   
In a situation where the training set ࢚࢘ contains linearly but non-
separable group members, then, it may be necessary to introduce the 
slack variables ߦ௜ to the constraints in (2.8.7). This is analogous to 
the soft margin loss function due to Bennett & Mangasarian (1992) 
which was later employed into SVM by Cortes & Vapnik (1995). The 
whole idea is to allow for some misclassification errors and the value 
ߦ௜ represents the amount by which the prediction function ݄ሺ࢞௜ሻ 
classifies subjects into the wrong side of the margin, Hastie et al 
(2009). Thus, the whole optimization problem in (2.8.6) then becomes 
that of  
 ݉݅݊࢝,௕ԡ࢝ԡ, subject to   ݕ௜ሾۃ࢝. ࢞௜ۄ ൅  ܾሿ ൒ 1 െ ߦ௜, ׊௜, ݅ ൌ 1, … , ݊     (2.8.8) 
 with additional condition that ߦ௜ ൐ 0, ׊௜, and that ∑ ߦ௜௡௜ୀଵ ൌ ߦ, for 
some fixed constant ߦ. 
The Lagrangian formulation of the above optimization problem is 
often preferred for easy generalization of the SVM procedures to 
pure non-linear separating data sets. This is done by constructing a 
 
 
 97 
Lagrange function to be minimized from the objective function in 
(2.8.6) which we called the primal objective function of the form 
                         ࣦ௣ ؔ
ଵ
ଶ
ԡ࢝ԡଶ െ ∑ ߙ௜ݕ௜ሾۃ࢝. ࢞௜ۄ ൅  ܾሿ ൅ ∑ ߙ௜௡௜ୀଵ  ௡௜ୀଵ       (2.8.9) 
subject to the constraint that ߙ௜ ൒ 0, ݅ ൌ 1, … , ݊. The ߙ௜ are the  
Lagrange multipliers on each of the inequality constraints in (2.8.7) 
or (2.8.8). After little algebra, the dual form of the convex 
optimization problem (2.8.9) is obtained (Burges, 1998; Lee, 2004) as  
                       ࣦௗሺߙ௜ሻ ؔ ∑ ߙ௜௡௜ୀଵ െ  
ଵ
ଶ
∑ ∑ ߙ௜ߙ௝ݕ௜ݕ௝௡௜ୀଵ௡௜ୀଵ ۃ࢝. ࢞௜ۄ        (2.8.10) 
This function is to be maximized subject to the conditions that ߙ௜ ൒ 0 
and ∑ ߙ௜ݕ௜ ൌ 0௡௜ୀଵ . The Karush-Kuhn-Tucker (KKT) condition 
(Karush, 1939, Kuhn & Tucker, 1951) that 
 ߙ௜ሼݕ௜ሾۃ࢝. ࢞௜ۄ ൅  ܾሿ െ 1ሽ ൌ 0  ׊௜, ݅ ൌ 1, … , ݊      (2.8.11) 
is often adopted to provide the estimate of ܾ. From KKT condition 
above, it is very easy to verify that only few of the ߙ௜ ’s, say ߙ௜כ, are 
non-zero at the optimal solution level and they are those ߙ௜כ’s for 
which the margin ݕ௜ሾۃ࢝. ࢞௜ۄ ൅  ܾሿ ൌ 1. Hence, the vector ࢝כ that 
defines the optimal maximal separating hyperplane has non-zero 
weights for the support vectors and can be easily obtained as  
                                           ࢝כ ൌ ∑ ߙ௜כݕ௜௡௜ୀଵ ࢞௜                               (2.8.12) 
More details on this can be found in Burges (1998), Bennett & 
Campbell (2000) and Lee (2004).  
The classification function ݄ሺ࢞ሻ in terms of the optimal separating 
hyperplane is now of the form  
                                         ݄ሺ࢞ሻ ൌ ݏ݅݃݊ሾۃ࢝כ. ࢞ۄ ൅ ܾכሿ 
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                             ՜   ݄ሺ࢞ሻ ൌ ݏ݅݃݊ሾ∑ ߙ௜כݕ௜௡௜ୀଵ ۃ࢞௜. ࢞ۄ ൅  ܾכሿ             (2.8.13) 
More generally, SVM algorithms embed data vector ሺ࢞௜, ࢞௜ᇲሻ from the 
input space Ը into the high-dimensional feature space ࣠ through the 
use of kernel functions ߈ሺ. , . ሻ. Given any non-linear mapping ׎ that 
embeds input vector ሺ࢞௜, ࢞௜ᇲሻ into the feature space ࣠, kernel ߈ሺ. , . ሻ 
has the following representation; 
                                       ߈ሺ࢞௜, ࢞௜ᇲሻ ൌ  ۃ׎ሺ࢞௜ሻ. ׎ሺ࢞௜ᇲሻۄ                     (2.8.14) 
where ࢞௜, ࢞௜ᇲ א Ը and ׎ሺ࢞௜ሻ, ׎ሺ࢞௜ᇲሻ  א ࣠. This implies that points  ࢞௜, ࢞௜ᇲ 
in the input space Ը correspond to the points ׎ሺ࢞௜ሻ, ׎ሺ࢞௜ᇲሻ in the 
feature space ࣠. The kernel representation allows efficient 
computation of the inner product directly in the feature space which 
saves a lot of rigorous data embedding and computational burden in 
the input space. The SVM method using kernel function separates 
the training data in the feature space by a hyperplane defined by the 
type of kernel function adopted. The kernel representation of the 
classification function ݄ሺ࢞ሻ is of the form 
                                   ݄ሺ࢞ሻ ൌ ݏ݅݃݊ሾ∑ ߙ௜כݕ௜௡௜ୀଵ ߈ሺ࢞௜. ࢞ሻ ൅  ܾכሿ          (2.8.15) 
The four types of kernels mostly adopted are the linear, polynomial, 
radial basis function and sigmoid kernels. The functional forms of 
these kernels are presented below: 
 Linear: ߈ሺ࢞௜. ࢞ሻ ൌ ۃ࢞௜. ࢞ۄ  
 Polynomial: ߈ሺ࢞௜. ࢞ሻ ൌ ሾۃߛ࢞௜. ࢞ ൅ ܿۄሿ௣ 
 Radial basis function (RBF): ߈ሺ࢞௜. ࢞ሻ ൌ ݁ݔ݌ሺെߛ|࢞௜ െ ࢞|ଶሻ 
 Sigmoid: ߈ሺ࢞௜. ࢞ሻ ൌ ݐ݄ܽ݊ۃߛ࢞௜. ࢞ ൅ ܿۄ 
The linear kernel corresponds to the single inner product function 
used by the linearly separable case as presented in (2.8.1) through 
(2.8.13). Both ߛ and ܿ are the parameters used to determine the 
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respective kernel functions while ݌ is the number of degree used in 
polynomial kernel. 
Like any other classification methods, the prediction accuracy of the 
SVM method over the test sample ࢚ࢋ is assessed through empirical 
misclassification rate analogous to the MER estimators given in 
(2.4.2) and (2.4.3). This is defined over the test sample ்݊ா by  
                                     መߴௌ௏ெ ൌ
ଵ
ଶ௡೅ಶ
∑ หݕ௜ െ ෠݄ሺ࢞௜ሻห
௡೅ಶ
௜ୀଵ                      (2.8.16) 
where  ݕ௜ א ሺെ1,1ሻ is the observed class labels and ෠݄ሺ࢞௜ሻ א ሺെ1,1ሻ is 
the predicted class label by SVM classifier ݄ሺ࢞ሻ for ݅ subject.  
The SVM procedures for response class prediction are implemented 
in R statistical package under the e1071 library. This we have 
adopted for analysis under the SVM implementations in this thesis.    
 2.8.2     ࢑-Nearest Neighbours (࢑-NN) 
The k-nearest neighbours (݇-NN) is a supervised learning algorithm 
where the predictions of future test samples are determined based 
on the majority of nearest neighbours’ category closest to them. It is 
the simplest form of classification procedure that has been adopted 
in many studies, (Zhang & Srihari, 2002; Baoli et al, 2003; 
Kuramochi & Karypis, 2005; Shang & Shen, 2005; etc.). It does not 
require any rigorous model to fit. For any given test data point, we 
only need to determine the number k of subjects in the training 
samples that are closest to that test data point. The classification is 
done through the use of simple majority votes of the classified 
categories.  
More formally, let us consider a set of training sample                    
࢚࢘ ൌ ൛൫ݔଵ௝, ݕଵ൯, ൫ݔଶ௝, ݕଶ൯, … , ൫ݔ௡೅ೃ௝, ݕ௡೅ೃ൯ൟ, ݆ ൌ 1, … , ݍ, on which the 
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expression  levels of ݍ genes were measured. We assumed that the 
response group has binary category ݕ א ሼ0,1ሽ. Now, to predict/classify 
each member in the test sample 
࢚ࢋ ൌ ൛൫ݔଵ௝, ݕଵ൯, ൫ݔଶ௝, ݕଶ൯, … , ൫ݔ௡೅ಶ௝, ݕ௡೅ಶ൯ൟ, the k-NN algorithm begins by 
calculating the minimum distance of each test subjects from their 
corresponding training subjects and determine the k-nearest 
neighbours by ranks. The simple majority of these k-nearest 
neighbours become the prediction of the respective test samples. The 
similarity measure commonly used to measure the distance between 
the training and test sample is the Euclidean distance measure. The 
misclassification error rate (MER) for k-NN algorithm is calculated 
using the estimator given in (2.4.3) as used by our k-SS method.   
2.8.3     Partial Least Squares (PLS) 
The partial least squares (PLS) method is one of the old data 
reduction methods originally pioneered by Harald Wold (Wold, 1966, 
1973, 1983, etc.). It has been adopted by chemometricians and other 
researchers for various purposes over many years, (Volmer et al, 
1993; Holland et al, 1998; Naik & Tsai, 2000; etc.).  The typical 
nature of microarray data in which it is often the interest to classify 
very few biological samples into their respective tumour groups 
using expression profiles of several thousand of genes has given the 
PLS approach a wider application in many microarray studies.  
For brief theoretical presentation of PLS procedures, we consider the 
regression model ௜ܻ ൌ ݃ሺࢄࢼ;  ߝሻ as given in (2.1.1) whose linear form  
௜ܻ ൌ ࢄࢼ ൅ ߝ is as provided in (1.5.1) where ࢄ ൌ ሺ ଵܺ, … , ܺ௤ሻ is a ݊ ൈ ݍ 
matrix of gene expression levels measured on ݊ biological subjects 
with binary response class ௜ܻ א ሼ0,1ሽ given that ݊ ൏ ݍ.  With ݊ ൏ ݍ 
however, it is obvious that the classical least squares regression 
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cannot be used to estimate parameter vector ࢼ of the above linear 
regression equation because the ݍ ൈ ݍ design matrix ࢄ்ࢄ on which 
the estimator of ࢼ is based is not non-singular. What is being done, 
according to PLS approach is to represent the linear regression 
equation ௜ܻ ൌ ࢄࢼ ൅ ߝ in terms of two separate equations of the form 
        ܻ ൌ ࢀࡽ் ൅  ܨ                                 (2.8.17) 
                                              ࢄ ൌ ࢀࡼ் ൅  ܧ                                 (2.8.18) 
dropping the subscript ݅ from ௜ܻ for simplicity, where ࢀ is a ݊ ൈ ܿ 
matrix of the latent components (factor scores) for the ݊ obervations, 
ࡽ் is a ܿ ൈ 1 vector of regression coefficients (the factor loadings of 
ܻ), ࡼ is a ݍ ൈ ܿ matrix of regression coefficients (the factor loadings of 
ࢄ), ܨ and ܧ are the residuals of regression models (2.8.17) and 
(2.8.18) respectively and ܿ is the number of latent components ࢀ to 
be constructed usually fixed by the user.  However, the maximum 
number ܿ of latent components that can be constructed in any given 
PLS regression is ܿ ൌ ݉݅݊ ሺ݊, ݍሻ. 
The latent component ࢀ is usually of the form  
                                  ࢀ ൌ ࢄࢃ                                      (2.8.19) 
for an appropriate ݍ ൈ ܿ  weight matrix ࢃ for ࢄ.  
The estimate of the regression coefficients ࡽ் in (2.8.17) is usually 
obtained through the normal least square method as 
                                             ࡽ෡் ൌ ሺࢀ்ࢀሻିଵࢀ்ܻ                       (2.8.20) 
Once the estimates of vector ࡽ has been determined, the estimates of 
the original coefficient ࢼ can then be estimated by  
                                      ࢼ෡ ൌ ࢃࡽ் ൌ ࢃሺࢀ்ࢀሻିଵࢀ்ܻ                     (2.8.21) 
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which can be simply expressed in terms of the weight matrix ࢃ as  
                                     ࢼ෡ ൌ ࢃሺࢃ்ࢄ்ࢄࢃሻିଵࢃ்ࢄ்ܻ                   (2.8.22) 
From the estimator of  ࢼ given by (2.8.22), it is obvious that the only 
quantity that needs to be determined to get ࢼ෡ is the weight matrix 
ࢃ.  Similarly, the estimator of ࡼ் in (2.8.18) can be conceived as  
                                             ࡼ෡் ൌ ሺࢀ்ࢀሻିଵࢀ்ࢄ                            (2.8.23) 
However, several variants of PLS algorithms are available in the 
literature all of which are targeted at extracting the vector of latent 
components ࢀ. The most common among this whose procedure we 
shall present here is the non-linear iterative partial least squares 
(NIPALS) algorithm due to Wold (1975). The NIPALS algorithm 
seeks to maximize the objective function 
࢝௜ ൌ ܽݎ݃݉ܽݔ௪ ܥ݋ݒ
ଶሺࢀ, ܻሻ 
                                  ൌ ܽݎ݃݉ܽݔ
௪
ሺࢀ்்ܻܻࢀሻ 
    ՜                     ࢝௜ ൌ ܽݎ݃݉ܽݔ௪ ሺࢃ
்ࢄ்்ܻܻࢃࢄሻ                  (2.8.24) 
subject to the constraints that      
                ࢝௜்࢝௜ ൌ 1                                   (2.8.25) 
and that   
                                             ࢚௜்࢚௝ ൌ ࢝௜்ࢄ்ࢄ࢝௝ ൌ 0                       (2.8.26) 
for ݅ ് ݆ א ሼ1, … , ܿሽ.  The quantity ࢝௜ and ࢚௜ are the columns of  ݍ ൈ ܿ 
and ݊ ൈ ܿ  weight matrix ࢃ and latent components ࢀ with both  ࢝௜ 
and ࢚௜ defined as ࢝௜ ൌ ሺ࢝ଵ௜, ࢝ଶ௜, … , ࢝௤௜ሻ் and ࢚௜ ൌ ሺ࢚ଵ௜, ࢚ଶ௜, … , ࢚௡௜ሻ் 
respectively. Thus, the row-vector representations of ࢃ and ࢀ are 
given by ࢃ ൌ ሺ࢝ଵ, ࢝ଶ, … , ࢝௖ሻ and ࢀ ൌ ሺ࢚ଵ, ࢚ଶ, … , ࢚௖ሻ respectively. By 
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the objective function given by (2.8.24), each of the weight vector ࢝௜ 
is computed such that the square of the covariance of the response 
variable ܻ and latent components ࢀ ൌ ࢄࢃ is maximized subject to 
the conditions that each ࢝௜ is of unit norm (by (2.8.25)) and that all 
the latent vectors ࢚௜ א ሼࢀሽ are purely orthogonal (by (2.8.26)).  
After the construction of the PLS components, the classification of 
the response groups would be performed using the ܿ PLS 
components constructed by adapting any of the standard 
classification methods such as the linear discriminant analysis 
(LDA), logistic discriminant (LD) analysis, quadratic discriminant 
analysis (QDA) and the like. More details about the PLS method for 
classification can be found in Martens (1985), Wold et al (1983), Dai 
et al (2006), Rosipal & Krämer (2006), Boulesteix & Strimmer (2007) 
and in many other related works. However, in our implementation of 
the PLS approach for classification, we have adapted the LDA 
procedure as implemented in the plsgenomics library of R 
statistical package. Detail applications of this classification method 
are provided in the next two chapters. 
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3 Simulation Studies 
3.1 Simulating Microarray data sets 
Simulation is the process of emulating the reality using 
mathematical models. The sole objective is to build models to 
replicate the actual system. This is often necessary especially when 
the cost, time and efforts of generating live observations for 
investigation purposes are rather too unbearable. In such a 
situation, models that are replica of the condition under study may 
be simulated to examine the behaviour of the system, proffer 
solutions to the identified problems and evaluate the practicability of 
the solutions provided before transferring them to the real world.  
For some years back, developing appropriate models to analyse 
microarray data was such a daunting task due to the sparseness of 
relevant data sets. This is not unconnected with the huge costs and 
times involve in generating such data sets. The situations become a 
lot better in the past few decades due to the advent of several 
microarray technologies. However, the sensitive nature of 
microarray studies especially with the involvement of human data 
has made it more imperative for the investigators to carryout 
analysis on similar pseudo (simulated) data to ascertain the 
appropriateness of their methods and results before such could be 
implemented on live data. 
To implement our newly proposed k-SS classifier, we intend to 
simulate typical microarray data set on which the procedure would 
be tested to ascertain its suitability and results’ efficiencies. The 
performance of our method relative to some of the existing 
classification methods shall be equally assessed using such 
simulated data. 
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The procedure we employed for simulating microarray data set here 
follows the method adopted, with little modifications, by Bura & 
Pfeiffer (2003), and Molinaro et al (2005) both of which were 
adaptations of the earlier approaches used by Cook & Lee (1999) and 
Kepler et al (2002).  We simulated ݊ ൌ 100 observations representing 
the number of mRNA samples with two distinct biological groups 
ܻ ൌ 0 (normal patients) and ܻ ൌ 1 (diseased/tumour patients). On 
each observation, 1000 covariates, ࢄ ൌ ሺ ଵܺ, … , ଵܺ଴଴଴ሻ′, representing 
the observed gene expression profiles were simulated. Each 
biological group 0 or 1 has 50 observations which we denoted as ݊଴ 
for group 0 and ݊ଵ for group 1 with ݊଴ ൅ ݊ଵ ൌ ݊. The data sets 
ࢄ| ܻ ൌ 0 were simulated from multivariate normal distribution with 
mean ߤ଴, ߤ଴ ് 0 and variance-covariance matrix Σ. That is 
ሾሺ ଵܺ, … , ଵܺ଴଴ሻ′|ܻ ൌ 0ሿ~ܰሺߤ଴, Σሻ. Of 1000 genes simulated on group 1 
subjects, 5 of them were simulated from the mixture of two 
multivariate normal densities with the same covariance matrix Σ, 
and means ߤଵଵ and ߤଵଶ respectively, ߤଵଵ ് ߤଵଶ and ߤଵଵ, ߤଵଶ ൐ ߤ଴. That 
is, ሾሺ ଵܺ, … , ܺହሻ′|ܻ ൌ 1ሿ~ሾߨ כ ܰሺߤଵଵ, Σሻ ൅ ሺ1 െ ߨሻ כ ܰሺߤଵଶ, Σሻሿ with the 
estimate of the mixing parameter ߨ taken to be 0.5. The remaining 
995 genes for group 1 were simulated from ܰሺߤ଴, Σሻ distribution as 
those in group 0. The 5 genes simulated from multivariate mixture 
models represent those genes that are differentially expressed. They 
are the genes whose expression levels are believed to be strongly 
related to the tumour group. The remaining genes that were 
simulated from ܰሺߤ଴, Σሻ densities constitute the genes with relatively 
low expression levels, but not necessarily zero, only that their 
expression levels are not as strong as those in the former group. The 
covariance matrix Σ defined as Σ ൌ ൛σ୧୨ൟ, has a block structure such 
that  
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                                        σ୧୨ ൌ ൜
0.2, ݂݅ |݆ െ ݅| ൑ 5
0,     ݋ݐ݄݁ݎݓ݅ݏ݁                                (3.1.1) 
The variance-covariance formulation in (3.1.1) is to allow for some 
level of correlations among the simulated genes, typifying a real 
gene expression data sets.   
The whole data set we simulated is of dimension ݊ ൈ ݍ ሺ100 ൈ 1000ሻ, 
݊ ൏ ݍ, as usually the case with microarray data. This is the data we 
have used to test-run our proposed k-SS method and the data was 
use for further analysis at various stages in this thesis.  
In what follows, we provided the distribution of the test statistics 
used for the construction of our sequential test procedure.   
3.2 Determining the critical values  ܥఈ௦ of the ݇-SS tests 
As established in Chapter 2, the ߜመ௝ೞ,  ݆ ൌ 1, … , ݍ െ 1, ݏ ൌ 1,2, are the 
differences of two minimum average MERs between any successive 
pairs of selection steps ݆ and ݆ ൅ 1 in the construction of our 
sequential test procedures.  However, the estimates of the critical 
values ܥఈଵ and ܥఈଶ simply written as ܥఈ௦, for ݏ ൌ 1,2, as required by our 
test procedures in (2.4.34), (2.4.35) and (2.4.50), (2.4.51) respectively 
depend on the theoretical distribution of the test statistic ߜመ௝ೞ or 
ܼఋ෡ೕೞ ൌ
ఋ෡ೕೞିாቀఋ෡ೕೞቁ
ටఙమቀఋ෡ೕೞቁ
 designed for the tests. Based on the methodologies 
adopted for the construction of our k-SS procedure, we highly 
suspected that neither of the test statistics ߜመ௝ೞ or ܼఋ෡ೕೞ  may be fitted 
by the Gaussian distribution as earlier assumed. Therefore, to 
determine the true distribution of ߜመ௝ೞ, we developed a set of 
algorithms to simulate the ߜመ௝ೞ ൌ േ ቀ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ ቁ 
estimates for ݏ ൌ 1 or 2 respectively according to our proposed k 
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sequential selection and prediction procedures. The simulated 
microarray data matrix of 100 samples by 1,000 genes according to 
the scheme presented in Section 3.1 is used for simulating the  ߜመ௝ೞ 
values.  
The values of the two average MER differences ߜመ௝ೞ ൌ േ ቀ ҧߴመ௠భ,௠మ,…,௠ೕ െ
ҧߴመ௠భ,௠మ,…,௠ೕశభሻ, for ݏ ൌ 1 or 2, [ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ for ݏ ൌ 1, 
ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ for ݏ ൌ2] were simulated at 50, 100, 
200, 500 and 1000 sample sizes according to our k-SS procedures. 
The R code we developed for simulating the ߜመ௝ೞ values is presented in 
Appendix B.4.  
To confirm our suspicion that the Gaussian density might not be 
suitable to fit the ߜመ௝ೞ values, we compared the empirical distribution 
(red) of 1000 simulated ߜመ௝భ ’s (for ݏ ൌ 1) with the theoretical density 
function of the normal distribution (blue) (see Fig 3.1). The 
maximum likelihood estimates of the two parameters ߤ and ߪଶ of the 
normal distribution (estimated from the simulated ߜመ௝భ data) are 
computed to be ̂ߤ ൌ 0.0069 and ߪොଶ ൌ 0.0002. The histogram (green) of 
the raw ߜመ௝భ data is equally presented in Fig 3.1. From the results 
displayed in Fig 3.1, it is obvious that the true distribution of the ߜመ௝ೞ 
is not Gaussian as earlier assumed. This is clearly evident from the 
deviation of the theoretical Gaussian density function (blue) from 
the empirical distribution (red) of the ߜመ௝భ data in Fig 3.1. This lack of 
Gaussian fit is equally revealed by the quantile-quantile (Q-Q) plot 
of the simulated ߜመ௝భ data as provided again in Fig 3.1.  
More specifically, the empirical distribution of the ߜመ௝భ data obviously 
suggested a typically skewed distribution for the ߜመ௝ೞ ’s in contrast to 
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the symmetry property that characterize a typical Gaussian 
distribution. For clarity purposes however, we presented in Fig 3.2, 
the empirical distributions (histograms and line graphs) of the ߜመ௝ೞ 
using the simulated 1,000 ߜመ௝ೞ data for ݏ = 1 and 2. It can be easily 
observed from the two plots in Fig 3.2 that the empirical distribution 
of the ߜመ௝భ data (left) is positively skewed while that of ߜመ௝మ data (right), 
though similar to that of ߜመ௝భ, is negatively skewed. 
 
Fig 3.1: The plots in the left present the empirical (red) and the theoretical Normal 
[N(0.0069,0.0002)] (blue) distributions fitted to the simulated ߜመ௝భ ൌ  ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ (the 
differences of minimum mean MERs) data at 1,000 sample size. The parameters of the Normal 
distribution are  obtained  by  Maximum Likelihood Estimation (MLE) using the simulated ߜመ௝భ data.  
                   The Q-Q plot (right) clearly indicated lack-of-fit of normal density to the ߜመ௝భ data. 
 
Fig 3.2: The empirical distributions of the simulated 1000 ߜመ௝భ ൌ  ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ for s = 1 
(left) and ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ ݂݋ݎ ݏ ൌ  2 ሺݎ݄݅݃ݐሻ(differences of minimum mean MERs) 
data. 
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After several considerations given to some of the common probability 
distribution functions like Gamma, Exponential, lognormal, Weibull 
or Beta as well as the Skew-Laplace distribution as used by Fieller 
& Flenley (1992) for the distribution of particle size to fit ߜመ௝ೞ data, 
our simulation studies finally revealed that the true distribution of 
the ߜመ௝ೞ data, ݏ ൌ 1 or 2, belong to the Skew-Normal parametric class 
of density functions originally due to Azzalini (1985). 
The Skew-Normal (SN) densities were developed to capture the 
continuous variations from normality to non-normality. It is a 
density function for normal-like data but with lack of symmetry. In 
what follows, we present the basic theoretical formulations of this 
distribution and its relevance to our situation under study. 
Let ߶ሺݖሻ be the standard normal density function of random variable 
ܼ defined by ߶ሺݖሻ ൌ ݁ݔ݌ሺെݖଶ/2ሻ/√2ߨ and Φሺߣݖሻ be its distribution 
function but evaluated at ߣݖ. Thus, it is obvious that Φሺߣݖሻ ൌ
׬ ߶ሺݐሻ݀ݐఒ௭ିஶ . If another density function is defined by                         
߶ሺݖ; ߣሻ ൌ 2߶ሺݖሻΦሺߣݖሻ, then, under this new formulation, random 
variable ܼ is said to have a skew-normal (SN) density with 
parameter ߣ, Azzalini (1985,1986). Thus, we have; 
                                 ߶ሺݖ; ߣሻ ൌ ଶ
√ଶగ
݁ݔ݌ሺെݖଶ/2ሻ ׬ ߶ሺݐሻ݀ݐఒ௭ିஶ       (3.2.1) 
That is, ܼ~ܵܰሺߣሻ and in line with the usual ܰሺ0,1ሻ notation used to 
denote the standard normal variable ܼ, the (standard) skew-normal 
variate ܼ with shape parameter ߣ can be equally written as 
ܼ~ܵܰሺ0,1, ߣሻ which literally translates to a skew-normal random 
variable ܼ with location parameter = 0, scale parameter = 1 and 
shape parameter = ߣ. The value of ߣ determines the shape of the 
density function ߶ሺݖ; ߣሻ. As the value of ߣ increases, the skewness of 
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the function also increases and positive values of ߣ provide positive 
skewness and vice-versa.  
From (3.2.1), the cumulative distribution function (cdf) of ߶ሺݖ; ߣሻ can 
be obtained as 
                           Φሺݖ; ߣሻ ൌ 2 ׬ ׬ ߶ሺݒሻ߶ሺݑሻఒ௭ିஶ
௭
ିஶ ݀ሺݒሻ݀ሺݑሻ                (3.2.2) 
The histograms and density plots of 104 samples drawn from ܵܰሺߣሻ 
family in (3.2.1) at ߣ ൌ 5 and -5 are presented in Fig 3.3. 
 
Fig 3.3: The histograms and density plots of 10,000 samples simulated from the Skew-Normal 
                               density SN(ߣ) with shape parameters ߣ = 5 (left) and ߣ = -5 (right). 
The ܵܰ density in (3.2.1) enjoys similar properties of the normal 
distribution except for symmetry. However, if ߣ ൌ 0, it is obvious 
from (3.2.1) that ߶ሺݖ; 0ሻ ൌ ߶ሺݖሻ, the standard normal density. For 
any quantity ߦ defined as ߦ ൌ ߣ/√1 ൅ ߣଶ therefore, both the mean and 
variance of ܼ are respectively given as  ܧௌேሺܼሻ ൌ ඥ2/ߨߦ and ௌܸேሺܼሻ ൌ
1 െ 2ߦଶ/ߨ, Azzalini (1985). Further details on the distributional 
properties of ߶ሺݖ; ߣሻ could be found in Azzalini (1985, 1986, 2001, 
2005, 2006), Azzalini & Capitanio (1999) and Azzalini et al (2003). 
After the original work of Azzalini and his co-workers on the 
development of the skew-normal class of distributions, several other 
variants and modifications of the SN probability functions have been 
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developed, see, for example, Gupta et al (2004), Arellano-Valle et al 
(2004), Armando et al (2007) among others.  
Now, if we consider a transformation on SN variate ܼ of the form 
                                              ߜመ௝ೞ ൌ  ߤ௦ ൅ ߪ௦ܼ                                   (3.2.3)       
then, random variable ߜመ௝ೞ has a SN distribution with location and 
scale parameters ߤ௦ and ߪ௦ (different from 0 and 1) respectively, and 
shape parameter still remain ߣ.                                               
From (3.2.3), it is easy to verify that, 
               ܧ൫ߜመ௝ೞ൯ ൌ ߤ௦ ൅ ߣߪ௦√2 /ඥߨሺ1 ൅ ߣଶሻ                   (3.2.4) 
and that 
      ܸ൫ߜመ௝ೞ൯ ൌ ߪ௦ଶሾ1 െ 2ߣଶ/ߨሺ1 ൅ ߣଶሻሿ               (3.2.5)   
Thus, the distribution of random variable ߜመ௝ೞ can be written as  
߶൫ߜመ௝ೞ; ߤ௦, ߪ௦, ߣ൯, a skew-normal density with location parameter = ߤ௦, 
scale parameter = ߪ௦ and shape parameter = ߣ or as  
ߜመ௝ೞ~ܵܰሺߤ௦, ߪ௦ଶ, ߣሻ. If ߣ ൌ 0, it is obvious again from (3.2.4) and (3.2.5) 
that ܧ൫ߜመ௝ೞ൯ ൌ ߤ௦ and ܸ൫ߜመ௝ೞ൯ ൌ ߪ௦ଶ  and variable ߜመ௝ೞ would become a 
(symmetric) normal random variable, i.e. ߜመ௝ೞ~ܰሺߤ௦, ߪ௦ଶሻ.  On the other 
hand, when ߤ௦ ൌ 0 and ߪ௦ ൌ 1, it follows from (3.2.3) to (3.2.5) that 
ߜመ௝ೞ ൌ ܼ~ܵܰሺߣሻ. Hence, it follows that given any skew-normal variate 
ߜመ௝ೞ with specified location, scale and shape parameters ߤ௦, ߪ௦, ߣ, 
respectively, the statistic ܼఋ෡ೕೞ ൌ
ఋ෡ೕೞିாቀఋ෡ೕೞቁ
ට௏ቀఋ෡ೕೞቁ
 would have a skew-normal 
distribution with  location, scale and shape parameters 0, 1, and ߣ 
respectively simply written as ܼఋ෡ೕೞ ~ܵܰሺߣሻ as defined in (3.2.1).   
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Obviously, the statistic ܼఋ෡ೕೞ ൌ
ఋ෡ೕೞିாቀఋ෡ೕೞቁ
ට௏ቀఋ෡ೕೞቁ
  is in the form of the test 
statistics (2.4.33) to (2.4.35) constructed for our sequential 
hypothesis tests of (2.4.32) and (2.4.49) with ߜመ௝ೞ ൌ േ ቀ ҧߴመ௠భ,௠మ,…,௠ೕ െ
ҧߴመ௠భ,௠మ,…,௠ೕశభሻ, for ݏ ൌ 1 or 2 respectively (i.e. ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ
ҧߴመ௠భ,௠మ,…,௠ೕశభ for ݏ ൌ 1 and ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ for ݏ ൌ 2). 
Hence, to determine the critical values ܥఈ௦, ݏ ൌ 1 or 2, of the test 
statistics ߜመ௝ೞ as used in (2.4.36) for ݏ ൌ 1 and (2.4.50) for ݏ ൌ 2, it is 
sufficient to establish that random variable ߜመ௝ೞ has a skew-normal 
distribution with location, scale and shape parameters ߤ௦, ߪ௦ and ߣ 
respectively [i.e. ߜመ௝ೞ~ܵܰሺߤ௦, ߪ௦ଶ, ߣሻ] or equivalently that the 
standardized variate ܼఋ෡ೕೞ  has a (standard) skew-normal density 
function with shape parameter ߣ [i.e. ܼఋ෡ೕೞ ~ܵܰሺߣሻ] as earlier stated.  
Following our simulation procedures, it is quite easy to establish 
that random variable ߜመ௝ೞ actually follows the skew-normal 
distribution. Firstly, we fitted the skew-normal density 
߶൫ߜመ௝ೞ; ߤ௦, ߪ௦, ߣ൯ to the simulated ߜመ௝ೞ, ݏ ൌ1, 2,  data at 50, 100, 200, 500 
and 1000 sample sizes. The maximum likelihood estimates (MLE) of 
parameters ߤ௦, ߪ௦ଶ,  ߣ, of each of the five fitted skew-normal densities 
were estimated using expectation-maximization (EM) algorithm. 
Thereafter, random sample of size 10,000 were drawn from each of 
the fitted SN densities. The empirical distributions (histograms and 
line graphs) of the ߜመ௝ೞ data (under all the five samples) are plotted 
based on the 10,000 samples drawn. These are respectively 
compared with the theoretical (skew-normal) densities using the 
estimated parameters. Due to space consideration, we only present 
in Fig 3.4, the empirical (red) and theoretical (blue) density plots as 
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well as the respective histograms (green) of the ߜመ௝ೞ data, for ݏ ൌ 2, at 
all the five chosen sample sizes. The quantile-quantile (Q-Q) plot of 
each of the simulated ߜመ௝ೞ data sets is equally presented in Fig 3.4. 
From the various density plots, the closeness of both the empirical 
(observed) and theoretical (skew-normal) distributions can be easily 
observed, therefore, confirming the fitness of the skew-normal 
density to the ߜመ௝ೞ data. This result is corroborated by the respective 
Q-Q plots as displayed in Fig 3.4. 
Furthermore, among the popular statistical test procedures that are 
commonly adopted to establish whether or not a set of data comes 
from a specified theoretical distribution are the Kolmogorov-Smirnov 
test (Chakravart et al, 1967), Anderson-Darling goodness-of-fit test 
(Stephens,1974) and the Chi-square goodness-of-fit test (Snedecor & 
Cochran, 1989) among others. While the approach of Kolmogorov-
Smirnov test has been reported to be highly sensitive at rejecting 
that a data comes from a given theoretical distribution even when it 
does, (http://www.itl.nist.gov/div898/handbook/eda/section3/eda35g.htm), the method of Anderson-
Darling goodness-of-fit test only exists for a very few distribution 
which does not include the skew-normal density to the best of our 
knowledge. Therefore, in addition to the probability density function 
(pdf) and the Q-Q plots presented in Fig 3.4, we equally constructed 
the Chi-square goodness-of-fit test to determine the fitness of the 
Skew-Normal density to the simulated ߜመ௝ೞ data. The results from the 
Chi-square test for both ߜመ௝భ and ߜመ௝మ data are presented in Tables 3.1a 
& 3.1b respectively. All the results clearly confirmed the 
appropriateness of the skew-normal distribution to fit the ߜመ௝ೞ data.  
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Fig 3.4: The plots in the left showed the empirical (red) and the theoretical (Skew-Normal, blue) 
distributions of the ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,… ,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ data at the chosen five sample sizes of 50, 100, 
200, 500, and 1000. The estimates of location, scale, and shape parameters ߤ, ߪ and ߣ of the skew-
normal   densities  are   indicated  for   each  plot.  The   corresponding   Q-Q  plots  (right)  for   each  
                                                              sample are  also presented. 
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̂ߤ ൌ 0.0073  
ߪො ൌ 0.0195         
ߣመ ൌ െ3.0212      
n = 200 
̂ߤ ൌ 0.0082  
ߪො ൌ 0.0170         
ߣመ ൌ െ4.5873         
n = 500 
̂ߤ ൌ 0.0078  
ߪො ൌ 0.0204         
ߣመ ൌ െ4.8565            
n = 1000 
̂ߤ ൌ 0.0082  
ߪො ൌ 0.0205         
ߣመ ൌ െ3.6002       
̂ߤ ൌ 0.0082  
ߪො ൌ 0.0217         
ߣመ ൌ െ4.1532      
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   No. of ࢾ෡࢐૚ ’s 
(n) simulated 
Estimated parameters of Skew-Normal density 
fitted to ࢾ෡࢐૛ data 
Chi-square goodness-of-fit test 
Location 
parameter 
Scale 
parameter 
Shape 
parameter 
Critical 
values p-values 
50 -0.0064 0.0180 3.9363 0.1445 1.0000 
100 -0.0072 0.0200 4.9813 1.6946 0.9890 
200 -0.0079 0.0197 3.1463 0.1150 0.9998 
500 -0.0084 0.0216 4.0917 0.0665 1.0000 
1000 -0.0086 0.0212 4.0244 0.1183 1.0000 
Average -0.0077 0.0201 4.0360   
 
Table 3.1a: The Chi-square goodness-of-fit test to establish the fitness of the simulated ߜመ௝భ ൌ
ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ data to the Skew-Normal distribution. The Chi-square estimates and the 
corresponding p-values are respectively shown in the last two columns of the table. The parameter 
estimates of the fitted SN densities presented are computed using 10,000 random samples drawn 
from the fitted SN distributions for each respective simulated ߜመ௝భ data. All results indicated  that the  
                                                         Skew-Normal density fits the ߜመ௝భ data.  
No. of   ࢾ෡࢐૛ ’s 
(n) simulated 
Estimated parameters of Skew-Normal density 
fitted to ࢾ෡࢐૛ data 
Chi-square goodness-of-fit test 
Location 
parameter 
Scale 
parameter 
Shape 
parameter 
Critical 
values p-values 
50 0.0073 0.0195 -3.0212 0.1907 0.9999 
100 0.0082 0.0170 -4.5873 0.1278 0.9980 
200 0.0078 0.0204 -4.8565 0.2692 1.0000 
500 0.0082 0.0205 -3.6002 0.1442 1.0000 
1000 0.0082 0.0217 -4.1532 0.1380 1.0000 
Average 0.0075 0.0198 -4.0437   
 
Table 3.1b: The Chi-square goodness-of-fit test to establish the fitness of the simulated ߜመ௝మ ൌ
ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ data to the Skew-Normal distribution. The Chi-square estimates and the 
corresponding p-values are respectively shown in the last two columns of the table. The parameter 
estimates of the fitted SN densities presented are computed using 10,000 random samples drawn 
from the fitted SN distributions for each respective simulated  ߜመ௝మ data. All results indicated that the 
                                                      Skew-Normal density fits the ߜመ௝మ data.  
The family of the skew-normal density functions is implemented in 
the sn library of R statistical package. We have employed this to fit 
the skew-normal distribution to all the simulated ߜመ௝ೞ data sets. 
It can be observed from Tables 3.1a & b that, except for the sign 
differences in both location and shape parameters, all the estimated 
parameters of the skew-normal densities for both ߜመ௝భ and ߜመ௝మ variates 
are essentially similar at each of the selected sample sizes. These are 
clearly shown by the respective density plots in Fig 3.2. While ߜመ௝భ 
has more positive values than negatives and is positively skewed, ߜመ௝మ 
has more negative values than the positives and is negatively 
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skewed. More justifications are provided by the Box-and-Whiskers 
plots of the simulated ߜመ௝భ and ߜመ௝మ values at the five selected sample 
sizes as shown in Fig 3.5a and Fig 3.5b respectively. This is more 
conspicuously presented by the box-plot of the ߜመ௝ೞ data, ݏ ൌ 1,2, at 
1000 sample size as shown in Fig 3.5c. Except for their sign 
differences due to skewness as indicated in all the plots, the two ߜመ௝ೞ 
data have similar distribution patterns but in the opposite sense. 
 
 
Fig 3.5 a &b: The box-plot of the simulated minimum average MER differences, ߜመ௝భ (a) and ߜመ௝మ (b)   
                                                     data at the selected five sample sizes. 
As previously discussed in Chapter 2 under the two ߜመ௝ೞ k-SS 
formulations, ݏ ൌ 1, 2,  the strict inequality ҧߴመ௠భ,௠మ,…,௠ೕశభ ൏ ҧߴመ௠భ,௠మ,…,௠ೕ 
shall be observed as long as the selection of additional gene 
continues to improve the prediction accuracy of the current models. 
This will continue to yield positive ߜመ௝భ values (or negative  ߜመ௝మ values) 
at each successive selection steps until no further improvement is 
brought into the model despite the inclusion of additional gene. At 
such selection levels, the condition that ߜመ௝భ ൑ 0 (or ߜመ௝మ ൒ 0) shall hold. 
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These are the pictures displayed in Fig 3.2 for the empirical 
distributions of both ߜመ௝భ and ߜመ௝మ simulated data sets.  
 
Fig 3.5c: The box-plot of the simulated minimum average MER differences for both ߜመ௝భ (delta1) and  
       ߜመ௝మ (delta2) at 1000 sample size showing the effects of skewness under the two formulations. 
Now that it has been established that the ߜመ௝ೞ data have the skew-
normal distribution, it is therefore obvious that the test statistics           
ܼఋ෡ೕೞ ൌ
ఋ෡ೕೞିாቀఋ෡ೕೞቁ
ට௏ቀఋ෡ೕೞቁ
, ݏ ൌ 1, 2, ݆ ൌ 1, … , ݍ െ 1, as stated for testing one 
directional hypotheses sets (2.4.32) and (2.4.49) are also distributed 
skew-normal. To compute the critical values ܥఈ௦ therefore, we only 
need to determine the shape parameters of the skew-normal 
densities ߶൫ߜመ௝భ; ߣଵ൯ and ߶൫ߜመ௝మ; ߣଶ൯ or simply that of ߶ ቀܼఋ෡ೕభ ; ߣଵቁ and 
߶ ቀܼఋ෡ೕమ ; ߣଶቁ. We recall that the skewness of the two SN densities 
߶ ቀܼఋ෡ೕభ ; ߣଵቁ and  ߶ ቀܼఋ෡ೕమ ; ߣଶቁ are different only by their signs, such 
that when ߜመ௝భ is positively skewed by ߣଵ magnitude ߜመ௝మ would be 
negatively skewed by ߣଶ magnitude with ߣଶ ൌ െߣଵ. Therefore, if the 
random variable ܼఋ෡ೕభ  is distributed skew-normal with shape 
parameter ߣଵ i.e. ܼఋ෡ೕభ ~ܵܰሺ ߣଵሻ, it can be easily shown (Azzalini, 1985, 
pp172) that random variable ܼఋ෡ೕమ  would be distributed skew-normal 
with shape parameter ߣଶ i.e. [ܼఋ෡ೕమ ~ܵܰሺߣଶሻ], ߣଶ ൌ െߣଵ. From this 
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relationship, another basic property of ܵܰ family of distributions as 
adapted here, using (3.2.2) equally holds that  
     Φ ቀܼఋ෡ೕభ ; ߣଵቁ ൌ 1 െ Φ ቀܼఋ෡ೕమ ; ߣଶቁ ՞ Φ ቀܼఋ෡ೕభ ; ߣଶቁ ൌ 1 െ Φ ቀܼఋ෡ೕమ ; ߣଵቁ(3.2.6) 
Azzalini (1985, pp174), where the absolute value of the ‘joint’ shape 
parameter |ߣ௦|, ݏ ൌ 1,2, that satisfies (3.2.6) is to be determined.  
To this end therefore, we shall let the joint estimate of the absolute 
value of the shape parameter for both ߶൫ߜመ௝భ; ߣଵ൯ and ߶൫ߜመ௝మ; ߣଶ൯ skew-
normal densities be denoted by ߣכ෡ .  This can be determined by taken 
the average of the absolute values of all the estimated shape 
parameters of the skew-normal densities ߶൫ߜመ௝భ; ߣଵ௠൯ and ߶൫ߜመ௝మ; ߣଶ௠൯ 
fitted for simulated ߜመ௝ೞ data sets, ݏ ൌ 1,2, at ݉ chosen number of 
sample sizes, ݉ ൌ 1, … , ܯ. Thus, ߣכ෡  is obtained by 
                                  ߣכ෡ ൌ ଵ
ଶெ
൫∑ หߣመଵ௠หெ௠ୀଵ ൅ ∑ หߣመଶ௠หெ௠ୀଵ ൯                  (3.2.7) 
Based on the results of our simulations, the estimates of each of the 
ߣ௦௠, ݏ ൌ 1,2, ݉ ൌ 1, … , 5, are provided in Tables 3.1a & 3.1b for 
simulated ߜመ௝భ and ߜመ௝మ data sets respectively. From these results, the 
value of ߣכ෡  is estimated to be ߣכ෡ ൌ ૝. ૙૜ૢૡ using (3.2.7). Henceforth, 
this value of ߣכ෡  shall be used as the true value of parameter ߣכ of the 
skew-normal densities ߶ ቀܼఋ෡ೕభ ; ߣ
כቁ and ߶ ቀܼఋ෡ೕమ ; ߣ
כቁ for the critical 
values  ܥఈଵ ൌ  ܼଵିఈሺߣכ෡ ሻ and ܥఈଶ ൌ ܼଵିఈሺെߣכ෡ ሻ of our k-SS test procedures 
(2.4.32) and (2.4.49) respectively at any given value of ߙ. 
Therefore, for testing the hypothesis sets (2.3.32) and (2.4.49) the 
respective test statistics ܼఋ෡ೕభ ൌ
ఋ෡ೕభିாቀఋ
෡
ೕభቁ
ට௏ቀఋ෡ೕభቁ
 and ܼఋ෡ೕమ ൌ
ఋ෡ೕమିாቀఋ
෡
ೕమቁ
ට௏ቀఋ෡ೕమቁ
 have the 
skew-normal distributions with shape parameters ߣכ and െߣכ 
 
 
 119 
respectively with ߣכ estimated as ߣכ෡ ൌ ૝. ૙૜ૢૡ and ܧ൫ߜመ௝ೞ൯ ൌ 0 under 
ܪ଴௦௝, ݏ ൌ 1,2, ݆ ൌ 1, … , ݍ െ 1. From the distributions of the two test 
statistics ܼఋ෡ೕೞ  given above, one can easily determine the estimates of 
their critical values ܥఈ௦ for our k-SS test procedures in (2.4.32) and 
(2.4.49) for ݏ ൌ 1 and 2 respectively. These are presented in what 
follows.  
Let us consider one directional hypothesis set given in (2.4.32), i.e. 
ܪ଴ଵ௝: ߜ௝భ ൑ 0 vs. ܪ௔ଵ௝ : ߜ௝భ ൐ 0, for ݆ ൌ 1, … ݍ െ 1. Since the test statistic 
ܼఋ෡ೕభ  as used in (2.4.33) for this test is distributed skew-normal, 
ܼఋ෡ೕభ ~ܵܰሺߣ
כሻ, then, at any significance level ߙ (to be determined by 
cross-validation), the critical values ܥఈଵ for this test, as used in 
(2.4.34) through (2.4.37), shall be estimated by  
                                       ܥఈଵ ൌ  ܼଵିఈሺߣכ෡ ሻ                                 (3.2.8) 
where ܼଵିఈሺߣכ෡ ሻ is the quantile of the skew-normal distribution 
߶ ቀܼఋ෡ೕభ ; ߣ
כቁ with shape parameter ߣכ computed at significance level ߙ.   
Similarly, under the one directional hypothesis set in (2.4.49), i.e. 
ܪ଴ଶ௝: ߜመ௝మ ൒ 0 vs. ܪ௔ଶ௝ : ߜመ௝మ ൏ 0, each of the test statistic ܼఋ෡ೕమ  for the test 
is equally distributed skew-normal, ܼఋ෡ೕమ ~ܵܰሺെߣ
כሻ, and at any given 
significance level ߙ, the critical values ܥఈଶ for this test, as defined in 
(2.4.50) and (2.4.50), shall be estimated by  
                                     ܥఈଶ ൌ  ܼଵିఈሺെߣכ෡ ሻ                                (3.2.9) 
where ܼଵିఈሺെߣכ෡ ሻ is the quantile of the skew-normal density 
߶ ቀܼఋ෡ೕమ ; ߣ
כቁ with shape parameter െߣכ at significance level ߙ also to 
be determined by cross-validation.  
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Having determined the theoretical distributions of ܼఋ෡ೕೞ  or ߜመ௝ೞ, ݏ ൌ 1,2, 
we then present in what follows, the complete form of our k-SS 
algorithm. However, it is to be noted that the implementation of 
either of two k-SS test procedures in (2.4.32) or (2.4.49) on a given 
microarray data set would essentially yield similar results. 
The k-SS algorithm 
Input: Training samples ்݊ோ and test samples ்݊ா of ݊ biological subjects with binary 
response group ܻ א ሼ0,1ሽ and ݍ-dimensional vector ࢄ ൌ ሺ ଵܺ, … , ܺ௤ሻ் of genes whose 
expression levels are measured on all the ݊ samples, ݊ ൌ ்݊ோ ൅ ்݊ா. 
Out-put:  The k-SS classifiers and various performance indices. 
Step 0-0: #Search for the first best gene to be selected into the classification model  
    among all the ݍ genes. 
 
i) Fit logit model, ݈݋݃݅ݐ൫ߨሺ ௝ܺሻ ൯ ൌ ߙ ൅ ߚ௝ܺ௝, ݆ ൌ 1, … , ݍ, on individual gene ௝ܺ 
using the training sample ்݊ோ. 
ii) Construct the classifiers ߮൫ ௝ܺ൯ ൌ  ܽݎ݃݉ܽݔ௬ ݌̂൫ݕห ௝ܺ൯ for each gene ௝ܺ, ݆ ൌ 1, … , ݍ, and 
predict the two class labels (0,1) of the test sample ்݊ா via the classification scheme; 
ො߮௜൫ ௝ܺ൯ ൌ ቊ
1,   if ݌̂௜൫1ห ௝ܺ൯  ൒  0.5 
0,   if ݌̂௜൫0ห ௝ܺ൯  ൏  0.5
 
iii) Base on ii) above, compute the misclassification error rates (MERs), መߴ௝ ൌ
ଵ
௡೅ಶ
∑ ቂܫ൛ఝෝ೔൫௑ೕ൯ஷ௒೔ൟቃ , 0 ൑ መߴ௝ ൑ 1.
௡೅ಶ
௜ୀଵ  ݆ ൌ 1, … , ݍ, for each ௝ܺ, where ܫሼ.ሽ ൌ 1 if the 
argument is true and 0 otherwise. 
iv) Draw R replicates of training sample ்݊ோ randomly, without replacement, 
from the original ݊ sample and repeat steps i) to iii) on each sub-sample for 
each gene ௝ܺ and compute the average MERs  
             ҧߴመ௝ ൌ
ଵ
ோൈ௡೅ಶ
∑ ∑ ቂܫ൛ఝෝ೔ೝ൫௑ೕ൯ஷ௒೔ೝൟቃ
ோ
௥ୀଵ
௡೅ಶ
௜ୀଵ , ݆ ൌ 1, … , ݍ. 
v) Define the minimum average MER from iv) by 
ҧߴመ௠భ ൌ ҧߴመሺଵሻ ൌ ݉݅݊ ቀ ҧߴመሺଵሻ, ҧߴመሺଶሻ, … , ҧߴመሺ௤ሻቁ and select the corresponding gene 
ܺ௠భ ൌ ሺܺଵሻ  א ൛ܺሺଵሻ, ሺܺଶሻ, … , ܺሺ௤ሻൟ as the first gene candidate into our 
classification model. 
Step 1-0:  #Search for the next best gene to be included with gene ܺ௠భ in the 
                    model 
i) For the remaining ݍ െ 1 genes, construct classification rules as in Step 0-0 i) 
to v) above but using each gene pair ܺ௠భ ሺܺଶሻ, …,  ܺ௠భ ሺܺ௤ሻ. Obtain the 
minimum average MERs defined as   
                  ҧߴመ௠భ௠మ ൌ ݉݅݊ ቀ ҧߴመ௠భሺమሻ , ҧߴመ௠భሺయሻ, … , ҧߴመ௠భሺ೜ሻቁ                
which is provided by the corresponding gene pair 
ܺ௠భܺ௠మ א ൛ܺ௠భ ܺሺଶሻ, ܺ௠భ ܺሺଷሻ, … , ܺ௠భ ܺሺ௤ሻൟ.  
ii) Select gene ܺ௠మ into our classification model which already has gene ܺ௠భ to 
form gene pair ܺ௠భܺ௠మ in the new classification model.  
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Step 1-1: #Test for the significance of the gain in prediction accuracy of the 
                  current model due to the inclusion of gene ܺ௠మ. 
 
i.) Test one directional hypothesis test of the form: 
ܪ଴ଵଵ: ߤణ
௠భ െ ߤణ
௠భ,௠మ ൑ 0  vs. ܪ௔ଵଵ: ߤణ
௠భ െ ߤణ
௠భ,௠మ ൐ 0 
       ՜ ܪ଴ଵଵ : ߜଵభ ൑ 0  vs. ܪ௔ଵଵ: ߜଵభ ൐ 0 
where ߜଵభ ൌ  ߤణ
௠భ െ ߤణ
௠భ,௠మ with its unbiased estimator given by  
ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ. 
ii.) Use the test statistic, ܼఋ෡భభ ൌ
ఋ෡భభିாሺఋ෡భభሻ
ට௏൫ఋ෡భభ൯
~ܵܰሺߣכሻ,     
ܵܰሺߣכሻ ՜ Skew-Normal density with shape parameter ߣכ. Under ܪ଴ଵଵ, 
ܧ൫ߜመଵభ൯ ൌ 0. 
iii.) Construct decision rules (for gene(s) selection(s)): 
At some range of significance level ߙ (determined by cross-validation), 
a.) accept ܪ଴ଵଵ (reject the selection of gene ܺ௠మ into the model)  if 
ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ ൑ ܼଵିఈሺ4.0398ሻටߪଶ൫ߜመଵభ൯ 
b.) reject ܪ଴ଵଵ (accept the selection of gene ܺ௠మ into the model) if 
ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ ൐ ܼଵିఈሺ4.0398ሻටߪଶ൫ߜመଵభ൯ 
where ܼଵିఈሺ4.0398ሻ is the quantile of the skew-normal density at the 
estimated shape parameter ߣכ෡ ൌ 4.0398. 
iv.) If the null hypothesis ܪ଴ଵଵ is rejected base on decision rule iii.)b.), retain 
gene ܺ௠మ in the model and go back to Step 1-0 in search of the next best 
gene to be added to the gene pair ܺ௠భܺ௠మ in the model. If ܪ଴ଵଵ is accepted, 
drop the selected gene ܺ௠మ from the model and stop further gene selection. 
v.) Execute Steps 1-0 (i-ii) to Step 1-1 (i-iv) repeatedly until no more gene 
satisfies the decision rule iii.)b.) above 
vi.) STOP and RETURN the k-sequentially selected (k-SS) informative genes, 
݇ א ሼ1, . . , ݍሽ and various performance indices. 
3.3 Applications of ࢑-SS method 
The new k-SS method proposed here is first applied here on the 
simulated microarray dataset. The method is later applied on eleven 
published microarray data sets as presented in Chapters 4 and 5. 
Details of all the data sets used are provided in the next Chapter. 
Since the 100 by 1,000 data matrix we simulated here represents a 
typical microarray data set, appropriate data normalization and 
standardization as discussed in Chapter 1 are carried out prior to 
analysis of the data such that each vector of genes has zero mean 
and unit standard deviation across the mRNA samples. This is 
followed by preliminary gene selection using the student-t statistics 
based on the procedures described in Section 1.4.2. Using the range 
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of the observed ݌-values from the data as a guide, the cut-point       
݌-value, ݌כ is taken to be 0.05. The univariate filtering using this 
student-t method hereby reduced the original ݍ ൌ 1000 genes to   
ݍכ ൌ 55 genes.  
We begin the implementation of our ݇ sequential gene selection (݇-
SS) method by random splitting of the mRNA sample size ݊ using 
the splitting ratio 19:1 for ்݊ோ (training sample) : ்݊ா (test sample) 
respectively as discussed in Section 2.1. Therefore, with the 
simulated mRNA sample size ݊ ൌ 100, ்݊ோ ൌ 95 would be used to 
build our classifier while  ்݊ா ൌ 5 would be used to evaluate its 
performance.  
Sub-sampling scheme of Monte Carlo Cross-Validation (MCCV) is 
adopted to ensure stability of results and minimize bias in our 
estimates. By this, random sample of size ்݊ோ ൌ 95 is repeatedly 
drawn from the entire ݊ ൌ 100 sample 5000 times without 
replacement and univariate logit model is fitted on each of the 
ݍכ ൌ 55 genes using each selected ்݊ோ sample. Each of the fitted 
model is used to predict the response class labels ݕ א ሼ0,1ሽ of the 
remaining left-out ்݊ா ൌ 5 samples from which the misclassification 
error rates (MERs) are computed. Thereafter, the average MERs 
ҧߴመଵ, ҧߴመଶ, … , ҧߴመହହ, averaged over the entire 5000 repetitions, are 
computed. All the 55 genes are then ordered in ascending order of 
their averaged MER estimates. This resulted into the following 
genes sequence and their respective average MER estimates (in 
parenthesis): g5(0.1737), g4(0.18170),…,V879(0.4850), V876(0.5171). 
It should be recalled that the genes labelled g1 to g5 are the 5 
simulated genes with up-regulated expression values while genes 
labelled V6 to V1000 are the 995 simulated genes with moderate 
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gene expressions values according to our simulation procedures as 
presented in Section 3.1.  
Base on the above estimated mean MERs sequence the ordered 
prediction performance of the genes can be vividly seen. The gene 
labelled g5 is the gene that provided the best prediction accuracy for 
having the least mean MER of 0.1737 among the 55 preliminarily 
selected genes. Hence, gene g5 is the first gene to be selected by our 
k-SS procedure.  This is then followed by searching for the next best 
gene among the remaining 54 genes to be included in the model with 
g5. We determined this by fitting the logit model on each of the 54 
gene pairs g5g4, … , g5V879, g5V876 and use the fitted model to 
predict the response category of the test samples. Here again, the 
mean MER for each prediction is computed and the gene pair that 
produces the minimum mean MER among the 54 mean MERs is 
selected for consideration into the model. At this selection step, any 
of the one directional null hypothesis set of the form ܪ଴ଵ௝: ߤణ
௠భ,௠మ,…,௠ೕ െ
ߤణ
௠భ,௠మ,…,௠ೕశభ ൑ 0 or ܪ଴ଶ௝: ߤణ
௠భ,௠మ,…,௠ೕశభ െ ߤణ
௠భ,௠మ,…,௠ೕ ൒ 0 as given in (2.4.32) 
or (2.4.49) respectively with ݆ ൌ 1  is to be tested between the two 
minimum mean MERs obtained at the previous two gene selections. 
We shall first consider the use of the hypothesis test (2.4.32) after 
which the second hypothesis test (2.4.49) shall be considered to 
illustrate the applications our ݇-SS method. It shall be finally 
established thereafter that the ݇-SS results under the two test 
formulations are essentially similar.  
Using hypothesis test (2.4.32), the test hypothesis required at this 
gene selection stage is of the form   
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ܪ଴ଵଵ: ߤణ
௠భ െ ߤణ
௠భ,௠మ ൑ 0  vs. ܪ௔ଵଵ: ߤణ
௠భ െ ߤణ
௠భ,௠మ ൐ 0 
           ՜                     ܪ଴ଵଵ : ߜଵభ ൑ 0  vs. ܪ௔ଵଵ: ߜଵభ ൐ 0             (3.3.1) 
where ߜଵభ ൌ  ߤణ
௠భ െ ߤణ
௠భ,௠మ. Based on the decision rules in (2.4.36) and 
(2.4.37) additional one gene would be selected and added to gene g5 
(accepting ܪ௔ଵଵ) if ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ ൐ ܥఈଵටߪଶ൫ߜመଵభ൯, while the 
selection of additional one gene would be stopped (accepting ܪ଴ଵଵ) if 
ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ ൑ ܥఈଵටߪଶ൫ߜመଵభ൯ where ܥఈଵ ൌ ܼଵିఈሺߣכ෡ ሻ is the critical 
value of the percentage points of the skew-normal distribution as 
defined in Section 3.2 at some Type I error ߙ to be determined by 
internal cross-validation.  
The value of the shape parameter ߣכ෡  of the skew-normal density has 
been estimated to be 4.0398 through simulation studies in the 
previous section. This shall be used to determine ܥఈଵ at each selection 
step. In a nutshell, if the null hypothesis ܪ଴ଵଵ is accepted, further 
variable selection stops, but if the alternative set ܪ௔ଵଵ is accepted, 
then, additional one gene would be included into the model and the 
search for the next best gene to be selected begins by repeating the 
above procedures.  The R code we develop to run this test procedure 
is provided in Appendix B.1. 
We would like to reiterate here again that the size ߙ of our k-SS test 
procedure is not arbitrarily fixed by us but rather, it is being 
determined through cross-validation. By this, different estimates of 
the critical values ܥఈଵටߪଶ൫ߜመଵభ൯ would be computed over all possible 
values of ߙ in the interval ሾ0,1ሿ and the value(s) of ߙ at which the 
decision rule (2.4.36) is satisfied and for which the best prediction 
results are obtained becomes the size of our test.  
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Based on these criteria, additional one gene labelled “g3” is selected 
at step 1 having satisfied the decision rule ߜመଵభ ൌ ҧߴመ௠భ െ ҧߴመ௠భ,௠మ ൐
ܥఈଵටߪଶ൫ߜመଵభ൯ as given by (2.4.37). Therefore, gene “g3” was added to 
gene “g5” at step 1 to make gene pair “g5, g3” in the k-SS 
classification function.  
Selection 
steps ࢐ 
Min. mean 
MERs 
ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ 
Min. mean 
MERs 
ࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ 
ࢾ෡࢐૚ ൌ ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ 
െࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ 
No. of genes 
selected Decision 
0 0.1831 - - 1 continue  
1 0.1831 0.1132 0.0701 2 ?  
2 0.1120 0.0783 0.0337 3 ?  
3 0.0787 0.0697 0.0090 4 ?  
4 0.0718 0.0602 0.0116 5 ?  
5 0.0598 0.0459 0.0139 6 ?  
6 0.0463 0.0485 -0.0021 ൈ stop 
 
Table 3.2a: Table of results of ݇-SS classifier under the ߜመ௝భ formulations at each gene selection step 
for simulated data. Optimal selection (the best prediction result) is achieved at the fifth selection step 
at which the sixth gene is selected. The size ߙ of the ݇-SS test, determined by cross-validation, 
satisfies the range ߙ א ሺ0, 0.975ሿ. The corresponding rage of the critical value ܥఈଵටߪଶ൫ߜመ଺భ൯ of the test 
statistic ߜመ଺భ for this range of ߙ is estimated as ܥఈଵටߪଶ൫ߜመ଺భ൯ א ሺ∞, െ1.2081 ൈ 10ିସሿ. The six genes 
selected in order of selection steps 0,1, … ,5 are “g5”, “g3”, “V192”, “V805”, “V566”, “g2” respectively. 
At step 2, the decision rule ߜመଶభ ൌ ҧߴመ௠భ,௠మ െ ҧߴመ௠భ,௠మ,௠య ൐ ܥఈଵටߪଶ൫ߜመଶభ൯ was 
also satisfied with the selection of gene “V192”. This was again 
added to the gene pair “g5, g3” to increase the number of selected 
informative genes from two (“g5, g3”) to three (“g5, g3, V192”). The 
gene selections and response class predictions processes continue 
until step 5 at which the gene selection and classification were 
optimal. At that optimal selection step, step 5, the following six 
informative genes, “g5”, “g3”, “V192”, “V805”, “V566” and “g2”,  have 
been selected in that sequence. We present in Table 3.2a, the k-SS 
prediction results which include the minimum mean MERs and their 
differences as well as the number of gene selected at each gene 
selection step.  
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At the 6th selection step however, consideration was being given to 
the 7th gene to be selected. At this step, the minimum mean MER 
difference ߜመ଺భ ൌ ҧߴመ௠భ,௠మ,…,௠ల െ ҧߴመ௠భ,௠మ,…,௠ళ was estimated given the 
following summary statistics: ҧߴመ௠భ,௠మ,…,௠ల ൌ 0.0463, ҧߴመ௠భ,௠మ,…,௠ళ ൌ
0.0485, ߜመ଺భ ൌ  െ0.0021. Also, with ܥఈଵ already found to be               
ܥఈଵ ൌ ܼଵିఈሺ4.0398ሻ, the estimates of the critical value ܥఈଵටߪଶ൫ߜመ଺భ൯ of 
the test statistic ߜመ଺భ as given by the decision rules (2.4.36) and 
(2.4.37) with ݆ ൌ 6 has a range 
      ܼଵିఈሺ4.0398ሻ ൈ ටߪଶ൫ߜመ଺భ൯ א ሺ∞, െ1.2081 ൈ 10ିସሿ    (3.3.2) 
computed over the corresponding range of significance level ߙ, 
estimated by cross-validation, given by 
             ߙ א ሺ0, 0.975ሿ                                  (3.3.3) 
It can be easily observed from (3.3.2) that ߜመ଺భ ൌ  െ0.0021 ൏
ܼଵିఈሺ4.0398ሻ ൈ ටߪଶ൫ߜመ଺భ൯ over all the range of  ߙ as given in (3.3.3). 
Therefore, by decision rule (2.4.37), further gene selection is stopped 
and the 7th gene is excluded from k-SS classification model. This 
simply implies that, our k-SS procedure considers the relative loss in 
prediction accuracy of െ0.0021, the difference between the mean 
MER ҧߴመ௠భ,௠మ,…,௠ల ൌ 0.0463 (obtained at 5th selection step from 6 
genes) and the mean MER ҧߴመ௠భ,௠మ,…,௠ళ ൌ 0.0485  (obtained at 6th 
selection step from 7 genes), to be too large enough to warrant the 
stoppage of further gene selection beyond the 5th selection step. 
Hence, the reason why the inclusion of the seventh gene at the 6th 
selection steps is rejected by k-SS criteria.  
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Based on our simulated microarray data set therefore, the best 
prediction results are obtained at the 5th selection step at which    
݇ ൌ 6 informative genes (“g5”, “g3”, “V192”, “V805”, “V566”, “g2”) are 
selected by our k-SS method.  The average prediction accuracy 
achieved by our k-SS classifier using the six genes is 95.37%. This 
yielded an average MER of 0.0463.  
If we adopt the minimum mean MER ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ 
formulation in the construction of one directional hypothesis set as 
stated in (2.4.49), the same test procedures above would be followed 
with the only exception that the test statistic used would now be ߜመ௝మ 
or ܼఋ෡ೕమ  with ܼఋ෡ೕమ ~ܵܰሺെߣ
כሻ as earlier established in this chapter. The 
critical value ܥఈଶ of the test statistic ܼఋ෡ೕమ  would be ܥఈ
ଶ ൌ
ܼଵିఈሺെ4.0398ሻ. 
According to our k-SS results under the ߜመ௝మ formulation, the optimal 
selection step is also attained at the 5th selection step after the 
selection of the 6th gene into the model. At the 6th selection step 
however, consideration is being given to the 7th gene to be selected 
into the model. The minimum mean MER difference ߜመ଺మ ൌ
ҧߴመ௠భ,௠మ,…,௠ళ െ ҧߴመ௠భ,௠మ,…,௠ల is computed at this selection step (step 7) and 
the following summary statistics are obtained; ҧߴመ௠భ,௠మ,…,௠ల ൌ 0.0473 ,   
ҧߴመ௠భ,௠మ,…,௠ళ ൌ 0.0490 and  ߜመ଺మ ൌ  0.0017. The estimated critical value 
ܥఈଶටߪଶ൫ߜመ଺మ൯ for the test statistic ߜመ଺మ has a range  
                    ܼଵିఈሺെ4.0398ሻ ൈ ටߪଶ൫ߜመ଺మ൯ א ሾ2.1629 ൈ 10ିସ, െ∞ሻ     (3.3.4) 
which is obtained over the corresponding range of ߙ estimated as  
                                               ߙ א ሾ0.025, 1ሻ                                    (3.3.5) 
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Selection 
steps ࢐ 
Min. mean 
MERs 
ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ 
Min. mean 
MERs 
ࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ 
ࢾ෡࢐૛ ൌ ࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ 
െࣖഥ෡࢓૚,࢓૛,…,࢓࢐ 
No. of genes 
selected Decision 
0 0.1822 - - 1 continue 
1 0.1768 0.1090 -0.0678 2 ?  
2 0.1121 0.0772 -0.0349 3 ?  
3 0.0817 0.0712 -0.0105 4 ?  
4 0.0722 0.0584 -0.0138 5 ?  
5 0.0601 0.0461 -0.0140 6 ?  
6 0.0473 0.0490  0.0017 ൈ stop 
 
Table 3.2b: Table of results of ݇-SS classifier under the ߜመ௝మ formulations at each gene selection step 
for simulated data. Optimal selection (the best prediction result) is achieved at the fifth selection step 
at which the sixth gene is selected. The size ߙ of the ݇-SS test, determined by cross-validation, 
satisfies the range ߙ א ሾ0.025, 1ሻ. The corresponding rage of the critical value ܥఈଶටߪଶ൫ߜመ଺మ൯ of the test 
statistic ߜመ଺మ for this range of ߙ is estimated as ܥఈଶටߪଶ൫ߜመ଺మ൯ א ሾ2.1629 ൈ 10ିସ, െ∞ሻ. The six genes 
selected in order of selection steps 0,1, … ,5 are “g5”, “g3”, “V192”, “V805”, “V566”, “g2” respectively. 
Based on the above results, it could be observed that ߜመ଺మ ൌ  0.0017 ൐
ܼଵିఈሺെ4.0398ሻ ൈ ටߪଶ൫ߜመ଺మ൯, which satisfied the decision rule (2.4.50) 
over all the range of  ߙ as given in (3.3.5). Therefore, the selection of 
the 7th gene into the model at the 6th selection step is rejected and 
further gene selection stops. The results’ estimates at each selection 
step as provided by our ݇-SS procedures are presented in Table 3.2b. 
At the optimal selection step, step 5 after which no additional genes 
is allowed into the model again, the following sequence of 6 genes, 
“g5”, “g3”, “V192”, “V805”, “V566”, “g2” as selected under the ߜመ௝భ test 
formulations have being equally selected.  This simply confirms our 
earlier remark that the use of ߜመ௝భ ൌ  ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ or 
ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ formulations for the construction of 
our ݇-SS procedure would yield similar prediction results. 
Results from Tables 3.2a & b showed that the average prediction 
error rate estimated by ݇-SS method using six genes is about 4.7% 
under the two test formulations. This shows that, for the simulated 
microarray data set, the new ݇-SS method provided prediction 
 
 
 129 
accuracy of about 95%. By this result, our k-SS method correctly 
classified 95% of the subjects in the population from which the data 
was simulated while it misclassify just about 5% of the subjects. The 
estimates of other performance measures for the ݇-SS classifier are 
provided as follows; sensitivity ൎ 96%, specificity ൎ 98%, positive 
predictive value (PPV) ൎ 98%, negative predictive value (NPV) 
ൎ 96%, Jaccard Index ൎ 91%. All these performance measures as 
obtained under the two test conditions (2.4.32) and (2.4.49) as 
considered by our ݇-SS method is presented in Table 3.3. The cross-
validated ROC (CVROC) curve and the estimated area under the 
curve called the cross-validated AUC (CVAUC) area, for the optimal 
k-SS classification model (containing six selected genes) under the 
ߜመ௝భ formulation is presented in Fig 3.6. 
࢑-SS 
formulations 
Performance Measures on ࢑-SS classifiers 
MER Sensitivity Specificity +predictive 
value 
-predictive 
value 
Jaccard 
Index 
No. of 
selected 
Genes 
ࢾ෡࢐૚ 0.0463 0.9593 0.9789 0.9785 0.9601 0.9131 6 
ࢾ෡࢐૛ 0.0473 0.9592 0.9790 0.9786 0.9600 0.9112 6 
Average 
performance 
0.0468 0.9593 0.9790 0.9786 0.9601 0.9122 6 
 
Table 3.3: Table of estimated performance indices for the ݇-SS classifier on simulated microarray  
                    data set under the two minimum mean MER test formulations ߜመ௝భ and ߜመ௝మ. 
Due to some argument raised in favour of the use of brier score as an 
important assessment measure of classification rules (Hand, 1997), 
we equally obtained the average cross-validated estimates of the 
brier score, ҧߴመ௕௥௜௘௥ to access the performance of the k-SS method. This 
is estimated to be  ҧߴመ௕௥௜௘௥ ൌ 0.0492 for the simulated microarray data. 
It can be observed that the estimated brier score of 0.0492 is very 
close to the estimated MER of 0.0473. To this end, we shall ignore 
the brier scores estimates in our subsequent analyses. 
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The plot of the average MERs at each selection steps against the 
number of genes selected as presented in Fig 3.7 clearly indicated 
successive improvements in k-SS prediction results as additional 
genes are selected into the models.  
 
Fig: 3.6: The cross-validated ROC (CVROC) curve for the optimal k-SS prediction results (with six 
selected genes)  under  the  ߜመ௝భ  test formulation. The  cross-validated  AUC  area  is  estimated  to  be  
                                                                                  0.9702. 
 
Fig 3.7: The graph of the successive average MER estimates at each selection step against the 
number of gene selected. The graph shows improvement in prediction accuracy by ݇-SS method as 
additional genes are  selected into the  model  until optimal  gene  selection is  reached at the 6th gene 
                                                                                selection. 
Furthermore, we present in Fig 3.8 the plots of the estimated 
minimum mean MER differences for ߜመ௝భ and ߜመ௝మ at successive 
selection steps ݆ against the number of selected genes. It can be 
easily observed from the plots that both ߜመ௝భ and ߜመ௝మ, though having 
different estimates, provided the same gene selection results and 
they both reach their optimal selection levels after the selection of 
the sixth informative genes.   
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Fig 3.8: The graphs of the successive estimated minimum mean MER differences under the two k-SS 
test formulations ߜመ௝భ (Delta 1) and ߜመ௝మ (Delta 2).The optimal gene selection step was reached when     
k = 6 genes were  selected as  indicated  by  the  two  plots. The  optimal selection point is the point at  
                            which the ߜመ௝భ ՜  െݒ݁ݏ or  ߜመ௝మ ՜  ൅ݒ݁ݏ by some estimated critical values. 
Backward checks on the selected genes 
As briefly discussed in the last chapter, we intend to examine the 
importance of each selected genes by our ݇-SS classifier in the 
presence of other genes in the model. By this, we want to find out if 
the previously selected genes are still important in the model given 
that additional new gene is selected into the model. Each of the six 
selected genes is examined for their relevance in the presence of 
other selected genes as detailed in Section 2.4.2 under the backward 
checks procedure.  The R code we developed for the implementation 
of the backward checks on genes selected by k-SS method is provided 
in Appendix B.2.    
The results of our backward checks for the six selected genes by our 
k-SS classifier are presented in Table 3.4. From the table, it can be 
easily observed that all the genes selected by k-SS method are 
important in the presence of other selected gene variables in the 
model. In all cases, the prediction performance of the model without 
the removed gene are worst than when the removed gene are put 
back into the model. Based on these results, we can simply suspect 
that the k-SS method only selects the most suitable gene 
ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ  
ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ 
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combinations in any given microarray data set. Our suspicion in this 
regard shall be confirmed when the k-SS procedures are applied on 
real microarray data sets in the next chapter. The box-plot of the 
results of the backward checks at the 2nd selection step is provided in 
Fig 3.9. 
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MER    
of full 
Model 
MER of the model when the indicated gene was removed 
0 1 0.1831 g5       - 
     
1 2 0.1132 g5 0.2563 
g3 
0.1847 
    
2 3 0.0783 g5 0.2192 
g3 
0.1479 
V192 
0.1067 
   
3 4 0.0697 g5 0.2189 
g3 
0.1241 
V192 
0.1092 
V805 
0.0779 
  
4 5 0.0602 g5 0.1936 
g3 
0.0922 
V192 
0.0893 
V805 
0.07123 
V566 
0.0880 
 
5 6 0.0459 g5 0.1677 
g3 
0.0542 
V192 
0.1142 
V805 
0.0616 
V566 
0.0835 
g2 
0.0625 
 
Table 3.4: Results of the backward checks on each of the selected gene by k-SS classifier. The MER 
indicated against each gene at each selection step is the MER of the model without the indicated 
gene. The results generally showed  that all the selected genes by k-SS  method  are  important in the  
                                                                                 model. 
 
Fig 3.9: The box plot of the backward checks on k-SS selection and prediction results for simulated 
microarray data. The plot shows the MER of the full model and the models without the indicated 
gene variables at the third gene selection. The triangular spots are the mean MERs of the models 
while  the red horizontal  line  indicated  the  mean  MER  of  the  full  model. Results  from  the plot  
                  revealed that all the genes selected by k-SS classifier are important in the model. 
The sub-sampling technique of Monte-Carlo cross-validation (MCCV) 
has been adopted in the above implementation of the k-SS 
procedures.  It is essential to report that when the cross-validation 
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technique of bootstrap.632+ scheme as proposed by Efron & 
Tibshirani (1997) was used for the implementation of the k-SS 
procedures, similar results as in MCCV were obtained. To achieve 
stable results however, we recommend that sufficient cross-
validation runs are used for k-SS implementation. Since the results 
of the k-SS method under the bootstrap.632+ scheme are essentially 
similar to those obtained using the MCCV scheme, the results for 
bootstrap are therefore not reported here to save space. However, 
the R codes we wrote to implement k-SS procedure under the 
bootstrap.632+ scheme are provided in Appendix B.6. 
In the next section, we present the prediction results of three 
existing classifiers – SVM, k-NN, PLS as implemented in this work 
on our simulated data and their prediction performances are 
compared to that of the new ݇-SS classifier. 
3.4. Applications of some other classifiers 
In this section, we only present the implementation of each of the 
three selected methods - SVM, ݇-NN, PLS on simulated microarray 
data. The results of the remaining five classifiers on published 
microarray data sets are provided in the relevant section of this 
thesis.  
We begin by using the splitting ratio of 19:1 in favour of training : 
test samples as used for the construction of  our ݇-SS classifier. For 
all the analyses performed using the three selected methods, the 
cross-validation approach of MCCV is adopted with 5000 repetitions.  
Support Vector Machines (SVM) 
As used for the ݇-SS implementation, 95% of the sample is used to 
train the SVM classifier while the remaining 5% is used for its 
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assessment. There are various forms of algorithms that executes 
SVM for classification. We have adopted the SVM implementation in 
R located under the e1071 library. Since SVM approach is kernel 
based whose prediction accuracy is often a function of the type of 
kernel used for analysis, we shall implement the SVM algorithm 
using all the four basic kernel functions – i.e. linear, polynomial, 
radial, and sigmoid kernels as fully discussed in Section 2.8.1. In 
addition to this, we have discovered that the polynomial kernel 
implemented in the e1071 library of R is for cubic polynomial by 
default. We shall, in addition to this, examine the performance of 
SVM for classification under a polynomial kernel of second degree 
for possible results’ improvements. Thus, all together we have 
considered five types of kernel for the implementation of SVM and 
the kernel that provides the best prediction results is finally selected 
for further inferences. 
Performance 
Measures 
Kernel Types 
Linear Polynomial3 radial sigmoid polynomial2 
MER 0.0340 0.0668 0.0368 0.3812 0.0674 
Sensitivity 0.9987 0.9967 0.9975 0.2951 0.9965 
Specificity 0.9979 0.9966 0.9988 1.000 0.9968 
 
Table 3.5: Results of support vector machines for classification using simulated microarray data 
 
Fig 3.10: The box-plots of average MERs estimates from five support vector machines (SVM) kernels 
for  simulated  microarray  data. The triangular spots are the mean MERs  of  the  models  for  each 
                    kernel type and the red horizontal line indicated the minimum mean MER.  
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We present in Table 3.5, the classification results from SVM 
implementation on the simulated microarray data for all the five 
kernel types. The basic performance measures we reported in the 
table are the average misclassification error rates MERs, sensitivity 
and specificity which were all computed over 5000 repetitions using 
the MCCV sub-sampling scheme. 
It can be easily observed from Table 3.5 that prediction results of 
SVM using linear or radial kernel seems the best among the five 
kernel types based on the three performance indices. This 
superiority performance of the two kernels is clearly shown on the 
box-plot of the estimated MERs for all the five kernels as presented 
in Fig 3.10. However, the radial basis kernel has been reported in 
many works to yield more stable results and is generally been 
preferred in many works (Brown et al, 2000; Lee, 2004; etc.). As a 
result of this, the results of the SVM with radial basis kernel shall 
be used for further discussions and implementations. Using the 
radial basis kernel as a standard, the SVM prediction results for the 
simulated data shows a misclassification error rate (MER) of about 
3.7% with 99.75% sensitivity and 99.88% specificity.  
݇-Nearest Neighbours (݇-NN) 
As in SVM, the performance of ݇-NN method also depends on the 
choice of parameter ݇, the number of neighbour to  be used for 
classification. In some studies the value of ݇ is fixed a priori (Shang 
& Shen, 2005, Hastie et al, 2009) the practice that has been 
criticized elsewhere for its biasness due to heterogeneity in group 
samples (Baoli et al, 2003). In another studies, the number of 
neighbours, ݇  between 15 and 20 has been suggested (Cover & Hart, 
1968; Broder, 1986; etc.) in search for optimal prediction accuracy. 
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What is however clear is that, prediction accuracy of ݇-NN classifier 
largely depends on the number of neighbours adopted for analyses 
and that the number of neighbour, ݇, adopted is not unique to all 
microarray data sets. Therefore, we shall implement the ݇-NN 
algorithm for all values of  ݇ within the range 1 ൑ ݇ ൑ 20 and the 
best classification results among these as determined through cross-
validation shall be chosen as our ݇-NN result. The ݇-NN procedure 
is implemented in the library(class) of the R statistical package 
and this we have used for our ݇-NN implementation. 
  
 
 
 
  
 
 
 
Fig 3.11: The box-plot of the average MERs for ݇-NN response class prediction at different number of 
neighbours (݇ሻ for simulated microarray data. The best performance occurred at ݇ ൌ 15 neighbours 
where the least MER is  achieved. The triangular spots are the mean MERs of the models at each 
           number of neighbour while the red horizontal line indicated the minimum mean MER. 
Using the splitting ration of 19:1 for training : test samples as 
before, the prediction results under the ݇-NN method for the 
simulated microarray data shows the best prediction accuracy at 
݇=15 neighbours. The following performance measures are however 
estimated: MER = 0.0313, sensitivity = 0.9928 and specificity =    
0.9638. The box-plot of the ݇-NN performance based on MER index 
at different number of neighbours is presented in Fig 3.11. 
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 Partial Least Squares (PLS) 
As remarked in the last chapter, the PLS method is, by itself not a 
classification method but a dimension reduction technique. It is 
mostly adopted to reduce several thousand of ݍ genes to a very few ݇ 
gene components, which most often is less than 10 in a high-
dimensional microarray data. The number of components, ݇, 
constructed from the original ݍ genes are then being used to classify 
biological subjects into their response groups using any of the 
standard classification methods. Among the common classification 
techniques usually adopted for class prediction with PLS 
components include the linear discriminant analysis (Boulesteix & 
Strimmer, 2005 & 2007), logistic discriminant analysis (Nguyen & 
Rocke, 2002a,b; Fort & Lambert-Lacroix,2005), and Quadratic 
discriminant analysis (Nguyen & Rocke, 2002a,b) among others.  
The method that combined dimension reduction of PLS with 
classification method of the linear discriminant analysis (LDA) 
simply written as PLS-LDA as implemented in the R library 
plsgenomics (Boulesteix & Strimmer, 2005 & 2007) is adopted for 
analyses in this work. The number of the PLS components to be 
constructed can be fixed a priori or determined through cross-
validation. Generally, between two to three components have been 
suggested in some studies (Nguyen & Rocke, 2002a,b,c), while other 
numbers different from these have are adopted in some others (Ding 
& Gentleman, 2004). In our implementation of the PLS-LDA, the 
optimal number of components ݇ desirable for each microarray data 
set is determined among the first twenty PLS components through 
cross-validation. By this, the number of component at which the best 
prediction accuracy is achieved becomes the optimal number of 
component for each data set.   
 
 
 138 
Based on our simulated microarray data, the classification results of 
the PLS-LDA revealed a better prediction at just one component. 
The summary of the estimated performance indices are as follows; 
MER = 0.0248, sensitivity = 0.9600 and specificity = 0.9994. The box-
plot of the MERs at different number of components is presented in 
Fig 3.12 where it can be seen that the best prediction is achieved at 
just one component for the simulated data. 
 
 
 
 
 
Fig 3.12: The box-plot of the average MERs for PLS-LDA response class prediction at different 
number of components (݇ሻ for simulated microarray data. The best prediction accuracy occurred at 
the first PLS component (at ݇ ൌ 1ሻ where the least MER is observed. The triangular spots are the 
mean MERs of the models at different number of components while the red horizontal line  indicated 
                                                             the minimum mean MER.  
 
Performance Measures 
Proposed 
classifier Other classifiers 
݇-SS SVM ݇-NN PLS-LDA 
MER 0.0463 0.0368 0.0313 0.0248 
*CPR 0.9537 0.9632 0.9687 0.9752 
Sensitivity 0.9593 0.9975 0.9928 0.9600 
Specificity 0.9790 0.9988 0.9638 0.9994 
No. of genes used for 
prediction 
6 1000 1000 1000 
 
Table 3.6: Summary of the estimated performance indices of the new ݇-SS classifier and three of the 
existing classification methods (SVM, ݇-NN, PLS) on simulated microarray data. The values 
reported for ݇-SS are the average estimated prediction performances under the ߜመ௝భ and ߜመ௝మ k-SS test 
formulations  as  reported  in  Table 3.3. The  correct  prediction rate (*CPR) is the complement of the  
                                                                     estimated MER.  
The summary of the estimated performance measures for our new    
݇-SS classifier and that of other three classifiers (SVM, ݇-NN, PLS) 
for simulated microarray data are presented in Table 3.6. It can be 
seen clearly from the table that our ݇-SS method competes 
favourably with the three state-of-the art methods in terms of 
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prediction accuracy. The prediction accuracies of all the four 
classifiers, including the k-SS, revolved around 95%. In addition to 
this, the k-SS method has additional advantage of been capable to 
identify and select those genes that actually contributed to the 
prediction accuracy estimated. Detail discussions on this and some 
other benefits of the k-SS method shall be provided in the next two 
chapters.  
In the section that follows, we examine the impacts of some random 
splitting ratios for the training and test samples on the performance 
of our new k­SS classifier as well as other existing classification 
methods we have so far considered using MCCV sub-sampling 
scheme. 
3.5 Effects of training-test sample splitting ratios on 
classifier’s performance 
When the sub-sampling techniques of MCCV, bootstrap or any of 
their variants is to be adopted to improve the performance of any 
classification rule, the usual practice is to perform a random split of 
the original sample size ݊ into the training and test sample. The 
idea is to build the classifier using the training sample and 
evaluates its prediction performance on the test sample. Different 
splitting ratios between the training and the test samples have been 
suggested in the literature the most common of which is the ratio 2:1 
in favour of training : test sample respectively proposed by Dudoit et 
al (2002). By this, 2/3 of the whole data would be used to train the 
classifiers and the remaining 1/3 would be used to evaluate their 
performance via any preferred prediction accuracy indices.  
 In this section, we seek to examine the effects of some random 
splitting ratios between the training and test samples on the 
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prediction performance of our k-SS classifier as well as other three 
classifiers so far considered up to this point. Due to small sample 
size scenario as common to microarray data sets, we suspected that 
the common choice of 2:1 splitting ratio might yield unstable and 
misleading results. Our argument here is that, further reduction of 
the original sample size n by 1/3rd (used as the training sample) 
might result into loss of some useful information in the sample that 
might be needed to construct efficient and stable classification rules. 
Hence, it is important to keep as much as possible, substantial part 
of the data in the training set while the remaining few left-out 
sample shall be used to assess the performance of the classifiers. 
To buttress our argument, we shall consider the prediction 
performances of the k-SS, SVM, k-NN and PLS-LDA classifiers on 
four different random splitting ratios 1:1, 2:1, 4:1 and 19:1 for 
training : test samples respectively. This literally translates to using 
50%, 66%, 80% and 95% of the whole sample size n as training 
samples and the remaining 50%, 33%, 20%, and 5% as the test 
samples respectively. 
Splitting ratios  1:1 2:1 4:1 19:1 
MERs (%) 8.37 6.38 4.92 4.63 
No. of genes selected 6 8 9 6 
 
Table 3.7: Table of gene selection and class prediction results by k-SS method at four different 
splitting ratios of training : test samples. The  best  prediction  results  are  obtained  at 19:1 random  
                              splitting ratio, i.e. at 95% training sample(test sample of 5%).   
Using our simulated microarray data set, the prediction results of   
the new k-SS classifier under each of the selected splitting ratios are 
provided in Table 3.7. The corresponding box-plot for these results is 
provided in Fig 3.13.   
It can be easily observed from the results of Table 3.7 and Fig 3.13 
that the performance of the k-SS classifier is sensitive to the choice 
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of splitting ratios between the training and test samples adopted for 
analysis. The results indicated that the more observations we have 
in the training samples the better the prediction accuracy of the k-SS 
classifier. The best prediction accuracy (the least mean MER value) 
however occurred when the k-SS classifier is trained with 95% of the 
whole sample while its prediction performance is only being assessed 
based on the remaining 5% of the sample.  
 
Fig 3.13: The box-plot of the misclassification error rates (MERs) in Table 3.7 for k-SS performances 
at four different splitting ratios between the training and test samples. The box-plot shows the best 
prediction  accuracy (the least MER value) of the k-SS classifier at 19:1 random splitting ratio i.e. at  
                                            95% training sample (test sample of 5%).   
 
Splitting ratios  1:1 2:1 4:1 19:1 
Classifiers Average MERs (%) 
SVM 4.63 4.02 3.65 3.53 
k-NN 6.22 5.33 4.58 3.13 
PLS-LDA 3.69 3.18 2.96 2.48 
 
Table 3.8: Prediction results of SVM, k-NN and PLS-LDA classifier at four different training : test 
sample  splitting  ratios. The  best  prediction  results  of  the  three  classifiers  are  obtained  at 19:1  
                                                                      random splitting ratio. 
We equally present in Table 3.8 the prediction performances of other 
three existing classification rules (SVM, k-NN, PLS-LDA) at the four 
splitting ratios 1:1, 2:1, 4:1 and 19:1 for training : test samples 
respectively. The corresponding box-plots are provided in Figs 3.14. 
All the results also confirmed a better performance of each of the 
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classifiers at the splitting ratio of 19:1 for training : test samples 
respectively. 
  
                          SVM                                                       k-NN                                                   PLS-LDA 
Fig 3.14: Box-plots of the misclassification error rates (MERs) of SVM, k-NN and PLS-LDA 
classifiers at four different training : test sample random splitting ratios. The three box-plots showed 
the  best  prediction  accuracy (the  least  MER  value)  of  all  the  three  classifiers  at  19:1  random  
                                 splitting ratio i.e. at 95% training sample (test sample of 5%).   
 
In summary, all the above results clearly provided a clear 
justification of our choice of random splitting ratio of 19:1 in favour 
of training : test samples respectively while constructing our k-SS 
classifier. 
3.6 Applications of AUC preliminary feature selection 
method 
We briefly present here, the discussion of results obtained from the 
application of AUC preliminary feature selection we proposed in 
Section 2.6 of this thesis as applied on our simulated microarray 
data set. Under the student-t preliminary feature selection 
procedure, 55 genes were selected by setting the cut-point of the p-
value at 0.05.  However, when our proposed AUC criteria as detailed 
in Section 2.6 were applied, 101 genes were selected at the threshold 
value of 0.05 for ߙ. When all the 101 genes were ordered in terms of 
their average AUC values, gene “g5” was found to be the best gene 
having the highest average AUC value of 0.9075. The worst gene 
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with the least mean AUC value of 0.5950 is gene “V948”. What we 
can quickly infer from this two results (student-t’s and AUC’s) is 
that given the same significance level ߙ, the AUC criteria will select 
more genes than the t-statistic, thereby saving us from the risk of 
leaving out some of the potentially relevant genes at the primary 
selection stage for further consideration by standard classification 
methods. Additional advantage of our AUC preliminary selection 
procedure is that, it is possible to have idea of the possible predictive 
power of each gene selected under via their estimated cross-
validated AUC values.   
However, as remarked in Section 2.6, any gene with its AUC value 
revolving around 0.5 is not expected to uniquely provide good 
prediction of the response class.  Due to this fact, we decided to lower 
the value of the significance level ߙ used by the AUC selection from 
0.05 to 0.02. At this level of ߙ, a total of 50 potentially good genes 
were selected with the best gene, “g5”, having the highest AUC value 
of 0.9196 while the weakest gene in the group in terms of its AUC 
contribution has estimated AUC value of 0.6169. 
Surprisingly, the use of the AUC preliminary gene selection on  our 
k-SS method yielded the same final gene selection results as those 
provided by it under the features selection by the t-statistics. For 
instance, the following six genes, “g5”, “g3”, “V192”, “V805”, “V566”, 
“g2”, as previously selected by k-SS classifier under the preliminary 
selection by the t-test are equally selected using AUC preliminary 
feature selection method. The full results are not presented here due 
to space consideration. 
However, it is necessary to remark that, though, both the AUC and 
the t preliminary feature selection methods as used with our k-SS 
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method provided similar results based on the simulated microarray 
data only. It is not unexpected in some instances however to discover 
some differences in the results provided under the two approaches in 
terms of the crop and number of genes selected as well as overall 
prediction performances of the classifiers that might used them. This 
should be expected because the two methods adopted different 
criteria for feature selection. If this situation arises, the crop of 
genes finally selected for class prediction by k-SS method under the 
two approaches might differ and one would expect better classifier’s 
performance under the AUC feature selection criteria. This 
particular scenario was encountered when the two methods were 
applied on real microarray data sets. This is discussed in detail in 
the next chapter.  
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4 Applications of ࢑-SS method to        
Microarray data sets 
4.1 Data descriptions 
In this chapter, we present the application of the new ݇-SS method 
on real microarray data sets. To start with, the performances of our 
new classifier are first compared with those provided by three of the 
existing state-of-the art classification methods to assess its relative 
worth under the real microarray data situations.  Eleven microarray 
data sets are used to demonstrate the implementation of the k-SS 
method. Ten of these data sets are published microarray data that 
are freely available at their respective web links as later provided. 
The eleventh data set, as analysed in Section 4.2, is base on 
microarray rectal cancer study carried out in the Department of 
Surgery, Klinikum rechts der Isar, Technical University of Munich, 
Munich, Germany. Details about this particular data are provided in 
the next section. The brief descriptions of other ten data sets are 
presented in what follows. We want to remark that, only the results 
of our ݇-SS method under its ߜመ௝భ formulation shall be reported for all 
the data sets. 
Colon cancer data: These data were first analysed by Alon et al 
(1999). They contain 2,000 gene expression profiles of 62 tissue 
samples with two distinct clinical groups of tumourous (40 tissue 
samples) and normal (22 tissue samples) subjects. These data are 
freely available and can be downloaded at http://microarray.princeton.edu 
/oncology/affydata/index.html. 
Leukemia cancer data1: These data set are pre-loaded with any 
version of R statistical software (http://www.R-project.org) under the 
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package multtest. The data contained 3,051 genes whose 
expression levels were measured on 38 biological samples containing 
27 acute lymphoblastic leukemia (ALL) and 11 acute myeloid 
leukemia (AML). The data set were also described in Golub et al 
(1999) and is publicly available at http://www-genome.wi.mit.edu/MPR/. 
Leukemia cancer data2: The Leukemia cancer data 2 have 7,129 
genes and 72 samples. As in Leukemia cancer data 1, the sample 
contains 47 ALL and 25 AML biological subjects. More details on 
these data can be found in Golub et al (1999). The data can be freely 
downloaded at http://www-genome.wi.mit.edu/MPR/. 
CNS data: These data described the embryonal tumours of the 
central nervous system (CNS) and were analysed by Pomeroy et al 
2002. The data contained 7,129 genes and 34 tissue samples. The 34 
sample contains 25 classic (C) and 9 desmoplastic (D) tumour 
groups.  
DLBCL data: These data set were on 7,129 gene expressions of 77 
biological samples. The data were analysed in Ship et al (2002) to 
distinguish 58 Diffuse large B-cell lymphoma (DLBCL) samples from 
19 follicular lymphoma (FL) samples. The data are publicly 
available at www.genome.wi.mit.edu/MPR/lymphoma.  
Lung cancer data: These are lung cancer data described in Gordon 
et al (2002). They contained 12,533 genes and 181 samples, 150 of 
which were those with malignant pleural mesothelioma (MPM) and 
the remaining 31 subjects having adenocarcinoma (ADCA) of the 
lung. The data can be found at http://www.chestsurg.org. 
Prostate cancer data1: These are prostate cancer data described in 
Singh et al (2002). They contained expression profiles of 12,600 
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genes that were measured on 102 samples of 52 tumour and 50 
normal samples. The data are available at http://www.genome.wi.mit.edu/MPR 
/prostate. 
Prostate cancer data2: These are prostate cancer data used by 
Stuart et al (2004). They have expression measures of 12,625 genes 
on 88 biological subjects with 38 tumour and 50 normal samples. 
The data are available at www.affymetrix.com. 
Prostate cancer data3: These are another prostate cancer data 
described by Welsh et al (2001). They contained 12,626 gene 
expression profiles of 33 samples. The sample has 24 tumour and 9 
normal patients. The data are publicly available at 
http://www.gnf.org/cancer/prostate. 
GCM data: These are molecular cancer data described in 
Ramaswamy et al (2001). The data have 16,063 genes with 280 
samples 190 of which are tumourous while 90 are normal samples. 
The data are available at www.genome.wi.mit.edu_MPR_GCM.html. 
4.2 Molecular classifications of rectal and colon cancer 
patients with ࢑-SS method 
This section presents detail applications of the new k-SS method on 
both rectal and colon cancer microarray data sets. 
Rectal cancer data 
As briefly highlighted in Section 4.1, the rectal cancer data analysed 
here are based on microarray study carried out in the Department of 
Surgery, Klinikum rechts der Isar, Technical University of Munich, 
Munich, Germany, on preoperative endoscopic biopsy specimen of 43 
patients that were diagnosed for locally advanced rectal carcinomas 
(LARC). In that study, all the 43 patients were subjected to 
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neoadjuvant radiochemotherapy treatments followed by surgical 
resection. Thereafter, expression profiles of 24,026 probe sets 
representing 24,026 human genome U133 plus 2.0 gene-chip arrays 
were measured on each of the 43 patients. At the end of the clinical 
diagnoses and treatments, it was discovered that 14 out the 43 
patients responded very well to neoadjuvant radiochemotherapy 
treatments while the remaining 29 patients did not respond to these 
treatments. However, since it was possible to observe the expression 
profiles of a good number of genes on these patients, the task now is 
to   
i) determine whether it is possible carry out pre-operative 
prediction of the clinical status (responder or none-
responder to neoadjuvant treatment) of any future LARC 
patients using the gene expression profiles of some of the 
observed genes. 
ii) identify and select those gene sub-set that are really 
correlated with the two clinical status of the LARC patients 
in i) for possible determination of appropriate therapeutic 
measures among other things.      
However, the rectal cancer data set analysed here have been  
recently analysed also by Rimkus et al (2008) where some results 
regarding the prediction of the clinical status of the 43 LARC 
patients using their gene expression profiles were equally reported. 
Further details on clinical characteristics of all the 43 patients are 
provided in that work. We shall discuss some of the results reported 
in the article later. 
By our preferred random splitting ratio of 19:1 in favour of training 
and test samples, we used ்݊ோ ൌ 41 sample as training set and ்݊ா ൌ 
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2 sample as the test set. The sub-sampling scheme of MCCV as 
discussed in Section 2.7 is adopted for analysis. The expression 
measures for all the genes were normalized so that each gene vector 
has zero mean and unit variance across the mRNA samples. 
Since the crop of genes selected for further analyses at the 
preliminary selection stage can greatly influence the performance of 
any classification rule, we shall therefore examine the prediction 
performance of our ݇-SS method under the conventional preliminary 
selection provided by the t-statistics and that of the AUC feature 
selection criteria as proposed in this work. 
i) ݇-SS applications under the preliminary selection by t-statistic  
Here, the preliminary genes selection was performed using the 
Student-t statistic as discussed in Section 1.4.2. The cut-point we 
adopted for the p-values of the t-statistic is 0.001 as also used in 
many studies, (Nguyen & Rocke, 2002 a, b, c; Rimkus et al, 2008; 
etc.). This procedure selected 34 probe sets whose p-values of their 
estimated t-statistic are less than or equal to the pre-selected 
implied p-value of 0.001. These are the genes passed into our ݇-SS 
algorithm for further analyses.  
Results of our analysis on rectal cancer data showed that the ݇-SS 
method selected seven genes with gene symbols “SF3A1”, “TOE1”, 
“RBM18”, “RPL31”, “227353_at”, “ETS2”, “TNFRSF1B” at the end of 
the 6th selection step to classify/predict the clinical status of the 
LARC patients in the test sample as shown in Tables 4.1 & 4.2. The 
probe sets numbers, the genes’ symbols and the genes’ names of each 
selected gene are provided in the Table 4.1. Details of the selection 
and prediction results at each selection steps are provided in Table 
4.2.  
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Probe-set 
Number 
Gene 
Symbol Gene Name 
216457_s_at SF3A1 Splicing factor 3a, subunit 1, 120kDa 
204080_at TOE1 Target of EGR1, member 1 (nuclear) 
238963_at RBM18 RNA binding motif protein 18 
221593_s_at RPL31 Ribosomal protein L31 
227353_at “227353_at” “227353_at” 
201329_s_at ETS2 v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) 
203508_at TNFRSF1B Tumor necrosis factor receptor superfamily, member 1B 
 
Table 4.1: The selected genes from rectal cancer data by k-SS method under the t-test preliminary 
feature  selection. Only  the  probe-set  number is available for the fifth gene selected as shown on the 
                                                                          table. 
Selection 
steps 
Min. mean 
MERs 
ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ 
Min. mean 
MERs 
ࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ 
ࢾ෡࢐૚ ൌ ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ 
െࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ 
No. of genes 
selected Decision 
0 0.1570 - - 1 continues 
1 0.1570 0.0897 0.0673 2 ?  
2 0.0940 0.0665 0.0275 3 ?  
3 0.0734 0.0609 0.0125 4 ?  
4 0.0539 0.0482 0.0057 5 ?  
5 0.0456 0.0018 0.0438 6 ?  
6 0.0017 0.0011 0.0006 7 ?  
7 0.0015 0.0018 -0.0003 ൈ stops 
 
Table 4.2: Table of results for ݇-SS classifier at each gene selection step for rectal cancer data under 
the preliminary selection by the t-test. Optimal selection is attained after the selection of the 7th gene 
at  the 6th selection step. The seven genes selected in order of selection sequence are “SF3A1”, “TOE1”, 
                                      “RBM18”, “RPL31”, “227353_at”, “ETS2”, “TNFRSF1B”. 
 
Fig: 4.1: The cross-validated ROC (CVROC) curve estimated by k-SS method from seven selected  
                           genes for rectal cancer data. The cross-validated AUC ൎ 1. 
It can be easily observed from Table 4.2 that the ݇-SS method 
provides correct prediction rate of about 99.89% (average MER of 
0.0011) using seven genes. The cross-validated ROC (CVROC) curve 
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and its corresponding AUC area for this result are provided in Fig 
4.1 where it can be seen that the estimated AUC area is almost 1. 
To ensure that all the seven selected genes deserve to stay in the 
model, we perform backward checks on each of the selected genes as 
discussed in Section 3.3 and the results obtained, as presented in 
Table 4.3, confirmed that all the seven selected genes are important 
in the model as selected by the k-SS classifier and they should all 
remain in the model. 
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MER of the model if the indicated gene is removed 
0 1 0.1570 SF3A1 - 
      
1 2 0.0890 SF3A1 0.2700 
TOE1 
0.1565      
2 3 0.0652 SF3A1 0.1334 
TOE1 
0.1587 
RBM18 
0.0961     
3 4 0.0571 SF3A1 0.1248 
TOE1 
0.1799 
RBM18 
0.0955 
RPL31 
0.0700    
4 5 0.0474 SF3A1 0.1106 
TOE1 
0.1371 
RBM18 
0.1117 
RPL31 
0.1017 
227353_at 
0.0518   
5 6 0.0012 SF3A1 0.0020 
TOE1 
0.1200 
RBM18 
0.1201 
RPL31 
0.0025 
227353_at
0.1164 
ETS2 
0.0459  
6 7 0.0009 SF3A1 0.0675 
TOE1 
0.0910 
RBM18 
0.1335 
RPL31 
0.0015 
227353_at 
0.1160 
ETS2 
0.0255 
TNFRSF1B 
0.0013 
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selected under the t-statistic criteria, but might not necessarily be 
the crop of genes selected under the AUC criteria. Further 
discussions on this shall be provided later.  
 The ݇-SS method, under the AUC preliminary feature selection, 
selected nine genes in the following sequence with gene symbols 
“SF3A1”, “TOE1”, “RBM18”, “ZNF24”, “227353_at”, “222303_at”, 
“CASP1”, “ADPRHL2”, “BLVRA”. The average MER obtained using 
the 9 genes for prediction is 0.000 translating to 100% correct 
prediction rate. The k-SS results at each selection steps are 
presented in Table 4.4.  
Selection 
steps ࢐ 
Min. mean 
MERs 
ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ 
Min. mean 
MERs 
ࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ 
ࢾ෡࢐૚ ൌ ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ 
െࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ 
No. of genes 
selected Decision 
0 0.1580 - - 1 continues 
1 0.1580 0.0881 0.0699 2 ?  
2 0.0904 0.0670 0.0234 3 ?  
3 0.0701 0.0470 0.0231 4 ?  
4 0.0471 0.0278 0.0193 5 ?  
5 0.0311 0.0020 0.0291 6 ?  
6 0.0015 0.0010 0.0005 7 ?  
7 0.0009 0.0005 0.0004 8 ?  
8 0.0005 0.0000 0.0005 9 ?  
9 0.0000 0.0000 0.0000 ൈ stops 
 
Table 4.4: Table of results for ݇-SS classifier at each gene selection step for Rectal data under the 
preliminary selection by AUC criteria. Optimal selection is attained when nine genes were selected. 
The  nine  informative  genes  selected  in  order  of  selection  steps  are  “SF3A1”, “TOE1”, “RBM18”,  
                         “ZNF24”, “227353_at”, “222303_at”, “CASP1”, “ADPRHL2”, “BLVRA”. 
It can be easily observed from the results that the first three genes 
selected here are the same set of genes selected by the ݇-SS 
procedure under the preliminary selection by t-statistic. However, at 
the 3rd selection step, the 4th gene with gene symbol “ZNF24” was 
selected by ݇-SS method. The inclusion of this gene with three other 
previously selected genes (“SF3A1”, “TOE1”, “RBM18”) reduced the 
average MER from 0.0701 to 0.0470 (red bold in Table 4.4), 
contributing a reduction in prediction error rate by about 33%. The 
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estimates of other performance indices at the end of the genes 
selection steps provided the following results; sensitivity = 100%, 
specificity = 100%, positive predictive value (PPV) = 100%, negative 
predictive value (NPV) = 100%, Jaccard Index = 100%. The cross-
validated ROC curve for the ݇-SS classifier is presented in Fig 4.2 
where it can be seen that the estimated cross-validated AUC is 
exactly 1. 
 
Fig: 4.2: The cross-validated ROC (CVROC) curve estimated by k-SS classifier from nine selected 
genes   for  rectal  cancer  data  under  the  AUC  preliminary  feature  selection  criteria.  The  cross- 
                                         validated area under the ROC curve (CVAUC) is 1. 
In the implementation of the k-SS method using the preliminarily 
selected genes by the t-test procedure as presented in i) above,  it is 
observed that gene “ZNF24”, which was among the 76 genes 
preliminarily selected under the AUC criteria, was not among the 34 
genes preliminarily selected by the t-statistics criteria (see Table 
4.2), hence, it was not available for consideration by the ݇-SS 
algorithm during the gene selection and prediction processes. In the 
sequence of genes selected by the t-statistics, gene “RPL31” was the 
next best gene available among the remaining genes and this was 
duly identified and selected by the ݇-SS classifier at the third 
selection step. This gene was considered as the fourth best gene due 
to non-existence of the right gene “ZNF24” (see Table 4.2).  
As can be observed from Table 4.2, the selection of gene “RPL31” by 
݇-SS classifier at the 3rd selection step reduced the average MER 
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from 0.0734 to just 0.0609 (red bold in Table 4.2), contributing a 
reduction in prediction error rate by about 17%. This is just about 
50% of the gain in prediction accuracy of 33% achieved by k-SS 
method for selecting gene “ZNF24” as presented in ii) using the crop 
of genes selected under the AUC preliminary selection criteria.  
More generally, it can be observed from the above results that the 
prediction accuracy of the k-SS classifiers progressively improves as 
more suitable genes are selected for prediction at each selection step 
(see Tables 2 & 4). This improvement shall be more remarkable if all 
the potentially discriminative genes are selected at the preliminary 
selection stage for further analyses as obtainable under the AUC 
selection criteria.  It is not surprising however, to observe in Table 
4.4 (for k-SS results under the AUC preliminary selection criteria) 
that the prediction error rate finally approach zero at the optimal 
gene selection step, step 10 at which the 9th gene was selected. This 
result simply underscores the need to adopt a good preliminary 
selection method that would ensure the selection of all potentially 
relevant genes at the preliminary selection stage before any 
standard gene selection and/or classification method like the new    
k-SS technique are implemented on the features selected. 
Based on the results obtained under i) and ii) above, we can simply 
conclude that the best set of genes combination that are capable to 
discriminate between responder and non-responder LARC patients 
to neoadjuvant radiochemotherapy treatments are the 9 genes 
“SF3A1”, “TOE1”, “RBM18”, “ZNF24”, “227353_at”, “222303_at”, 
“CASP1”, “ADPRHL2”, “BLVRA” as provided by ݇-SS method under 
the AUC preliminary selection criteria. Detail information about 
these nine genes is provided in Table 4.5. Further comments on 
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these results are provided in the next chapter under the discussion 
of results.  
Probe-set 
Number Gene Symbol Gene Name 
216457_s_at SF3A1 Splicing factor 3a, subunit 1, 120kDa 
204080_at TOE1 Target of EGR1, member 1 (nuclear) 
238963_at RBM18 RNA binding motif protein 18 
203247_s_at ZNF24 Zinc finger protein 24 (KOX 17) 
227353_at “227353_at” “227353_at” 
222303_at “222303_at” “222303_at” 
1552703_s_at CASP1 Caspase 1, apoptosis-related cysteine peptidase  
223097_at ADPRHL2 ADP-ribosylhydrolase like 2 
203773_x_at BLVRA Biliverdin reductase A 
 
Table 4.5: The selected genes from rectal cancer data by k-SS method using the crop of genes selected 
at preliminary  selection  stage  by  AUC setlecion criteria. Only the probe-set number is available for  
                                      the fifth and sixth selected genes as shown on the table. 
The above results clearly showed that the crop of features selected at 
the preliminary selection stage has significant influence on the 
performance of classification rules. The goodness or otherwise of the 
crop of genes selected at the preliminary selection stage directly 
depends on the efficiency of selection method adopted. If the 
selection method adopted at the preliminary selection stage is very 
efficient like the newly proposed AUC feature criteria, the prediction 
results of k-SS or that of any other classifiers would also be efficient 
and reliable. But if wrong crop of genes are selected at the 
preliminary selection stage due to the adoption of inefficient method, 
then, the prediction performance of any adopted classification rule 
would be badly affected. 
 It is important to remark that the rectal cancer data considered 
here has been earlier investigated by Rimkus et al (2008) where the 
classification procedure of PLS-LDA was adopted using sub-
sampling scheme of leave-one-out cross-validation (LOOCV). In their 
results, they reported correct classification rate of responders 
(specificity) to be 71% while correct classification rate of non-
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responders (sensitivity) was estimated to be 86%.  These results 
indicated an overall estimated correct prediction rate (CCR) of about 
81.4% suggesting a misclassification of about 8 out of the 43 LARC 
patients. Obviously, this prediction results fell far below the 
estimated prediction accuracy of 100% provided by our k-SS method 
under the two cases considered above for this same data set.  
Colon cancer   
These are cDNA microarray colon cancer data that has been 
previously analysed elsewhere, (Alon et al, 1999) using unsupervised 
technique of two-way hierarchical clustering with single linkage 
search to separate cancerous from non-cancerous tissues among 62 
colon cancer patients. The same data were analysed at different 
times by Furey et al (2000) using support vector machines (SVM) and 
Ding  & Gentleman (2004) using iterative reweighted partial least 
square (IRWPLS) methods to classify the biological subjects into two 
distinct sub-cancer groups of tumour and normal patients.  
The data contain the expression profiles of 2,000 genes on 40 tumour 
and 22 normal colon tissue samples. Our task is to (i) identify and 
select those genes that are predictive of these two biological groups 
and (ii) use the selected genes to predict any future (unseen) colon 
tissue samples as either tumourous or normal using the new ݇-SS 
method.  We shall only present here, the ݇-SS results under the 
AUC preliminary feature selection.  
Results of our k-SS method for the colon cancer data revealed the 
four genes that provided the best discrimination between tumour 
and normal patients. The probe-set numbers of the four selected 
genes are "Hsa.8147", "Hsa.5392", "Hsa.1410", "Hsa.490". With these 
four genes, the k-SS prediction accuracy is 93.83% indicating a 
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misclassification of about 4 subjects. The estimates of other 
performance measures computed by k-SS method are as follows; 
sensitivity = 94.96%, specificity = 95.22%, positive predictive value 
(PPV) = 97.32%, negative predictive value (NPV) = 91.23%, Jaccard 
Index = 90.94%. The CVROC curve for this data is presented in Fig 
4.3 with the estimated cross-validated AUC area (CVAUC) of 0.9465. 
The prediction results at each gene selection steps are presented in 
Table 4.6. The results of the backward checks on all the four selected 
genes are presented in Table 4.7 where it is clear that all the four 
selected genes are relevant in the model. The box-plot of one of the 
results of the backward checks at the third gene selection is provided 
in Fig 4.4 where it is revealed that the average MER of the models 
without the indicated genes are higher than the estimated mean 
MER of the full model. This evidently underscores the relative 
importance of each of the selected genes for prediction by k-SS 
method. 
 
Fig: 4.3: The cross-validated ROC (CVROC) curve estimated by k-SS method using the four selected  
   genes from colon cancer data. The cross-validated area under the ROC curve (CVAUC) is 0.9465. 
Selection 
steps ࢐ 
Min. mean 
MERs 
ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ 
Min. mean 
MERs 
ࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ 
ࢾ෡࢐૚ ൌ ࣖഥ෡࢓૚,࢓૛,…,࢓࢐ 
െࣖഥ෡࢓૚,࢓૛,…,࢓࢐శ૚ 
No. of genes 
selected Decision 
0 0.1454 - - 1 continues 
1 0.1454 0.1095 0.0359 2 ?  
2 0.1096 0.0679 0.0417 3 ?  
3 0.0661 0.0604 0.0057 4 ?  
4 0.0617 0.0688 -0.0071 ൈ stops 
 
 
Table 4.6: Table of results for ݇-SS classifier at each gene selection step for colon cancer data. 
Optimal  selection  is attained  after  the  selection of the 4th gene at the 3rd selection step. The four  
      genes selected in order of selection sequence are "Hsa.8147", "Hsa.5392", "Hsa.1410", "Hsa.490". 
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Selection 
steps ݆ 
No. of 
genes 
selected 
MER of 
full Model 
MER of the model when the indicated gene was 
removed 
0 1 0.1454 Hsa.8147  - 
   
1 2 0.1095 Hsa.8147 0.3299 
Hsa.5392  
0.1449 
  
2 3 0.0679 Hsa.8147 0.2748 
Hsa.5392   
0.1956 
Hsa.1410  
0.1056 
 
3 4 0.0604 Hsa.8147 0.3014 
Hsa.5392  
0.0962 
Hsa.1410  
0.1378 
Hsa.490 
0.0646 
 
Table 4.7: Results of the backward checks on the four selected genes by k-SS classifier from colon 
cancer data. The MER indicated against each gene is the MER of the model without the indicated 
gene. The MERs of the full models at each selection step are relatively smaller than that of the 
models  without  the indicated genes. This  showed  that  all  the  selected  genes  by k-SS method are 
                                                                 important in the model. 
 
Fig 4.4: The box plot of the backward checks for colon cancer data. It shows the MER of the full 
model and that of the models without the indicated genes at the third gene selection. The triangular 
spots are the mean MERs of the models while the red horizontal line indicated the mean of the full 
model. The estimated average MERs of the model without the indicated genes are relatively higher 
than that of the full model and  indication  that  all  the  four  genes  selected by  k-SS  classifier  are 
                                                                important in the model. 
As earlier remarked, this colon cancer data has been previously 
analysed at different times by Furey et al (2000) and Ding & 
Gentleman (2004) and the two studies reported a misclassification of 
about 6 of the 62 colon cancer subjects on the average. More 
specifically, Ding & Gentleman (2004) employs the IRWPLS 
approach and its variant that incorporated the Firth’s procedure, 
Firth (1992), and selected the first 20 genes with the highest 
absolute t-statistics for classification. The best prediction results 
reported in their work indicated a misclassification of 7 of the 62 
biological subjects. On the other hand, the study of Furey et al (2000) 
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misclassified 6 of the 62 subjects using support vector machines 
procedures for classification. In their study, a preliminary selection 
method that uses the statistic ܨ௝ ൌ
ቚ௫ҧೕ
శି௫ҧೕ
షቚ
ఙೕ
శାఙೕ
ష  was employed, where ݔҧ௝ା 
and ݔҧ௝ି are the average expression measures of gene ݆, ߪ௝ା and ߪ௝ି are 
their respective standard deviations for the two biological groups 
denoted by + and – signs respectively. The Furey’s statistic, though 
similar to the usual t-statistic, has no theoretical support in 
statistics for its use. Nonetheless, the k-SS classifier, using just four 
genes, provided better predictions than any of these earlier methods 
for this data set.   
4.3 ࢑-SS results for other microarray data sets 
We present the classification results of our ݇-SS method for other 
nine publicly available microarray data sets as considered in this 
work. The remaining data sets whose results are presented under 
this section are Leukemia data 1 & 2, Prostate data 1, 2 & 3, CNS, 
DLBCL, Lung and GCM data. The number of genes in each data 
ranges from 2,000 to 16,000 while the mRNA samples ranges from 
33 to 180. The performance measures estimated by the ݇-SS 
classifier as shown in Table 4.8 for each microarray data set are the 
average MER, correct classification rate (CCR), sensitivity, 
specificity, PPV, NPV, and Jaccard Index, all of them expressed in 
percentages.  The cross-validated ROC curves as well as their 
respective cross-validated AUC (CVAUC) area for ݇-SS classifier for 
each microarray data set is presented in Fig 4.5.    
It can be observed from all the results in Table 4.8 that the new ݇-SS 
classifier generally performs very well in all cases of microarray data 
sets considered. On the overall average, this new method provides 
 
 
 160 
about 96% correct classification rate of the tissue samples with an 
average of 6 selected genes. More discussions on the performance of 
this new classifier shall be provided in the next chapter. 
Microarray 
data 
Estimated performance indices (in %) on ݇-SS classifier No. of 
selected 
genes 
MER CCR Sensitivity Specificity PPV NPV Jaccard 
Leukemia1 0.00 100.00 100.00 100.00 100.00 100.00 100.00 1 
Leukemia2 0.00 100.00 100.00 100.00 100.00 100.00 100.00 9 
Prostate1 2.85 97.15 97.99 98.00 98.07 97.92 94.45 8 
Prostate2 12.01 87.99 84.82 93.89 91.34 89.07 75.10 8 
Prostate3 0.00 100.00 100.00 100.00 100.00 100.00 100.00 2 
CNS 3.57 96.43 99.54 99.69 99.89 98.85 95.03 4 
Lung 0.00 100.00 100.00 100.00 100.00 100.00 100.00 9 
DLBCL 0.00 100.00 100.00 100.00 100.00 100.00 100.00 5 
GCM 13.17 86.83 96.84 67.63 86.33 91.03 83.28 8 
Average 
performance 
3.51 96.49 97.69 95.47 97.29 97.43 94.21 6 
 
Table 4.8: The various performance indices on the new k-SS classifier for nine published microarray 
data  sets.  MER = misclassification   error  rate,  CCR = correct  classification  rate,   PPV = positive 
                                          predictive value, NPV = negative predictive value. 
4.4 k-SS methods versus other classifiers 
In order to determine the goodness of the new k-SS method in 
comparison to some of the existing classification methods it is 
necessary to examine its performance relative to some of these 
classifiers. For this reason, we shall consider the three selected 
classification methods - SVM, k-NN and PLS-LDA- as presented in 
Sections 2.8 & 3.4 against which the goodness of our new k-SS 
classifier would be compared using all the eleven published 
microarray data sets as presented in Sections 4.1 and 4.2. The 
comparison of the prediction results of the k-SS method with that of 
the remaining five classifiers (Prediction analysis for microarray, 
Decision trees, Naïve bayes, Top scoring pair, k-Top scoring pair) is 
provided in Chapter 5.  
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 Fig 4.5: The cross-validated ROC (CVROC) curves for the prediction results of the ݇-SS classifier for 
nine  published  microarray  data  sets  as  shown  in  Table 4.8. The  respective  estimates  of the 
                     cross-validated area under the ROC curve (CVAUC) are equally reported. 
The various estimated correct prediction rates (CCR), expressed in 
percentages, from SVM, k-NN, PLS-LDA classifiers as well as that of 
our new k-SS classification method are presented in Table 4.9. To 
ensure that all the classifiers are evaluated on the same platform, 
we only presented in Table 4.9 the prediction results of each 
classifier under preliminary selection by the t-statistic.  
It can be generally observed from Table 4.8 that all the four 
classifiers including the new k-SS method provide good predictions of 
the biological samples in all the eleven microarray data sets 
considered. However, a closer look at their results revealed that the 
k-SS method has a little edge over other three existing classifiers. 
Out of the eleven data sets, the prediction rates provided by k-SS 
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method is better than that of other classifiers in seven cases, (about 
64% of the cases) and performed equally well as others in two 
instances, (about 18% of the cases) while its prediction performance 
is slightly lower than others in just two cases, (about 18% of the 
cases). However, if we consider the average overall performances it 
can be easily observe that the k-SS classifier performs better than all 
the three existing classifiers considered with respect to their 
prediction accuracies. In addition, the k-SS methods uses a very few 
sub-sets of genes for classification unlike other earlier methods that 
used all the available genes for the same purpose. 
Microarray 
data sets 
Number of 
genes in the 
data 
Correct Classification Rate (CCR) (%) 
New 
classifier Existing classifiers 
k-SS SVM k-NN PLS-LDA 
Rectal 24,026 99.89  (7) 95.17 93.62 96.73 
Colon 2,000 93.83  (4) 81.27 85.65 86.30 
Leukemia 1 3,051 100.00 (1) 99.97 100.00 100.00 
Leukemia 2 7,129 100.00 (9) 98.48 93.49 98.63 
CNS 7,129 96.43  (4) 88.03 96.75 91.14 
DLBCL 7,129 100.00 (5) 89.22 91.33 91.74 
Prostate 1 12,600 97.15  (8) 91.67 90.71 95.36 
Prostate 2 12,625 87.99  (8) 78.40 81.38 81.61 
Prostate 3 12,626 100.00 (2) 100.00 97.45 100.00 
Lung 12,533 100.00 (9) 98.83 99.74 99.48 
GCM 16,063 86.83  (8) 87.60 90.28 86.23 
Average Performance 96.57 91.69 92.76 93.38 
 
Table 4.9: The correct classification rates (CCR) of the new k-SS classifier and that of three of the 
existing methods – SVM, k-NN, PLS-LDA, for eleven published microarray data sets. Out of all the 
eleven data sets, the k-SS method out-performed other three classifiers in seven instances (about 64% 
of the cases), it performed equally with others in three cases while it under-performed in just one 
case. The figures in parenthesis are the number of genes selected for classification by k-SS method 
from respective microarray data sets. The  preliminary  feature  selection  of  the  t-statistic  is  used  
                                                               by all the classifiers.  
4.5 k-SS classifier and cluster analysis 
Cluster analysis is one of the earlier unsupervised statistical 
learning methods commonly adopted for classification and pattern 
recognition. It is unsupervised because the inherent sub-classes of 
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the subjects are not known a priori and are to be discovered from the 
data. Therefore, the major aim of clustering is to determine the 
intrinsic grouping in a set of unlabelled data. When applied to 
microarray data, it performs the task of revealing some systematic 
patterns underlying the gene expressions and several sub-classes of 
the tissue samples. This has been successfully adopted in many 
microarray studies to identify various sub-classes of cancers in 
mRNA samples. See Eisen et al (1998 & 1999), Alon et al (1999), 
Golub et al (1999), Alizadeh et al (2000), Gordon et al (2002) and 
Stuart et al (2004) among others. 
As earlier stated, while applying clustering techniques for 
classification of mRNA samples, it is assumed that the various 
subject groups in the data are not previously known and the task is 
to use the measured genes expression profiles to discover these 
unknown different biological sub-groups. In other words, it is 
possible to use the observed gene expression profiles on mRNA 
samples to discover their various biological sub-groups without an a 
priori knowledge of those biological groupings through clustering.   
In microarray technology, the expression patterns of several 
thousand of genes are studied simultaneously at the same time. 
However, if there exist a procedure, like our new k-SS method, that 
can identify and select the few marker genes that are directly 
related to the existing biological sub-groupings of the mRNA 
samples, then it would be more appealing and easier while 
performing clustering, to use only the relevant selected maker genes 
to identify the different biological groupings of any unidentified 
future subjects rather than labouring unnecessarily on the entire 
thousands of genes for the same task. To this end, we shall send the 
selected k-SS classifiers from each microarray data set considered 
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into a suitable clustering algorithm to determining whether they 
would be capable to identify the inherent biological sub-groups of the 
unlabelled mRNA samples. 
Few of the clustering techniques commonly adopted in the literature 
are the k-Means, fuzzy c-Means and hierarchical clustering methods 
among others. However, the method of two-way single-linkage 
hierarchical clustering (SLHC) has received wider applications in 
the literature (Alon et al, 1999; Alizadeh et al, 2000; Gordon et al, 
2002 etc.) than others and its procedure shall be employed using the 
k-SS selection results. 
In the SLHC method as adopted here, the distance matrix between 
the gene expression data is computed and a linkage or 
amalgamation rule to determine when two clusters are sufficiently 
similar to be linked together is defined. By this procedure, a 
hierarchical tree (dendrogram) is developed which shows the links 
between all the gene sets and/or between the tissue samples. The 
clusters are nested together rather than being mutually exclusive as 
in k-means cluster procedure. By this, more and more objects are 
linked together as larger and larger clusters of increasing dissimilar 
elements are amalgamated. Therefore, larger clusters created at 
later stages contained smaller clusters created at earlier stages of 
agglomeration. In the last step, all objects (genes or tissue samples) 
are joined together and a horizontal linkage distance is formed. The 
closer to 1.00 the line that connects two or more genes (or samples) 
is, the more related the genes (or samples) are to one another. The 
SLHC becomes a two-way type when both the genes and mRNA 
samples are clustered simultaneously as performed in Alon et al 
(1999). More details about this clustering method can be found in 
 
 
 165 
Everitt (1980), Alon et al (1999), Speed (2003), Lee (2004), Abonyi & 
Feil (2007) and many other related literatures. 
The distance measure we adopted is the Euclidean distance metric 
between any two genes ݔ௝ and ݔ௝′ defined by  
                               ݀ଶ൫ݔ௝, ݔ௝′൯ ൌ ቂ∑ ൫ݔ௜௝ െ ݔ௜௝′൯
ଶ௡
௜ୀଵ ቃ
ଵ/ଶ
       (4.5.1) 
which is a special case of Minkowski distance metric given by  
   ݀௣൫ݔ௝, ݔ௝ᇲ൯ ൌ ൣ∑ ൫ݔ௜௝ െ ݔ௜௝ᇲ൯
௣௡
௜ୀଵ ൧
ଵ/௣
  
with ݌ ൌ 2. 
As earlier remarked, to demonstrate the goodness of the genes 
selected by our k-SS method, only the selected genes from rectal, 
Leukemia 2, and Lung cancer data sets out of all the eleven 
microarray data sets are considered for cluster analysis. We have 
used the clustering software, cluster 3.0 due to de Hoon et al (2004) 
which is an enhanced version of cluster software developed by Eisen 
et al, (1998) for clustering using the SLHC techniques. 
Rectal cancer data 
In rectal cancer data, the 43 LARC patients consist of 14 responders 
and 29 non-responders to neoadjuvant radiochemotherapy 
treatments as obtained from the clinical results. Each subject in the 
two response group is given a distinct mRNA label. For instance, the 
14 responder subjects were given the following labels; p24, p66, p79, 
p80, p105, p211, p215, p224, p309, p332, p354, p380, p402, and 
p410. The remaining 29 subjects with mRNA labels different from 
these fourteen constitute the non-responder patients. Though, we 
have assumed that the clinical status of the patients is not known, 
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Nucleoside-diphosphate kinase(Y07604) and LTC4synthase 
(U50136), for which the ALL subjects group have low expression 
levels. On the other hand, the ALL patients are mostly those with 
high expression levels of the remaining four genes 
Macmarcks(HG1612), Terminal transferase mRNA (M11722), Cyclin 
D3(M92287) and Op 18 (M31303) for which the AML patients 
equally have low expressions.  The six genes asterisked in Fig 4.7 
were among the fifty differentially expressed genes identified by 
Golub et al (1999). More discussions on this are provided in the next 
chapter. 
Lung cancer data 
The lung cancer data contain 12,533 genes and 181 samples, 150 of 
which are those with adenocarcinoma (ADCA) of the lung and the 
remaining 31 are those with malignant pleural mesothelioma 
(MPM). Except for the rectal, colon and leukemia 1 & 2 data sets 
where we have information on both gene names and probe-set 
numbers (rectal, leukemia 2), or probe-set numbers only (colon & 
leukemia1), we do not have information on both the gene names and 
probe-set numbers for the remaining seven microarray data sets 
considered in this thesis. As a result of this, we have labelled the 
probe-sets in each of the affected data sets including the Lung cancer 
data 3 as V1, V2, V3, … , and so on, indicating the sequence of 
available genes in each microarray data set. These are the labels we 
used in the clustering algorithm for the lung cancer data.   
Out of the entire 12,533 genes in the lung cancer data, the following 
nine genes, “V8005”, “V9707”, “V2255”, “V9607”, “V2421”, “V8858”, 
“V8537”, “V5979”, “V6189” were identified and selected by our k-SS 
method for predicting the 181 tissue samples. These nine genes are 
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As described in Section 4.1, the Prostate 1 cancer data consist of 
12,600 genes and 102 samples. The 102 samples consist of 52 
tumour (cancerous) and 50 normal (non-cancerous) patients. Our     
k-SS classifier selected 8 informative genes for prediction out of the 
entire 12,600 genes which eventually yielded correct 
prediction/classification rate (CCR) of about 97.15% (see Table 4.8), 
indicating a misclassification of about 3 subjects.  
 
  Rectal cancer data                    Leukemia cancer data 2 
  
                            Lung cancer data                                         Prostate cancer data 1 
Fig 4.9: The plots of the first two principal components, PCA plots, constructed using the genes 
selected by k-SS classifier for four different microarray data sets. All the four PCA plots showed good 
discriminations of the biological groups of the mRNA  samples  based  on  the  genes selected by k-SS  
                                                                           classifier. 
The plot of the first two principal components for each of the data 
sets is provided in Fig 4.9. It can be observed that the different 
biological groups in each microarray data set are clearly separated 
on the PCA plots, an indication that the selected genes by  k-SS 
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classifier are good predictors of the mRNA samples. The two 
misclassifications (a normal subject misclassified as tumour and a 
tumour subject misclassified as normal) noticed on the PCA plot for 
Prostate 1 cancer data is justified by correct prediction rate of 
97.15% estimated by k-SS classifier using the 8 selected genes as 
reported for these data in Table 4.8. 
Based on all the various results as demonstrated in this work, we 
can generally conclude therefore that the new k-SS classifier is 
capable at selecting the best combination of informative marker 
genes from several available thousand of genes for good prediction of 
biological samples in any microarray data sets. 
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5 Summary of the Study 
5.1 Summary of results 
This research study is basically designed to address one of the major 
challenges in microarray studies. The advent of microarray 
technology which has made it possible to monitor and observe 
simultaneously the expression levels of several thousand of both 
relevant and irrelevant genes on a given set of biological subjects has 
made it more important for us to identify and select the few most 
relevant genes that are actually related to the tumour conditions 
being investigated. This task becomes very necessary since the 
discovery of such relevant genes could tremendously help in the 
development of appropriate therapeutic measures. 
Several methods have being proposed in the literature to carry out 
this task, but unfortunately a good number of these methods only 
classify the biological samples into their various cancer sub-groups 
but not the selection of the relevant informative gene that are easily 
interpretable with respect to the category of tumour conditions they 
classified. In addition to this, none of the earlier dimension reduction 
and/or classification methods like SVM, k-NN, PLS, naïve bayes 
(NB), prediction analysis for microarray (PAM), decision tree (DT), 
top scoring pair (TSP) and the like, has been reputed to be capable at 
achieving 100 percent prediction accuracy in all cases of tumour 
classifications in microarray studies.  
It is obvious that the cost of misclassify an early stage cancer patient 
as a normal patient and a normal patient as being cancerous might 
be too enormous. To avert such negative consequences, it becomes 
imperative to continuously seeking to develop more efficient 
classification techniques, like the k-SS method proposed here, that 
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could efficiently select the most relevant sub-set of the observed gene 
chips and provide accurate and stable prediction of biological 
samples into their various tumour groups in any given high 
dimensional genomic data. 
The new k-SS procedure proposed in this thesis is one of the methods 
targeted at unravel the riddles of dimension reduction, relevant gene 
selection as well as accurate prediction of various tumour conditions 
of the mRNA samples as hitherto being desirable in various 
microarray studies.  Given any microarray data set therefore, our 
new k-SS classifier simply adopts unambiguous and easy-to-
understand procedures to select only the most informative and 
biologically relevant marker genes and accurately classify the mRNA 
samples into their various biological conditions based on the genes 
selected. This argument is supported by all prediction results 
provided by our k-SS method. For instance, in rectal cancer data, all 
the 9 selected genes by our k-SS procedure are genes encoding 
proteins. It is clear from the cluster result of Fig 4.6 for these data 
that all the selected 9 genes indicated high expressions patterns 
across all the histopathologically responder patients while they 
indicated reduced expressions for all the non-responder patients. 
The two genes “SF3A1” and “TOE1” are genes encoding proteins that 
perform important function in the nucleus, Rimkus et al (2008). 
Caspases is the family of genes that serve as initiator or executioner 
of the intrinsic or extrinsic signals that may result into 
morphological changes that are related to apoptosis, Boatright & 
Salvesen (2003), Boatright et al (2003), Danial & Korsmeyer (2004). 
Caspase-1 for instance, was the first member of this family whose 
functions in apoptosis and inflammation have been reported in many 
studies, Yuan et al (1993), Kondo et al (1995), Martinon & Tschopp 
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(2004), Thalappilly et al (2006). Among the genes encoding protein 
that perform transport functions are Biliverdin reductase A 
(BLVRA) and Zinc finger protein 24 (ZNF24). The BLVRA performs 
oxidoreductase activities and is capable of initiating several 
biological processes through energy pathways metabolism. The 
ZNF24 on the other hand performs transcription regulatory 
activities and it regulates nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism (see http://www.biocompare.com/ 
gene/gene_details.asp?geneid=11229#products, HPRD®, for more details on 
biological functions of these selected genes) 
In the leukemia2 cancer data on the other hand, the nine genes 
selected by k-SS method clearly discriminates the acute myeloid 
leukemia (AML) group from acute lymphoblastic leukemia (ALL) as 
shown by cluster result in Fig 4.7 and PCA plots in Fig 4.9. As 
asterisked on the cluster result of Fig 4.7, six of the nine selected 
genes by k-SS classifier have been previously identified as good 
discriminators between AML and ALL subjects in a microarray 
study of Golub et al (1999). More specifically, the following four 
genes, Adipsin, IL-8, HoxA9, and LTC4synthase out of the five genes 
selected by k-SS classifier for which AML subjects have high 
expression profiles and the two genes, Cyclin D3 and Oncoprotein 18 
(Op18) out of the remaining four selected genes by k-SS method for 
which the ALL subjects are up-regulated were among the fifty genes 
identified by Golub et al (1999). More importantly, the two genes 
Cyclin D3 and Op 18 have been reported to be genes encoding 
proteins which are critical to S-phase cell cycle progression, Golub et 
al (1999). It has been further reported (Ross et al 1984; Golub et al 
1999) that some of these identified informative genes encodes 
topoisomerase II, which is the principal target of the anti-leukemic 
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drug etoposide. All these findings confirm the biological relevance of 
the genes selected by our new k-SS method. 
The fact, however remains that all the eleven microarray data sets 
as used in this thesis have been previously analysed elsewhere at 
different times to assess the performance of some classification 
methods. A particular study that interests us among these is the 
work of Tan et al (2005). Except for rectal and leukemia1 cancer 
data, the remaining nine data sets used in this thesis were also 
analysed by Tan and his co-workers to assess the performances of 
their TSP family of classifiers relative to selected five existing 
classification methods. The two classifiers, PAM and DT that equally 
perform gene selection as well as classification of biological samples 
were among the five methods considered in their study.  
Like our new k-SS method, the TSP family of classifiers which 
consist of TSP and k-TSP, perform gene selection and class 
prediction and have been adopted for analysis in some studies since 
they were developed, (Geman et al 2004, Xu et al, 2005; Price et al, 
2007, Xu et al 2008). We shall therefore, assess the performance of 
our new k-SS classifier relative to that of TSP, k-TSP, PAM and DT, 
all of which perform the same functions like the k-SS method as well 
as one other classifier, Naïve (Idiot) Bayes (NB) which we have not 
really discussed in this study using the nine microarray data sets as 
considered in Tan et at (2005). For simplicity, we shall only report 
the various results for the above five classifiers as provided in Tan et 
at (2005), pp 3900 for all the nine microarray data sets and 
compared these prediction results with the corresponding results 
provided by our k-SS method.  The correct classification rates (CCR) 
estimated by these classifiers are provided in Table 5.1 while the 
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respective number of genes selected for classification by each of the 
methods, except NB, is presented in Table 5.2.   
Method 
Correct classification rates (in %) of classifiers 
Colon Leuk.2 CNS DLBCL Prost.1 Prost.2 Prost.3 Lung GCM Average 
k-SS 93.83 100.00 96.43 100.00 97.15 87.99 100.00 100.00 86.83 95.80 
*TSP 91.10 93.80 77.90 98.10 95.10 67.60 97.00 98.30 75.40 88.26 
*k-TSP 90.30 95.83 97.10 97.40 91.18 75.00 97.00 98.90 85.40 92.01 
*DT 80.65 73.61 67.65 80.52 87.25 64.77 84.85 96.13 77.86 79.25 
*PAM 85.48 97.22 82.35 85.71 91.18 79.55 100.00 99.45 79.29 88.91 
*NB 58.06 100.00 82.35 80.52 62.75 73.86 90.91 97.79 84.29 81.17 
 
Table 5.1: Prediction performances of k-SS method and four other similar gene selection and 
classification methods (TSP, k-TSP, PAM, DT) as well as NB classifier on nine published 
microarray data sets. *The reported results are from Tan et al (2005). 
Method 
Number of genes used for classification 
Colon Leuk.2 CNS DLBCL Prost.1 Prost.2 Prost.3 Lung GCM 
k-SS 4 9 4 5 8 8 2 9 8 
*TSP 2 2 2 2 2 2 2 2 2 
*k-TSP 2 18 10 2 2 18 2 10 10 
*DT 3 2 2 3 4 4 1 3 14 
*PAM 15 2,296 4 17 47 13 701 9 47 
 
Table 5.2: Number of genes selected for classification by each classification method from nine 
published microarray data sets. *The reported results are from Tan et al (2005). 
It can be observed from Table 5.1 that the new k-SS method 
performs excellently well than all the five existing classifiers. 
Although, k-SS, TSP, k-TSP and PAM classifiers provided average 
prediction accuracy in the neighbourhood of 90% while DT and NB 
provided average prediction accuracy in the neighbourhood of 80%, 
the k-SS classifier outperformed all the five classifiers in six of the 
nine cases (Colon, DLBCL, Prostate 1 & 2, Lung, GCM) while it 
performed equally in one case each with NB (Leukemia2) and PAM 
(Prostate 3). The k-TSP method slightly performs better than the k-
SS method in just one instance (CNS) but uses ten genes as against 
four used by k-SS to achieve almost the same result. In the case for 
which PAM performs equally with k-SS (Prostate 3), the k-SS 
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method uses only 2 genes to yield 100% correct prediction while 
PAM uses as large as 701 genes to achieve the same result (see 
Table 5.2). It can be observed generally that PAM uses more genes 
for classifications than any other classifiers with very little 
appreciable relative performance over others. 
Based on the estimated average prediction accuracies on all the nine 
binary classification problems presented in Table 5.1, it is very clear 
that the best classifier is the k-SS classifier (95.80%) followed by      
k-TSP (92.01%), then PAM (88.91%), TSP (88.26%), NB (81.17%) and 
lastly DT (79.25%) in that order.    
The usual practice in which the random splitting ratio of 2:1 is used 
to split the original sample size into training sample (2/3) and test 
sample (1/3) for the construction and assessment of classifiers 
respectively has been established in this work to be capable of 
providing unstable and misleading results. Not only in k-SS method, 
other three classifiers considered (SVM, k-NN, PLS-LDA) at four 
different splitting ratios (1:1, 2:1, 4:1, 19:1) all provided their best 
prediction performances at 19:1 random splitting ratio for which 
95% of the sample is used as training and the remaining 5% is used 
as the test samples. Therefore, due to very small number of 
biological subjects that characterizes a typical microarray data, and 
to truly minimize average prediction error variance, we wish to 
recommend that 95% of the entire n mRNA sample should be used to 
training the classifiers while the remaining 5% should be set aside 
as independent test sample to assess their performances while 
adopting any of the sub-sampling schemes (with or without 
replacement) for cross-validation.  
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Since the preliminary feature selection is inevitable in the 
application of virtually all the proposed classification rules including 
the k-SS method due to huge size of a typical microarray data often 
encountered, it is important therefore to be conscious of the kind of 
preliminary feature selection methods to be adopted. Most 
importantly, care must be taken to ensure that the chosen 
preliminary selection method does not weed out the potentially 
relevant genes at the preliminary selection stage. However, since 
none of the existing preliminary selection methods has been reported 
to be a super-method that is suitable for all cases of microarray data 
problems, we have also proposed here, a new classifier-like 
preliminary feature selection method – the AUC feature selection 
method- that is capable at retaining all the potentially relevant 
features at the close of its preliminary selection exercise. Unlike 
some of the existing data pruning methods, this new method 
employs the ݒ-fold cross-validation sub-sampling technique to ensure 
the stability and consistency of the features selected. 
5.2 Discussions and conclusion 
In this thesis a novel comprehensive but flexible sequential 
procedure that simultaneously performs dimension reduction, 
informative gene selection and accurate prediction of tumour 
conditions of biological samples in any given microarray study has 
been proposed. The procedure sequentially selects only the most 
informative k genes that are related to the sub-tumour groups in any 
high dimensional microarray data set, hence, the name k-sequential 
selection (k-SS) given to the method. 
It has been demonstrated in this thesis that the new k-SS method 
competes favourably with some of the existing dimension reduction 
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and classification methods. Eleven publicly available microarray 
data sets have been used to assess the performance of this new 
classifier relative to eight other existing methods.  In virtually all 
the cases considered, the k-SS method exerts its superiority over 
other methods in terms of prediction accuracies and biological 
relevance of genes selected. It is hoped that the ability of the k-SS 
method to identify and select only the biologically relevant 
transcripts shall facilitate pre-operative predictions of several sub-
classes of cancers. This shall tremendously help at determining 
proper therapeutic measures for various kinds of cancers. 
In conclusion, the k-SS method is a novel dimension reduction and 
class prediction method that is capable of selecting the most 
biologically relevant genes in a clearly understood manner, thereby 
satisfying the yearnings of molecular biologists, physicians and other 
health workers who are not only interested in the correct 
classification of different tumour groups but also want to know, in an 
unambiguous manner, the kind of genes that are related to different 
tumour conditions of the mRNA samples. 
Apart from its simplicity, the k-SS method, unlike the ‘black-box’ 
approach of some of the earlier methods, is user friendly because the 
various steps that lead to optimum gene selection and class 
prediction can easily be understood by any user with very little 
statistical background.  
The new k-SS classifier clearly underscores the fact that good 
variable selection and response class prediction do not necessarily 
lies in the complexity of the method adopted, as equally remarked by 
Tan et al(2005). The major tasks of informative genes selection and 
classification of mRNA samples, as often desirable in microarray 
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studies can be accomplished using a very simple, unambiguous but 
still efficient procedure like the newly developed k-SS procedure in 
this thesis.  
Finally, we want to remark that the algorithms that execute the      
k-SS method are developed using R statistical software. All 
necessary R codes we developed for its implementation shall be 
incorporated into the main R library within a very short period to 
facilitate its availability to any interested users.   
5.3 Suggestions for future studies    
The current form of our new k-SS method as proposed in this thesis, 
like any other methods, presents several opportunities for further 
improvements in order to enhance its general usage. However, 
whatever modifications intended at this stage shall be addressed in 
future research works. Few of the areas that come to mind for the 
benefit of future studies are highlighted in what follows.  
Although, binary classification problems are the most common 
scenario in microarray studies, the dynamic nature of this research 
area has brought about a few cases that require multiclass 
prediction problems. An example of this is the three response groups 
prediction problem of Beer et al (2002) using Affymetrix lung cancer 
microarray data set or the five class predictions using breast cancer 
data as described in Perou et al (2000).  However, the suitability of 
the k-SS method to handle multiclass predictions problems has been 
conjectured in this work. This particular area of application needs to 
be given thorough practical treatments to enhance its versatility. 
More generally, the biological importance of the genes selected by    
k-SS method has been established in this thesis, this particular 
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advantage of the method need to be further demonstrated within the 
purview of survival analysis where the selected genes could serve as 
suitable prognostic factors to predict the survival times of cancer 
patients. This would particularly discourage the use of either the 
PLS or PCA components, which are often difficult to interpret, to 
predict the survival times of cancer patients as adopted in some 
studies, (Nguyen & Rocke, 2002c; Nguyen, 2005). Using the genes 
selected by k-SS method as predictors in survival models would 
enable us to establish meaningful biological relationship between 
the gene expression levels and the survival time or status of 
individual cancer patients. A related study in this regard is the 
recent study carried out by Yahya & Ulm (2009) in which some 
histopathological variables were used as predictors of survival times 
of breast and small-cell lung cancer patients.  
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Appendix A 
List of some symbols and notations 
We present some of the symbols and notations used for the 
construction of k-SS method. 
Symbols/Notations Descriptions/Functions 
ࢄ ൌ ሺ ଵܺ, … , ܺ௤ሻ  
ݍ-dimensional vector of expression level of ݍ genes 
measured on ݊ biological samples. 
௜ܻ א ሼ0,1ሽ  
Binary response variable indicating the two groups (0,1) 
of biological subjects.  
߮௝൫ ௝ܺ൯  The k-SS classifier using gene ௝ܺ, ݆ ൌ 1, … , ݍ 
߮௠భ,௠మ,…,௠ೕሺ࢞ሻ  The k-SS classifier using the gene sets ܺ௠భ, ܺ௠మ, … , ܺ௠ೕ 
ҧߴመ௠భ,௠మ,…,௠ೕ  
Minimum average MER estimated using ݆ genes 
ܺ௠భ, ܺ௠మ, … , ܺ௠ೕ  
ҧߴመ௠భ,௠మ,…,௠ೕశభ  
Minimum average MER estimated using ሺ݆ ൅ 1ሻ genes  
ܺ௠భ, ܺ௠మ, … , ܺ௠ೕ, ܺ௠ೕశభ 
δ෠௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ  
Estimated difference of the two minimum average 
MERs using the first formulation δ෠௝భ 
δ෠௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ  
Estimated difference of the two minimum average 
MERs using the second formulation δ෠௝మ 
δ෠௝ೞ, ݏ ൌ 1,2  The two minimum average MERs  
ܧ ቀ ҧߴመ௠భ,௠మ,…,௠ೕቁ ൌ ߤణ
௠భ,௠మ,…,௠ೕ  Expected value of ҧߴመ௠భ,௠మ,…,௠ೕ 
E ቀ ҧߴመ௠భ,௠మ,…,௠ೕశభቁ ൌ ߤణ
௠భ,௠మ,…,௠ೕశభ  Expected value of ҧߴመ௠భ,௠మ,…,௠ೕశభ 
ܧ൫δ෠௝భ൯ ൌ ߜ௝భ  Expected value of δ෠௝భ 
ܵܰሺߣכሻ  The Skew-normal density with shape parameter ߣכ 
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Appendix B 
R functions 
B.1 The R function that implements the k-SS method using sub-
sampling technique of Monte-Carlo cross-validation (MCCV). 
The following instructions should be noted for using any of the 
k-SS functions provided here: 
i) The response variable Y, the vector of the group labels of biological 
subjects should be in the first column. 
ii)  The binary group should be coded 0 for normal, and 1 for tumourous or 
any other outcomes of interest.  
#   This function returns preliminary genes selected by the t-statistics, and the  
     misclassification error rates (MERs) from logistic discriminant (LD) rules for  
     each of the preliminarily selected genes. 
############################################################## 
#   dat = Microarray data  
#   repetitions = Number of cross-validation runs 
#   test.sample = Number of test sample to be predicted/classified  
#   alpha = t-statistics' p-value cut-point 
############################################################## 
      mer.select <- function(dat, repetitions, test.sample, alpha) 
      { 
 
      t.selection <- function(dat) 
      { 
      t.vec <- c() 
      for (i in 2:ncol(dat)) 
      { 
      t.statistic <- abs(t.test(dat[, i] ~ dat[, 1], var.equal = F)$p.value) 
      t.vec <- c(t.vec, t.statistic) 
      } 
      names(t.vec) <- names(dat[-1]) 
      return(t.vec) 
      } 
     
      t.result <- t.selection(dat) 
      t.result <- t.result[t.result <= alpha] 
      print(sort(t.result, decreasing = F)) 
      dat <- cbind(dat[, 1], dat[, is.element(names(dat), names(t.result))]) 
 
      dat <- as.matrix(dat) 
      dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center = T, scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
 
      mer.mat <- matrix(NA, ncol = ncol(dat) - 1, nrow = repetitions, 
                      dimnames = list(1:repetitions, names(dat)[-1])) 
     
      cat("Repetitions done:", "\n"); utils::flush.console() 
      for (i in 1:repetitions) 
      { 
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      repeat 
      { 
      samp <- sample(1:nrow(dat), test.sample) 
      dat2 <- dat[samp, ] 
      dat3 <- dat[-samp, ] 
      if(length(unique(dat2[, 1])) != 1 && length(unique(dat3[, 1])) != 1) 
      { 
      for (j in names(dat)[-1]) 
      { 
      test.data <- data.frame("response" = dat2[, 1], "x.variable" = dat2[, j]) 
      train.data <- data.frame("response" = dat3[, 1], "x.variable" = dat3[, j]) 
 
      mod <- glm(response ~ x.variable, dat = train.data, family = "binomial") 
      pred <- predict(mod, newdat = test.data, type = "response") 
      mer.mat[i, j] <- sum(abs(test.data$response -  
                               ifelse(pred < 0.5, 0, 1))) / length(pred) 
      } 
      if (i %in% seq(0, repetitions, round(repetitions/10)))  
      cat(i, "... "); utils::flush.console() 
      break 
      } 
      } 
      } 
      return(list("MER" = mer.mat)) 
      } 
 
      MER.results <- mer.select(dat, repetitions, test.sample, alpha) 
 
      mer <- apply(MER.results$MER, 2, mean) 
      mer.ordering <- sort(mer, decreasing=F) 
      mer.ordering 
 
 
#   This function returns the k-SS results at each of the gene selection steps  
 
############################################################## 
#   dat = Microarray data 
#   ordering = mer.ordering (from the previous out-put) 
#   iterations = Number of cross-validation runs 
#   test.sample = Test sample to be predicted/classified 
#   alpha.range = sequence of positive integer from 1 to 1000 (or any 
     preferred number) upon which the range of alpha (0,1) is divided 
#   plot.ROC = F (default). If set to T, the plot of ROC curve is   
     provided, otherwise, no ROC curve will be plotted. 
#   first = F (default). If set to T, only the first ROC curve at which  
     the k-SS criteria is satisfied will be plotted. 
#   cells = c(0,0), specifies the number of cell space to be created for  
     ROC curve plot. 
 ############################################################## 
      
      library(ROCR) 
      library(sn) 
 
      sequential.selection <- function(dat, ordering, iterations, test.sample,  
                                       alpha.range, plot.ROC = F, first = F,  
                                       cells = c(0,0)) 
      { 
      names(dat)[1] <- "response" 
      dat <- dat[, c("response", names(ordering))] 
      dat <- as.matrix(dat) 
      dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center = T , scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
 
      if(plot.ROC == T && first == F) par(mfrow = cells) 
 
      final.result <- matrix(NA, ncol = length(alpha.range), nrow = 9) 
      Mer.mat <- Brier.mat <- Sens.mat <- Spec.mat <- ppv.mat <- 
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      npv.mat <- match.matrix <- jaccard.matrix <-  
      matrix(NA, ncol = length(alpha.range), nrow = iterations) 
         
      colnames(final.result) <- colnames(match.matrix) <- 
      colnames(jaccard.matrix) <- colnames(Mer.mat) <-  
      colnames(Brier.mat) <- colnames(Sens.mat) <- colnames(Spec.mat) <- 
      colnames(ppv.mat) <- colnames(npv.mat) <- alpha.range 
      rownames(final.result) <- c("MER", "Jaccard.Index", "Match.Index",  
                                    "Brier-Score", "Sensitivity",  
                                    "Specificity", "Positive PV",  
                                    "Negative PV", "Number of Genes selected") 
 
 
      selection <- (c(names(ordering)[which(ordering == min(ordering))]))[1] 
      comparison <- rep(FALSE, length(alpha.range)) 
 
      cat("Gene added:", "\n"); utils::flush.console() 
      count <- 0 
 
      while(length(selection) < length(ordering)) 
      { 
      count <- count + 1 
      mer1.vec <- jaccard.vec <- match.vec <- brier.vec <- spec.vec <- 
      sens.vec <- ppv.vec <- npv.vec <- R.prediction <- R.true.values <- c() 
 
      predicted.mer.matrix <- true.mer.matrix <-  
      matrix(NA, ncol = iterations, nrow = test.sample) 
 
      mer2.mat <- matrix(NA, nrow = iterations, 
                           ncol = length(names(ordering)[ 
                           which(!is.element(names(ordering), selection))])) 
      colnames(mer2.mat) <- names(ordering)[ 
                              which(!is.element(names(ordering), selection))] 
 
      for (j in 1:iterations) 
      { 
      samp <- sample(1:nrow(dat), test.sample) 
      glm1 <- glm(response ~ ., data = dat[-samp, c("response", selection)],  
                    family = "binomial") 
      pred1 <- ifelse(predict(glm1, newdat = dat[samp, -1],  
                                type = "response") < 0.5, 0, 1) 
      probab <- predict(glm1, newdat = dat[samp, -1], type = "response") 
      mer1 <- sum(abs(pred1 - dat[samp, 1])) / test.sample 
      R.prediction <- c(R.prediction, probab) 
      R.true.values <- c(R.true.values, dat[samp, 1]) 
 
      predicted.mer.matrix[, j] <- pred1 
      true.mer.matrix[, j] <- dat[samp, 1] 
 
      brier.score <- sum((dat[samp, 1] - probab)^2) / test.sample 
      pred1.all <- ifelse(predict(glm1, newdat = dat[ ,-1],  
                                    type = "response") < 0.5, 0, 1) 
      mer1.vec <- c(mer1.vec, mer1) 
 
      brier.vec <- c(brier.vec, brier.score) 
 
 
      sensitivity <- (sum(c(pred1.all == dat[ ,c("response")])[ 
                            which(dat[ ,c("response")] == 1)]) 
                        /length(dat[ ,c("response")][ 
                                which(dat[ ,c("response")] == 1)])) 
      specificity <- (sum(c(pred1.all == dat[ ,c("response")])[ 
                            which(dat[ ,c("response")] == 0)]) 
                        /length(dat[ ,c("response")][ 
                                which(dat[ ,c("response")] == 0)])) 
      spec.vec <- c(spec.vec, specificity) 
      sens.vec <- c(sens.vec, sensitivity) 
      ppv <- (sum(c(pred1.all == dat[ ,c("response")])[ 
                    which(dat[ ,c("response")] == 1)]) 
                      / length(pred1.all[which(pred1.all == 1)])) 
      npv <- (sum(c(pred1.all == dat[ ,c("response")])[ 
                    which(dat[ ,c("response")] == 0)]) 
                     / length(pred1.all[which(pred1.all == 0)])) 
      ppv.vec <- c(ppv.vec, ppv) 
      npv.vec <- c(npv.vec, npv) 
 
      for (i in names(ordering)[which(!is.element(names(ordering), selection))]) 
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      { 
      glm2 <- glm(response ~ .,  
                    data = dat[-samp, c("response", selection, i)],  
                    family = "binomial") 
      pred2 <- ifelse(predict(glm2, newdat = dat[samp, -1],  
                        type = "response") < 0.5, 0, 1) 
      mer2 <- sum(abs(pred2 - dat[samp, 1])) / test.sample 
      mer2.mat[j, i] <- mer2 
      } 
      } 
 
      jaccard.mat <- predicted.mer.matrix + true.mer.matrix 
      jaccard.vec <- apply(jaccard.mat, 2, function(x) 
                           {sum(x == 2) / sum(x != 0)}) 
      match.vec <- apply(jaccard.mat, 2, function(x)  
                           {sum(x == 2 | x == 0) / length(x)}) 
 
      mean.mer1 <- mean(mer1.vec) 
      mean.brier <- mean(brier.vec) 
      mean.mer2 <- colMeans(mer2.mat) 
      mer.diff <-  mean.mer1 - min(mean.mer2)[1] 
         
      cat("selection.step:", count, "\n"); utils::flush.console() 
      cat("min.average.MER1:", mean.mer1, "\n"); utils::flush.console() 
      cat("min.average.MER2:", min(mean.mer2)[1], "\n"); utils::flush.console() 
      cat("difference.delta1:", mer.diff, "\n"); utils::flush.console() 
         
      mean.sens <- mean(sens.vec) 
      mean.spec <- mean(spec.vec) 
      mean.ppv <- mean(ppv.vec) 
      mean.npv <- mean(npv.vec) 
 
      cat("genes.selected", selection, "\n"); utils::flush.console() 
 
      comparison2 <- comparison 
 
      var.mer1 <- sum(mer1.vec * (1 - mer1.vec)) / (iterations^2 *  
                                                       test.sample) 
 
 
      var.mer2 <- sum(mer2.mat[, which(mean.mer2 == min(mean.mer2))[1]] * 
                      (1 - mer2.mat[, which(mean.mer2 == min(mean.mer2))[1]])) / 
                      (iterations^2 * test.sample) 
 
      critical.value <-  qsn(1 - alpha.range * 0.001, shape = 4.0398) *  
                               ifelse(var.mer1 == 0 || var.mer2 == 0, 0, 
                                      sqrt(abs(var.mer1 + var.mer2 - 
                                      2 * cor(mer1.vec, mer2.mat[,  
                                      which(mean.mer2 == min(mean.mer2))[1]]) * 
                                      sqrt(var.mer1 * var.mer2)))) 
 
      comparison <- mer.diff <= critical.value 
      criteria <- comparison == comparison2 
 
      if(sum(criteria) != length(criteria)) 
      { 
      filled.before <- sum(!is.na(colSums(final.result))) 
 
      final.result[, which(criteria == F)[which(criteria == F) %in% 
                       which(is.na(colSums(final.result)) == T)]] <-  
                       c(mean.mer1, mean(jaccard.vec, na.rm = T),  
                       mean(match.vec), mean.brier, mean.sens, mean.spec,  
                       mean.ppv, mean.npv, length(selection)) 
      Mer.mat[,          which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Mer.mat)) == T)]] <- mer1.vec 
      Brier.mat[,        which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Brier.mat)) == T)]] <- brier.vec 
      Sens.mat[,         which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Sens.mat)) == T)]] <- sens.vec 
      Spec.mat[,         which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Spec.mat)) == T)]] <- spec.vec 
      ppv.mat[,          which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(ppv.mat)) == T)]] <- ppv.vec 
      npv.mat[,          which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(npv.mat)) == T)]] <- npv.vec 
      jaccard.matrix[,   which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Spec.mat)) == T)]] <- jaccard.vec 
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      match.matrix[,     which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Spec.mat)) == T)]] <- match.vec 
 
      filled.after <- sum(!is.na(colSums(final.result))) 
 
      if (plot.ROC == T && filled.before != filled.after) 
      { 
      if (first == T && filled.before == 0 && filled.after == 1) 
      { 
      pred <- prediction(R.prediction, R.true.values) 
      perf <- performance(pred, "tpr", "fpr" ) 
      plot(perf); abline(a=0, b=1) 
      } 
      if (first == F) 
      { 
      pred <- prediction(R.prediction, R.true.values) 
      perf <- performance(pred, "tpr", "fpr" ) 
      plot(perf, main = paste("alpha-factor:", paste(sort(alpha.range,  
                                decreasing = T)[ 
                                (filled.before + 1):filled.after],  
                                collapse = ", ")), sub = paste("AUC =",  
                                performance(pred, 'auc')@y.values[[1]]),  
                                col = "red"); abline(a=0, b=1) 
      } 
      } 
      } 
      cat("sequential.result.output:", "\n") 
      utils::flush.console() 
      print(final.result) 
                               
      ifelse(sum(comparison) == length(alpha.range), 
               break,  
               selection <- c(selection, names(mean.mer2[ 
                              which(mean.mer2 == min(mean.mer2))])[1])) 
      } 
      cat("\n") 
      return(list("RESULT.MATRIX" = final.result,  
                    "GENE.SELECTED" = selection, 
                    "MER.MAT" = Mer.mat, "BRIER.MAT" = Brier.mat, 
                    "SENS.MAT" = Sens.mat, "SPEC.MAT" = Spec.mat, 
                    "PPV.MAT" = ppv.mat, "NPV.MAT" = npv.mat, 
                    "JACCARD.MAT" = jaccard.matrix,  
                    "MATCH.MAT" = match.matrix, "R.PREDICTION" = R.prediction,  
                    "R.TRUE.VALUES" = R.true.values)) 
      } 
 
      KSS.results <- sequential.selection(dat, ordering, iterations, test.sample, 
                                                       alpha.range, plot.ROC = T, 
                                                       first = F, cells = c(1,1)) 
                                                 
B.2 The R function that performs backward checks on the genes   
selected by k-SS method under B.1.  
############################################################## 
#   dat = Microarray data  
#   genes = genes selected by k-SS method 
#   iterations = Number of cross-validation runs 
#   test.sample = test sample to predict/classify 
#   bootstrap = F (default) which uses MCCV. If set to T, it uses  
     bootstrap cross-validation. 
############################################################## 
 
      back.check <- function(genes, iterations, test.sample, dat, bootstrap = F) 
      { 
      names(dat)[1] <- "response" 
      dat <- as.matrix(dat)     
      dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center = T , scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
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      mer.mat <- matrix(NA, nrow = iterations, ncol = length(genes)+1) 
      colnames(mer.mat) <- c("full.model", genes)   
      names(dat)[1] <- "response" 
      for (j in 1:iterations) 
      { 
      ifelse(bootstrap == F, samp <- sample(1:nrow(dat),  
                                       nrow(dat) - test.sample),  
                                       samp <- sample(1:nrow(dat), replace = T)) 
      glm1 <- glm(response ~ ., data = dat[samp, c("response", genes)],  
                    family = "binomial") 
      pred1 <- ifelse(predict(glm1, newdat = dat[-samp, -1],  
                                type = "response") < 0.5, 0, 1) 
      mer1 <- mean(abs(pred1 - dat[-samp, 1])) 
      mer.mat[j, 1] <- mer1 
 
      for (i in 1:(length(genes))) 
      { 
      glm2 <- glm(response ~ ., data = dat[samp, c("response", genes[-i])],  
                    family = "binomial") 
      pred2 <- ifelse(predict(glm2, newdat = dat[-samp, -1],  
                                type = "response") < 0.5, 0, 1) 
      mer2 <- mean(abs(pred2 - dat[-samp, 1])) 
      mer.mat[j, i + 1] <- mer2 
      } 
      } 
      return(mer.mat) 
      } 
      KSS.backward.checks <- back.check (genes, iterations, test.sample, dat,  
                                         bootstrap = F) 
 
B.3 The R function that implements the proposed AUC 
preliminary feature selection. 
#   This code returns the number and types of the preliminarily selected genes  
     as well as their cross-validated AUC estimates. 
 
############################################################## 
#   dat = Microarray data  
#   alpha = The chosen size alpha for the AUC test 
#   fold = Number of fold chosen for cross-validation 
############################################################## 
 
     library(ROCR) 
      mer.select <- function(dat, alpha, fold) 
      { 
 
      dat <- as.matrix(dat) 
      dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center = T, scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
 
      auc.mat <- matrix(NA, ncol = ncol(dat) - 1, nrow = fold, 
                        dimnames = list(1:fold, names(dat)[-1])) 
 
      groups <- sample(rep(1:fold, len = nrow(dat))) 
      for (k in 1:fold) 
      { 
      repeat 
      { 
      dat2 <- dat[groups == k, ] 
      dat3 <- dat[groups != k, ] 
 
      if(length(unique(dat2[, 1])) != 1 && length(unique(dat3[, 1])) != 1) 
      { 
      for (m in names(dat)[-1]) 
      { 
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      test.dat <- data.frame("response" = dat2[, 1], "x.variable" = dat2[, m]) 
      train.dat <- data.frame("response" = dat3[, 1], "x.variable" = dat3[, m]) 
 
      mod <- glm(response ~ x.variable, data = train.dat, family = "binomial") 
      pred <- predict(mod, newdata = test.dat, type = "response") 
      roc <- prediction(pred, test.dat$response) 
      auc.mat[k, m] <- performance(roc, 'auc')@y.values[[1]] 
      } 
      break 
      } 
      } 
      } 
 
      mean.auc <- colMeans(auc.mat) 
      p.1 <- mean.auc / (2 - mean.auc) 
      p.2 <- 2 * mean.auc^2 / (1 + mean.auc) 
      sigma <- (mean.auc * (1 - mean.auc) + 
           (sum(dat[, 1]) - 1) * (p.1 - mean.auc^2) + 
           (length(dat[, 1]) - sum(dat[, 1]) - 1) * (p.2 - mean.auc^2)) / 
           (sum(dat[, 1]) * (length(dat[, 1]) - sum(dat[, 1]))) 
 
      auc.result <- names(mean.auc)[which(mean.auc >= 0.5 + qnorm(1 - alpha) * 
                                                            sqrt(sigma))] 
      auc.select <- sort(mean.auc[auc.result], decreasing = T) 
      print(length(auc.select)) 
      return(list(auc.select)) 
      } 
       
      AUC.selection <- mer.select(dat, alpha, fold) 
      AUC.selection 
 
 
B.4 The R function that simulates the estimates of the minimum 
mean MER differences ߜመ௝భ ൌ ҧߴመ௠భ,௠మ,…,௠ೕ െ ҧߴመ௠భ,௠మ,…,௠ೕశభ and 
ߜመ௝మ ൌ ҧߴመ௠భ,௠మ,…,௠ೕశభ െ ҧߴመ௠భ,௠మ,…,௠ೕ as used by the k-SS method. 
############################################################## 
#   dat = data to be used 
#   repetitions = Number of cross-validation runs 
#   test.sample = the number of test sample to predict/classify  
#   alpha = the t-statistics' p-value cut-point 
############################################################## 
 
      mer.select <- function(dat, repetitions, test.sample, alpha) 
      { 
 
      t.selection <- function(dat) 
      { 
      t.vec <- c() 
      for (i in 2:ncol(dat)) 
      { 
      t.statistic <- abs(t.test(dat[, i] ~ dat[, 1], var.equal = F)$p.value) 
      t.vec <- c(t.vec, t.statistic) 
      } 
      names(t.vec) <- names(dat[-1]) 
      return(t.vec) 
      } 
     
      t.result <- t.selection(dat) 
      t.result <- t.result[t.result <= alpha] 
      print(sort(t.result, decreasing = F)) 
      dat <- cbind(dat[, 1], dat[, is.element(names(dat), names(t.result))]) 
 
      dat <- as.matrix(dat) 
      dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center = T, scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
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      mer.mat <- matrix(NA, ncol = ncol(dat) - 1, nrow = repetitions, 
                      dimnames = list(1:repetitions, names(dat)[-1])) 
     
      cat("Repetitions done:", "\n"); utils::flush.console() 
      for (i in 1:repetitions) 
      { 
      repeat 
      { 
      samp <- sample(1:nrow(dat), test.sample) 
      dat2 <- dat[samp, ] 
      dat3 <- dat[-samp, ] 
      if(length(unique(dat2[, 1])) != 1 && length(unique(dat3[, 1])) != 1) 
      { 
      for (j in names(dat)[-1]) 
      { 
      test.data <- data.frame("response" = dat2[, 1], "x.variable" = dat2[, j]) 
      train.data <- data.frame("response" = dat3[, 1], "x.variable" = dat3[, j]) 
 
      mod <- glm(response ~ x.variable, dat = train.data, family = "binomial") 
      pred <- predict(mod, newdat = test.data, type = "response") 
      mer.mat[i, j] <- sum(abs(test.data$response -  
                               ifelse(pred < 0.5, 0, 1))) / length(pred) 
      } 
      if (i %in% seq(0, repetitions, round(repetitions/10)))  
      cat(i, "... "); utils::flush.console() 
      break 
      } 
      } 
      } 
      return(list("MER" = mer.mat)) 
      } 
 
      MER.results <- mer.select(dat, repetitions, test.sample, alpha) 
 
      mer <- apply(MER.results$MER, 2, mean) 
      mer.ordering <- sort(mer, decreasing=F) 
      mer.ordering 
 
#   This function returns a matrix of ࢾ෡࢐૚ values whose dimension is [iterations by  
     (mer.ordering - 1)] 
 
############################################################## 
#   dat = Microarray data 
#   ordering = mer.ordering 
#   iterations = Number of ߜመ௝భ to be generated from each gene pair 
#   repetitions = Number of cross-validation run 
############################################################## 
 
      sequential.selection <- function(dat, ordering, iterations, repetitions,  
                                                                 test.sample) 
      { 
      names(dat)[1] <- "response" 
      dat <- dat[, c("response", names(ordering))] 
      dat <- as.matrix(dat) 
      dat <- cbind(dat[, 1], scale((dat)[,2:ncol(dat)], center =T , scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
 
      Mer.mat <- matrix(NA, nrow = iterations, ncol = length(ordering)) 
      colnames(Mer.mat) <- names(ordering) 
       
      cat("Iterations:", "\n") 
 
      for (j in 1:iterations) 
      { 
      selection <- (c(names(ordering)[which(ordering == min(ordering))]))[1] 
      while(length(selection) != (ncol(dat) - 1)) 
      { 
      mer1.vec <- c() 
      mer2.mat <- matrix(NA, nrow = repetitions, 
                           ncol = length(names(ordering)[ 
                           which(!is.element(names(ordering), selection))])) 
      colnames(mer2.mat) <- names(ordering)[ 
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                              which(!is.element(names(ordering), selection))] 
 
      for (k in 1:repetitions) 
      { 
          
      samp <- sample(1:nrow(dat), test.sample) 
      glm1 <- glm(response ~ ., data = dat[-samp, c("response", selection)],  
                                family = "binomial") 
      pred1 <- ifelse(predict(glm1, newdat = dat[samp, -1],  
                                type = "response") < 0.5, 0, 1) 
      mer1 <- sum(abs(pred1 - dat[samp, 1])) / test.sample 
      mer1.vec <- c(mer1.vec, mer1) 
 
      for (i in names(ordering)[which(!is.element(names(ordering), selection))]) 
      { 
      glm2 <- glm(response ~ ., data = dat[-samp, c("response", selection, i)],  
                                family = "binomial") 
      pred2 <- ifelse(predict(glm2, newdat = dat[samp, -1],  
                        type = "response") < 0.5, 0, 1) 
      mer2 <- sum(abs(pred2 - dat[samp, 1])) / test.sample 
      mer2.mat[k, i] <- mer2 
      } 
      } 
      mer1 <- mean(mer1.vec) 
      mer2.vec <- colMeans(mer2.mat) 
      mer.diff <-   mer1 - min(mer2.vec)[1] 
      Mer.mat[j, names(mer2.vec[ 
                         which(mer2.vec == min(mer2.vec))])] <- mer.diff 
      selection <- c(selection, names(mer2.vec[ 
                                       which(mer2.vec == min(mer2.vec))])[1]) 
      } 
      if (j %in% seq(0, iterations, round(iterations / 1)))  
      cat(j, "... "); utils::flush.console() 
      } 
      cat("\n") 
      return(Mer.mat) 
      } 
 
      mini.mean.mer.diffiference <-  sequential.selection(dat, ordering, iterations,  
                                                           repetitions, test.sample) 
                                                            
 
B.5 The R function that implements the k-SS method using the 
new AUC preliminary feature selection under the sub-
sampling technique of Monte-Carlo cross-validation (MCCV). 
#   This function returns preliminary genes selected by newly proposed AUC    
     criteria, and  the Misclassification error rates (MERs) from logistic  
     discriminant (LD) rules for each preliminarily selected genes. 
 
############################################################## 
#   dat = Microarray data 
#   repetitions = Number of cross-validation runs 
#   test.sample = Number of test sample to be predicted/classified  
#   alpha = The chosen size alpha for the AUC test 
#   fold = the number of fold used for cross-validation  
############################################################## 
 
      library(ROCR) 
      mer.select <- function(dat, repetitions, test.sample, alpha, fold) 
      { 
 
      dat <- as.matrix(dat) 
      dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center = T, scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
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      auc.mat <- matrix(NA, ncol = ncol(dat) - 1, nrow = fold, 
                        dimnames = list(1:fold, names(dat)[-1])) 
 
      groups <- sample(rep(1:fold, len = nrow(dat))) 
      for (k in 1:fold) 
      { 
      repeat 
      { 
      dat2 <- dat[groups == k, ] 
      dat3 <- dat[groups != k, ] 
 
      if(length(unique(dat2[, 1])) != 1 && length(unique(dat3[, 1])) != 1) 
      { 
      for (m in names(dat)[-1]) 
      { 
      test.dat <- data.frame("response" = dat2[, 1], "x.variable" = dat2[, m]) 
      train.dat <- data.frame("response" = dat3[, 1], "x.variable" = dat3[, m]) 
 
      mod <- glm(response ~ x.variable, data = train.dat, family = "binomial") 
      pred <- predict(mod, newdata = test.dat, type = "response") 
      roc <- prediction(pred, test.dat$response) 
      auc.mat[k, m] <- performance(roc, 'auc')@y.values[[1]] 
      } 
      break 
      } 
      } 
      } 
 
      mean.auc <- colMeans(auc.mat) 
      p.1 <- mean.auc / (2 - mean.auc) 
      p.2 <- 2 * mean.auc^2 / (1 + mean.auc) 
      sigma <- (mean.auc * (1 - mean.auc) + 
                (sum(dat[, 1]) - 1) * (p.1 - mean.auc^2) + 
                (length(dat[, 1]) - sum(dat[, 1]) - 1) * (p.2 - mean.auc^2)) / 
                (sum(dat[, 1]) * (length(dat[, 1]) - sum(dat[, 1]))) 
 
      auc.result <- names(mean.auc)[which(mean.auc >= 0.5 +  
                                    qnorm(1 - alpha) * sqrt(sigma))] 
       
      cat("preliminary.features.selected:", "\n")  
      print(sort(mean.auc[auc.result], decreasing = T)) 
      utils::flush.console() 
           
      dat <- cbind(dat[, 1], dat[, is.element(names(dat), auc.result)]) 
 
      mer.mat <- matrix(NA, ncol = ncol(dat) - 1, nrow = repetitions, 
                      dimnames = list(1:repetitions, names(dat)[-1])) 
 
      cat("Repetitions done:", "\n"); utils::flush.console() 
       
      for (i in 1:repetitions) 
      { 
      repeat 
      { 
      samp <- sample(1:nrow(dat), test.sample) 
      dat2 <- dat[samp, ] 
      dat3 <- dat[-samp, ] 
      if(length(unique(dat2[, 1])) != 1 && length(unique(dat3[, 1])) != 1) 
      { 
      for (j in names(dat)[-1]) 
      { 
      test.data <- data.frame("response" = dat2[, 1], "x.variable" = dat2[, j]) 
      train.data <- data.frame("response" = dat3[, 1], "x.variable" = dat3[, j]) 
 
      mod <- glm(response ~ x.variable, dat = train.data, family = "binomial") 
      pred <- predict(mod, newdat = test.data, type = "response") 
      mer.mat[i, j] <- sum(abs(test.data$response -  
                           ifelse(pred < 0.5, 0, 1)))/length(pred) 
      } 
      if (i %in% seq(0, repetitions, round(repetitions/10))) cat(i, "... ") 
      break 
      } 
      } 
      } 
      return(list("MER" = mer.mat)) 
      } 
      MER.results <- mer.select(dat, repetitions, test.sample, alpha, fold) 
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      mer <- apply(MER.results$MER, 2, mean) 
      mer.ordering <- sort(mer, decreasing=F) 
      mer.ordering 
 
#   This function returns the k-SS results at each of the gene selection steps  
 
############################################################## 
#   dat = Microarray data 
#   ordering = mer.ordering (from the previous out-put) 
#   iterations = Number of cross-validation runs 
#   test.sample = Test sample to be predicted/classified 
#   alpha.range = sequence of positive integer from 1 to 1000 (or any  
     preferred number) upon which the range of alpha (0,1) is divided 
#   plot.ROC = F (default). If set to T, the plot of ROC curve is  
     provided, otherwise, no ROC curve will be plotted. 
#   first = F (default). If set to T, only the first ROC curve at which 
     the k-SS criteria satisfied will be plotted. 
#   cells = c(0,0), specifies the number of cell space to be created for  
     ROC curve plot. 
 ############################################################## 
 
      library(ROCR) 
      library(sn) 
 
      sequential.selection <- function(dat, ordering, iterations, test.sample,  
                                       alpha.range, plot.ROC = F, first = F,  
                                       cells = c(0,0)) 
      { 
      names(dat)[1] <- "response" 
      dat <- dat[, c("response", names(ordering))] 
      dat <- as.matrix(dat) 
      dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center = T , scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
 
      if(plot.ROC == T && first == F) par(mfrow = cells) 
 
      final.result <- matrix(NA, ncol = length(alpha.range), nrow = 9) 
      Mer.mat <- Brier.mat <- Sens.mat <- Spec.mat <- ppv.mat <- 
      npv.mat <- match.matrix <- jaccard.matrix <-  
      matrix(NA, ncol = length(alpha.range), nrow = iterations) 
         
      colnames(final.result) <- colnames(match.matrix) <- 
      colnames(jaccard.matrix) <- colnames(Mer.mat) <-  
      colnames(Brier.mat) <- colnames(Sens.mat) <- colnames(Spec.mat) <- 
      colnames(ppv.mat) <- colnames(npv.mat) <- alpha.range 
      rownames(final.result) <- c("MER", "Jaccard.Index", "Match.Index",  
                                    "Brier-Score", "Sensitivity",  
                                    "Specificity", "Positive PV",  
                                    "Negative PV", "Number of Genes selected") 
 
 
      selection <- (c(names(ordering)[which(ordering == min(ordering))]))[1] 
      comparison <- rep(FALSE, length(alpha.range)) 
 
      cat("Gene added:", "\n"); utils::flush.console() 
      count <- 0 
 
      while(length(selection) < length(ordering)) 
      { 
      count <- count + 1 
      mer1.vec <- jaccard.vec <- match.vec <- brier.vec <- spec.vec <- 
      sens.vec <- ppv.vec <- npv.vec <- R.prediction <- R.true.values <- c() 
 
      predicted.mer.matrix <- true.mer.matrix <-  
      matrix(NA, ncol = iterations, nrow = test.sample) 
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      mer2.mat <- matrix(NA, nrow = iterations, 
                           ncol = length(names(ordering)[ 
                           which(!is.element(names(ordering), selection))])) 
      colnames(mer2.mat) <- names(ordering)[ 
                              which(!is.element(names(ordering), selection))] 
 
      for (j in 1:iterations) 
      { 
      samp <- sample(1:nrow(dat), test.sample) 
      glm1 <- glm(response ~ ., data = dat[-samp, c("response", selection)],  
                    family = "binomial") 
      pred1 <- ifelse(predict(glm1, newdat = dat[samp, -1],  
                                type = "response") < 0.5, 0, 1) 
      probab <- predict(glm1, newdat = dat[samp, -1], type = "response") 
      mer1 <- sum(abs(pred1 - dat[samp, 1])) / test.sample 
      R.prediction <- c(R.prediction, probab) 
      R.true.values <- c(R.true.values, dat[samp, 1]) 
 
      predicted.mer.matrix[, j] <- pred1 
      true.mer.matrix[, j] <- dat[samp, 1] 
 
      brier.score <- sum((dat[samp, 1] - probab)^2) / test.sample 
      pred1.all <- ifelse(predict(glm1, newdat = dat[ ,-1],  
                                    type = "response") < 0.5, 0, 1) 
      mer1.vec <- c(mer1.vec, mer1) 
 
      brier.vec <- c(brier.vec, brier.score) 
 
 
      sensitivity <- (sum(c(pred1.all == dat[ ,c("response")])[ 
                            which(dat[ ,c("response")] == 1)]) 
                        /length(dat[ ,c("response")][ 
                                which(dat[ ,c("response")] == 1)])) 
      specificity <- (sum(c(pred1.all == dat[ ,c("response")])[ 
                            which(dat[ ,c("response")] == 0)]) 
                        /length(dat[ ,c("response")][ 
                                which(dat[ ,c("response")] == 0)])) 
      spec.vec <- c(spec.vec, specificity) 
      sens.vec <- c(sens.vec, sensitivity) 
      ppv <- (sum(c(pred1.all == dat[ ,c("response")])[ 
                    which(dat[ ,c("response")] == 1)]) 
                      / length(pred1.all[which(pred1.all == 1)])) 
      npv <- (sum(c(pred1.all == dat[ ,c("response")])[ 
                    which(dat[ ,c("response")] == 0)]) 
                     / length(pred1.all[which(pred1.all == 0)])) 
      ppv.vec <- c(ppv.vec, ppv) 
      npv.vec <- c(npv.vec, npv) 
 
      for (i in names(ordering)[which(!is.element(names(ordering), selection))]) 
      { 
      glm2 <- glm(response ~ .,  
                    data = dat[-samp, c("response", selection, i)],  
                    family = "binomial") 
      pred2 <- ifelse(predict(glm2, newdat = dat[samp, -1],  
                        type = "response") < 0.5, 0, 1) 
      mer2 <- sum(abs(pred2 - dat[samp, 1])) / test.sample 
      mer2.mat[j, i] <- mer2 
      } 
      } 
 
      jaccard.mat <- predicted.mer.matrix + true.mer.matrix 
      jaccard.vec <- apply(jaccard.mat, 2, function(x) 
                           {sum(x == 2) / sum(x != 0)}) 
      match.vec <- apply(jaccard.mat, 2, function(x)  
                           {sum(x == 2 | x == 0) / length(x)}) 
 
      mean.mer1 <- mean(mer1.vec) 
      mean.brier <- mean(brier.vec) 
      mean.mer2 <- colMeans(mer2.mat) 
      mer.diff <-  mean.mer1 - min(mean.mer2)[1] 
         
      cat("selection.step:", count, "\n"); utils::flush.console() 
      cat("min.average.MER1:", mean.mer1, "\n"); utils::flush.console() 
      cat("min.average.MER2:", min(mean.mer2)[1], "\n"); utils::flush.console() 
      cat("difference.delta1:", mer.diff, "\n"); utils::flush.console() 
         
      mean.sens <- mean(sens.vec) 
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      mean.spec <- mean(spec.vec) 
      mean.ppv <- mean(ppv.vec) 
      mean.npv <- mean(npv.vec) 
 
      cat("genes.selected", selection, "\n"); utils::flush.console() 
 
      comparison2 <- comparison 
 
      var.mer1 <- sum(mer1.vec * (1 - mer1.vec)) / (iterations^2 *  
                                                       test.sample) 
 
 
      var.mer2 <- sum(mer2.mat[, which(mean.mer2 == min(mean.mer2))[1]] * 
                      (1 - mer2.mat[, which(mean.mer2 == min(mean.mer2))[1]])) / 
                      (iterations^2 * test.sample) 
 
      critical.value <-  qsn(1 - alpha.range * 0.001, shape = 4.0398) *  
                               ifelse(var.mer1 == 0 || var.mer2 == 0, 0, 
                                      sqrt(abs(var.mer1 + var.mer2 - 
                                      2 * cor(mer1.vec, mer2.mat[,  
                                      which(mean.mer2 == min(mean.mer2))[1]]) * 
                                      sqrt(var.mer1 * var.mer2)))) 
 
      comparison <- mer.diff <= critical.value 
      criteria <- comparison == comparison2 
 
      if(sum(criteria) != length(criteria)) 
      { 
      filled.before <- sum(!is.na(colSums(final.result))) 
 
      final.result[, which(criteria == F)[which(criteria == F) %in% 
                       which(is.na(colSums(final.result)) == T)]] <-  
                       c(mean.mer1, mean(jaccard.vec, na.rm = T),  
                       mean(match.vec), mean.brier, mean.sens, mean.spec,  
                       mean.ppv, mean.npv, length(selection)) 
      Mer.mat[,          which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Mer.mat)) == T)]] <- mer1.vec 
      Brier.mat[,        which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Brier.mat)) == T)]] <- brier.vec 
      Sens.mat[,         which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Sens.mat)) == T)]] <- sens.vec 
      Spec.mat[,         which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Spec.mat)) == T)]] <- spec.vec 
      ppv.mat[,          which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(ppv.mat)) == T)]] <- ppv.vec 
      npv.mat[,          which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(npv.mat)) == T)]] <- npv.vec 
      jaccard.matrix[,   which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Spec.mat)) == T)]] <- jaccard.vec 
      match.matrix[,     which(criteria == F)[which(criteria == F) %in% 
                         which(is.na(colSums(Spec.mat)) == T)]] <- match.vec 
 
      filled.after <- sum(!is.na(colSums(final.result))) 
 
      if (plot.ROC == T && filled.before != filled.after) 
      { 
      if (first == T && filled.before == 0 && filled.after == 1) 
      { 
      pred <- prediction(R.prediction, R.true.values) 
      perf <- performance(pred, "tpr", "fpr" ) 
      plot(perf); abline(a=0, b=1) 
      } 
      if (first == F) 
      { 
      pred <- prediction(R.prediction, R.true.values) 
      perf <- performance(pred, "tpr", "fpr" ) 
      plot(perf, main = paste("alpha-factor:", paste(sort(alpha.range,  
                                decreasing = T)[ 
                                (filled.before + 1):filled.after],  
                                collapse = ", ")), sub = paste("AUC =",  
                                performance(pred, 'auc')@y.values[[1]]),  
                                col = "red"); abline(a=0, b=1) 
      } 
      } 
      } 
      cat("sequential.result.output:", "\n") 
      utils::flush.console() 
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      print(final.result) 
                               
      ifelse(sum(comparison) == length(alpha.range), 
               break,  
               selection <- c(selection, names(mean.mer2[ 
                              which(mean.mer2 == min(mean.mer2))])[1])) 
      } 
      cat("\n") 
      return(list("RESULT.MATRIX" = final.result,  
                    "GENE.SELECTED" = selection, 
                    "MER.MAT" = Mer.mat, "BRIER.MAT" = Brier.mat, 
                    "SENS.MAT" = Sens.mat, "SPEC.MAT" = Spec.mat, 
                    "PPV.MAT" = ppv.mat, "NPV.MAT" = npv.mat, 
                    "JACCARD.MAT" = jaccard.matrix,  
                    "MATCH.MAT" = match.matrix, "R.PREDICTION" = R.prediction,  
                    "R.TRUE.VALUES" = R.true.values)) 
      } 
 
      KSS.results <- sequential.selection(dat, ordering, iterations,  
                                                test.sample, alpha.range,  
                                                plot.ROC = T, first = F,  
                                                cells = c(1,1)) 
 
B.6 The R function that implements the k-SS method using 
bootstrap .632+ sub-sampling scheme under the preliminary 
feature selection by the t-statistics. 
#   This function returns preliminary gene selection by the t-statistic, and the  
     Misclassification error rates (MERs) from logistic discriminant (LD) rules for  
     each preliminarily selected genes. 
 
 ############################################################## 
                  #   dat = Microarray data 
#   repetitions = Number of cross-validation runs 
#   alpha = the t-statistics' p-value cut-point 
 ############################################################## 
    
    mer.select <- function(dat, repetitions, alpha) 
    { 
    dat <- as.matrix(dat) 
    dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center = T, scale = T)) 
    dat <- as.data.frame(dat) 
    names(dat)[1] <- "response" 
 
    t.selection <- function(dat) 
    { 
    t.vec <- c() 
    for (i in 2:ncol(dat)) 
    { 
    t.statistic <- abs(t.test(dat[, i] ~ dat[, 1], var.equal = F)$p.value) 
    t.vec <- c(t.vec, t.statistic) 
    } 
    names(t.vec) <- names(dat[-1]) 
    return(t.vec) 
    } 
     
    t.result <- t.selection(dat) 
    t.result <- t.result[t.result <= alpha] 
    cat("preliminary.features.selected", "\n") 
    print(sort(t.result, decreasing = F)) 
    utils::flush.console() 
    dat <- cbind(dat[, 1], dat[, is.element(names(dat), names(t.result))]) 
 
    mer.mat <- matrix(NA, ncol = ncol(dat) - 1, nrow = repetitions, 
                        dimnames = list(1:repetitions, names(dat)[-1])) 
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    cat("Repetitions done:", "\n"); utils::flush.console() 
    for (i in 1:repetitions) 
    { 
    repeat 
    { 
    samp <- sample(1:nrow(dat), replace = T) 
    dat2 <- dat[-samp, ] 
    dat3 <- dat[samp, ] 
    if(length(unique(dat2[, 1])) != 1 && length(unique(dat3[, 1])) != 1) 
    { 
    for (j in names(dat)[-1]) 
    { 
    test.data <- data.frame("response" = dat2[, 1], "x.variable" = dat2[, j]) 
    train.data <- data.frame("response" = dat3[, 1], "x.variable" = dat3[, j]) 
     
    mod <- glm(response ~ x.variable, dat = train.data, family = "binomial") 
    pred <- predict(mod, newdat = test.data, type = "response") 
    mer.mat[i, j] <- 0.632 * sum(abs(test.data$response -  
                                   ifelse(pred < 0.5, 0, 1))) / nrow(dat) + 
                       0.368 * sum(abs(train.data$response -  
                                   ifelse(mod$fitted.values < 0.5, 0, 1))) /  
                                   nrow(dat2) 
    } 
    if (i %in% seq(0, repetitions, round(repetitions/10)))  
    cat(i, "... "); utils::flush.console() 
    break 
    } 
    } 
    } 
    return(list("MER" = mer.mat)) 
    } 
 
    MER.results <- mer.select (dat, repetitions, alpha) 
    mer <- apply(MER.results$MER, 2, mean) 
    mer.ordering <- sort(mer, decreasing=F) 
    mer.ordering 
 
#   This function returns the k-SS results at each of the gene selection steps  
 
############################################################## 
#   dat = Microarray data 
#   ordering = mer.ordering (from the previous out-put) 
#   iterations = Number of cross-validation runs 
#   alpha.range = sequence of positive integer from 1 to 1000 (or any 
     preferred number) upon which the range of alpha (0,1) is 
     divided 
#   plot.ROC = F (default). If set to T, the plot of ROC curve is  
     provided, otherwise, no ROC curve will be plotted. 
#   cells = c(0,0), specifies the number of cell space to be created for 
     ROC curve plot. 
############################################################## 
 
     
      library(ROCR) 
      library(sn) 
      sequential.selection <- function(dat, ordering, iterations, alpha.range,  
                                 plot.ROC = F, cells = c(0,0)) 
      { 
      names(dat)[1] <- "response" 
      dat <- dat[, c("response", names(ordering))] 
      dat <- as.matrix(dat) 
      dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center =T , scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
 
      if(plot.ROC == T) par(mfrow = cells) 
 
      final.result <- matrix(NA, ncol = length(alpha.range), nrow = 2) 
      Mer.mat <- match.matrix  <- matrix(NA, ncol = length(alpha.range),  
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                                           nrow = iterations) 
      colnames(final.result) <- colnames(Mer.mat) <- alpha.range 
 
      rownames(final.result) <- c("MER", "Number of Genes selected") 
 
      selection <- (c(names(ordering)[which(ordering == min(ordering))]))[1] 
      comparison <- rep(FALSE, length(alpha.range)) 
 
      cat("Gene added:", "\n"); utils::flush.console() 
      count <- 0 
     
      while(length(selection) < length(ordering)) 
      { 
      count <- count + 1 
         
      mer1.vec <-  R.prediction <- R.true.values <- 
      mer1.test.vec <- mer1.train.vec <- c() 
         
      mer2.mat <- mer2.test.mat <- mer2.train.mat <-  
                    matrix(NA, nrow = iterations, 
                           ncol = length(names(ordering)[ 
                                  which(!is.element(names(ordering),  
                                                    selection))])) 
      colnames(mer2.mat) <- colnames(mer2.test.mat) <-  
      colnames(mer2.train.mat) <-  
      names(ordering)[which(!is.element(names(ordering), selection))] 
 
      for (j in 1:iterations) 
      { 
      samp <- sample(1:nrow(dat), replace = T) 
      glm1 <- glm(response ~ ., data = dat[samp, c("response", selection)],  
                                family = "binomial") 
      pred1 <- ifelse(predict(glm1, newdat = dat[-samp, -1],  
                                type = "response") < 0.5, 0, 1) 
      probab <- predict(glm1, newdat = dat[-samp, -1], type = "response") 
 
      mer1.test <- mean(abs(pred1 - dat[-samp, 1])) 
      mer1.train <- mean(abs(ifelse(glm1$fitted.values < 0.5, 0, 1) -  
                                                             dat[samp, 1])) 
      mer1 <- 0.632 * mer1.test + 0.368 * mer1.train 
         
      R.prediction <- c(R.prediction, probab) 
      R.true.values <- c(R.true.values, dat[-samp, 1]) 
 
      mer1.vec <- c(mer1.vec, mer1) 
      mer1.test.vec <- c(mer1.test.vec, mer1.test) 
      mer1.train.vec <- c(mer1.train.vec, mer1.train) 
         
      for (i in names(ordering)[which(!is.element(names(ordering), selection))]) 
      { 
      glm2 <- glm(response ~ ., data = dat[samp, c("response", selection, i)],  
                                family = "binomial") 
      pred2 <- ifelse(predict(glm2, newdat = dat[-samp, -1],  
                                type = "response") < 0.5, 0, 1) 
 
      mer2 <- 0.632 * mean(abs(pred2 - dat[-samp, 1])) + 
              0.368 * mean(abs(ifelse(glm2$fitted.values < 0.5, 0, 1) -  
                                                                dat[samp, 1])) 
 
      mer2.mat[j, i] <- mer2 
      mer2.test.mat[j, i] <- mean(abs(pred2 - dat[-samp, 1])) 
      mer2.train.mat[j, i] <- mean(abs( 
                                     ifelse(glm2$fitted.values < 0.5, 0, 1) -  
                                                                dat[samp, 1])) 
      } 
      } 
 
      mean.mer1 <- mean(mer1.vec) 
      mean.mer2 <- colMeans(mer2.mat) 
      mer.diff <-  mean.mer1 - min(mean.mer2)[1] 
        
      cat("selection.step:", count, "\n"); utils::flush.console() 
      cat("min.average.MER1:", mean.mer1, "\n"); utils::flush.console() 
      cat("min.average.MER2:", min(mean.mer2)[1], "\n"); utils::flush.console() 
      cat("difference.delta1:", mer.diff, "\n"); utils::flush.console() 
        
      cat("genes.selected", selection, "\n"); utils::flush.console() 
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      comparison2 <- comparison 
      
      var.mer1 <- .632^2 * (iterations^2 * nrow(dat[-samp, ]))^(-1) *  
                             sum(mer1.test.vec * (1 - mer1.test.vec)) + 
                  .368^2 * (iterations^2 * nrow(dat))^(-1) *  
                             sum(mer1.train.vec * (1 - mer1.train.vec)) 
        
      var.mer2 <- .632^2 * (iterations^2 * nrow(dat[-samp, ]))^(-1) *  
                   sum(mer2.test.mat[, which(mean.mer2 == min(mean.mer2))[1]] * 
                    (1 - mer2.test.mat[, which(mean.mer2 ==  
                                         min(mean.mer2))[1]])) + 
                  .368^2 * (iterations^2 * nrow(dat))^(-1) *  
                  sum(mer2.train.mat[, which(mean.mer2 == min(mean.mer2))[1]] * 
                  (1 - mer2.train.mat[, which(mean.mer2 == min(mean.mer2))[1]])) 
       
      critical.value <-  qsn(1 - alpha.range * 0.001, shape = 4.0398) *  
                              ifelse(var.mer1 == 0 || var.mer2 == 0, 0, 
                                 sqrt(abs(var.mer1 + var.mer2 - 
                                      2 * cor(mer1.vec, mer2.mat[,  
                                      which(mean.mer2 == min(mean.mer2))[1]]) * 
                                      sqrt(var.mer1 * var.mer2)))) 
      comparison <- mer.diff <= critical.value 
      criteria <- comparison == comparison2 
 
      if(sum(criteria) != length(criteria)) 
      {             
      filled.before <- sum(!is.na(colSums(final.result))) 
 
      final.result[, which(criteria == F)[which(criteria == F) %in% 
                     which(is.na(colSums(final.result)) == T)]] <-  
                     c(mean.mer1, length(selection)) 
      Mer.mat[, which(criteria == F)[which(criteria == F) %in% 
                which(is.na(colSums(Mer.mat)) == T)]] <- mer1.vec 
         
      filled.after <- sum(!is.na(colSums(final.result))) 
 
      if (plot.ROC == T && filled.before != filled.after) 
      { 
      pred <- prediction(R.prediction, R.true.values) 
      perf <- performance(pred, "tpr", "fpr" ) 
              plot(perf, main = paste("alpha-factor:", 
                  paste(sort(alpha.range, decreasing = T)[ 
                        (filled.before + 1):filled.after], 
                  collapse = ", ")),  
                  sub = paste("AUC =", performance(pred, 'auc')@y.values[[1]]),  
                  col = "red"); abline(a=0, b=1) 
      } 
      } 
      cat("sequential.result.output:", "\n") 
      utils::flush.console() 
      print(final.result) 
 
      ifelse(sum(comparison) == length(alpha.range), 
              break, selection <- c(selection, names(mean.mer2[ 
                                    which(mean.mer2 == min(mean.mer2))])[1])) 
      } 
      cat("\n") 
      return(list("RESULT.MATRIX" = final.result, "GENE.SELECTED" = selection, 
                   "MER.MAT" = Mer.mat, "R.PREDICTION" = R.prediction,  
                    "R.TRUE.VALUES" = R.true.values)) 
      } 
      KSS.results <- sequential.selection (dat, ordering, iterations, alpha.range,  
                                                     plot.ROC = T, cells = c(0,0)) 
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B.7 The R function that implements the k-SS method using 
bootstrap .632+ sub-sampling scheme under the new AUC 
preliminary feature selection. 
#   This function returns preliminary genes selected by the new AUC feature 
     selection method, and the Misclassification error rates (MERs) from logistic 
     discriminant (LD) rules for each preliminarily selected genes. 
 
 ############################################################## 
                  #   dat = Microarray data 
#   repetitions = Number of cross-validation runs 
#   alpha = The chosen size alpha for the AUC test 
#   fold = Number of fold chosen for cross-validation 
 ############################################################## 
 
      library(ROCR) 
      mer.select <- function(dat, repetitions, alpha, fold) 
      { 
 
      dat <- as.matrix(dat) 
      dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center = T, scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
 
      auc.mat <- matrix(NA, ncol = ncol(dat) - 1, nrow = fold, 
                        dimnames = list(1:fold, names(dat)[-1])) 
 
      groups <- sample(rep(1:fold, len = nrow(dat))) 
      for (k in 1:fold) 
      { 
      repeat 
      { 
      dat2 <- dat[groups == k, ] 
      dat3 <- dat[groups != k, ] 
 
      if(length(unique(dat2[, 1])) != 1 && length(unique(dat3[, 1])) != 1) 
      { 
      for (m in names(dat)[-1]) 
      { 
      test.dat <- data.frame("response" = dat2[, 1], "x.variable" = dat2[, m]) 
      train.dat <- data.frame("response" = dat3[, 1], "x.variable" = dat3[, m]) 
 
      mod <- glm(response ~ x.variable, data = train.dat, family = "binomial") 
      pred <- predict(mod, newdata = test.dat, type = "response") 
      roc <- prediction(pred, test.dat$response) 
      auc.mat[k, m] <- performance(roc, 'auc')@y.values[[1]] 
      } 
      break 
      } 
      } 
      } 
 
      mean.auc <- colMeans(auc.mat) 
      p.1 <- mean.auc / (2 - mean.auc) 
      p.2 <- 2 * mean.auc^2 / (1 + mean.auc) 
      sigma <- (mean.auc * (1 - mean.auc) + 
                (sum(dat[, 1]) - 1) * (p.1 - mean.auc^2) + 
                (length(dat[, 1]) - sum(dat[, 1]) - 1) * (p.2 - mean.auc^2)) / 
                (sum(dat[, 1]) * (length(dat[, 1]) - sum(dat[, 1]))) 
 
      auc.result <- names(mean.auc)[which(mean.auc >= 0.5 +  
                                    qnorm(1 - alpha) * sqrt(sigma))] 
       
      cat("preliminary.features.selected:", "\n")  
      print(sort(mean.auc[auc.result], decreasing = T)) 
      utils::flush.console() 
           
      dat <- cbind(dat[, 1], dat[, is.element(names(dat), auc.result)]) 
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        mer.mat <- matrix(NA, ncol = ncol(dat) - 1, nrow = repetitions, 
                        dimnames = list(1:repetitions, names(dat)[-1])) 
       
      cat("Repetitions done:", "\n"); utils::flush.console() 
      for (i in 1:repetitions) 
      { 
      repeat 
      { 
      samp <- sample(1:nrow(dat), replace = T) 
      dat2 <- dat[-samp, ] 
      dat3 <- dat[samp, ] 
      if(length(unique(dat2[, 1])) != 1 && length(unique(dat3[, 1])) != 1) 
      { 
      for (j in names(dat)[-1]) 
      { 
      test.data <- data.frame("response" = dat2[, 1], "x.variable" = dat2[, j]) 
      train.data <- data.frame("response" = dat3[, 1], "x.variable" = dat3[, j]) 
 
      mod <- glm(response ~ x.variable, dat = train.data, family = "binomial") 
      pred <- predict(mod, newdat = test.data, type = "response") 
      mer.mat[i, j] <- 0.632 * sum(abs(test.data$response -  
                                   ifelse(pred < 0.5, 0, 1))) / nrow(dat) + 
                       0.368 * sum(abs(train.data$response -  
                                   ifelse(mod$fitted.values < 0.5, 0, 1))) /  
                                   nrow(dat2) 
      } 
      if (i %in% seq(0, repetitions, round(repetitions/10)))  
      cat(i, "... "); utils::flush.console() 
      break 
      } 
      } 
      } 
      return(list("MER" = mer.mat)) 
      } 
      MER.results <- mer.select(dat, repetitions, alpha, fold) 
      mer <- apply(MER.results$MER, 2, mean) 
      mer.ordering <- sort(mer, decreasing=F) 
      mer.ordering 
 
#   This function returns the k-SS results at each of the gene selection steps  
############################################################## 
#   data = Microarray data 
#   ordering = mer.ordering (from the previous out-put) 
#   iterations = Number of cross-validation runs 
#   alpha.range = sequence of positive integer from 1 to 1000 (or any 
     preferred number) upon which the range of alpha (0,1) is   
    divided plot.ROC = F (default). If set to T, the plot of ROC curve  
    is provided, otherwise, no ROC curve will be plotted. 
#   cells = c(0,0), specifies the number of cell space to be created for 
     ROC curve plot. 
############################################################## 
 
      library(ROCR) 
      library(sn) 
      sequential.selection <- function(dat, ordering, iterations, alpha.range,  
                                 plot.ROC = F, cells = c(0,0)) 
      { 
      names(dat)[1] <- "response" 
      dat <- dat[, c("response", names(ordering))] 
      dat <- as.matrix(dat) 
      dat <- cbind(dat[,1], scale((dat)[,2:ncol(dat)], center =T , scale = T)) 
      dat <- as.data.frame(dat) 
      names(dat)[1] <- "response" 
 
      if(plot.ROC == T) par(mfrow = cells) 
 
      final.result <- matrix(NA, ncol = length(alpha.range), nrow = 2) 
      Mer.mat <- match.matrix  <- matrix(NA, ncol = length(alpha.range),  
                                           nrow = iterations) 
      colnames(final.result) <- colnames(Mer.mat) <- alpha.range 
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      rownames(final.result) <- c("MER", "Number of Genes selected") 
 
      selection <- (c(names(ordering)[which(ordering == min(ordering))]))[1] 
      comparison <- rep(FALSE, length(alpha.range)) 
 
      cat("Gene added:", "\n"); utils::flush.console() 
      count <- 0 
     
      while(length(selection) < length(ordering)) 
      { 
      count <- count + 1 
         
      mer1.vec <-  R.prediction <- R.true.values <- 
      mer1.test.vec <- mer1.train.vec <- c() 
         
      mer2.mat <- mer2.test.mat <- mer2.train.mat <-  
                    matrix(NA, nrow = iterations, 
                           ncol = length(names(ordering)[ 
                                  which(!is.element(names(ordering),  
                                                    selection))])) 
      colnames(mer2.mat) <- colnames(mer2.test.mat) <-  
      colnames(mer2.train.mat) <-  
      names(ordering)[which(!is.element(names(ordering), selection))] 
 
      for (j in 1:iterations) 
      { 
      samp <- sample(1:nrow(dat), replace = T) 
      glm1 <- glm(response ~ ., data = dat[samp, c("response", selection)],  
                                family = "binomial") 
      pred1 <- ifelse(predict(glm1, newdat = dat[-samp, -1],  
                                type = "response") < 0.5, 0, 1) 
      probab <- predict(glm1, newdat = dat[-samp, -1], type = "response") 
 
      mer1.test <- mean(abs(pred1 - dat[-samp, 1])) 
      mer1.train <- mean(abs(ifelse(glm1$fitted.values < 0.5, 0, 1) -  
                                                             dat[samp, 1])) 
      mer1 <- 0.632 * mer1.test + 0.368 * mer1.train 
         
      R.prediction <- c(R.prediction, probab) 
      R.true.values <- c(R.true.values, dat[-samp, 1]) 
 
      mer1.vec <- c(mer1.vec, mer1) 
      mer1.test.vec <- c(mer1.test.vec, mer1.test) 
      mer1.train.vec <- c(mer1.train.vec, mer1.train) 
         
      for (i in names(ordering)[which(!is.element(names(ordering), selection))]) 
      { 
      glm2 <- glm(response ~ ., data = dat[samp, c("response", selection, i)],  
                                family = "binomial") 
      pred2 <- ifelse(predict(glm2, newdat = dat[-samp, -1],  
                                type = "response") < 0.5, 0, 1) 
 
      mer2 <- 0.632 * mean(abs(pred2 - dat[-samp, 1])) + 
              0.368 * mean(abs(ifelse(glm2$fitted.values < 0.5, 0, 1) -  
                                                                dat[samp, 1])) 
 
      mer2.mat[j, i] <- mer2 
      mer2.test.mat[j, i] <- mean(abs(pred2 - dat[-samp, 1])) 
      mer2.train.mat[j, i] <- mean(abs( 
                                     ifelse(glm2$fitted.values < 0.5, 0, 1) -  
                                                                dat[samp, 1])) 
      } 
      } 
 
      mean.mer1 <- mean(mer1.vec) 
      mean.mer2 <- colMeans(mer2.mat) 
      mer.diff <-  mean.mer1 - min(mean.mer2)[1] 
        
      cat("selection.step:", count, "\n"); utils::flush.console() 
      cat("min.average.MER1:", mean.mer1, "\n"); utils::flush.console() 
      cat("min.average.MER2:", min(mean.mer2)[1], "\n"); utils::flush.console() 
      cat("difference.delta1:", mer.diff, "\n"); utils::flush.console() 
        
      cat("genes.selected", selection, "\n"); utils::flush.console() 
 
      comparison2 <- comparison 
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      var.mer1 <- .632^2 * (iterations^2 * nrow(dat[-samp, ]))^(-1) *  
                             sum(mer1.test.vec * (1 - mer1.test.vec)) + 
                  .368^2 * (iterations^2 * nrow(dat))^(-1) *  
                             sum(mer1.train.vec * (1 - mer1.train.vec)) 
        
      var.mer2 <- .632^2 * (iterations^2 * nrow(dat[-samp, ]))^(-1) *  
                   sum(mer2.test.mat[, which(mean.mer2 == min(mean.mer2))[1]] * 
                    (1 - mer2.test.mat[, which(mean.mer2 ==  
                                         min(mean.mer2))[1]])) + 
                  .368^2 * (iterations^2 * nrow(dat))^(-1) *  
                  sum(mer2.train.mat[, which(mean.mer2 == min(mean.mer2))[1]] * 
                  (1 - mer2.train.mat[, which(mean.mer2 == min(mean.mer2))[1]])) 
       
      critical.value <-  qsn(1 - alpha.range * 0.001, shape = 4.0398) *  
                              ifelse(var.mer1 == 0 || var.mer2 == 0, 0, 
                                 sqrt(abs(var.mer1 + var.mer2 - 
                                      2 * cor(mer1.vec, mer2.mat[,  
                                      which(mean.mer2 == min(mean.mer2))[1]]) * 
                                      sqrt(var.mer1 * var.mer2)))) 
      comparison <- mer.diff <= critical.value 
      criteria <- comparison == comparison2 
 
      if(sum(criteria) != length(criteria)) 
      {             
      filled.before <- sum(!is.na(colSums(final.result))) 
 
      final.result[, which(criteria == F)[which(criteria == F) %in% 
                     which(is.na(colSums(final.result)) == T)]] <-  
                     c(mean.mer1, length(selection)) 
      Mer.mat[, which(criteria == F)[which(criteria == F) %in% 
                which(is.na(colSums(Mer.mat)) == T)]] <- mer1.vec 
         
      filled.after <- sum(!is.na(colSums(final.result))) 
 
      if (plot.ROC == T && filled.before != filled.after) 
      { 
      pred <- prediction(R.prediction, R.true.values) 
      perf <- performance(pred, "tpr", "fpr" ) 
              plot(perf, main = paste("alpha-factor:", 
                  paste(sort(alpha.range, decreasing = T)[ 
                        (filled.before + 1):filled.after], 
                  collapse = ", ")),  
                  sub = paste("AUC =", performance(pred, 'auc')@y.values[[1]]),  
                  col = "red"); abline(a=0, b=1) 
      } 
      } 
      cat("sequential.result.output:", "\n") 
      utils::flush.console() 
      print(final.result) 
 
      ifelse(sum(comparison) == length(alpha.range), 
              break, selection <- c(selection, names(mean.mer2[ 
                                    which(mean.mer2 == min(mean.mer2))])[1])) 
      } 
      cat("\n") 
      return(list("RESULT.MATRIX" = final.result, "GENE.SELECTED" = selection, 
                   "MER.MAT" = Mer.mat, "R.PREDICTION" = R.prediction,  
                    "R.TRUE.VALUES" = R.true.values)) 
      } 
      KSS.results <- sequential.selection (dat, ordering, iterations, alpha.range,  
                                                     plot.ROC = T, cells = c(0,0)) 
      ############################################################## 
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